WorldWideScience

Sample records for abortus inmunidad vacunas

  1. Brucella abortus: inmunidad, vacunas y estrategias de prevención basadas en ácidos nucleicos Brucella abortus: immunity, vaccines and prevention strategies based on nucleic acids

    R Rivers

    2006-01-01

    Full Text Available Brucelosis, enfermedad causada por la bacteria intracelular facultativa Brucella abortus, es una zoonosis ampliamente distribuida a nivel mundial que afecta principalmente al ganado bovino, causando esterilidad en machos y abortos en hembras en gestación. La resistencia depende del desarrollo de una inmunidad mediada por células, con la participación de células T CD4+ de tipo Th1, que secreten interferón gama (-INF, citosina que estimula la actividad bactericida por macrófagos y la actividad citotóxica de linfocitos T CD8+, que son capaces de matar células infectadas con Brucella. Brucella posee como componentes antigénicos importantes el lipopolisacárido (LPS y las proteínas, entre las que se destaca por su demostrada capacidad inmune la superóxido dismutasa (SOD. La prevención de la diseminación de la brucelosis se fundamenta en el desarrollo de vacunas eficientes contra B. abortus, utilizándose cepas atenuadas de Brucella abortus como la cepa 19, cepa 45/20 y la cepa RB51; vacunas subcelulares en base a antígenos que forman parte de la estructura de la bacteria y vacunas basadas en moléculas de ácidos nucleicos, como las vacunas ADN y las vacunas ARN. En la presente revisión se pretende dar una visión actualizada sobre la brucelosis, su patogenia y cuadro clínico. Se hace un análisis de las características genéticas, antigénicas e inmunológicas de Brucella. Luego, una exposición de las vacunas actualmente en uso para su prevención y los estudios con vacunas subcelulares para finalizar con las nuevas tendencias en la generación de vacunas, como las vacunas ADN y ARN para Brucella.Brucellosis, a disease caused by the intracellular facultative bacteria Brucella abortus, is a widely distributed zoonosis throughout the world, affecting mainly cattle and causing sterility in males and abortion in pregnant females. Protection against B. abortus relies on the activation of cellular immunity involving lymphocytes T CD4

  2. Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos

    Ana María Rodríguez

    2010-12-01

    Full Text Available Han pasado casi 30 años de la detección de los primeros casos de infección con HIV-1 y aún no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud pública, especialmente en los países en desarrollo, donde es difícil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habría unos 120 000 infectados. Uno de los desafíos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, además de las 48 formas recombinantes circulantes y más de cien formas recombinantes únicas. La epidemia de HIV en nuestro país es tan compleja como en el resto del mundo, con la co-circulación principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterización de la respuesta inmune y al desarrollo de vacunas, no queda claro cuál es el impacto de la variabilidad en la elección del antígeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra región.

  3. Respuesta inmune humoral y celular a la vacuna Brucella abortus cepa RB51 en vaquillas en pastoreo suplementadas con selenio y α-tocoferol

    V Leyán

    2015-01-01

    Full Text Available Con el objetivo de evaluar el efecto de una suplementación con selenio y α-tocoferol sobre la respuesta inmune a la vacuna Brucella abortus cepa RB51, se emplearon cuatro grupos de seis vaquillas en pastoreo. Tres meses previo al inicio del ensayo, los grupos Se-T y Se fueron suplementados en dosis única con selenato de bario (1 mg selenio/kg peso vivo y los grupos Se-T y T con 500 UI de α-tocoferol/100 kg cada dos meses. El grupo C fue mantenido sin suplementación. Una vez establecidas las diferencias en el balance metabólico en los grupos, el ensayo se inició con la administración de la vacuna RB51. De cada vaquilla se obtuvieron muestras de sangre con heparina y sin aditivo con la finalidad de determinar la actividad sanguínea de glutatión peroxidasa (GPx y las concentraciones plasmáticas de colesterol y α-tocoferol. La respuesta inmune humoral se evaluó mediante ELISA y la respuesta inmune celular mediante una prueba de intradermorreacción a antígenos de B. abortus. Las diferencias entre grupos se evaluaron mediante las pruebas ANDEVA de medidas repetidas, t de muestras pareadas y Kruskal-Wallis. Se consideró significativo cuando el valor de P fue menor a 0,05. La suplementación con selenio y α-tocoferol estableció diferencias entre grupos (P < 0,05. La respuesta inmune humoral y la respuesta celular a la vacuna RB51 fue menor en el grupo T (P < 0,05. Es posible concluir que la respuesta inmune celular y humoral puede ser modulada negativamente por la concentración plasmática de α-tocoferol al momento de la inmunización.

  4. Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos Development of vaccines for HIV-1: Relevance of subtype-specific cellular immunity

    Ana María Rodríguez

    2010-12-01

    Full Text Available Han pasado casi 30 años de la detección de los primeros casos de infección con HIV-1 y aún no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud pública, especialmente en los países en desarrollo, donde es difícil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habría unos 120 000 infectados. Uno de los desafíos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, además de las 48 formas recombinantes circulantes y más de cien formas recombinantes únicas. La epidemia de HIV en nuestro país es tan compleja como en el resto del mundo, con la co-circulación principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterización de la respuesta inmune y al desarrollo de vacunas, no queda claro cuál es el impacto de la variabilidad en la elección del antígeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra región.It has been almost 30 years since the detection of the first HIV-1 cases and yet an effective and safe vaccine has not been developed. Although, advances in antiretroviral therapy (HAART have produced a major impact on the pandemic, and even though HIV/aids remains a major concern for developing countries, where access to therapy is limited. The last report from UNAIDS notified 33 million people living with HIV/aids, worldwide

  5. Suplementación con selenio en vaquillas: Efecto sobre la respuesta inmune a las vacunas Brucella abortus cepa RB51 y toxoide tetánico Selenium suplementation in heifers: Effect on the immune response to Brucella abortus strain RB51 and tetanus toxoid vaccines

    V Leyán; D Pesutic; G Schurig; F. WITTWER; P.A. CONTRERAS; J. KRUZE

    2005-01-01

    El trabajo tiene por objetivo evaluar el efecto de una suplementación con selenio (Se) sobre la respuesta inmune a las vacunas Toxoide tetánico y Brucella abortus cepa RB51 en vaquillas con un adecuado balance metabólico de selenio (GSH-Px >130 U/g Hb). Para ello se empelaron 32 vaquillas Friesian de 18 a 24 meses de edad, asignadas al azar a dos grupos de 16 animales; uno suplementado (Se-S) el día 0 con una dosis de selenato de bario (1 mg Se/kg, s.c.), permaneciendo el otro como control no...

  6. Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos Development of vaccines for HIV-1: Relevance of subtype-specific cellular immunity

    Ana María Rodríguez; Gabriela Turk; María Fernanda Pascutti; Juliana Falivene; María Magdalena Gherardi

    2010-01-01

    Han pasado casi 30 años de la detección de los primeros casos de infección con HIV-1 y aún no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV), el HIV/sida sigue constituyendo un grave problema para la salud pública, especialmente en los países en desarrollo, donde es difícil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus d...

  7. Efecto de una dieta con bajo aporte de selenio sobre la respuesta inmune a la vacuna Brucella abortus Cepa RB51 en vacas lecheras Effect of a low selenium diet on the immune response to Brucella abortus strain RB51 vaccine in dairy cows

    V Leyán

    2006-01-01

    Full Text Available Se estudió el efecto de una dieta con bajo aporte de selenio (Se sobre la respuesta inmune a la vacuna Brucella abortus Cepa RB51 y la concentración de inmunoglobulinas séricas en vacas. Se utilizaron 12 vacas Friesian, estabuladas desde aproximadamente dos meses preparto y hasta el cuarto mes de lactancia mantenidas con una dieta basada en heno de pradera con bajo contenido de Se (0,02 ppm de MS y balanceada según requerimientos para el resto de nutrientes. Seis vacas conformaron el grupo de animales con bajo aporte de Se (Se-D y otras seis el grupo de animales suplementados (Se-S con selenato de bario (1 mg de Se/kg , 45 días previos al parto. Los animales fueron inmunizados con la vacuna RB51 al cuarto mes del experimento. Muestras de sangre fueron obtenidas previo a la suplementación con Se y cada 15 días hasta el término del experimento. El balance de Se fue medido mediante la actividad sanguínea de GSH-Px. Las concentraciones séricas de IgG, IgM e IgA se determinaron por inmunodifusión y los anticuerpos específicos contra Brucella abortus mediante ELISA y la respuesta inmune celular mediante pruebas de intradermorreacción a antígenos de Brucella abortus y estudio histológico de la reacción. La dieta con bajo contenido de Se provocó una disminución lenta y progresiva de la actividad de GSH-Px (The effect of a diet with a low selenium (Se content on the immune response to Brucella abortus Strain RB51 vaccine in dairy cows and in their serum inmunoglobulin concentrations was studied. Twelve pregnant Friesian cows (7 to 8 months were randomly allocated into two homogeneous groups of six animals each. Animals were maintained during 6 months in individual cubicles with water ad libitum and a diet based on grass hay with a low Se content (0.02 ppm base on dry matter and nutritionally balanced for other nutrients. One group was maintained only with the low Se diet (Se-D and the other group (Se-S was treated with barium selenate

  8. Suplementación con selenio en vaquillas: Efecto sobre la respuesta inmune a las vacunas Brucella abortus cepa RB51 y toxoide tetánico Selenium suplementation in heifers: Effect on the immune response to Brucella abortus strain RB51 and tetanus toxoid vaccines

    V Leyán

    2005-01-01

    Full Text Available El trabajo tiene por objetivo evaluar el efecto de una suplementación con selenio (Se sobre la respuesta inmune a las vacunas Toxoide tetánico y Brucella abortus cepa RB51 en vaquillas con un adecuado balance metabólico de selenio (GSH-Px >130 U/g Hb. Para ello se empelaron 32 vaquillas Friesian de 18 a 24 meses de edad, asignadas al azar a dos grupos de 16 animales; uno suplementado (Se-S el día 0 con una dosis de selenato de bario (1 mg Se/kg, s.c., permaneciendo el otro como control no suplementado (No-S. Todas las vaquillas fueron mantenidas durante 9 meses (abril a enero a pastoreo sobre una pradera naturalizada con un contenido de Se de 0,04 ppm/MS. Los animales fueron inmunizados con vacuna RB51 el día 60 y posteriormente con Toxoide tetánico los días 120 y 150. Muestras de sangre fueron obtenidas previo a la suplementación y cada 15 días hasta el término del experimento. El balance metabólico de selenio fue evaluado mediante la actividad sanguínea de Glutatión peroxidasa (GSH-Px. La respuesta inmune humoral se evaluó determinando los anticuerpos séricos específicos para ambos antígenos mediante ELISA y la respuesta inmune celular mediante pruebas de intradermorreacción a antígenos de Brucella abortus. La administración de Se aumentó (P 0,05 en ambos grupos experimentales, mientras que la respuesta celular a la vacuna RB51 fue menor (P The effect of selenium (Se supplementation on the immune response to tetanus toxoid and Brucella abortus strain RB51 vaccines was studied in heifers with a normal Se status (GSH-Px activity > 130 U/g Hb. Frisian heifers (n-32, 18 to 24 months old were randomly allocated into two groups of 16 animals each. Animals from one group were supplemented (Se-S with one dose of barium selenate (1 mg/Se/kg. s.c. on day 0; animals from the other group remained as a control without supplementation (No-S. The heifers grazed during 9 months (April to January a pasture that contained 0.04 ppm/DM of Se

  9. La inmunidad antituberculosa y su aplicación en el desarrollo de candidatos vacunales

    María de los Ángeles García

    2009-04-01

    Full Text Available La incidencia de la tuberculosis ha alcanzado proporciones alarmantes. BCG, única vacuna disponible para su prevención en humanos, ha sido ineficiente, comprobado en varias pruebas de campo. Por ello es imperiosa la necesidad de lograr nuevas vacunas contra la tuberculosis. Una mejor comprensión de la respuesta inmune inducida durante la infección por Mycobacyterium tuberculosis pudiera ayudar a obtener en relativo corto tiempo la vacuna deseada contra este microorganismo. El objetivo de la presente revisión es mostrar una panorámica general acerca del ciclo de infección de Mycobacterium tuberculosis, las principales células efectoras que participan en la inmunidad antituberculosa y las estrategias fundamentales para el desarrollo de vacunas contra esta enfermedad.

  10. Identificación de la cepa vacunal Brucella abortus S19 en muestras de leche de vaca

    Luary Carolina Martínez Chavarría; Antonio Verdugo Rodríguez; Rigoberto Hernández Castro

    2006-01-01

    La brucelosis es una enfermedad infectocontagiosa de origen bacteriano que afecta tanto al humano como a diferentes especies animales domésticas y silvestres. En la década pasada, la vacuna que se usaba ampliamente en los bovinos era la cepa vacunal B. abortus S19, que tiene una deleción en dos de los genes del operón ery que participa en el catabolismo del eritritol. En México, desde 1997 se aprobó la cepa B. abortus RB51 como vacuna para el ganado. Esta cepa presenta una secuencia de inserc...

  11. Medición de respuesta inmune humoral y celular frente a antígenos de Brucella abortus RB51 en bovinos (Evaluation of) Humoral and cellular immune response evaluation against Brucella abortus strain RB51 antigens in bovine

    N.I. Montaña S.; O.E. Rueda L.; C.P. Calderon P.; Ortega, A.; A .R. Puentes; M.I. Gallego M.; O.C. Mariño J.

    1998-01-01

    Con el objeto de evaluar comparativamente el tipo de respuesta inmune inducido por los antígenos estructurales purificados y vacunas vivas de Brucella abortus, 14 bovinos criollos hembras de 19 meses de edad fueron distribuidos al azar, en cinco grupos experimentales e inmunizados vía subcutánea de la siguiente manera: OMP-II (proteínas de membrana externa), OMP-II-Cadena-O, OMP II acoplado a polisacárido-O, B. abortus cepa RB51, B. abortus cepa 19 (C19) y solución salina para el grupo contro...

  12. Inmunidad frente a infecciones: bacterias, virus, hongos y parásitos

    Sen Fernández, María Luz de la; Sempere Ortells, José Miguel; Marco de la Calle, Francisco Manuel; Vázquez Araujo, Begoña

    2012-01-01

    Respuesta inmune frente a la infección: Bacterias extracelulares, bacterias intracelulares, hongos, virus, parásitos. Inmunidad innata, inmunidad adaptativa, mecanismos de evasión, consecuencias perjudiciales de la respuesta inmune.

  13. Perspectivas para el desarrollo de vacunas e inmunoterapia contra cáncer cervicouterino

    GUZMÁN-ROJAS LILIANA

    1998-01-01

    Full Text Available El cáncer cervicouterino representa un grave problema de salud pública, debido a la asociación de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este patógeno, mediante vacunas, que podrían ser de gran utilidad para el control de la progresión de la enfermedad. El estudio tanto de la inmunología humoral como celular ha servido para el desarrollo de vacunas. Así, la utilización de partículas virales sintéticas para el estudio de anticuerpos neutralizantes y el uso de proteínas tempranas virales, entre otras, para la inducción de inmunidad mediada por células, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infección celular tanto hacia células infectadas no transformadas como hacia células transformadas viralmente con resultados favorables.

  14. Vacuna fenol-insoluble contra la brucelosis humana: evaluacion del poder inmunogenico en cobayos Phenol insoluble extract vaccine for the prevention of brucellosis in humans: evaluation in guinea pigs

    J. Bolpe

    1991-02-01

    Full Text Available Se examinó una vacuna diseñada para inmunizar al hombre, preparada con extracto de fenol insoluble, para determinar si protegía a cobayos contra el desafío con la cepa virulenta B. abortus 2308. Se incluyeron en el experimento las vacunas vivas atenuadas B. abortus cepa 19 y B. melitensis Rev. 1, para comparar los resultados. Se vacunaron 93 animales en cada grupo, que fueron subdivididos en subgrupos de 31 y se los desafió con 10(4, 10³ y 10² unidades formadoras de colonias de la cepa B. abortus 2308 virulenta. El análisis global de los resultados demostró una protección del 11.9% en animales vacunados con el extracto de fenol insoluble, 65% en los vacunados con B. abortus cepa 19 y 95% en el grupo que recibió vacuna B. melitensis Rev. 1.A phenol insoluble extract vaccine proposed to immunize men against brucellosis was tested for its ability in protecting guinea pigs against challenge with virulent Brucella abortus strain 2308. Living attenuated Brucella abortus strain 19 and B. melitensis Rev. 1 were included in the experiment for comparison. Ninety three animals were vaccinated in each group and subdivided in subgroups of 31 for challenge with 10(4,10³ and 10² colony forming units of virulent B. abortus 2308. A global analysis of the results showed protection of 11.9%, 65% and 95% in animals vaccinated with phenol insoluble extract, strain 19 and Rev. 1, respectively.

  15. Vacuna contra el VPH (HPV Vaccine)

    2013-07-25

    Desde el 2006, hay una vacuna que protege contra los tipos de VPH que causan cáncer con mayor frecuencia. Este podcast habla sobre la importancia de que los padres hablen con los proveedores de atención médica de sus hijos sobre ponerles la vacuna contra el VPH.  Created: 7/25/2013 by MMWR.   Date Released: 11/4/2013.

  16. Evaluación De la inmunidad contra el tétanos y la difteria en trabajadores del Instituto Finlay ocupacionalmente expuestos a riesgos

    Rolando Fernández

    2004-12-01

    Full Text Available El Instituto Finlay es un centro rector en la producción e investigación de vacunas, en él laboran técnicos e investigadores encargados del desarrollo y la producción de la vacuna múltiple DPT, los cuales, al estar en contacto directo con los microorganismos necesarios para su producción, constituyen un personal con riesgo de contraer una de estas enfermedades infecciosas. Es importante disponer de vacunas eficaces que minimicen los riesgos por la exposición a agentes biológicos patógenos durante el trabajo, las cuales deben ser aplicadas siguiendo un esquema de inmunización que garanticen una adecuada protección. Debido a la carencia en nuestro país de datos sobre el estado de inmunidad de trabajadores expuestos laboralmente contra estas enfermedades y dada la importancia de esta información para la aplicación de un esquema de inmunización que cumpla con un criterio real de protección, nos propusimos realizar este trabajo. Para el desarrollo del mismo se suministró una dosis de refuerzo de una vacuna combinada de toxoide tetánico y diftérico a un grupo de trabajadores expuestos; los títulos fueron determinados antes y después de la vacunación por métodos inmunoenzimáticos. La mayor parte de los trabajadores presentaban al inicio del estudio un nivel adecuado de antitoxina tetánica, sin embargo se demostró una inadecuada protección para el caso de la difteria antes de la inmunización, por otra parte el empleo de una dosis de DT no parece que sea suficiente para inducir una respuesta antidiftérica duradera, por lo que se propuso modificar el esquema actual de vacunación de los trabajadores.

  17. Autismo y vacunas pediátricas

    Alejandro Roque Valdés

    2004-04-01

    Full Text Available El presente trabajo es un artículo de revisión que pretende abordar un tema tan controvertido como actual: la posible asociación causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la última década del siglo XX se producen una serie de cambios en la clasificación, nomenclatura y criterios diagnósticos del autismo. Los hallazgos de estudios epidemiológicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo son en la actualidad muy superiores a las de hace 15 años. Entre los factores que se esgrimen para explicar este fenómeno están las vacunas, y entre los mecanismos que se invocan para tratar de inculpar a las vacunas en la etiología del autismo están el exceso de mercurio derivado del tiomersal que se emplea como conservante de las mismas y procesos autoinmunes que de forma directa o indirectamente actúan sobre el SNC, induciendo lesiones a nivel de la mucosa intestinal, lo cual favorecerá la absorción de macromoléculas, antígenos y toxinas que una vez en el torrente sanguíneo llegarían al SNC produciendo allí las lesiones responsables de la génesis del autismo.

  18. PREVALENCIA DE FALLA EN LA TRANSFERENCIA DE INMUNIDAD PASIVA EN TERNERAS DE LECHERÍA

    Juan Jos\\u00E9 Arroyo-Arroyo

    2014-01-01

    Full Text Available Prevalencia de falla en la transferencia de inmunidad pasiva en terneras de lechería. El objetivo del presente estudio fue determinar por tercer año consecutivo, la falla en la transferencia de inmunidad pasiva en terneras de lechería en la Región Huetar Norte de Costa Rica. Los datos presentados corresponden a determinaciones de la concentración de proteína sérica total (PST obtenidos durante el periodo comprendido entre agosto y noviembre del 2012, en veintitrés fincas lecheras. Fueron evaluadas 657 terneras. Las razas de las vacas se clasificaron en Holstein, Jersey, cruce Holstein × Jersey y otras. Para fines del presente estudio, se consideró una falla en la adquisición de inmunidad pasiva cuando la concentración de PST fue menor a 5,5 g/dl. La concentración de PST varió entre 2,4 y 10,0 g/dl, con un promedio general de 5,7 g/dl. De todos los animales evaluados un 44,9% presentaron falla en la transferencia de inmunidad pasiva. Los animales provenientes de la raza Jersey y del cruce Holstein × Jersey, obtuvieron una concentración significativamente mayor a los de la raza Holstein y otras razas. Al considerar el número de parto de la madre, no se encontraron diferencias significativas en la concentración de PST de las crías. Sin embargo, las crías de vacas de tercer parto presentaron la menor proporción de terneras con niveles inadecuados de inmunidad. Es necesario establecer prácticas de manejo del calostro que permitan minimizar el riesgo de terneras con una transferencia de inmunidad pasiva inadecuada en hatos lecheros de la región Huetar Norte de Costa Rica.

  19. Autismo y vacunas pediátricas

    Alejandro Roque Valdés

    2004-01-01

    El presente trabajo es un artículo de revisión que pretende abordar un tema tan controvertido como actual: la posible asociación causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la última década del siglo XX se producen una serie de cambios en la clasificación, nomenclatura y criterios diagnósticos del autismo. Los hallazgos de estudios epidemiológicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo s...

  20. Prevalencia de falla en la transferencia de inmunidad pasiva en terneras de lechería.

    Juan José Aroyo-Arroyo

    2014-08-01

    Full Text Available El objetivo del presente estudio fue determinar por tercer año consecutivo, la falla en la transferencia de inmunidad pasiva en terneras de lechería en la Región Huetar Norte de Costa Rica. Los datos presentados corresponden a determinaciones de la concentración de proteína sérica total (PST obtenidos durante el periodo comprendido entre agosto y noviembre del 2012, en veintitrés fincas lecheras. Fueron evaluadas 657 terneras. Las razas de las vacas se clasificaron en Holstein, Jersey, cruce Holstein × Jersey y otras. Para fines del presente estudio, se consideró una falla en la adquisición de inmunidad pasiva cuando la concentración de PST fue menor a 5,5 g/dl. La concentración de PST varió entre 2,4 y 10,0 g/dl, con un promedio general de 5,7 g/dl. De todos los animales evaluados un 44,9% presentaron falla en la transferencia de inmunidad pasiva. Los animales provenientes de la raza Jersey y del cruce Holstein × Jersey, obtuvieron una concentración significativamente mayor a los de la raza Holstein y otras razas. Al considerar el número de parto de la madre, no se encontraron diferencias significativas en la concentración de PST de las crías. Sin embargo, las crías de vacas de tercer parto presentaron la menor proporción de terneras con niveles inadecuados de inmunidad. Es necesario establecer prácticas de manejo del calostro que permitan minimizar el riesgo de terneras con una transferencia de inmunidad pasiva inadecuada en hatos lecheros de la región Huetar Norte de Costa Rica.

  1. Estudio de la inmunidad y reactividad cruzada entre Fasciola hepatica y Schistosoma bovis

    Rojas-González, J.; Rodríguez, M.; Ramajo Martín, Vicente; Gómez, V.; Manga-González, M. Yolanda; González Lanza, Camino

    1991-01-01

    Los objetivos del presente trabajo han sido los siguientes: a) determinación de la existencia de inmunidad cruzada entre F.hepática y S.bovis, b) estudio cualitativo de la reactividad (antígenos y anticuerpos circulantes) entre ambos helmintos mediante ELISA y c) determinación de los antígenos responsables de la reactividad cruzada mediante «western blot»...

  2. Vacunas contra el VIH, Papilomavirus, Rotavirus, Virus Respiratorio Sincitial. Futuro de las vacunas

    Farjas Abadía, Mª Pilar

    2005-01-01

    El desarrollo de la vacunología desde el descubrimiento de Jenner de la capacidad de prevenir la viruela mediante la inoculación del virus de la vacuna, ha permitido erradicar la viruela y controlar enfermedades como la difteria, el tétanos, el sarampión, la tos ferina y la parotiditis entre otras, siendo una de las causas del espectacular aumento en la esperanza de vida de las últimas décadas. El desarrollo de la biotecnología e ingeniería genética está permitiendo el estudio de nuevas vacun...

  3. Perspectivas para el desarrollo de vacunas e inmunoterapia contra cáncer cervicouterino Perspectives for vaccines and immunotherapy against cervical cancer

    LILIANA GUZMÁN-ROJAS

    1998-01-01

    Full Text Available El cáncer cervicouterino representa un grave problema de salud pública, debido a la asociación de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este patógeno, mediante vacunas, que podrían ser de gran utilidad para el control de la progresión de la enfermedad. El estudio tanto de la inmunología humoral como celular ha servido para el desarrollo de vacunas. Así, la utilización de partículas virales sintéticas para el estudio de anticuerpos neutralizantes y el uso de proteínas tempranas virales, entre otras, para la inducción de inmunidad mediada por células, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infección celular tanto hacia células infectadas no transformadas como hacia células transformadas viralmente con resultados favorables.Cervical cancer represents a severe public health problem and has been associated to the presence of human papillomavirus. Strategies are presently being tested which target the virus to attempt to control disease progress. Studies on the humoral and cell-mediated immunity of the papillomavirus infection have been useful in the development of a vaccine. Synthetic virus-like particles have been validated as vaccine against several animal papillomaviruses and used to map the seroepidemiology of the human papillomavirus infection, and define neutralizing antibodies. Induction of cell-mediated immunity to HPV early proteins is bound to become a therapeutic approach to HPV infections. Recent advances have centered on directing the immune response to prevent infection, to virus-infected cells and to virally transformed cells, with favourable results.

  4. Vacunas en situaciones especiales. Embarazo, inmunodepresión, transplante

    Farjas Abadía, Mª Pilar; Zubizarreta Alberdi, Raquel; Louro González, Arturo

    2005-01-01

    En las recomendaciones de vacunación de grupos de población que por su situación de salud requieren medidas específicas deben conjugarse: Las limitaciones en la aplicación de determinadas vacunas por la mayor probabilidad de efectos secundarios en estos pacientes (por ejemplo la aplicación de vacunas de virus vivos en pacientes inmunodeprimidos). El mayor riesgo de infección frente a determinados agentes que genera la patología o situación inmunitaria del paciente, y que determina un mayor in...

  5. Papel de Fast (Fas-activated serine/threomine phosphoprotein) en la inmunidad innata

    Antolín Simón, Eva María

    2012-01-01

    La identificación de genes importantes en la respuesta inmune innata mejorará nuestro conocimiento de la respuesta de defensa del huésped frente a las bacterias. Las células clave en la inmunidad innata son los fagocitos entre los que se incluyen los macrófagos y la fagocitosis es uno de los principales mecanismos de eliminación de las bacterias extracelulares Gram positivas y Gram negativas que producen enfermedad. FAST (Fas-activated serine/threonine phosphoprotein) es una proteína mult...

  6. Las vacunas nos protegen (Vaccines Help Protect Us)

    2013-04-23

    En este podcast, los niños de Kidtastics hablan sobre la importancia de las vacunas y cómo funcionan.  Created: 4/23/2013 by Centers for Disease Control and Prevention (CDC).   Date Released: 12/11/2013.

  7. Genotipos de aislados de campo de Brucella abortus de distintas regiones geográficas de Chile Genotypes of Brucella abortus field isolates from different geographical regions of Chile

    M Mancilla

    2008-01-01

    Full Text Available La brucelosis bovina es una enfermedad zoonótica, endémica de alto impacto económico. La identificación genética de las cepas prevalentes de Brucella abortus, el patógeno, es clave para establecer estrategias epidemiológicas de control de la enfermedad. La secuencia de inserción IS711 ha sido utilizada como un marcador genético para diferenciar entre especies de Brucella, miembros de una misma especie y dentro de un mismo biovar. Hemos analizado los perfiles de IS711-RFLP de 46 aislados de B. abortus, recolectados durante el periodo 1997-2005, provenientes de 16 áreas geográficas diferentes de Chile. Todos los aislados fueron previamente identificados como B. abortus biovar 1, utilizando las técnicas convencionales. De estos, el 87% compartieron el mismo perfil de IS711-RFLP, mientras que el 8,7% correspondió al patrón de la cepa vacuna RB51. En este trabajo se informa el hallazgo de dos cepas indistinguibles por PCR AMOS con perfiles nuevos de IS711-RFLP, no reportados previamente.Bovine brucellosis is an endemic, zoonotic disease of high economic impact. The genetic identification of the prevalent Brucella abortus strains, the pathogen, is key to pursue further epidemiological strategies for disease control. The insertion sequence IS711 has been used as genetic marker to differentiate among Brucella species, members of the same specie and within the same biovar. We have analyzed the IS711-RFLP pattern for 46 B. abortus isolates, collected during the period of 1997-2005 from 16 different geographical areas of Chile. All isolates were previously identified by conventional techniques as B. abortus biovar 1. Of these, 87% sharedthesame IS711 DNA profile, while an 8.7 % corresponded to the pattern of RB51 vaccine strain. We report the finding of two new strains, not differentiated by AMOS PCR, which showed unreported patterns of IS711-RFLP.

  8. Vacunas, biotecnología y su relación con el aborto provocado

    José Luis Redondo Calderón

    2008-01-01

    Las vacunas de células diploides humanas (WI-38, MRC-5) tienen un origen éticamente objetable, dado que dichas células proceden de abortos provocados. Entre ellas destacan vacunas empleadas contra rubéola, sarampión, parotiditis, rabia, poliomielitis, viruela, hepatitis A, varicela y herpes zóster. Actualmente se encuentran en desarrollo otras vacunas cultivadas en células (293, PER.C6) transformadas mediante virus, procedentes de abortos. Entre ellas hay vacunas contra la grip...

  9. Vigilancia de eventos adversos a vacunas: Adverse events surveillance Vaccines

    Katia Abarca V

    2007-02-01

    Full Text Available El propósito de los sistemas de vigilancia de eventos adversos a vacunas es monitorizar aquellos temporalmente relacionados con las vacunaciones, para evaluar su causalidad y para describir eventos acaecidos luego de la introducción de nuevas vacunas. El fin último de estos sistemas es proporcionar a la población el mejor estándar de seguridad relativo a vacunas. El sistema de vigilancia puede ser pasivo (reportes espontáneos o activo (seguimiento activo de los vacunados; la mayoría en ejercicio es pasiva. Este artículo presenta un resumen abreviado de los sistemas de vigilancia de eventos adversos a vacunas más conocidos, incluyendo los sistema empleados en los Estados Unidos de América (Vaccine Adverse Events Report System-VAERS, Canadá y Europa, como así también una referencia al sistema chileno, destacando las principales ventajas y limitaciones en cada casoThe objective of the surveillance systems of vaccine adverse events is monitoring events temporally related to vaccination, to evaluate their causality with the vaccine and to detect events after the introduction of new vaccines. The ultimate goal of these systems is to provide the population with the best safety standard of the vaccines. The surveillance system can be passive (spontaneous reports or active (active follow up of vaccinees; the majority of them are passive. The article gives a brief review of the most known vaccine adverse events surveillance systems, including the American Vaccine Adverse Events Report System (VAERS, the Canadian and European systems, a commentary about the Chilean one, highlighting its main advantages and also its limitations

  10. En busca de una vacuna anti-malárica

    Edith Suzarte Portal

    2009-01-01

    Full Text Available El desarrollo e implementación de una vacuna contra la malaria representa una necesidad médica urgente para la población que habita las regiones donde ella es endémica. En los últimos años, se han visto progresos significativos en el desarrollo de vacunas, con numerosos candidatos iniciando evaluación en ensayos clínicos. A pesar del optimismo y algunos resultados prometedores, hasta el momento no se cuenta con una vacuna efectiva, en parte, por la falta de conocimiento del tipo de respuesta inmune necesaria para la protección. A esto, se adiciona la dificultad de identificar, seleccionar y producir los antígenos protectores del parásito que posee más de 5 000 genes y un ciclo de vida complejo. Por otra parte, el gran polimorfismo de los antígenos de Plasmodium y los diferentes mecanismos que utiliza para evadir la respuesta inmune hacen necesario aumentar la inmunogenicidad de los antígenos purificados, a través del uso de nuevos adyuvantes o sistemas de liberación. El reto no es meramente científico, se necesita involucrar investigadores competentes, lograr colaboración entre academias, industrias y agencias financiadoras y comprometimiento político. Actualmente, se ensayan diferentes estrategias dirigidas hacia los distintos estadios del parásito. En este manuscrito se destacan algunas de las más avanzadas, otras aún en fase preclínica y algunos fracasos, todas dirigidas contra P. falciparum, así como los principales retos a vencer en la búsqueda de una vacuna anti-malárica efectiva.

  11. Medición de respuesta inmune humoral y celular frente a antígenos de Brucella abortus RB51 en bovinos (Evaluation of Humoral and cellular immune response evaluation against Brucella abortus strain RB51 antigens in bovine

    N.I. Montaña S.

    1998-01-01

    Full Text Available Con el objeto de evaluar comparativamente el tipo de respuesta inmune inducido por los antígenos estructurales purificados y vacunas vivas de Brucella abortus, 14 bovinos criollos hembras de 19 meses de edad fueron distribuidos al azar, en cinco grupos experimentales e inmunizados vía subcutánea de la siguiente manera: OMP-II (proteínas de membrana externa, OMP-II-Cadena-O, OMP II acoplado a polisacárido-O, B. abortus cepa RB51, B. abortus cepa 19 (C19 y solución salina para el grupo control. Dos meses posinmunización, los animales fueron desafiados, vía intramuscular, con cepa patógena de referencia B. abortus 2308 y evaluados en su nivel de protección 30 días posdesafío. La respuesta inmune humoral específica fue determinada mediante las pruebas convencionales, de aglutinación Rosa de Bengala, fijación de complemento, inmunodifusión radial, ELISA indirecta, a los 8, 15, 30, 60 y 90 días posinmunización. Adicionalmente se determinó la subclase de IgG por ELISA tipo doble sandwich. La evaluación de respuesta celular fue determinada mediante linfoproliferación, expresada en índices de estimulación (IS, obtenidos por los niveles de incorporación de 3H timidina, medición de Interferón gamma (IFN-g, igualmente expresado como IS y cuantificación de subpoblaciones linfoides CD4+ y CD8+ por citofluorometría. Animales vacunados con cepas vivas demostraron protección total al reto, mientras se observó un 66% de protección en los vacunados con antígenos purificados. Se observó ausencia de anticuerpos a lipopolisacárido, sLPS, por las pruebas convencionales para B. abortus en todos los grupos inmunizados, excepto el vacunado con cepa 19, confirmando la ventaja diagnóstica de la utilización de la cepa RB51 o sus antígenos purificados. La linfoproliferación como una de las medidas de respuesta celular no demostró IS significativos (p0.05 frente a los antígenos estructurales purificados, OMP-II, Cadena-O y sLPS en

  12. Recent advances in Brucella abortus vaccines.

    Dorneles, Elaine M S; Sriranganathan, Nammalwar; Lage, Andrey P

    2015-01-01

    Brucella abortus vaccines play a central role in bovine brucellosis control/eradication programs and have been successfully used worldwide for decades. Strain 19 and RB51 are the approved B. abortus vaccines strains most commonly used to protect cattle against infection and abortion. However, due to some drawbacks shown by these vaccines much effort has been undertaken for the development of new vaccines, safer and more effective, that could also be used in other susceptible species of animals. In this paper, we present a review of the main aspects of the vaccines that have been used in the brucellosis control over the years and the current research advances in the development of new B. abortus vaccines. PMID:26155935

  13. Chlamydophila abortus em animais de produção Chlamydophila abortus in production animals

    Francielle Gibson da Silva

    2006-02-01

    Full Text Available A Chlamydophila abortus (anteriormente classificada como Chlamydia psittaci sorotipo 1 tem sido descrita em muitos países, associada principalmente com distúrbios reprodutivos em ovinos, bovinos e caprinos. O aborto enzoótico dos ovinos e caprinos e o aborto epizoótico dos bovinos são as doenças mais importantes causadas por esta bactéria. No Brasil, as pesquisas com C. abortus são praticamente inexistentes. O objetivo desta revisão é apresentar informações sobre modificações taxonômicas, ciclo de vida, epidemiologia, patogenia, sinais clínicos e diagnóstico da infecção por C. abortus principalmente em ovinos, bovinos e caprinos.Chlamydophila abortus (previously known as Chlamydia psittaci serovar 1 has been reported in many countries, associated with reproductive disorders in sheep, cattle, and goats. The enzootic abortion of sheep and goats and the epizootic bovine abortion are the most important diseases produced by this bacterium. In Brazil, there is scarce information about C. abortus. The objective of this review is to show information about taxonomic changes, life cycle, epidemiology, pathogenesis, clinical signs and diagnosis of C. abortus in sheep, cattle and goats.

  14. Evaluación De la inmunidad contra el tétanos y la difteria en trabajadores del Instituto Finlay ocupacionalmente expuestos a riesgos

    Rolando Fernández; Rolando Ochoa; Beatriz Agüero

    2004-01-01

    El Instituto Finlay es un centro rector en la producción e investigación de vacunas, en él laboran técnicos e investigadores encargados del desarrollo y la producción de la vacuna múltiple DPT, los cuales, al estar en contacto directo con los microorganismos necesarios para su producción, constituyen un personal con riesgo de contraer una de estas enfermedades infecciosas. Es importante disponer de vacunas eficaces que minimicen los riesgos por la exposición a agentes biológicos patógenos dur...

  15. Brucella abortus Infection Acquired in Microbiology Laboratories

    Fiori, Pier Luigi; Mastrandrea, Scilla; Rappelli, Paola; Cappuccinelli, Piero

    2000-01-01

    We report an outbreak of laboratory-acquired Brucella abortus infection originating in the accidental breakage of a centrifuge tube. A total of 12 laboratory workers were infected (attack rate of 31%), with an incubation time ranging from 6 weeks to 5 months. Antibody titers were evaluated weekly in all personnel exposed, allowing the diagnosis of the infection in most cases before the onset of clinical symptoms, so that specific therapy could be administrated.

  16. ESTRUCTURA MOLECULAR Y ANTIGÉNICA DE LA VACUNA

    SÁNCHEZ GLORIA INÉS

    2008-12-01

    Full Text Available La proteína L1 del Virus del Papiloma Humano (VPH constituye el 80% de la cápside viral. Las vacunas profilácticas contra el VPH son sintetizadas a partir de la proteína L1 ensamblada en Partículas similares al Virus (del inglés VLP, las cuales son altamente inmunogénicas generando anticuerpos específicos de tipo y en algunos casos pueden presentar reacción cruzada entre tipos de VPH filogenéticamente próximos. La estructura de la proteína L1 del VPH es importante porque confiere estabilidad a la cápside mediante el establecimiento de interacciones intra e intercapsoméricas lo que asegura la integridad viral y antigénicamente porque contiene los epítopes que inducen la respuesta inmune protectora. En estudios en los que se evaluó la antigenicidad de la proteína L1 se determinó que los epítopes inmunodominantes de la cápside viral se encuentran en los bucles B-C, D-E, F-G, H-I y en el extremo C-terminal. Estos bucles son poco conservados entre los diferentes genotipos y se encuentran en segmentos de la proteína expuestos en la superficie de la cápside. Los aminoácidos situados en los bucles B-C, F-G y H-I son primordiales para el reconocimiento por los anticuerpos neutralizantes. Los diferentes subtipos y variantes presentan cambios en estos aminoácidos o en residuos que conforman otros epítopes. En esta revisión se presentará un estado del arte de la proteína L1 del VPH genotipo 16, la estructura y su importancia en el desarrollo de vacunas contra la infección producida por este virus.

  17. Coombs Antiglobulin Test Using Brucella abortus 99 as Antigen To Detect Incomplete Antibodies Induced by B. abortus RB51 Vaccine in Cattle

    Ciuchini, Franco; Adone, Rosanna; Pasquali, Paolo

    2002-01-01

    This study showed that vaccination of cattle with Brucella abortus rough strain RB51 induces incomplete antibodies that can be detectable by a Coombs antiglobulin test using the B. abortus 99 smooth strain.

  18. The Effect of Irradiation on the Immunogenity of Brucella Abortus

    An experiment was carried out to study the effect of irradiation on the immunogenity of B. abortus. The B. abortus were irradiated by Gamma Cells (60Co). An experiment were divided into four groups. The first group (V1) was inoculated by irradiated B. abortus with the dose of 0.25 kGy. The second group (V2) was inoculated by irradiated B. abortus with the dose of 0.50 kGy. The third group (V3) was inoculated by irradiated B. abortus with the dose of 0.75 kGy. The fourth group (V4) was inoculated by Brucella vaccine 8.19. The observation respectively were included purely test, safety test, RBT serological test, diffusion test, development the colony of B. abortus in lien, and pathology anatomic inspection. The results obtained showed that 0.25 kGy was the expectantly dose of irradiation which could not only decreasing the infectivity of B. abortus but also has the ability to become a good immunogen for stimulating the immune response in the experiment animals. (author)

  19. Características de los vídeos en español publicados en Youtube sobre la vacuna contra el virus del papiloma humano

    Tuells Hernández, José; Martínez-Martínez, Pedro Javier; Duro Torrijos, José Luis; Caballero Pérez, Pablo; Fraga-Freijeiro, Paula; Navarro-López, Vicente

    2015-01-01

    Fundamentos: Internet constituye un recurso de búsqueda de información relacionada con la salud. El objetivo de este trabajo fue conocer las características de los vídeos en idioma español de YouTube relacionados con la vacuna contra el virus del papiloma humano (VPH). Métodos: Se realizó un estudio observacional a partir de una búsqueda en YouTube el 26 de julio de 2013, con las palabras claves: “vacuna virus papiloma humano”, “vacuna VPH”, “vacuna Gardasil”, “vacuna Cervarix”. Se establecie...

  20. Perspectivas para el desarrollo de vacunas e inmunoterapia contra cáncer cervicouterino

    GUZMÁN-ROJAS LILIANA; ALCOCER-GONZÁLEZ JUAN MANUEL; MADRID-MARINA VICENTE

    1998-01-01

    El cáncer cervicouterino representa un grave problema de salud pública, debido a la asociación de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este patógeno, mediante vacunas, que podrían ser de gran utilidad para el control de la progresión de la enfermedad. El estudio tanto de la inmunología humoral como celular ha servido para el desarrollo de vacunas. Así, la utilización de partículas virales sintéticas para el est...

  1. Desarrollo de vacunas antipertúsicas via genómica-proteómica

    Celso Pérez-Bolaños; Lourdes Lisbet Proenza-Alfonzo; Rafael Fando-Calzada

    2013-01-01

    Las vacunas convencionales se basan en la aplicación de diversos métodos bioquímicos, microbiológicos e inmunológicos sobre los agentes causales de las enfermedades. A pesar del éxito alcanzado en el control y prevención vacunal de muchas patologías infecciosas, en otros casos los resultados no han sido fructíferos, de modo que se impone explorar nuevos enfoques y posibilidades. El desarrollo y auge de la biología molecular representa una revolución en el diseño de nuevas vacunas contra una g...

  2. Brucella abortus S19 genome sequenced, points toward virulence genes

    Whyte, Barry James

    2008-01-01

    Researchers at the Virginia Bioinformatics Institute at Virginia Tech; the National Animal Disease Center in Ames, Iowa; and collaborators at 454 Life Sciences, Branford, Conn., have sequenced the genome of Brucella abortus strain S19.

  3. El legado de la Real Expedición Filantrópica de la Vacuna (1803-1810: las juntas de vacuna

    Ramírez Martín, Susana María

    2004-06-01

    Full Text Available The Royal Vaccination Expedition, directed by the physicians Francisco Xavier Balmis and José Salvany, was the most important scientific and medical achievement of the Spanish colonial era. It took place at a time of political restlessness, and its achievements were thus conditioned by each of the cultures into which the vaccine was introduced. As its legacy, the philantropic expedition left the Vaccination Boards, established in the Americas as centers of medical expertise to sustain the expedition´s principal objetive: the battle against the smallpox epidemics in pursuit of public health.

    La Expedición de la Vacuna, dirigida por los médicos Francisco Xavier Balmis y José Salvany, es la gesta científica y sanitaria más importante de época colonial. Su desarrollo tuvo lugar en un momento político convulso y los resultados estuvieron condicionados por las sociedades donde la vacuna se estableció. El legado de esta expedición filantrópica fue la creación de las Juntas de Vacuna. Estas instituciones se erigieron como centros creadores de saber médico en América y consolidaron el objetivo primario de la expedición: la búsqueda de la salud pública luchando contra las epidemias de viruela.

  4. A combined vaccine against Brucella abortus and infectious bovine rhinotracheitis

    Kamaraj, Govindasamy; Chinchkar, Shankar R.; Rajendra, Lingala; Srinivasan, Villuppanoor Alwar

    2009-01-01

    The present study was undertaken to study the immune response in calves vaccinated with Brucella abortus strain 19, infectious bovine rhinotracheitis (IBR) vaccines in monovalent form and combined vaccine containing both antigen. The seroconversion of monovalent and combined vaccines was tested in seronegative cattle calves. IBR vaccine alone and combination with live Brucella abortus S19 vaccine elicited an anamnestic response on day 60 post booster but started declining from day 90 onwards ...

  5. Purificación de vacuna antirrábica por extracción lipídica

    De Filippo, J.; Paolazzi, Claudio C.

    1998-01-01

    Un nuevo método para la purificación de vacuna antirrábica fue desarrollado con el objeto de disminuir el contenido lipídico proveniente del sustrato animal empleado en la producción de vacuna. Dos técnicas extractivas fueron aplicadas sobre una vacuna de uso veterinario: uno de los métodos fue realizado empleando un homogeneizador Omnimixer Sorvall, seguido por centrifugación; el otro fue una extracción convencional realizada en ampolla de decantación. Ambos métodos fueron llevados a cabo ut...

  6. Avances en el desarrollo de las vacunas neumocócicas conjugadas

    Wendy Chan-Acón

    2010-07-01

    Full Text Available El Streptococcus pneumoniae se encuentra entre los mayores patógenos causantes de infecciones invasoras y no invasoras en los dos extremos de la vida: en niños menores de 5 años y en personas mayores de 65 años de edad. Las principales manifestaciones asociadas a infecciones neumocócicas son: neumonía, bacteriemia febril, septicemia, otitis media y meningitis. Esta bacteria es uno de los principales agentes involucrados en la mortalidad infantil, con un estimado de 1, 000,000 de muertes globales por año, en niños menores de 5 años de edad, la mayoría provenientes de países en vías de desarrollo, por lo que es considerada como un serio problema para la salud pública alrededor del mundo. En el 2000 se introdujo al mercado de los Estados Unidos de Norte América, la primera vacuna neumocócica conjugada, que a diferencia de la ya disponible vacuna neumocócica polisacárida, es capaz de proporcionar una respuesta inmune efectiva para la protección de niños menores de 2 años. La eficacia reportada para la vacuna conjugada heptavalente en los ensayos clínicos iniciales fue de un 97.4% contra la enfermedad neumocócica invasora producida por los serotipos incluidos en la vacuna (4, 9V, 14, 19F, 23F, 18C y 6B. En la actualidad diferentes entidades regulatorias, incluyendo la Agencia Europea de Medicamentos (EMEA, han autorizado la comercialización de la vacuna conjugada 10-valente, en la que, además de los serotipos descritos para la vacuna 7-valente, se incluyen los serotipos 1, 5 y 7F; de estos diez serotipos, ocho se encuentran conjugados con la proteína transportadora D, un elemento que se encuentra en la porción externa del Haemophilus influenzae. La otra nueva vacuna conjugada que está en fase de análisis por diferentes entidades regulatorias, incluyendo la Administración de Alimentos y Drogas de los Estados Unidos (FDA y la EMEA, pero que ya fue aprobada en Chile, es la que contiene 13 serotipos: los diez de la vacuna 10

  7. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo

    Vincenzo Caporale; Barbara Bonfini; Elisabetta Di Giannatale; Andrea Di Provvido; Simona Forcella; Armando Giovannini; Manuela Tittarelli; Massimo Scacchia

    2010-01-01

    Approximately 250 000 water buffalo (Bubalus bubalis) live in the Campania region of southern Italy where the breeding of this species is very popular. Of these animals, almost 150 000 are concentrated in the Caserta province where the prevalence of Brucella abortus in this species represents approximately 20% at herd level. The Italian brucellosis eradication programme provides a slaughter and vaccination strategy for this province. B. abortus strain RB51 (RB51) has become the official vacci...

  8. Recombinant Brucella abortus gene expressing immunogenic protein

    Mayfield, J.E.; Tabatabai, L.B.

    1991-06-11

    This patent describes a synthetic recombinant DNA molecule containing a DNA sequence. It comprises a gene of Brucella abortus encoding an immunogenic protein having a molecular weight of approximately 31,000 daltons as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis under denaturing conditions, the protein having an isoelectric point around 4.9, and containing a twenty-five amino acid sequence from its amino terminal end consisting of Gln-Ala-Pro-Thr-Phe-Phe-Arg-Ile-Gly-Thr-Gly-Gly-Thr-Ala-Gly-Thr-Tyr-Tyr-Pro-Ile-Gly-Gly-Leu-Ile-Ala, wherein Gln, Ala, Pro, Thr, Phe, Arg, Ile, Gly, Tyr, and Leu, respectively, represent glutamine, alanine, proline, threonine, phenylalanine, arginine, isolecuine, glycine, tyrosine, and leucine.

  9. Perfil de seguridad de la vacuna antileptospirósica trivalente vax-SPIRAL®

    Giset Jiménez

    2010-12-01

    Full Text Available Con el objetivo de mostrar el perfil de seguridad de la vacuna antileptospirósica cubana, vax-SPIRAL®, se realizó un estudio observacional descriptivo y transversal, a partir de la base de datos de la red nacional de farmacovigilancia a medicamentos. Se estimó la frecuencia de reportes por dosis de vacunas administradas, la valoración de causalidad, severidad, localización y los eventos adversos con mayor asociación estadística, a partir del cálculo de disproporcionalidad de las combinaciones de eventos adversos a vacunas de todos los diagnósticos en los reportes de eventos del grupo farmacológico de vacunas y el cálculo de la Razón de Riesgo Proporcional (PRR y la Razón Diferencial de Riesgo (ROR. Hubo 1,62 reportes por 100 000 dosis administradas y 1,9 diagnósticos por reporte en personas entre 18 y 77 años de edad y una media ±DE de 40 ± 13 años, con predominio del sexo femenino (65,54%. No se reportaron casos graves; el 74,17% fueron con severidad leve y el 66,96% fueron manifestaciones adversas sistémicas. El 94,17% de los reportes estuvieron relacionados con la vacuna. Los eventos adversos más frecuentes fueron: fiebre/hipertermia (18,75%, cefalea (14,73%, dolor local (13,84%, enrojecimiento/eritema/rubor en el sitio de inyección (12,05%, malestar general (8,48% y manifestaciones de hipersensibilidad mínimas, sólo a nivel cutáneo. Entre los que mostraron mayor asociación: cefalea, malestar general y rubor. Los resultados obtenidos son similares y con mejor perfil de seguridad que los de la vacuna francesa SPIROLEPT, por lo cual se recomienda para la protección en grupos de riesgo de leptospirosis.

  10. A combined vaccine against Brucella abortus and infectious bovine rhinotracheitis.

    Kamaraj, Govindasamy; Chinchkar, Shankar R; Rajendra, Lingala; Srinivasan, Villuppanoor Alwar

    2009-06-01

    The present study was undertaken to study the immune response in calves vaccinated with Brucella abortus strain 19, infectious bovine rhinotracheitis (IBR) vaccines in monovalent form and combined vaccine containing both antigen. The seroconversion of monovalent and combined vaccines was tested in seronegative cattle calves. IBR vaccine alone and combination with live Brucella abortus S19 vaccine elicited an anamnestic response on day 60 post booster but started declining from day 90 onwards against IBR. B. abortus S19 alone and in combination with IBR vaccine gave more than 2 log protection in mice two weeks post challenge. Fluorescence polarization assay analysis with sera samples of calves vaccinated with B. abortus S19 monovalent vaccine alone and in combination with IBR vaccine revealed the presence of B. abortus antibodies. The components of the combined vaccine did not show any evidence of interference in the development of immunity. This combined vaccine may provide economical and affordable biological for the control of brucellosis and IBR. PMID:23100765

  11. Plasmid transfer and plasmid-mediated genetic exchange in Brucella abortus.

    Rigby, C E; Fraser, A.D.

    1989-01-01

    Naturally-occurring plasmids and gene transfer mechanisms have not yet been reported in brucellae. Here we show that Brucella abortus is capable of maintaining and transferring the broad-host-range plasmids pTH10 (IncP), pSa (IncW) and R751 (IncP), and describe pTH10-mediated transfer of B. abortus chromosomal genes to Escherichia coli. All three plasmids transferred by conjugation from E. coli to B. abortus S19, and from B. abortus S19 to B. abortus 292 (biovar 4). They were stably maintaine...

  12. Deletion of the BCSP31 gene of Brucella abortus by replacement.

    Halling, S. M.; Detilleux, P G; Tatum, F M; Judge, B A; Mayfield, J E

    1991-01-01

    The 31-kDa salt-extractable immunogenic protein, BCSP31, was deleted from several Brucella abortus strains by replacement with a marker gene encoding resistance to the antibiotics kanamycin and neomycin. The BCSP31 gene replacement plasmids, constructed with ColE1-derived vectors, were introduced by electroporation into B. abortus strain 19 (S19), into a rough variant of B. abortus S19, and into B. abortus S2308, and antibiotic-resistant transformants were isolated. B. abortus S19 is an atten...

  13. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.

    Yang, Xinghong; Thornburg, Theresa; Walters, Nancy; Pascual, David W

    2010-01-22

    To create a new, safe brucellosis live vaccine, a double mutant strain was constructed from Brucella abortus 2308. Using the DeltaznuA B. abortus 2308 mutant, a second mutation was introduced by deleting purE gene. The DeltaznuA DeltapurE B. abortus 2308 strain was less capable of surviving in macrophages. When evaluated in vivo, it was cleared within 8 weeks (wks) from mice, causing significantly less inflammation than spleens obtained from wild-type B. abortus 2308-infected mice. Furthermore, two doses of DeltaznuA DeltapurE B. abortus 2308 conferred 0.79 log protection, similar to S19 as did a single dose of DeltaznuA B. abortus 2308. Thus, this study shows the DeltaznuA DeltapurE B. abortus 2308 strain to be a potential livestock vaccine candidate. PMID:19914192

  14. PRACTICAS MEDICAS, PRACTICAS POLITICAS. ROSAS Y LA «VACUNA INDIGENA»

    MARÍA SILVIA DI LISCIA

    2011-10-01

    Full Text Available BUENOS AIRES, 1830. Se declara una epidemia de viruela entre los indios «pampas» que están en la ciudad para honrar al Restaurador de las Leyes. Los caciques no disimulan su admiración ante la valentía de Rosas, quien los visita sin alarma ante el contagio y los estimula a vacunarse para eliminar el temible mal. Un número estimado en más de cien indios acepta, entonces, inmunizarse, colocándose, según el testimonio de Parish, la «vacuna a indígenas ». Buenos Aires, 1833. Francisco X. Muñiz, médico de la campaña bonaerense, inicia las investigaciones con las que diez años después se logra el redescubrimiento del cow pox, es decir, la viruela vacuna, llamada por Sarmiento «la vacuna indígena».

  15. La Real Expedición Filantrópica de la vacuna (1803 - 1810

    Jorge Veiga de Cabo

    2007-12-01

    Full Text Available La Expedición Filantrópica de la vacuna supuso una de las empresas sanitarias realizadas en el Siglo XVIII de mayor envergadura, por su complejidad, dificultad y sobre todo, por constituir una de las misiones de Salud Pública más importantes realizadas en la Historia. Supone el resultado de un proceso en el que una serie de acontecimientos históricos, sanitarios y sociales confluyen para generar uno de los primeros programas de intervención en salud pública a escala internacional y de expansión de la vacuna de la viruela. Se crean Centros de producción, almacenamiento y distribución de la vacuna, y programas de capacitación técnica enfocados a mantener campañas de vacunación poblacional.One of the most important medical achievements made in the eighteenth century was the Philanthropic Expedition of the Vaccine. Due to its complexity and difficulty it was one of the most important Public Health undertakings in history. It was the outcome of a series of historical, social and health advances that converged in creating one of the earliest international programs for the expansion of the smallpox vaccine, creating centres for the production, storage and distribution of the vaccine together with technical training programs aimed at maintaining population vaccination campaigns.

  16. Detection of Chlamydophila abortus in Sheep (Ovis aries in Mexico

    Juan M. Jiménez-Estrada

    2008-01-01

    Full Text Available Chlamydophila abortus is one of the pathogens which induce abortion in small ruminants; this pathogen has a tropism for ruminant placenta and causes the disease commonly referred to as Ovine Enzootic Abortion (OEA. In Europe are estimated economic losses of around 20 million pounds a year by OEA. In the American Continent the disease has been reported only in Canada, the United States, Colombia and Chile while in Mexico it is unknown whether OEA is common and it is causing abortions in flocks of sheep from “Estado de Mexico”. The objective of this study was investigating the prevalence of anti-Chlamydophila abortus IgG antibodies and detection of C. abortus DNA in sheep with clinical abort history by mean of ELISA assay (C. abortus ELISA, Institute Pourquier, Montpellier, France and molecular identification of the principal outer membrane protein (POMP 90-91B gene by PCR, respectively. A cross-sectional study was carried out to enroll and random sample of ewes from november 2003 until march 2005. A total of 349 sera and vaginal swabs samples were collected from 35 flocks of sheep from Xalatlaco. The results showed that the seropositive rate was 31.1% (14/45 for healthy and 21.3% (65/304 for sheep with history clinical of abort. In vaginal swabs, the PCR showed 0% (0/45 for healthy animals and 0.65% (2/304 for aborted sheep. Samples from the lungs and liver of the fetus of one of these animals were also positive for C. abortus. In conclusion, these results confirmed that infection with C. abortus is common and is affecting sheep flocks in the Mexican highlands. Therefore, is necessary that the authorities responsible for animal welfare in Mexico (SAGARPA to set up appropriate epidemiological surveillance and control programs to eradicate this disease.

  17. Immunological response to the Brucella abortus GroEL homolog.

    Lin, J.; Adams, L G; Ficht, T A

    1996-01-01

    Western blot (immunoblot) analysis of sera from cattle vaccinated with Brucella abortus S19 exhibit an elevated serologic response to Hsp62, the GroEL homolog (BaGroEL). Serologic screening of individual cows vaccinated with B. abortus S19 revealed no correlation between the immune response to BaGroEL and protection against a challenge with virulent organisms. The humoral immune response to BaGroEL was restricted to a region of the mature protein which mapped to amino acids 317 to 355 and may...

  18. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo

    Vincenzo Caporale

    2010-03-01

    Full Text Available Approximately 250 000 water buffalo (Bubalus bubalis live in the Campania region of southern Italy where the breeding of this species is very popular. Of these animals, almost 150 000 are concentrated in the Caserta province where the prevalence of Brucella abortus in this species represents approximately 20% at herd level. The Italian brucellosis eradication programme provides a slaughter and vaccination strategy for this province. B. abortus strain RB51 (RB51 has become the official vaccine for the prevention of brucellosis in cattle in several countries. The aim of this study was to evaluate the efficacy of RB51 in water buffalo compared to the B. abortus S19 vaccine (S19. The study was performed in accordance with a protocol described in mice. Female buffalo aged five months were inoculated. Five received a RB51 dosage on two occasions that was three times greater than that approved for use in cattle and a booster after one month, five received B. abortus S19 vaccine at the standard dosage and three controls received a phosphate buffer solution. Buffalo were then challenged with a virulent B. abortus strain 544 thirty days post vaccination. Antibodies that developed in the five animals vaccinated with RB51 were not detected by the Rose Bengal test or complement fixation test (CFT and were also tested by CFT prepared with RB51 antigen. After culling, B. abortus was cultured from the spleen, retropharyngeal and supra-mammary lymph nodes. A statistical evaluation was performed to assess the immunogenicity values obtained in buffalo vaccinated with S19, compared to those obtained in buffalo vaccinated with the RB51 vaccine and in the unvaccinated control group.

  19. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.

    Caporale, Vincenzo; Bonfini, Barbara; Di Giannatale, Elisabetta; Di Provvido, Andrea; Forcella, Simona; Giovannini, Armando; Tittarelli, Manuela; Scacchia, Massimo

    2010-01-01

    Approximately 250,000 water buffalo (Bubalus bubalis) live in the Campania region of southern Italy where the breeding of this species is very popular. Of these animals, almost 150,000 are concentrated in the Caserta province where the prevalence of Brucella abortus in this species represents approximately 20% at herd level. The Italian brucellosis eradication programme provides a slaughter and vaccination strategy for this province. B. abortus strain RB51 (RB51) has become the official vaccine for the prevention of brucellosis in cattle in several countries. The aim of this study was to evaluate the efficacy of RB51 in water buffalo compared to the B. abortus S19 vaccine (S19). The study was performed in accordance with a protocol described in mice. Female buffalo aged five months were inoculated. Five received a RB51 dosage on two occasions that was three times greater than that approved for use in cattle and a booster after one month, five received B. abortus S19 vaccine at the standard dosage and three controls received a phosphate buffer solution. Buffalo were then challenged with a virulent B. abortus strain 544 thirty days post vaccination. Antibodies that developed in the five animals vaccinated with RB51 were not detected by the Rose Bengal test or complement fixation test (CFT) and were also tested by CFT prepared with RB51 antigen. After culling, B. abortus was cultured from the spleen, retropharyngeal and supra-mammary lymph nodes. A statistical evaluation was performed to assess the immunogenicity values obtained in buffalo vaccinated with S19, compared to those obtained in buffalo vaccinated with the RB51 vaccine and in the unvaccinated control group. PMID:20391363

  20. Brucella abortus RB51 in milk of vaccinated adult cattle.

    Miranda, Karina Leite; Poester, Fernando Padilla; Dorneles, Elaine Maria Seles; Resende, Thiago Magalhães; Vaz, Adil Knackfuss; Ferraz, Sandra Maria; Lage, Andrey Pereira

    2016-08-01

    The aim of this study was to evaluate the shedding of Brucella abortus in the milk of cows vaccinated with a full dose of RB51 during lactation. Eighteen cows, nine previously vaccinated with S19 as calves and nine non-vaccinated, were immunized subcutaneously with 1.3×10(10)CFU of B. abortus RB51, 30-60days after parturition. Milk samples from all animals were collected daily until day 7, and at weekly interval for the next 9 weeks after vaccination. To evaluate the shedding of B. abortus, milk samples were submitted for culture and PCR. No B. abortus was isolated from any sample tested. Only one sample, collected on first day after vaccination from a cow previously vaccinated, was faintly positive in the PCR. In conclusion, the public health hazard associated with milk consumption from cows vaccinated with RB51 in post-partum is very low, despite vaccination with the full dose and regardless of previous S19 vaccination. PMID:27143220

  1. 9 CFR 113.65 - Brucella Abortus Vaccine.

    2010-01-01

    ... 9 Animals and Animal Products 1 2010-01-01 2010-01-01 false Brucella Abortus Vaccine. 113.65 Section 113.65 Animals and Animal Products ANIMAL AND PLANT HEALTH INSPECTION SERVICE, DEPARTMENT OF AGRICULTURE VIRUSES, SERUMS, TOXINS, AND ANALOGOUS PRODUCTS; ORGANISMS AND VECTORS STANDARD REQUIREMENTS Live Bacterial Vaccines § 113.65 Brucella...

  2. Seroprevalence of Brucella abortus and Leptospira hardjo in cattle

    S. Jegaveera Pandian

    2015-02-01

    Full Text Available Aim: The aim was to assess the seroprevalence of B. abortus and Leptospira hardjo in the cattle population of Bihar, this work was carried out. Materials and Methods: Randomly selected 450 cattle from nine districts of Bihar were serologically screened for antibodies against L. hardjo and B. abortus. DAS-ELISA for leptospira and AB-ELISA for brucella were carried out. Based on the results prevalence in each district and the state are reported herewith. Results: In this study, it was found that the seroprevalence of L. hardjo was 9.11% and that of B. abortus was 12.2% in Bihar. Indigenous cattle were found to be less susceptible to leptospirosis and brucellosis even though they accounted for 83.11% of the study population. Conclusion: Although there was no acute disease, antibodies detected against L. hardjo and B. abortus in the cattle population indicated the presence of chronic and subclinical infection, which could challenge the fertility of the animals.

  3. Endocarditis por Brucella abortus: Reporte del primer caso en C.R Brucella abortus Endocarditis

    Manuel Antonio Villalobos-Zúñiga; Edith Barrantes-Valverde; Patricia Monge-Ortega

    2011-01-01

    Paciente masculino de 36 años de edad, proveniente de la zona rural de Costa Rica, con un cuadro clínico de 8 meses de evolución de fiebre, mialgias, artralgias, pérdida de peso y lumbalgia; referido por la detección de un soplo de insuficiencia aórtica. El ecocardiograma reveló endocarditis de la válvula aórtica, y se obtuvieron 4 hemocultivos positivos por Brucella abortus biotipo 3, con serologías negativas por brucelosis. Se inició tratamiento con antibióticos y luego se le realizó un ree...

  4. Can Chlamydia abortus be transmitted by embryo transfer in goats?

    Oseikria, M; Pellerin, J L; Rodolakis, A; Vorimore, F; Laroucau, K; Bruyas, J F; Roux, C; Michaud, S; Larrat, M; Fieni, F

    2016-10-01

    The objectives of this study were to determine (i) whether Chlamydia abortus would adhere to or penetrate the intact zona pellucida (ZP-intact) of early in vivo-derived caprine embryos, after in vitro infection; and (ii) the efficacy of the International Embryo Transfer Society (IETS) washing protocol for bovine embryos. Fifty-two ZP-intact embryos (8-16 cells), obtained from 14 donors were used in this experiment. The embryos were randomly divided into 12 batches. Nine batches (ZP-intact) of five embryos were incubated in a medium containing 4 × 10(7)Chlamydia/mL of AB7 strain. After incubation for 18 hours at 37 °C in an atmosphere of 5% CO2, the embryos were washed in batches in 10 successive baths of a phosphate buffer saline and 5% fetal calf serum solution in accordance with IETS guidelines. In parallel, three batches of ZP-intact embryos were used as controls by being subjected to similar procedures but without exposure to C. abortus. The 10 wash baths were collected separately and centrifuged for 1 hour at 13,000 × g. The washed embryos and the pellets of the 10 centrifuged wash baths were frozen at -20 °C before examination for evidence of C. abortus using polymerase chain reaction. C. abortus DNA was found in all of the infected batches of ZP-intact embryos (9/9) after 10 successive washes. It was also detected in the 10th wash fluid for seven batches of embryos, whereas for the two other batches, the last positive wash bath was the eighth and the ninth, respectively. In contrast, none of the embryos or their washing fluids in the control batches were DNA positive. These results report that C. abortus adheres to and/or penetrates the ZP of in vivo caprine embryos after in vitro infection, and that the standard washing protocol recommended by the IETS for bovine embryos, failed to remove it. The persistence of these bacteria after washing makes the embryo a potential means of transmission of the bacterium during embryo transfer from

  5. Endocarditis por Brucella abortus: Reporte del primer caso en C.R Brucella abortus Endocarditis

    Manuel Antonio Villalobos-Zúñiga

    2011-09-01

    Full Text Available Paciente masculino de 36 años de edad, proveniente de la zona rural de Costa Rica, con un cuadro clínico de 8 meses de evolución de fiebre, mialgias, artralgias, pérdida de peso y lumbalgia; referido por la detección de un soplo de insuficiencia aórtica. El ecocardiograma reveló endocarditis de la válvula aórtica, y se obtuvieron 4 hemocultivos positivos por Brucella abortus biotipo 3, con serologías negativas por brucelosis. Se inició tratamiento con antibióticos y luego se le realizó un reemplazo valvular aórtico; 4 meses después ingresó con dolor torácico que se atribuyó a una oclusión de la arteria descendente anterior, demostrada angiográficamente, por posible embolismo. En la actualidad cursa clínicamente estable con manejo médico para su cardiopatía, sin recaída infecciosa.The case of a 36-year-old patient from a rural area is presented. He came with an 8 month history of fever, myalgias, arthralgias, weight loss and lower back pain; who also had an aortic insufficiency murmur detected. The diagnosis of aortic valve endocarditis was made by echocardiography, and had 4 positive blood cultures for Brucella abortus biotype 3, and negative serologic test for brucellosis. He was started on antibiotics and later on underwent aortic valve replacement, with a late coronary cardioembolism as a complication.

  6. Brucelosis: Inmunidad y vacunación (revisión bibliográfica - Brucellosis: Immunity and vaccination (a review

    Estein, Silvia Marcela

    2006-05-01

    Full Text Available Resumen.- En esta revisión se describe la estructura antigénica de Brucella y los mecanismos inmunitarios que activa este patógeno, dos puntos críticos para el desarrollo de nuevas vacunas. Se analizan los diferentes tipos de vacunas convencionales y de nueva generación empleadas a campo y a nivel experimental y se discute acerca de las ventajas que acarrearía el empleo de estas nuevas alternativas. Summary.- This review describes the antigenic structure of Brucella and the immune mechanisms elicited in response to this pathogen. These issues are critical in the development of new vaccines against brucellosis. Moreover, this work analyzes conventional and new generation vaccines employed in field and laboratory experimental designs, and discusses the advantages of these novel approaches.

  7. Vacuna contra la fiebre hemorrágica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad

    Delia A. Enria

    2010-06-01

    Full Text Available Se realizó un estudio clínico en 946 voluntarios humanos sanos, donde se comparó la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que había sido utilizada en estudios previos. Como objetivo primario se evaluó la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detección de anticuerpos neutralizantes. Como objetivo secundario se evaluó la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significación clínica y de resolución espontánea o con tratamiento sintomático; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (< 150 000 plaquetas/mm³, náuseas y/o vómitos, leucopenia leve (< 4 000 blancos/mm³, fiebre, dolor retroocular, mareos, microhematuria, lumbalgia y exantema. Estos resultados indican que la vacuna Candid #1 elaborada en la Argentina es equivalente a la elaborada en los EE.UU. Este estudio permitió el registro del biológico producido en la Argentina ante la autoridad regulatoria del país (ANMAT.

  8. Nueva metodología para la formulación de la vacuna Heberpenta-L

    Imeray Díaz; Maikel Villegas; Luis Carlos Hidalgo

    2014-01-01

    Título en ingles: New methodology for the formulation of the vaccine Heberpenta-LTítulo corto: Formulación de Heberpenta-LResumen: La vacuna Heberpenta-L, está indicada para la inmunización activa contra la difteria, tétanos, tos ferina (pertussis), hepatitis B y Haemophilus influenzae tipo b. En el Centro Nacional de Biopreparados se diseñó una nueva planta de producción de productos parenterales, resultando la vacuna pentavalente uno de los productos recién introducidos. Con tal propósito s...

  9. Vacunas de ADN: inducción de la respuesta inmunitaria DNA Vaccines: Induction of the immune response

    Javier Mota-Sánchez

    2009-01-01

    La efectividad de las vacunas y la inmunización en la prevención de las enfermedades infecciosas es uno de los grandes avances de la medicina. En la actualidad, el acceso a la tecnología de punta en el área de la genómica y la proteómica ha hecho posible acelerar el desarrollo de nuevos modelos de vacunas con características mejoradas en aspectos fundamentales, como la inmunogenicidad y la seguridad. A casi dos décadas del primer informe, en el cual se demostró que un gen puede expresarse med...

  10. Evaluación de la información sanitaria disponible en internet sobre la vacuna antigripal

    I. Hernández-García; R. González Celador

    2014-01-01

    Fundamento: La calidad de la información sanitaria en internet preocupa a gobiernos y usuarios. Nuestro objetivo fue determinar en qué medida la información sobre la vacuna antigripal se adhiere al gold estándar representado por lo establecido por el Ministerio de Sanidad español. Material y métodos: Entre junio-julio 2014 se evaluó la adhesión al gold estándar de la información sobre indicaciones, efectos adversos y contraindicaciones de la vacuna. Dicha información se obtuvo a través de Goo...

  11. Una vacuna pel virus de l’Ebola : un repte de desenvolupament i comunicació

    Velasco Muñoz, César; Casajuana, Cristina; Bosque-Prous, Marina

    2015-01-01

    L'Ebola es una malaltia transmissible, greu i sovint mortal. Els epidemiòlegs controlen les epidèmies d'ebola mitjançant mesures d'aïllament i seguiment de contactes. Quan el nombre de contagis és elevat una vacuna pot ser crucial en la disminució de la transmissió. La necessitat de disposar de vacunes enfront del virus de la ebola ha accelerat el desenvolupament experimental i els assajos clínics. En aquest article s'introdueix el virus de la ebola, s'exposen les fases de desenvolupament de ...

  12. Vectores recombinantes basados en el virus Vaccinia modificado de Ankara (MVA) como vacunas contra la leishmaniasis

    Pérez Jiménez, Eva; Larraga, Vicente; Esteban, Mariano

    2005-01-01

    Vectores recombinantes basados en el virus vaccinia modificado de Ankara (MVA) como vacunas contra la leishmaniasis. Los vectores de la invención contienen secuencias codificantes de la proteína LACK, preferentemente insertadas en el locus de hemaglutinina del virus y bajo el control de un promotor que permite su expresión a lo largo del ciclo de infección del virus. Son vectores seguros, estables, que dan lugar a una potente respuesta inmune que confiere protección frente a la leishmaniasis,...

  13. Desarrollo de vacunas antipertúsicas via genómica-proteómica

    Celso Pérez-Bolaños

    2013-01-01

    Full Text Available Las vacunas convencionales se basan en la aplicación de diversos métodos bioquímicos, microbiológicos e inmunológicos sobre los agentes causales de las enfermedades. A pesar del éxito alcanzado en el control y prevención vacunal de muchas patologías infecciosas, en otros casos los resultados no han sido fructíferos, de modo que se impone explorar nuevos enfoques y posibilidades. El desarrollo y auge de la biología molecular representa una revolución en el diseño de nuevas vacunas contra una gran variedad de microorganismos patógenos, causantes de enfermedades que afectan al hombre y a los animales. A partir del conocimiento de las secuencias genómicas completas de esos microorganismos, en combinación con nuevas tecnologías avanzadas tales como la bioinformática, los micromatrices de ADN y la proteómica, ha sido posible identificar nuevos antígenos importantes para el desarrollo de nuevos preparados vacunales. La combinación genómica-proteómica ha reportado grandes avances en el descubrimiento de sitios "diana" de vacunas contra bacterias patógenas. La vacuna ideal debe ser patógeno - específica y portadora de antígenos conservados en todas las cepas, de modo que posea una cobertura universal, con el mínimo número de antígenos. Apoyándose en estos conocimientos es posible predecir a priori todos los antígenos in silico, sin necesidad de crecer el microorganismo in vitro. Este nuevo enfoque ha sido aplicado con éxito en la identificación de nuevos antígenos que pueden ser evaluados de manera perspectiva para fines vacunales en Bordetella pertussis, lo que evidentemente representa un serio esfuerzo a escala global para enfrentar la resurgencia de la tosferina o pertussis.

  14. Vacuna frente a infestaciones provocadas por artrópodos hematófagos

    Fuente García, José de la; Villar, Margarita; Prudencio, Carlos Roberto; Pérez de Lastra, José Manuel

    2012-01-01

    [ES] La presente invención describe una vacuna frente a infestaciones provocadas por artrópodos hematófagos preferentemente garrapatas, mosquitos, flebótomos, ácaros rojos de las gallinas, pulgas, piojos, piojos de mar, etc. Así mismo, se protege un péptido capaz de inducir una respuesta inmune protectora y de reacción cruzada frente a una infestación provocada por artrópodos hematófagos, un polinucleótido, un vector de expresión, una célula hospedadora, un animal no humano, un anticuerpo, y ...

  15. Vacuna frente a infestaciones provocadas por artrópodos hematófagos

    Fuente García, José de la; Villar, Margarita; Prudencio, Carlos Roberto; Pérez de Lastra, José Manuel

    2012-01-01

    La presente invención describe una vacuna frente a infestaciones provocadas por artrópodos hematófagos preferentemente garrapatas, mosquitos, flebótomos, ácaros rojos de las gallinas, pulgas, piojos, piojos de mar, etc. Así mismo, se protege un péptido capaz de inducir una respuesta inmune protectora y de reacción cruzada frente a una infestación provocada por artrópodos hematófagos, un polinucleótido, un vector de expresión, una célula hospedadora, un animal no hum...

  16. La segunda expedición de Balmis, revolución y vacuna

    Tuells Hernández, José; Duro Torrijos, José Luis

    2013-01-01

    Cuatro años después de concluir la Real Expedición Filantrópica de la Vacuna (REFV) (1803-1806) en calidad de director, Francisco Xavier Balmis emprendió una nueva comisión con destino a México que le mantuvo allí desde 1810 a 1813. El objetivo inicial para el que fue comisionado pasaba por verificar si la estrategia de vacunación implantada a través de las Juntas era eficaz y, asimismo, encontrar una fuente de fluido vacuno autóctona que permitiera continuar la acción vacunadora. Balmis ejer...

  17. Estudio de tolerancia local de la vacuna vax-TyVi® en ratas Sprague Dawley

    Eligio Sosa Roble

    2005-05-01

    Full Text Available La vacuna antitifoídica vax-TyVi® consiste en una preparación de polisacárido capsular Vi de Salmonella typhi, el cual es diluido en una solución buffer isotónica solución amortiguador, a la que se le añade fenol como preservo. Cada dosis de 0,5 mL contiene 25 μg de polisacárido como sustancia activa. En nuestro país el esquema de vacunación contra la fiebre tifoidea con vax- TyVi® se aplica a los alumnos de 9-10 años (5to grado, una 2da dosis a la edad de 12-13 años (8vo grado y una 3ra dosis a la edad de 16-17 años (11no grado. Además, es vacunado el personal de riesgo de Salud Pública y el personal que manipula alimentos. En el presente trabajo se describe el ensayo de tolerancia local llevado a cabo con la vacuna vax-TyVi® durante su fase de estudios preclínicos, actualmente utilizada en la vacunación contra la fiebre tifoidea en Cuba. Se empleó un total de 170 ratas que fueron tratadas con la vacuna, su placebo (todos los componentes, excepto la materia prima activa, o que no recibieron tratamiento alguno (controles. Se realizaron observaciones clínicas diarias durante todo el ensayo, se determinó el consumo de agua y alimentos y se realizaron investigaciones anatomopatológicas a animales sacrificados 3, 7, 14, 21, 28, 35 y 42 días después de la inoculación. No se observaron muertes ni síntomas de toxicidad; no se encontraron diferencias estadísticamente significativas entre los pesos vivos, el consumo de agua ni el de alimentos entre los grupos del ensayo. Tampoco se observaron lesiones anatomopatológicas que indicaran toxicidad por parte del producto inoculado. Los resultados permitieron concluir que la potencialidad de la vacuna vax-TyVi® para producir efectos adversos locales es baja.

  18. Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19

    Kianmehr, Zahra; Kaboudanian Ardestani, Sussan; Soleimanjahi, Hoorieh; Fotouhi, Fatemeh; Alamian, Saeed; Ahmadian, Shahin

    2015-01-01

    Background: Brucella abortus RB51 is a rough stable mutant strain, which has been widely used as a live vaccine for prevention of brucellosis in cattle instead of B. abortus strain S19. B. abortus lipopolysaccharide (LPS) has unique properties in comparison to other bacterial LPS. Objectives: In the current study, two types of LPS, smooth (S-LPS) and rough (R-LPS) were purified from B. abortus S19 and RB51, respectively. The aim of this study was to evaluate biological and immunological prope...

  19. Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9.

    Baldi, P C; Giambartolomei, G H; Goldbaum, F A; Abdón, L F; C.A. Velikovsky; Kittelberger, R; Fossati, C A

    1996-01-01

    The humoral immune responses against three different antigens of Brucella abortus were monitored by enzyme-linked immunosorbent assay in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Immunoglobulin G (IgG) and IgM responses against (i) B. abortus lipopolysaccharide (LPS), (ii) total cytoplasmic proteins depleted of LPS (LPS-free CYT), and (iii) B. abortus 18-kDa cytoplasmic protein were measured. Vaccinated animals and Yersinia-inf...

  20. Utilización de indicadores metabólicos en la valoración de la transferencia de inmunidad pasiva en neonatos bovinos

    Loaiza Valentina

    2009-09-01

    Full Text Available Para determinar la utilidad de la actividad sérica de la fosfatasa alcalina (FA y las proteínas séricas totales (PST como indicadores de transferencia de inmunidad en terneros por el consumo de calostro en sus primeros días de vida, en un hato del trópico bajo de Colombia se escogieron al azar 15 vacas de las razas Gyr, Brahaman y el cruce Gyr x Holstein y sus respectivos terneros. En las vacas se recolectaron aproximadamente 300 ml de calostro el primer día del parto para determinar sólidos totales, proteína total y cenizas. En los terneros se tomaron muestras de sangre sin anticoagulante mediante venipunción yugular los días 0, 4, 12 y 30 posnacimiento. La concentración de las PST se determinó por refractometría y la FA mediante colorimetría enzimática. Se encontró relación alta y significativa (P < 0.05 entre los porcentajes de proteína total y sólidos totales del calostro, por lo que se concluye que una sola de estas mediciones es válida para evaluar ambos indicadores. Utilizando análisis de varianza se evaluó el efecto del tiempo sobre las concentraciones de PST y la actividad enzimática de la FA. En las PST se presentó una diferencia significativa (P < 0.05 entre el primer día (69 g/dl y el día 30 (58 g/dl cuando ocurrió la concentración más baja. Se observaron valores promedio de PST mayores que 4.5 g/dl, lo cual indica que los terneros adquirieron inmunidad pasiva por el consumo de calostro. La actividad enzimática de la FA disminuyó durante el período de estudio (1326.4 U/L en el primer día y 599 U/L en el día 30, posnacimiento (P < 0.05. No fue posible comprobar si la FA puede ser utilizada como indicador directo de falla en la transferencia de inmunidad pasiva.

  1. Utilización de indicadores metabólicos en la valoración de la transferencia de inmunidad pasiva en neonatos bovinos

    Angie Fairut Carrillo

    2009-07-01

    Full Text Available Resumen Para determinar la utilidad de la actividad sérica de la fosfatasa alcalina (FA y las proteínas séricas totales (PST como indicadores de transferencia de inmunidad en terneros por el consumo de calostro en sus primeros días de vida, en un hato del trópico bajo de Colombia se escogieron al azar 15 vacas de las razas Gyr, Brahaman y el cruce Gyr x Holstein y sus respectivos terneros. En las vacas se recolectaron aproximadamente 300 ml de calostro el primer día del parto para determinar sólidos totales, proteína total y cenizas. En los terneros se tomaron muestras de sangre sin anticoagulante mediante venipunción yugular los días 0, 4, 12 y 30 posnacimiento. La concentración de las PST se determinó por refractometría y la FA mediante colorimetría enzimática. Se encontró relación alta y significativa (P < 0.05 entre los porcentajes de proteína total y sólidos totales del calostro, por lo que se concluye que una sola de estas mediciones es válida para evaluar ambos indicadores. Utilizando análisis de varianza se evaluó el efecto del tiempo sobre las concentraciones de PST y la actividad enzimática de la FA. En las PST se presentó una diferencia significativa (P < 0.05 entre el primer día (69 g/dl y el día 30 (58 g/dl cuando ocurrió la concentración más baja. Se observaron valores promedio de PST mayores que 4.5 g/dl, lo cual indica que los terneros adquirieron inmunidad pasiva por el consumo de calostro. La actividad enzimática de la FA disminuyó durante el período de estudio (1326.4 U/L en el primer día y 599 U/L en el día 30, posnacimiento (P < 0.05. No fue posible comprobar si la FA puede ser utilizada como indicador directo de falla en la transferencia de inmunidad pasiva.

  2. Investigation of the possible role of Chlamydophila abortus in reproductive failures in nrazilian herds of domestic ruminants

    Francielle Gibson da Silva-Zacarias; Amauri Alcindo Alfieri; Kledir Anderson Hofstaetter Spohr; Bruna Azevedo de Carvalho Lima; Rosângela Claret de Oliveira; Carlo Turilli; Michele Lunardi; Rodrigo Alejandro Arellano Otonel; Julio Cesar de Freitas

    2009-01-01

    Chlamydophila abortus (C. abortus) infection is related to reproductive failure in domestic ruminants. Although it has not been well characterized worldwide, this pathogen has already been identified in some European countries and in the USA. In Brazil, preliminary studies have shown serological evidence of C. abortus infection in herds with low antibody prevalence. Until now, the identification of C. abortus in biological samples from females presenting reproductive failures has not been des...

  3. Validation of a PCR Assay for Chlamydophila abortus rRNA gene detection in a murine model

    Francielle Gibson da Silva-Zacarias; Amauri Alcindo Alfieri; Kledir Anderson Hofstaetter Spohr; Bruna Azevedo de Carvalho Lima; Fábio Juliano Negrão; Michele Lunardi; Julio Cesar de Freitas

    2009-01-01

    Chlamydophila abortus (C. abortus) is associated with reproductive problems in cattle, sheep, and goats. Diagnosis of C. abortus using embryonated chicken eggs or immortalized cell lines has a very low sensitivity. Polymerase chain reaction (PCR) assays have been used to detect C. abortus infection in clinical specimens and organ fragments, such as placenta, fetal organs, vaginal secretions, and semen. The aim of this study was to develop a PCR assay for the amplification of an 856-bp fragmen...

  4. Seroprevalence of Chlamydia abortus in camel in the western region of Libya

    Rabia Elzlitne

    2016-06-01

    Conclusion: The present findings signify the C. abortus as a potential agent to cause abortion in Libyan camel (C. dromedarius. Besides, the persons who handle camels in Libya are at risk of infecting with C. abortus. [J Adv Vet Anim Res 2016; 3(2.000: 178-183

  5. Vaccination of elk (Cervus canadensis with Brucella abortus strain RB51 overexpressing superoxide dismutase and glycosyltransferase genes does not induce adequate protection against experimental Brucella abortus challenge

    Pauline eNol

    2016-02-01

    Full Text Available In recent years, elk (Cervus canadensis have been implicated as the source of Brucella abortus infection for numerous cattle herds in the Greater Yellowstone Area. In the face of environmental and ecological changes on the landscape, the range of infected elk is expanding. Consequently, the development of effective disease management strategies for wild elk herds is of utmost importance, not only for the prevention of reintroduction of brucellosis to cattle, but also for the overall health of the Greater Yellowstone Area elk populations. In two studies, we evaluated the efficacy of B. abortus strain RB51 over-expressing superoxide dismutase and glycosytransferase for protecting elk from infection and disease caused by B. abortus after experimental infection with a virulent B. abortus strain. Our data indicate that the recombinant vaccine does not protect elk against brucellosis. Further work is needed for development of an effective brucellosis vaccine for use in elk

  6. Brucella abortus 1119-3 O-chain polysaccharide to differentiate sera from B. abortus S-19-vaccinated and field-strain-infected cattle by agar gel immunodiffusion.

    Cherwonogrodzky, J W; Nielsen, K H

    1988-01-01

    Purified Brucella abortus 1119-3 and Brucella melitensis 16M lipopolysaccharide O-chain polysaccharides were not precipitated in agar gel immunodiffusion by any of 24 sera from vaccinated cattle but were precipitated by 18 of 24 sera from infected cattle. This difference can be used to differentiate sera of cattle vaccinated with B. abortus S-19 from sera of some field-strain-infected cattle.

  7. Preventive vaccines for cervical cancer Vacunas para prevenir el cáncer cervical

    COSETTE M WHEELER

    1997-07-01

    Full Text Available The potential use of vaccines for the human papillomavirus (HPV in the prevention and treatment of cervical cancer is a possibility in the near future. Close to 20 genotypes of HPV, of the 75 that have been identified, infect the femine genital tract, but four subtypes (16, 18, 31 and 45 have been associated in close to 80% of cervical cancers. this article proposes that in order to design an effective prophylactic vaccine against HPV infection, an adequate immune response should be guaranteed through four goals; a activation of antigens present in the cell; b overcoming the host response and viral genetic variability in the T cell response; c generation of high levels of T and B memory cells; and d persistence of antigens.El potencial uso de vacunas de virus del papiloma humano (VPH en la prevención y tratamiento del cáncer cervical posiblemente será implementado durante los próximos años. Cerca de los 20 genotipos de VPH de los 75 que se encuentran identificados infectan el tracto genital femenino, pero son cuatro subtipos: 16, 18, 31 y 45 los que se han asociado en cerca de 80% a cáncer cervical. En este ensayo se plantea que para poder diseñar una vacuna profiláctica contra la infección de VPH, efectiva, se debe garantizar una adecuada respuesta inmune a través de cuatro metas: a activación de antígenos presentes en la célula; b superar la respuesta del huésped y la variabilidad genética viral en la respuesta de células T; c generación de altos niveles de células T y B de memoria, y d persistencia de antígenos.

  8. Isolation, purification, and partial characterization of Brucella abortus matrix protein.

    Moriyon, I; Berman, D T

    1983-01-01

    Peptidoglycan sacculi with peptidoglycan-associated proteins were prepared from cell envelopes of Brucella abortus by extraction with sodium dodecyl sulfate (SDS) at 50 degrees C. On extraction of these preparations with SDS at 100 degrees C, a protein was obtained whose removal from peptidoglycan was confirmed by electron microscopy. Incubation of the 50 degrees C SDS-extracted cell envelopes with 50 mM MgCl2 in SDS-2-beta-mercaptoethanol at 37 degrees C also extracted the protein, along wit...

  9. Cleavage of bovine immunoglobulin G1 in whey by an extracellular material from Brucella abortus.

    Nielsen, K.

    1985-01-01

    Culture extracts of in vitro grown Brucella abortus were demonstrated to cleave a part of the Fc portion of bovine immunoglobulin G1 in whey but not in serum or as a purified protein from serum. Supernates from Strains 19 and 2308 of B. abortus were both capable of this hydrolysis whereas living cells were not. The cleavage process was independent of antibody activity to B. abortus, appeared to require factor(s) found only in some whey samples and was ineffective with the other bovine immunog...

  10. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.

    Wallach, J C; Ferrero, M C; Victoria Delpino, M; Fossati, C A; Baldi, P C

    2008-08-01

    The pathological consequences of exposure to the vaccine strain Brucella abortus S19 were evaluated in 30 employees from vaccine-manufacturing plants. Active brucellosis was diagnosed in 21 subjects, of whom only five recalled an accidental exposure. Clinical manifestations were mild, and only one patient presented a complication. After antimicrobial therapy, initially symptomatic patients either experienced clinical remission or had mild persistent symptoms. This is the first study reporting infection by B. abortus S19 among workers from vaccine-manufacturing plants, which in many cases was acquired from unnoticed exposures. Measures to improve the safety of B. abortus S19 handling should be implemented. PMID:18727806

  11. Expression and validation of D-erythrulose 1-phosphate dehydrogenase from Brucella abortus: a diagnostic reagent for bovine brucellosis.

    Eoh, Hyungjin; Jeon, Bo-Young; Kim, Zhiyeol; Kim, Seung-Cheol; Cho, Sang-Nae

    2010-07-01

    Brucella abortus is a bacterium of brucellosis causing abortion in cattle. The diagnosis of bovine brucellosis mainly relies on serologic tests using smooth lipopolysaccharide (S-LPS) from B. abortus. However, the usefulness of this method is limited by false-positive reactions due to cross-reaction with other Gram-negative bacteria. In the present study, the eryC gene encoding B. abortus d-erythrulose 1-phosphate dehydrogenase, which is involved in the erythritol metabolism in virulent B. abortus strain but is absent from a B. abortus vaccine strain (S19), was cloned. Recombinant EryC was expressed and purified for the evaluation as a diagnostic reagent for bovine brucellosis. Other B. abortus proteins, Omp16, PP26, and CP39 were also purified and their seroreactivities were compared. Recombinant EryC, Omp16, PP26, and PP39 were all reactive to B. abortus-positive serum. The specificity of recombinant Omp16, PP26, CP39, and EryC, were shown to be approximately 98%, whereas that of B. abortus whole cell lysates was shown to be 95%. The sensitivity of Omp16, PP26, CP39, and EryC were 10%, 51%, 64%, and 43%, respectively, whereas that of B. abortus whole cell lysates was 53%. These results suggested that B. abortus EryC would be a potential reagent for diagnosis for bovine brucellosis as a single protein antigen. PMID:20622221

  12. Vacunas de ADN: inducción de la respuesta inmunitaria DNA Vaccines: Induction of the immune response

    Javier Mota-Sánchez

    2009-01-01

    Full Text Available La efectividad de las vacunas y la inmunización en la prevención de las enfermedades infecciosas es uno de los grandes avances de la medicina. En la actualidad, el acceso a la tecnología de punta en el área de la genómica y la proteómica ha hecho posible acelerar el desarrollo de nuevos modelos de vacunas con características mejoradas en aspectos fundamentales, como la inmunogenicidad y la seguridad. A casi dos décadas del primer informe, en el cual se demostró que un gen puede expresarse mediante la inyección directa de ADN desnudo, las vacunas de ADN han probado ser eficientes para inducir una respuesta inmunitaria protectora contra parásitos, virus y bacterias en diversos modelos animales. Esta revisión tiene por objetivo presentar un panorama general de las vacunas de ADN y los mecanismos mediante los cuales la inmunización con antígenos insertados en vectores de ADN (plásmidos inducen una respuesta inmunitaria.The effectiveness of vaccines and immunization in the prevention of infectious diseases is one of the greatest successes in medicine. In recent years, with access to cutting edge genomic and proteomic technology, it is possible to accelerate the development of new and improved vaccines with better immunogenicity and safety characteristics. Since the first report almost two decades ago, where it was demonstrated that gene expression is possible by directed injection of naked DNA, DNA vaccines have been proven to induce protective immune responses against parasites, virus and bacterium in diverse animal disease models. This review aims to present an overview about DNA vaccines and the mechanisms by which immune responses are induced after immunization with plasmid DNA-encoded antigens.

  13. Chlamydia abortus in Cows Oviducts, Occasional Event or Causal Connection?

    Appino, S; Vincenti, L; Rota, A; Pellegrini, S; Chieppa, M N; Cadoni, V; Pregel, P

    2015-06-01

    Fifty-seven genital tracts of regularly slaughtered culled Piedmontese cows, aged 7.4 ± 4.3 years (mean ± SD), range: 2.6-15.6 years, were grossly and microscopically examined. DNA extracted from oviducts was subjected to PCR to evaluate the presence of Chlamydia spp. The 15 PCR-positive oviducts were subjected to Sanger sequencing and showed the presence of Chamydia abortus, with an identity range between 99 and 100%. Nine of the PCR-positive samples belonged to the 24 animals with a normal macroscopic appearance of the whole genital tract (percentage of positive oviducts in normal genital tracts 9/24 = 37.5%), while six belonged to the 33 genital tracts with lesions in one or more organs (percentage of positive oviducts in pathological genital tracts 6/33 = 18.1%); of these, a single animal had salpingitis. The detection of C. abortus in bovine oviducts is of particular interest because it has never been previously investigated or reported. PMID:25704292

  14. Detection of Brucella abortus in Chiredzi district in Zimbabwe

    Calvin Gomo

    2012-02-01

    Full Text Available Brucellosis is an endemic disease in Zimbabwe caused by the genus Brucella. Brucella seroprevalence was recently reported to be high in the wildlife-livestock interface in the Chiredzi district and the neighbouring Gonarezhou National Park (GNP in Zimbabwe, and higher amongst communal cattle with an abortion history and access to grazing in GNP than amongst communal cattle with no abortion history or access to grazing in GNP. The aim of this study was to investigate Brucella species in brucellosis seropositive cattle in the Chiredzi district with access to GNP using isolation and identification. Isolation of Brucella species from whole blood (n = 18 and milk samples (n = 10 from seropositive animals with an abortion history was based on the rose Bengal test (RBT and enzyme-linked immunoassays (enzyme- linked immunosorbent assay [ELISA]; indirect ELISA and complement ELISA, using microbiology and polymerase chain reaction (PCR methods. Brucella abortus was cultured and identified from blood and milk collected from seropositive cows in both communal areas. The Brucella-specific 16-23S intergenic spacer (ITS PCR and multiplex AMOS-PCR assays verified the identification of the cultures. Our results confirmed that B. abortus is present in cattle on communal farms in the Chiredzi district in Zimbabwe and might cause cattle abortions. The need for implementing control measures and raising public awareness on zoonotic transmission of brucellosis are recommended.

  15. Biotyping and genotyping (MLVA16) of Brucella abortus isolated from cattle in Brazil, 1977 to 2008.

    Minharro, Sílvia; Silva Mol, Juliana P; Dorneles, Elaine M S; Pauletti, Rebeca B; Neubauer, Heinrich; Melzer, Falk; Poester, Fernando P; Dasso, Maurício G; Pinheiro, Elaine S; Soares Filho, Paulo M; Santos, Renato L; Heinemann, Marcos B; Lage, Andrey P

    2013-01-01

    Brucellosis is a worldwide distributed zoonosis that causes important economic losses to animal production. In Brazil, information on the distribution of biovars and genotypes of Brucella spp. is scarce or unavailable. This study aimed (i) to biotype and genotype 137 Brazilian cattle isolates (from 1977 to 2008) of B. abortus and (ii) to analyze their distribution. B. abortus biovars 1, 2 and 3 (subgroup 3b) were confirmed and biovars 4 and 6 were first described in Brazil. Genotyping by the panel 1 revealed two groups, one clustering around genotype 40 and another around genotype 28. Panels 2A and 2B disclosed a high diversity among Brazilian B. abortus strains. Eighty-nine genotypes were found by MLVA16. MLVA16 panel 1 and 2 showed geographic clustering of some genotypes. Biotyping and MLVA16 genotyping of Brazilian B. abortus isolates were useful to better understand the epidemiology of bovine brucellosis in the region. PMID:24324670

  16. Biotyping and genotyping (MLVA16 of Brucella abortus isolated from cattle in Brazil, 1977 to 2008.

    Sílvia Minharro

    Full Text Available Brucellosis is a worldwide distributed zoonosis that causes important economic losses to animal production. In Brazil, information on the distribution of biovars and genotypes of Brucella spp. is scarce or unavailable. This study aimed (i to biotype and genotype 137 Brazilian cattle isolates (from 1977 to 2008 of B. abortus and (ii to analyze their distribution. B. abortus biovars 1, 2 and 3 (subgroup 3b were confirmed and biovars 4 and 6 were first described in Brazil. Genotyping by the panel 1 revealed two groups, one clustering around genotype 40 and another around genotype 28. Panels 2A and 2B disclosed a high diversity among Brazilian B. abortus strains. Eighty-nine genotypes were found by MLVA16. MLVA16 panel 1 and 2 showed geographic clustering of some genotypes. Biotyping and MLVA16 genotyping of Brazilian B. abortus isolates were useful to better understand the epidemiology of bovine brucellosis in the region.

  17. Estado actual de la vacuna recombinante contra el virus del papiloma humano

    Wendy Chan Acón

    2008-12-01

    Full Text Available La infección por el virus del papiloma humano (VPH es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50%. El virus se asocia aproximadamente a un 100% de los casos de cáncer cervical; a un 100% de las neoplasias cervicales intraepiteliales grados 1, 2, 3; a un 40% de los casos de cáncer de vulva, vagina y pene, 100% de las verrugas genitales; a un 100% de las papilomatosis respiratorias recurrentes; a un 90% del cáncer anal y a un 12% del cáncer de cabeza y cuello, predominantemente en orofaringe y amígdala. Actualmente, el uso de dos vacunas está aprobado en diversos países: Gardasil® y Cervarix®. Ambas están compuestas por proteínas L1 de VPH, en forma de partículas no infecciosas similares al virus (VLPs producidas por tecnología de ADN recombinante, adsorbidas en adyuvantes que contienen aluminio. La eficacia hallada en diversos estudios en sujetos no expuestos previamente al virus se encuentran en el rango del 98.8% al 100.0% para la prevención de neoplasias cervicales, vulvares y vaginales intraepiteliales, grados 2 y 3, relacionados con el VPH-16/18, además de los adenocarcinomas in situ y verrugas genitales causadas por VPH- 16/18/6/11 en el caso de Gardasil® y una eficacia del 100% en el caso de Cervarix® para la prevención de neoplasias cervicales grado 2 y 3 relacionados con el VPH-16/18. La eficacia de ambas se mantiene alrededor de los 5 años. Hasta el momento no se le ha atribuido a la vacuna ningún efecto terapéutico, solo se administra con fines profilácticos, sin embargo, esta no debe ser considerada como un sustituto de las pruebas de tamizaje para la prevención del cáncer cervical.

  18. Transplacentally transmitted congenital brucellosis due to brucella abortus biotype 1 in sprague-dawley rats

    In the investigation on the transplacentally transmitted congenital brucellosis due to Brucella abortus biotype 1 in Sprague- Dawley rats, neither any stillbirth, abortion or premature birth nor any abnormality of fetus was observed in the infected group or in the control group. B. abortus biotype was isolated from the fetus of infected rats only. Only one band of 498 base pair DNA was obtained in polymerase chain reaction products from DNA of the fetuses of infected SD rats. (author)

  19. Biotyping and Genotyping (MLVA16) of Brucella abortus Isolated from Cattle in Brazil, 1977 to 2008

    Minharro, Sílvia; Silva Mol, Juliana P.; Elaine M. S. Dorneles; Pauletti, Rebeca B; Neubauer, Heinrich; Melzer, Falk; Poester, Fernando P.; Dasso, Maurício G.; Pinheiro, Elaine S.; Soares Filho, Paulo M.; Santos, Renato L.; Marcos B. Heinemann; Andrey P. Lage

    2013-01-01

    Brucellosis is a worldwide distributed zoonosis that causes important economic losses to animal production. In Brazil, information on the distribution of biovars and genotypes of Brucella spp. is scarce or unavailable. This study aimed (i) to biotype and genotype 137 Brazilian cattle isolates (from 1977 to 2008) of B. abortus and (ii) to analyze their distribution. B. abortus biovars 1, 2 and 3 (subgroup 3b) were confirmed and biovars 4 and 6 were first described in Brazil. Genotyping by the ...

  20. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes

    Pizarro-Cerda, J. (Javier); Meresse, S. (Stéphane); Parton, R G; van der Goot, G; Sola-Landa, A.; Lopez-Goñi, I. (Ignacio); Moreno, E.; Gorvel, J P

    1998-01-01

    Brucella abortus is an intracellular pathogen that replicates within a membrane-bounded compartment. In this study, we have examined the intracellular pathway of the virulent B. abortus strain 2308 (S2308) and the attenuated strain 19 (S19) in HeLa cells. At 10 min after inoculation, both bacterial strains are transiently detected in phagosomes characterized by the presence of early endosomal markers such as the early endosomal antigen 1. At approximately 1 h postinoculation, bacteria are loc...

  1. In Vitro Antibacterial Effects of Five Volatile Oil Extracts Against Intramacrophage Brucella Abortus 544

    Ayman Al-Mariri; George Saour; Razan Hamoud

    2012-01-01

    Background: Brucella abortus is a gram-negative facultative intracellular bacterium that can cause a highly contagious disease in sheep, goats, cattle and one-humped camels. It is responsible for one of the most important zoonosis in human. The aim of this study was to evaluate the role of Mentha piperita, Origanum majorana, Citrus lemon, Cinnamomum verum and Myristica fragrans essential volatile oil extracts on human macrophages infected by B. abortus 544. Methods: Essential volatile oil ext...

  2. Modulación de la respuesta inmune durante la infección por virus distemper canino: implicancias terapéuticas y en el desarrollo de vacunas Modulation of immune response during canine distemper virus infection: therapeutic and vaccine development implications

    PF Céspedes

    2010-01-01

    Full Text Available La infección por virus distemper canino (VDC es la principal causa infecciosa de muerte en caninos domésticos y especies exóticas alrededor del mundo, amenazando especies protegidas como el panda gigante y grandes félidos. A través de la infección de linfocitos y células mononucleares periféricas, VDC bloquea la síntesis y vías de señalización de interferones y citoquinas, fenómeno que produce agotamiento selectivo de linfocitos CD4+ Th1 y disminuye la proliferación de células B y T. Estos eventos explican la severa inmunosupresión que caracteriza la infección por VDC y que conduce a una enfermedad multisistémica asociada a infecciones oportunistas deletéreas. Durante el curso de la infección, complejos eventos como la disfunción celular causada directamente por el virus o la respuesta immune exagerada contribuyen a la inmunopatogénesis de SNC. Considerando que varias especies son afectadas y que la infección posee una elevada infectividad y letalidad, esta revisión destaca la importancia de diseñar vacunas más seguras, capaces de inducir una inmunidad estratégica y de prevenir la neuropatología. Adicionalmente, para comprender de mejor manera los diversos y dinámicos mecanismos involucrados en la disrupción de la respuesta immune adaptativa, así como aquellos responsables de la inducción de inmunidad durante la vacunación o la exposición al virus, esta revisión expone el rol de las células dendríticas durante la infección por VDC. Finalmente, se discute cómo las terapias combinadas basadas en la fisiología de estas células nos permitirán mejorar la recuperación de pacientes en términos de sobrevida y la prevención de las secuelas asociadas a la infección.Canine distemper virus (CDV infection is the main infectious cause of mortality in canines and exotic animals worldwide, and also threatens several endangered species such as the giant panda and big felids. The CDV blocks interferon and cytokines

  3. Isolation of Brucella abortus ssb and uvrA genes from a genomic library by use of lymphocytes as probes.

    Zhu, Y.; S.C. Oliveira; Splitter, G A

    1993-01-01

    Brucella abortus proteins from virulent S2308 expressed from a pBluescript II SK- genomic library stimulated peripheral blood mononuclear (PBM) cell proliferation from cattle vaccinated with B. abortus S19. The method described here permits a rapid and directed approach to isolate genes encoding antigens of B. abortus that interact with lymphocytes primed to the living bacterium. The supernatants from the bacterial host JM109 (DE3) were cultured with freshly isolated bovine PBM cells. A total...

  4. Estudio de toxicidad por dosis única y tolerancia local de una vacuna antimeningocócica tipo B en ratas Sprague Dawley

    Juan F. Núñez

    2006-08-01

    Full Text Available La vacuna antimeningocócica tipo B, objetivo de este estudio, contiene vesículas purificadas de la membrana externa del meningococo del serogrupo B de la cepa (Cu- 385 - 83 B:4:P1.19,15. El esquema de vacunación propuesto en humanos consiste en tres dosis de 0,5 mL, separadas por un intervalo óptimo de ocho semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley (SD fue determinar la toxicidad potencial, letalidad, órganos, sistemas susceptibles y otros eventos adversos, así como la toxicidad en el sitio de inoculación después de la administración de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones del estudio y según los criterios establecidos para evaluar los resultados, la vacuna antimeningocócica tipo B, no produce efectos tóxicos en el modelo animal usado. Todo lo que se observó fueron formaciones granulomatosas a nivel del punto de inoculación. Estas formaciones han sido reportadas como pertenecientes a los adyuvantes de depósito, como el hidróxido de aluminio, usado en otras vacunas parenterales. Se concluye que la vacuna antimeningocócica tipo B resultó satisfactoria en las pruebas de toxicidad por dosisúnica y tolerancia local realizadas en la especie rata.

  5. Pseudomonas aeruginosa. Vacunas: un reto a la investigación

    Sara C. Esnard

    2004-04-01

    Full Text Available Pseudomonas aeruginosa, patógeno gramnegativo versátil y oportunista debido a su gran adaptabilidad fisiológica, potencial metabólico y mecanismos de virulencia, es causa frecuente a escala mundial de severas o letales infecciones en pacientes hospitalizados. El empeño por lograr terapias alternativas para prevenir o combatir las infecciones producidas por P. aeruginosa ha ocupado a investigadores de todo el mundo desde la segunda mitad del pasado siglo y actualmente se continúan reportando trabajos que respaldan los ensayos de candidatos vacunales, fundamentalmente a partir de antígenos proteicos, mayoritariamente basados en la construcción de vacunas recombinantes. En este artículo se presenta una revisión de trabajos publicados sobre las investigaciones desarrolladas en diferentes países, con el objetivo de obtener candidatos vacunales para la prevención o tratamiento de las infecciones causadas por Pseudomonas aeruginosa, a partir de la década de los años 50 del siglo XX hasta el 2003.

  6. Avances en el desarrollo de las vacunas neumocócicas conjugadas Update on Pneumococcal Conjugate Vaccines

    Wendy Chan-Acón

    2010-07-01

    Full Text Available El Streptococcus pneumoniae se encuentra entre los mayores patógenos causantes de infecciones invasoras y no invasoras en los dos extremos de la vida: en niños menores de 5 años y en personas mayores de 65 años de edad. Las principales manifestaciones asociadas a infecciones neumocócicas son: neumonía, bacteriemia febril, septicemia, otitis media y meningitis. Esta bacteria es uno de los principales agentes involucrados en la mortalidad infantil, con un estimado de 1, 000,000 de muertes globales por año, en niños menores de 5 años de edad, la mayoría provenientes de países en vías de desarrollo, por lo que es considerada como un serio problema para la salud pública alrededor del mundo. En el 2000 se introdujo al mercado de los Estados Unidos de Norte América, la primera vacuna neumocócica conjugada, que a diferencia de la ya disponible vacuna neumocócica polisacárida, es capaz de proporcionar una respuesta inmune efectiva para la protección de niños menores de 2 años. La eficacia reportada para la vacuna conjugada heptavalente en los ensayos clínicos iniciales fue de un 97.4% contra la enfermedad neumocócica invasora producida por los serotipos incluidos en la vacuna (4, 9V, 14, 19F, 23F, 18C y 6B. En la actualidad diferentes entidades regulatorias, incluyendo la Agencia Europea de Medicamentos (EMEA, han autorizado la comercialización de la vacuna conjugada 10-valente, en la que, además de los serotipos descritos para la vacuna 7-valente, se incluyen los serotipos 1, 5 y 7F; de estos diez serotipos, ocho se encuentran conjugados con la proteína transportadora D, un elemento que se encuentra en la porción externa del Haemophilus influenzae. La otra nueva vacuna conjugada que está en fase de análisis por diferentes entidades regulatorias, incluyendo la Administración de Alimentos y Drogas de los Estados Unidos (FDA y la EMEA, pero que ya fue aprobada en Chile, es la que contiene 13 serotipos: los diez de la vacuna 10

  7. Protein profile of Chlamydophila abortus isolates from Kerala, India

    Binu K Mani

    Full Text Available Chlamydiae are of microbiological interest because of their mode of interaction with eukaryotic host cells and their specialized life cycle with unique features of parasitism. Reports regarding prevalence of infections of Chlamydophila abortus, the causative organism for chlamydial abortions in livestock, was the basis of the study. Two isolates, one each from cattle and goat abortion along with a reference isolate, were used for characterization with Sodium Dodecyl Sulphate-Poly Acrylamide Gel Electrophoresis (SDS-PAGE. Elementary bodies infected Mc Coy cells, harvested from bottle cultures were disrupted by Teflon coated magnetic pellet. Urografin-76 diluted with Tris-Potassium hydrochloride was used for purification of Elementary bodies of Chlamydophila abortus organism. On protein estimation of Elementary bodies by Biuret method, all the three isolates revealed protein concentration between 500-1000 mg/100ml, which were sufficient for electrophoresis. Ten percent of resolving gel and five percent of stacking gel of polyacrylamide in which 10g of processed isolate samples along with standard protein marker and Mc Coy cell protein (control were electrophoresed. Using Alpha Imager Gel Documentation System, the protein bands were analyzed. Twelve bands each for local bovine isolate and reference isolate were noticed while only 10 bands were there in the caprine isolate. Additional bands of 148 kDa and 135 kDa were present in bovine isolate, compared to the reference isolate, while 152 kDa and 137 kDa bands were unique for caprine isolate. [Vet. World 2011; 4(10.000: 470-472

  8. Evaluación de la toxicidad por dosis única de la vacuna antitetánica vax-TET en ratas Sprague Dawley

    2007-01-01

    La vacuna vax-TET® está indicada en la prevención del tétanos y es efectiva si se logra un completo y apropiado esquema de inmunización. Para investigar el potencial tóxico de este producto se realizó una prueba toxicológica con una dosis única, por vía intramuscular, en un volumen de 0,2 mL en ratas Sprague Dawley. La composición de la vacuna de ensayo probada fue la misma de la vacuna comercial. Los animales fueron observados diariamente en busca de síntomas locales y sistémicos de toxicida...

  9. Evaluación de la inmunidad celular en caninos: prueba de proliferación de linfocitos in vitro Evaluation of cellular immunity in dogs: in vitro lymphocyte proliferation test

    L.G. Ramayo; M.G Soba; Mundo, S.L.

    2005-01-01

    La prueba de proliferación de linfocitos inducida por mitógenos in vitro se utiliza para evaluar la inmunidad celular. En el presente trabajo, se comparan los resultados obtenidos con el método tradicional, que utiliza linfocitos purificados para el cultivo y la captación de timidina tritiada como método de medición de la proliferación (LP- ³H), con otras dos metodologías: el uso de sangre entera con revelado por captación de timidina tritiada (SE-³H) y el uso de linfocitos purificados con re...

  10. Desarrollo de biomodelos para la evaluación de la inmunidad secretora contra M. tuberculosis en ratones Balb/c

    Annette León

    2000-09-01

    Full Text Available Poco se ha estudiado acerca del papel de los anticuerpos específicos, presentes en las secreciones del aparato respiratorio, en la defensa contra patógenos intracelulares, como es el caso de las micobacterias causantes de la tuberculosis en el hombre: Micobacterium tuberculosis, bovis y africanum. Con el objetivo de desarrollar modelos adecuados para evaluar el posible papel de la inmunidad secretoria en la defensa contra la tuberculosis, se desarrollaron dos modelos animales con la utilización de un anticuerpo monoclonal IgA dirigido contra la proteína de 16 kD de M. tuberculosis y M. bovis. En el primer modelo se inocularon ratones Balb/c, por vía subcutánea al nivel de la nuca, con diferentes cantidades de células del hibridoma TBA61, productor de la IgA específica. En un segundo modelo, se inoculó por vía intraperitoneal líquido ascítico correspondiente a este hibridoma obtenido en ratón. En ambos casos se determinó, a diferentes tiempos, la concentración del monoclonal en saliva y sólo en suero para el segundo. En los dos modelos se demostró el paso del monoclonal a la saliva, donde alcanzó la máxima concentración: a los 21 días en los animales inoculados con el hibridoma, y a las 2 horas en saliva y suero en los animales inoculados con el líquido ascítico. Se sugiere, por su sencillez y mayor inocuidad, el uso del segundo modelo para la realización de estudios de reto por vía mucosal.

  11. Evaluación de la toxicidad por dosis única y tolerancia local de la vacuna vax-SPIRAL® en ratas Sprague Dawley

    Juan F. Infante

    2004-04-01

    Full Text Available Las pruebas preclínicas de toxicidad en dosis única y en dosis repetidas brindan una valiosa información sobre la seguridad del producto, al incluir el estudio macroscópico e histopatológico de órganos importantes, así como evaluaciones de las vías de administración y el régimen de dosificación. Cuba desarrolló una vacuna polivalente de células inactivadas químicamente adyuvadas con hidróxido de aluminio, vax-SPIRAL®. Esta vacuna presenta ventajas en relación con otras vacunas como la procedente de la antigua URSS. El esquema de vacunación para humanos consiste en dos dosis de 0,5 mL, separadas por un intervalo óptimo de seis semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley fue determinar la toxicidad potencial, letalidad, órganos y sistemas susceptibles y otros eventos adversos, así como la toxicidad en el sitio de inoculación después de la administración de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones en estudio y según los criterios establecidos para evaluar los datos obtenidos, la vacuna antileptospirósica trivalente no produce efectos tóxicos en el modelo animal usado. Las únicas alteraciones encontradas fueron formaciones granulomatosas a nivel del sitio de inoculación. Estas formaciones han sido reportadas como pertenecientes al adyuvante de depósito (hidróxido de aluminio, también usado en otras vacunas de aplicación parenteral.

  12. Nueva metodología para la formulación de la vacuna Heberpenta-L

    Imeray Díaz

    2014-06-01

    Full Text Available Título en ingles: New methodology for the formulation of the vaccine Heberpenta-LTítulo corto: Formulación de Heberpenta-LResumen: La vacuna Heberpenta-L, está indicada para la inmunización activa contra la difteria, tétanos, tos ferina (pertussis, hepatitis B y Haemophilus influenzae tipo b. En el Centro Nacional de Biopreparados se diseñó una nueva planta de producción de productos parenterales, resultando la vacuna pentavalente uno de los productos recién introducidos. Con tal propósito se diseñó una nueva metodología para la formulación de la vacuna, adecuando los procedimientos normalizativos de operación vigentes a esta nueva instalación. La validación con medio de cultivo caldo triptona soya, resultó una de las etapas más importantes para garantizar, tanto las operaciones de esterilización y enfriamiento de las soluciones, como todos los pasos críticos en la formulación y operaciones asépticas para futuros productos. Se estableció una nueva metodología en el proceso de formulación para la preparación de las soluciones, la cual tuvo lugar en un área independiente al área de la formulación final del producto. Los resultados satisfactorios obtenidos en la formulación de tres lotes de consistencia de la vacuna Heberpenta-L, no solo garantizaron el cumplimiento de los requisitos de calidad establecidos para esta vacuna, sino que además constituyeron la base preliminar a largas campañas de otros productos.Palabras clave: vacuna pentavalente, parenterales, producción.Abstract:  The vaccine Heberpenta-L, is suitable for the active immunization against diphtheria, tetanuses, ferocious cough (pertussis, hepatitis B and Haemophilus influenzae type b. In the National Center of Bioproducts a new plant of production of parenterals products was established, being the vaccine pentavalent one of the recently introduced products. With such a purpose, a new methodology was designed for the formulation of the vaccine

  13. Un momento de reflexión acerca de las vacunas Just a moment for thinking about vaccines

    G.G. Cáceres Bermejo

    2012-06-01

    Full Text Available Durante muchos siglos, los primeros atisbos de vacunación estuvieron ligados a la práctica de la variolización. En 1796 Edward Jenner desarrolló la primera vacuna contra la viruela: gracias a la vacunación se ha conseguido la erradicación de esta mortal enfermedad sobre el planeta. En otras enfermedades como el tétanos neonatal, la poliomielitis o el sarampión las campañas de vacunación han conseguido una drástica disminución de la morbi-mortalidad. Actualmente, estos logros conseguidos por las vacunas han producido una falsa percepción de ausencia de riesgo, en algunos casos han descendido las coberturas de vacunación, y se ha producido un aumento del número de casos y brotes de algunas enfermedades como el sarampión. A esta situación han contribuido los mensajes de algunos grupos contrarios a la vacunación que han atribuido a las vacunas una serie de efectos adversos que en ningún caso han sido probados por la comunidad científica.Throughout the last centuries, the first signs of vaccination were linked to variolation procedures. In 1796, Edward Jenner developed the first vaccine for smallpox: the world eradication of this mortal disease was achieved due to the vaccination. In other diseases, such as neonatal tetanus, poliomyelitis or measles, immunization programmes have drastically decreased morbidity and mortality. Nowadays, these achievements of vaccination have caused a false perception of lack of risk, causing a decrease in immunization coverage in some cases. There has been a considerable increase on reported cases and outbreaks of some diseases such as measles. The messages of anti-vaccination movements have contributed to generate this situation by associating some adverse effects with vaccines, but there is no scientific evidence to support it.

  14. Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tetánico y diftérico con concentración reducida en adolescentes cubanos

    2006-01-01

    Se realizó un estudio aleatorizado, controlado y a doble ciegas en 225 adolescentes cubanos entre 13 y 16 años de edad, con el objetivo de evaluar la reactogenicidad y la inmunogenicidad de una nueva vacuna de toxoide tetánico y toxoide diftérico con concentración reducida, producida en el Instituto Finlay, con respecto a su similar comercial IMOVAX dT adult de Aventis Pasteur. Se tomaron muestras de suero antes y 21 días después de la vacunación. La reactogenicidad de ambas vacunas fue simil...

  15. Fragmentación del polisacárido de Neisseria meningitidis serogrupo C para su uso en vacunas conjugadas

    Osmir Cabrera; Carmen R. Soto; Maribel Cuello; Miguel E. Martínez; Juan C. Martínez; Gustavo Sierra

    2001-01-01

    Las infecciones meningocócicas son una causa importante de morbilidad y mortalidad en el mundo. Los serogrupos B y C son los responsables de la mayoría de los casos reportados en muchos países e incluso en países desarrollados. Las vacunas meningocócicas que contienen al polisacárido capsular purificado del meningococo C inducen en adultos protección por la presencia de anticuerpos bactericidas en sueros, pero son pobremente inmunogénicos en niños pequeños y pueden inducir toleran...

  16. Un momento de reflexión acerca de las vacunas Just a moment for thinking about vaccines

    G.G. Cáceres Bermejo

    2012-01-01

    Durante muchos siglos, los primeros atisbos de vacunación estuvieron ligados a la práctica de la variolización. En 1796 Edward Jenner desarrolló la primera vacuna contra la viruela: gracias a la vacunación se ha conseguido la erradicación de esta mortal enfermedad sobre el planeta. En otras enfermedades como el tétanos neonatal, la poliomielitis o el sarampión las campañas de vacunación han conseguido una drástica disminución de la morbi-mortalidad. Actualmente, estos logros conseguidos por l...

  17. Vaccination of elk (Cervus canadensis) with Brucella abortus strain RB51 overexpressing superoxide dismutase and glycosyltransferase genes does not induce adequate protection against experimental brucella abortus challenge

    In recent years, elk (Cervus canadensis) have been implicated as the source of Brucella abortus infection for numerous cattle herds in the Greater Yellowstone Area (GYA). In the face of environmental and ecological changes on the landscape, the range of infected elk is expanding. Consequently, the d...

  18. Cytokine responses in camels (Camelus bactrianus) vaccinated with Brucella abortus strain 19 vaccine.

    Odbileg, Raadan; Purevtseren, Byambaa; Gantsetseg, Dorj; Boldbaatar, Bazartseren; Buyannemekh, Tumurjav; Galmandakh, Zagd; Erdenebaatar, Janchivdorj; Konnai, Satoru; Onuma, Misao; Ohashi, Kazuhiko

    2008-02-01

    In the present study, we determined the levels of cytokines produced by camel (Camelus bactrianus) peripheral blood mononuclear cells (PBMCs) in response to live attenuated Brucella abortus (B. abortus) S19 vaccine. Seven camels were vaccinated with commercial B. abortus S19 vaccine, and their cytokine responses were determined using a real-time PCR assay. Cytokine responses to B. abortus S19 were examined at 6 hr, 48 hr and 1, 2 and 3 weeks post-vaccination. Serological tests were performed to further confirm these immune responses. The results revealed that IFN-gamma and IL-6 were upregulated during the first week post-vaccination. Low level expressions of IL-1alpha, IL-1beta, TNFalpha and IL-10 and no expression of IL-2 and IL-4 were observed compared with the control camels. The findings showed that B. abortus stimulates cell-mediated immunity by directly activating camel Th1 cells to secrete IFN-gamma. This quantification of cytokine expression in camels is essential for understanding of Camelidae disease development and protective immune responses. This is the first report of in vivo camel cytokine quantification after vaccination. PMID:18319583

  19. Expression of Babesia bovis rhoptry-associated protein 1 (RAP1) in Brucella abortus S19.

    Sabio y García, Julia V; Farber, Marisa; Carrica, Mariela; Cravero, Silvio; Macedo, Gilson C; Bigi, Fabiana; Oliveira, Sergio C; Rossetti, Osvaldo; Campos, Eleonora

    2008-05-01

    Brucella abortus strain 19 (live vaccine) induces a strong humoral and cellular immune response and therefore, it is an attractive vector for the delivery of heterologous antigens. The objective of the present study was to express the rhoptry-associated protein (RAP1) of Babesia bovis in B. abortus S19, as a model for heterologous expression of immunostimulatory antigens from veterinary pathogens. A plasmid for the expression of recombinant proteins fused to the aminoterminal of the outer membrane lipoprotein OMP19 was created, pursuing the objective of increasing the immunogenicity of the recombinant antigen being expressed by its association to a lipid moiety. Recombinant strains of B. abortus S19 expressing RAP1 as a fusion protein either with the first amino acids of beta-galactosidase (S19pBB-RAP1) or B. abortus OMP19 (S19pBB19-RAP1) were generated. Plasmid stability and the immunogenicity of the heterologous proteins were analyzed. Mice immunized with S19pBB-RAP1 or S19pBB19-RAP1 developed specific humoral immune response to RAP1, IgG2a being the predominant antibody isotype. Furthermore, a specific cellular immune response to recombinant RAP1 was elicited in vitro by lymphocytes from mice immunized with both strains. Therefore, we concluded that B. abortus S19 expressing RAP1 is immunostimulatory and may provide the basis for combined heterologous vaccines for babesiosis and brucellosis. PMID:18462974

  20. N-Formyl-Perosamine Surface Homopolysaccharides Hinder the Recognition of Brucella abortus by Mouse Neutrophils.

    Mora-Cartín, Ricardo; Chacón-Díaz, Carlos; Gutiérrez-Jiménez, Cristina; Gurdián-Murillo, Stephany; Lomonte, Bruno; Chaves-Olarte, Esteban; Barquero-Calvo, Elías; Moreno, Edgardo

    2016-06-01

    Brucella abortus is an intracellular pathogen of monocytes, macrophages, dendritic cells, and placental trophoblasts. This bacterium causes a chronic disease in bovines and in humans. In these hosts, the bacterium also invades neutrophils; however, it fails to replicate and just resists the killing action of these leukocytes without inducing significant activation or neutrophilia. Moreover, B. abortus causes the premature cell death of human neutrophils. In the murine model, the bacterium is found within macrophages and dendritic cells at early times of infection but seldom in neutrophils. Based on this observation, we explored the interaction of mouse neutrophils with B. abortus In contrast to human, dog, and bovine neutrophils, naive mouse neutrophils fail to recognize smooth B. abortus bacteria at early stages of infection. Murine normal serum components do not opsonize smooth Brucella strains, and neutrophil phagocytosis is achieved only after the appearance of antibodies. Alternatively, mouse normal serum is capable of opsonizing rough Brucella mutants. Despite this, neutrophils still fail to kill Brucella, and the bacterium induces cell death of murine leukocytes. In addition, mouse serum does not opsonize Yersinia enterocolitica O:9, a bacterium displaying the same surface polysaccharide antigen as smooth B. abortus Therefore, the lack of murine serum opsonization and absence of murine neutrophil recognition are specific, and the molecules responsible for the Brucella camouflage are N-formyl-perosamine surface homopolysaccharides. Although the mouse is a valuable model for understanding the immunobiology of brucellosis, direct extrapolation from one animal system to another has to be undertaken with caution. PMID:27001541

  1. Que hay en el horizonte sobre el virus del papiloma humano, vacunas y el control del cáncer

    Patricia J. García

    2007-07-01

    Full Text Available Esta revisión provee una visión general sobre las infecciones genitales producidas por el virus del papiloma humano (VPH y de las neoplasias relacionadas con éste y la información sobre las expectativas crecientes de la vacunación como medio de prevención. Se explora como se han desarrollado las vacunas contra el VPH y que aspectos hay que tener en cuenta para una posible implementación de un programa de vacunación para prevenir el cáncer cervical, como los costos, el público objetivo (varones, mujeres o ambos, grupos de riesgo, a que edad vacunarlos, consideraciones que debemos tener en cuenta en la promoción de la vacuna, que pasaría con los programas de detección precoz de cáncer cervical y cuales son los potenciales problemas que tendría en países en desarrollo.

  2. - Las vacunas de ADN: una promisoria medicina para el paciente veterinario (DNA vaccines: a promising medicine for the veterinary patient

    Juan Carlos Díaz David

    2006-02-01

    Full Text Available Resumen. Las vacunas de ADN constituyen una promisoria herramienta en vacunología moderna. Al tratarse de una tecnología fácil de aplicar y de gran versatilidad, capaz de estimular una respuesta inmune humoral y celular, esenciales en la lucha contra infecciones virales, constituye una línea primordial de investigación y desarrollo. Esta revisión aborda las características de un vector de ADN y los mecanismos propuestos para la generación de la respuesta inmune mediante este tipo de vacunación. Igualmente, se discuten algunos regímenes de vacunación, ejemplos de respuestas inmunes protectoras obtenidas en especies de interés veterinario, y se hace referencia a las cuestiones de inocuidad inherentes a este tipo de vacuna. Abstract. DNA vaccines represent an invaluable tool in modern vaccinology. Besides being a simple versatile technology, capable of stimulating both cellular and humoral immune responses, it is also an essential weapon to fight against infections of viral etiology. This review emphasizes the characteristics of a DNA vaccine vector, as well as the proposed mechanisms responsible for the generation of a protective immune response. Furthermore, immunization regimes are discussed, examples of protective immune responses attained in target species of veterinary interest are given and reference is made to the safety concerns derived from this kind of vaccine.

  3. In vitro and in vivo characterization of smooth small colony variants of Brucella abortus S19.

    Jacob, J; Hort, G M; Overhoff, P; Mielke, M E A

    2006-02-01

    Brucella abortus is known to produce chronic infections in both humans and a variety of animal species. However, the mechanisms underlying the persistence of the bacteria in the presence of an ongoing immune response are still unknown. In this respect we made use of the observation that in vitro grown B. abortus S19 exhibits heterogenicity in colony size when plated onto TS agar, while experimental infection of mice uniformly results in the in vivo selection of the small colony variant. We demonstrate that the spontaneous smooth small colony variant is characterized not only by a slower growth rate in vitro but also by an increased tolerance to hyperosmotic medium and, most importantly, a less effective clearance from spleens and livers of experimentally infected mice. On a molecular level, a gene with homology to a formerly described galactoside transport ATP binding protein (mglA) was differentially expressed in small versus large colonies of B. abortus S19. PMID:16239117

  4. Proteomic Profile of Brucella abortus-Infected Bovine Chorioallantoic Membrane Explants

    Mol, Juliana P. S.; Pires, Simone F.; Chapeaurouge, Alexander D.; Perales, Jonas; Santos, Renato L.; Andrade, Hélida M.; Lage, Andrey P.

    2016-01-01

    Brucella abortus is the etiological agent of bovine brucellosis, a zoonotic disease that causes significant economic losses worldwide. The differential proteomic profile of bovine chorioallantoic membrane (CAM) explants at early stages of infection with B. abortus (0.5, 2, 4, and 8 h) was determined. Analysis of CAM explants at 0.5 and 4 h showed the highest differences between uninfected and infected CAM explants, and therefore were used for the Differential Gel Electrophoresis (DIGE). A total of 103 spots were present in only one experimental group and were selected for identification by mass spectrometry (MALDI/ToF-ToF). Proteins only identified in extracts of CAM explants infected with B. abortus were related to recognition of PAMPs by TLR, production of reactive oxygen species, intracellular trafficking, and inflammation. PMID:27104343

  5. Experimental infection of Richardson's ground squirrels (Spermophilus richardsonii) with attenuated and virulent strains of Brucella abortus.

    Nol, Pauline; Olsen, Steven C; Rhyan, Jack C

    2009-01-01

    A previous investigation of the safety of Brucella abortus strain RB51 (sRB51) in various nontarget species suggested that Richardson's ground squirrels (Spermophilus richardsonii) may develop persistent infections when orally inoculated with the vaccine. In the present study, sRB51, B. abortus strain 19 (s19), and virulent B. abortus strain 9941 (s9941) were administered orally to Richardson's ground squirrels to further characterize B. abortus infection in this species. Six groups of nongravid ground squirrels were orally inoculated with 6 x 10(8) colony forming units (cfu) sRB51 (n = 10), 2.5 x 10(4) cfu s19 (n = 10), 2.5 x 10(7) cfu s19 (n = 6), 1.3 x 10(6) cfu s9941 (n = 5), 2.1 x 10(8) cfu s9941 (n = 5), or vaccine diluent (control; n = 4). One of five animals in the lower-dose s19 group and two of three animals in the higher-dose s19 group showed persistence of bacteria in various tissues at 14 wk postinoculation (PI). At 18 wk PI, one of five animals in the sRB51 group and one of five animals in the high-dose s9941 group were culture positive. Although we did detect some persistence of B. abortus strains at 18 wk, we found no evidence of pathology caused by B. abortus strains in nonpregnant Richardson's ground squirrels based on clinical signs, gross lesions, and microscopic lesions. PMID:19204348

  6. A rare cause of native tricuspid valve endocarditis: Abortus

    M.Sıddık Evsen

    2011-03-01

    Full Text Available A 28-year-old female patient, who at her 7 weeks ofpregnancy, admitted to hospital with abdominal painand vaginal bleeding. She had been hospitalized in anothercenter with the diagnosis of spontaneous completeabortion. After discharge, her clinical process, deteriorateddue to fever, chills and fatigue therefore she hadbeen admitted to emergency unit of that hospital onceagain, and received non-specific antibiotics. She was referredto our clinic because of persistant complaints.Transthoracic echocardiography showed vegetations onthe tricuspid valve leading to diagnosis of infective endocarditis,so treatment was started at our clinic. No microorganismisolated in blood cultures. Following 15-days antibiotic therapy no reduction was seen in the diameterof the vegetation, therefore surgical operationwas planned and a bioprosthetic tricuspid valve was putinto place. In this article we aimed to report the developmentof spontaneous abortus at 7 weeks of pregnancy,in order to emphasize that tricuspid valve endocarditiscan be developed secondary to very rare causes.J Clin Exp Invest 2011; 2(1: 102-105

  7. Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.

    Jerod A Skyberg

    Full Text Available γδ T cells have been postulated to act as a first line of defense against infectious agents, particularly intracellular pathogens, representing an important link between the innate and adaptive immune responses. Human γδ T cells expand in the blood of brucellosis patients and are active against Brucella in vitro. However, the role of γδ T cells in vivo during experimental brucellosis has not been studied. Here we report TCRδ(-/- mice are more susceptible to B. abortus infection than C57BL/6 mice at one week post-infection as measured by splenic colonization and splenomegaly. An increase in TCRγδ cells was observed in the spleens of B. abortus-infected C57BL/6 mice, which peaked at two weeks post-infection and occurred concomitantly with diminished brucellae. γδ T cells were the major source of IL-17 following infection and also produced IFN-γ. Depletion of γδ T cells from C57BL/6, IL-17Rα(-/-, and GMCSF(-/- mice enhanced susceptibility to B. abortus infection although this susceptibility was unaltered in the mutant mice; however, when γδ T cells were depleted from IFN-γ(-/- mice, enhanced susceptibility was observed. Neutralization of γδ T cells in the absence of TNF-α did not further impair immunity. In the absence of TNF-α or γδ T cells, B. abortus-infected mice showed enhanced IFN-γ, suggesting that they augmented production to compensate for the loss of γδ T cells and/or TNF-α. While the protective role of γδ T cells was TNF-α-dependent, γδ T cells were not the major source of TNF-α and activation of γδ T cells following B. abortus infection was TNF-α-independent. Additionally, bovine TCRγδ cells were found to respond rapidly to B. abortus infection upon co-culture with autologous macrophages and could impair the intramacrophage replication of B. abortus via IFN-γ. Collectively, these results demonstrate γδ T cells are important for early protection to B. abortus infections.

  8. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge.

    Yang, Xinghong; Becker, Todd; Walters, Nancy; Pascual, David W

    2006-07-01

    znuA is known to be an important factor for survival and normal growth under low Zn(2+) concentrations for Escherichia coli, Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida. We hypothesized that the znuA gene present in Brucella melitensis 16 M would be similar to znuA in B. abortus and questioned whether it may also be an important factor for growth and virulence of Brucella abortus. Using the B. melitensis 16 M genome sequence, primers were designed to construct a B. abortus deletion mutant. A znuA knockout mutation in B. abortus 2308 (DeltaznuA) was constructed and found to be lethal in low-Zn(2+) medium. When used to infect macrophages, DeltaznuA B. abortus showed minimal growth. Further study with DeltaznuA B. abortus showed that its virulence in BALB/c mice was attenuated, and most of the bacteria were cleared from the spleen within 8 weeks. Protection studies confirmed the DeltaznuA mutant as a potential live vaccine, since protection against wild-type B. abortus 2308 challenge was as effective as that obtained with the RB51 or S19 vaccine strain. PMID:16790759

  9. Proceso para el desarrollo de una vacuna contra la fase hepática de Plasmodium vivax.

    Sócrates Herrera

    2009-11-01

    Full Text Available Introducción: Anualmente se producen en el mundo entre 80 y 100 millones de casos de malaria ocasionada por Plasmodium vivax, segunda especie de Plasmodium en importancia a nivel mundial y primera en el continente americano. Ante la falla de los métodos clásicos de control de la malaria, derivada de la creciente resistencia de los mosquitos a los insecticidas y de los parásitos a los medicamentos disponibles, se ha trabajado intensamente en la búsqueda de vacunas que puedan prevenir completamente la infección o limitar los efectos patológicos de la enfermedad. Objetivos: Este trabajo describe el proceso de desarrollo de una vacuna experimental dirigida contra las formas pre-eritrocíticas del parásito, para lo cual se ha seleccionado la proteína circumesporozoito (CS que se expresa de forma abundante en la superficie del parásito y que se halla comprometida en el proceso de invasión hepática. Metodología: El proceso consistió en una exhaustiva caracterización inmunológica de la proteína, mediante péptidos sintéticos de diferente longitud, seguida de pruebas de toxicidad e inmunogenicidad en animales con los tres péptidos largos que cubren las regiones N, R y C de la CS. Como etapa inicial de la prueba en humanos, se hizo un ensayo clínico fase I que probó la seguridad e inmunogenicidad, de cada uno de los péptidos formulados en el adyuvante Montanide ISA-720. El ensayo fue al azar, doble ciego y comprometió a 23 voluntarios sanos, hombres y mujeres entre 18 y 33 años de edad, sin historia de malaria. Conclusiones: La vacuna fue muy bien tolerada y demostró buena seguridad e inmunogenicidad en los ensayos preclínicos así como en todos los voluntarios, facilitando el avance a ulteriores fases de investigación clínica.

  10. Evaluación de la información sanitaria disponible en internet sobre la vacuna antigripal

    I. Hernández-García

    2014-12-01

    Full Text Available Fundamento: La calidad de la información sanitaria en internet preocupa a gobiernos y usuarios. Nuestro objetivo fue determinar en qué medida la información sobre la vacuna antigripal se adhiere al gold estándar representado por lo establecido por el Ministerio de Sanidad español. Material y métodos: Entre junio-julio 2014 se evaluó la adhesión al gold estándar de la información sobre indicaciones, efectos adversos y contraindicaciones de la vacuna. Dicha información se obtuvo a través de Google, utilizando términos proporcionados por estudiantes de medicina. Se realizó un análisis univariante, donde variable resultado fue obtener información correctamente adherida, y variables explicativas fueron el tipo de origen de la información y su país. Resultados: Con los términos de 104 alumnos se obtuvieron 134 enlaces web diferentes. La adhesión alcanzó el 65,7% (88/134 en cuanto a la indicación en trabajadores sanitarios (TS. El 19,4% aportaron información incorrecta sobre indicación en embarazadas. La información de organismos oficiales de salud pública se adhirió significativamente mejor (indicación en TS (OR: 2,6, embarazadas (OR: 5,4 e inmunodeprimidos (OR: 2,2. La información de enlaces web españoles se adhirió peor (indicación en embarazo (OR: 0,3 y contraindicación si alergia al huevo (OR: 0,5. Conclusiones: El nivel de adhesión detectado fue mejorable. Se debe urgir y promocionar en los usuarios la utilización de las páginas web de organismos oficiales de salud pública cuando busquen información sobre la vacuna antigripal en internet.

  11. Vaccination of Elk (Cervus canadensis) with Brucella abortus Strain RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes Does Not Induce Adequate Protection against Experimental Brucella abortus Challenge

    Nol, Pauline; Olsen, Steven C.; Rhyan, Jack C.; Sriranganathan, Nammalwar; McCollum, Matthew P.; Hennager, Steven G.; Pavuk, Alana A.; Sprino, Phillip J.; Boyle, Stephen M.; Berrier, Randall J.; Salman, Mo D.

    2016-01-01

    In recent years, elk (Cervus canadensis) have been implicated as the source of Brucella abortus infection for numerous cattle herds in the Greater Yellowstone Area. In the face of environmental and ecological changes on the landscape, the range of infected elk is expanding. Consequently, the development of effective disease management strategies for wild elk herds is of utmost importance, not only for the prevention of reintroduction of brucellosis to cattle, but also for the overall health o...

  12. Valutazione dell’efficacia del vaccino Brucella abortus ceppo RB51 rispetto al vaccino di referenza Brucella abortus ceppo 19 nel bufalo

    Massimo Scacchia; Armando Giovannini; Manuela Tittarelli; Simona Forcella; Andrea Di Provvido; Elisabetta Di Giannatale; Barbara Bonfini; Vincenzo Caporale

    2010-01-01

    Il patrimonio zootecnico della specie bufalina (Bubalus bubalis) della regione Campania, è di 250 000 capi, di questi 150 000 allevati in aziende zootecniche della provincia di Caserta. In queste aziende, nel 2007, l’infezione da Brucella abortus ha avuto la prevalenza media, per allevamento, del 20%. Complessivamente, i 2/3 degli allevamenti positivi hanno evidenziato una prevalenza superiore al 10% e, di questi, i 3/4 una prevalenza superiore al 20%. Prendendo il 20% come valore di riferime...

  13. Antibody Production From Immunized Rabbits By Brucella Abortus

    In this research Brucella abortus was used as antigen which was made by killing the bacteria in boiling water for 1 hour and then add 0.5% phenol. The suspension of bacteria of 6x108 cells/mm3 was used as antigen. Rabbits of about 3 months old were injected with 0.50 mI of the antigen by intradermal route with an interval of two weeks. The animals were divided in three groups i.e. A (control group), B (immunization group) and C (immunization and irradiation group). In C group, the animals were first immunized by the antigen and then 2 days later were irradiated by a low dose of 0.50 Gy of gamma rays. Each group consisted of 3 animals. Parameters were observed by weighing the animals, counting leucocyte and lymphocyte cells, and anaIysing the antisera. The research were done two times, included immunization I x, boostered 4 x and analysed 5x. The results obtained were as follows: A (control group) yielded 2.34 g/dl of non specific antibody, B (immunization group) yielded 3.22 g/dI of specific antibody, C (immunization and irradiation group) yielded 3.50 g/dl of spesific antibody. The leucocyte cells of A, B , and C group were 8.240, 7.887, and 8.120 cells/mm3, respectively. The lymphocyte cells of A, B, and C group were 69%, respectively. The weigh of A, B, and C group were 1.44; 1.53; and l.41 kg, respectively. The purpose of this research was prepared to produce the diagnostic reagen (RIA Kit) for a rapid detection of animals disease especially brucellosis. It seemed that C group (the combination of immunization and irradiation treatments) yielded the highest value of antibody production compared to another group

  14. Experimental Infection of Richardson's Ground Squirrels (Spermophilus richardsonii) with Attenuated and Virulent Strains of Brucella abortus

    Exposure of non-target species to wildlife vaccines is an important concern when evaluating a candidate vaccine for use in the field. A previous investigation of the safety of Brucella abortus strain RB51 (sRB51) in various non-target species suggested that Richardson’s ground squirrels (Spermophil...

  15. Ferrochelatase is present in Brucella abortus and is critical for its intracellular survival and virulence.

    Almirón, M; Martínez, M; Sanjuan, N; Ugalde, R A

    2001-10-01

    Brucella spp. are pathogenic bacteria that cause brucellosis, an animal disease which can also affect humans. Although understanding the pathogenesis is important for the health of animals and humans, little is known about virulence factors associated with it. In order for chronic disease to be established, Brucella spp. have developed the ability to survive inside phagocytes by evading cell defenses. It hides inside vacuoles, where it then replicates, indicating that it has an active metabolism. The purpose of this work was to obtain better insight into the intracellular metabolism of Brucella abortus. During a B. abortus genomic sequencing project, a clone coding a putative gene homologous to hemH was identified and sequenced. The amino acid sequence revealed high homology to members of the ferrochelatase family. A knockout mutant displayed auxotrophy for hemin, defective intracellular survival inside J774 and HeLa cells, and lack of virulence in BALB/c mice. This phenotype was overcome by complementing the mutant strain with a plasmid harboring wild-type hemH. These data demonstrate that B. abortus synthesizes its own heme and also has the ability to use an external source of heme; however, inside cells, there is not enough available heme to support its intracellular metabolism. It is concluded that ferrochelatase is essential for the multiplication and intracellular survival of B. abortus and thus for the establishment of chronic disease as well. PMID:11553564

  16. A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle.

    Hu, Xi-Dan; Yu, Da-Hai; Chen, Su-Ting; Li, Shu-Xia; Cai, Hong

    2009-04-01

    We evaluated the immunogenicity and protective efficacy of a combined DNA vaccine containing six genes encoding immunodominant antigens from Mycobacterium bovis and Brucella abortus. The number of lymph node and spleen cultures positive for M. bovis and B. abortus from calves immunized with the combined DNA vaccine was significantly reduced (p abortus 544. The combined DNA vaccine group displayed stronger antigen-specific interferon-gamma (IFN-gamma) responses and antigen-specific IFN-gamma ELISPOT activities 2 months after final immunization and after challenge. Antigen-specific CD4(+) and CD8(+) T cell responses in the combined DNA vaccine group were higher than either the Bacillus Calmette-Guerin (BCG)-positive or S19-positive control group. Likewise, more calves in the DNA vaccine group exhibited antigen-specific IgG titers and had higher IgG titers than those in the BCG- or S19-immunized groups 2 months after the final immunization. Moreover, two antigens in the combined DNA vaccine induced significant antigen-specific IFN-gamma responses 6 months after challenge (p S19 against B. abortus. This is the first report to demonstrate that a single combined DNA vaccine protects cattle against two infectious diseases. PMID:19364278

  17. Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers

    Kaissar Tabynov

    2016-01-01

    Full Text Available ABSTRACT: The present study provides the first information about the safety of a new influenza viral vector vaccine expressing the Brucella ribosomal protein L7/L12 or Omp16 containing the adjuvant Montanide Gel01 in pregnant heifers. Immunization of pregnant heifers was conducted via the conjunctival (n=10 or subcutaneous (n=10 route using cross prime and booster vaccination schedules at an interval of 28 days. The vector vaccine was evaluated in comparison with positive control groups vaccinated with B. abortus S19 (n=10 or B. abortus RB51 (n=10 and a negative (PBS+Montanide Gel01; n=10 control group. Clinical studies, thermometry, assessment of local reactogenicity and observation of abortion showed that the vector vaccine via the conjunctival or subcutaneous route was completely safe for pregnant heifers compared to the commercial vaccines B. abortus S19 or B. abortus RB51. The only single adverse event was the formation of infiltration at the site of subcutaneous injection; this reaction was not observed for the conjunctival route.

  18. Pyruvate kinase is necessary for Brucella abortus full virulence in BALB/c mouse.

    Gao, Jianpeng; Tian, Mingxing; Bao, Yanqing; Li, Peng; Liu, Jiameng; Ding, Chan; Wang, Shaohui; Li, Tao; Yu, Shengqing

    2016-01-01

    Brucellosis, caused by a facultative intracellular pathogen Brucella, is one of the most prevalent zoonosis worldwide. Host infection relies on several uncanonical virulence factors. A recent research hotpot is the links between carbon metabolism and bacterial virulence. In this study, we found that a carbon metabolism-related pyruvate kinase (Pyk) encoded by pyk gene (locus tag BAB_RS24320) was associated with Brucella virulence. Determination of bacterial growth curves and resistance to environmental stress factors showed that Pyk plays an important role in B. abortus growth, especially under the conditions of nutrition deprivation, and resistance to oxidative stress. Additionally, cell infection assay showed that Pyk is necessary for B. abortus survival and evading fusion with lysosomes within RAW264.7 cells. Moreover, animal experiments exhibited that the Pyk deletion significantly reduced B. abortus virulence in a mouse infection model. Our results elucidated the role of the Pyk in B. abortus virulence and provided information for further investigation of Brucella virulence associated carbon metabolism. PMID:27561260

  19. Identification of biovars of Brucella abortus in aborted cattle and buffaloes herd in Sri Lanka

    M. A. R. Priyantha

    Full Text Available Bovine brucellosis is an endemic disease in Sri Lanka, caused by Brucella abortus and had been reported all part of the country for last six decades. Since available biovar is still unknown, the objective of the study was to identify the biovar of B.abortus from sporadically aborted cattle and buffaloes. Samples were collected from 18 aborted herds out of 19 herds of Cattle and Buffaloes in the year 2010. Rose Bengal plate test and Compliment Fixation test were carried out. Milk, vaginal swabs, placental contents and aborted fetus were collected and cultured by conventional bacteriological methods. The detection of biovars were based on growth on Thionin and Bacto fuschin,CO2 requirement, H2S production, serum agglutination with Brucella negative, A,M and R reference antiserum. Eighteen herds investigated out of 19 herds reported, 11 herds were serologically positive for brucellosis (61.11% and only Brucella abortus were isolated from 8 individuals from six herds. All were identified as Biovar 3 of Brucella abortus. [Vet. World 2011; 4(12.000: 542-545

  20. Molecular Epidemiology of Brucella abortus in Northern Ireland-1991 to 2012.

    Adrian Allen

    Full Text Available Brucellosis is the most common bacterial zoonoses worldwide. Bovine brucellosis caused by Brucella abortus has far reaching animal health and economic impacts at both the local and national levels. Alongside traditional veterinary epidemiology, the use of molecular typing has recently been applied to inform on bacterial population structure and identify epidemiologically-linked cases of infection. Multi-locus variable number tandem repeat VNTR analysis (MLVA was used to investigate the molecular epidemiology of a well-characterised Brucella abortus epidemic in Northern Ireland involving 387 herds between 1991 and 2012.MLVA identified 98 unique B. abortus genotypes from disclosing isolates in the 387 herds involved in the epidemic. Clustering algorithms revealed the relatedness of many of these genotypes. Combined with epidemiological information on chronology of infection and geographic location, these genotype data helped to identify 7 clonal complexes which underpinned the outbreak over the defined period. Hyper-variability of some VNTR loci both within herds and individual animals led to detection of multiple genotypes associated with single outbreaks. However with dense sampling, these genotypes could still be associated with specific clonal complexes thereby permitting inference of epidemiological links. MLVA- based epidemiological monitoring data were congruent with an independent classical veterinary epidemiology study carried out in the same territory.MLVA is a useful tool in ongoing disease surveillance of B. abortus outbreaks, especially when combined with accurate epidemiological information on disease tracings, geographical clustering of cases and chronology of infection.

  1. SAFETY OF REVACCINATION OF PREGNANT BISON WITH BRUCELLA ABORTUS STRAIN RB51 DURING PREGNANCY

    From December of 1998 through February of 1999, a study was conducted in a Brucella-infected bison herd to evaluate the safety of booster vaccination of adult bison with 6 x 10**9 CFU of Brucella abortus strain RB51 (SRB51), in bison which had previously been vaccinated as yearlings with 1 x 10**10 ...

  2. Simultaneous detection and differentiates of Brucella abortus and Brucella melitensis by combinatorial PCR

    Reza Mirnejad; Reza Hosseini Doust; Reza Kachuei; Seied Mojtaba Mortazavi; Mehdi Khoobdel; Ali Ahamadi

    2012-01-01

    Objective:To evaluate simultaneous detection and differentiates of Brucella abortus(B. abortus) and Brucella melitensis (B. melitensis) through the combinatorial PCR method. Methods:This study was designed using three primers that could simultaneously identify and differentiate two major species of pathogenic Brucella in humans and animals. Identification and differentiation of each species using the size of the PCR product were determined. To determine the specificity of the method, bacteria close to the genus Brucella were used. Finally, to confirm PCR products, In addition to the products sequence, RFLP was performed on PCR products using restriction enzymes. Results:The method of optimized combinatorial PCR in this study could simultaneously detect and differentiate B. abortus and B. melitensis with high specificity and sensitivity in clinical samples. Differentiation of species is based on the resulting bands;therefore, the band 494 bp for B. abortus and 733 bp for B. melitensis were obtained. RFLP and sequencing results confirmed PCR results. Conclusions:The results of this study shows that without routine diagnostic methods such as culture and serology tests, using the molecular method of combinatorial PCR, important species of Brucella can be simultaneously identified and differentiated in clinical samples.

  3. Estudio de una metodología para la obtención de biodiesel a partir de grasa vacuna

    Javier Rodríguez

    2010-11-01

    Full Text Available La utilización de grasas vacunas de baja calidad (acidez mayor a 1%, fue considerada para la obtención de biodiesel (mezcla de ésteres metílicos de ácidos grasos para uso vehicular. Así, cuatro muestras diferentes de grasas bovinas se caracterizaron en base a su acidez y su composición en triglicéridos. Para cada una de ellas se evaluó el rendimiento y las características del proceso de producción del biodiesel estudiando, entre otras, las siguientes variables: concentración de base y metanol, temperatura y tiempo de reacción. Los productos obtenidos se caracterizaron cualitativamente para su uso vehicular.

  4. In Vitro Antibacterial Effects of Five Volatile Oil Extracts Against Intramacrophage Brucella Abortus 544

    Ayman Al-Mariri

    2012-06-01

    Full Text Available Background: Brucella abortus is a gram-negative facultative intracellular bacterium that can cause a highly contagious disease in sheep, goats, cattle and one-humped camels. It is responsible for one of the most important zoonosis in human. The aim of this study was to evaluate the role of Mentha piperita, Origanum majorana, Citrus lemon, Cinnamomum verum and Myristica fragrans essential volatile oil extracts on human macrophages infected by B. abortus 544. Methods: Essential volatile oil extracts from M. piperita, O. majorana, C. lemon, C. verum and M. fragrans were extracted. Human macrophages were cultured at a density of 2×105 cells per well in sterile 96-well microtiter plates, and infected with B. abortus 544 at a ratio of 1:100 bacteria/cell. Then essential volatile oil extracts were added at a concentration of 1%. At specified times; cells were washed, lysed with 0.1% Triton, and plated on 2YT agar to determine the number of intracellular bacteria. Results: Cinnamomum verum volatile oil at a concentration of 1% had the highest antibacterial activity against B. abortus 544 inside human macrophages. Its inhibitory effect observed from 24 h and continued till 144 h after the infection. Moreover, C. verum (0.1% in combination with 1% concentration of M. piperita, O. majorana, C. lemon or M. fragrans volatile oil extracts produced a synergistic inhibitory effect against B. abortus 544. Conclusion: The results indicate that, among the five selected oil extracts, C. verum volatile oil applied either separately or in combination with other oil extracts had the most effective antimicrobial activity against Brucella.

  5. Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil

    Barbosa Pauletti, Rebeca; Reinato Stynen, Ana Paula; Pinto da Silva Mol, Juliana; Seles Dorneles, Elaine Maria; Alves, Telma Maria; de Sousa Moura Souto, Monalisa; Minharro, Silvia; Heinemann, Marcos Bryan; Lage, Andrey Pereira

    2015-01-01

    This study aimed to determine the susceptibility profile of Brazilian Brucella abortus isolates from cattle to eight antimicrobial agents that are recommended for the treatment of human brucellosis and to correlate the susceptibility patterns with origin, biotype and MLVA16-genotype of the strains. Screening of 147 B. abortus strains showed 100% sensitivity to doxycycline and ofloxacin, one (0.68%) strain resistant to ciprofloxacin, two strains (1.36%) resistant to streptomycin, two strains (...

  6. Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting.

    Brooks-Worrell, B M; Splitter, G A

    1992-01-01

    Cellular immune responses are influential for protection against intracellular bacteria such as brucellae. Therefore, identification of Brucella abortus antigens that activate primed bovine lymphocytes is fundamental for discerning the breadth of cellular response in bovine brucellosis. Potentially antigenic components of B. abortus S19 were isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by nitrocellulose blotting. Specific one-dimensional blot segments induced...

  7. Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes

    Crasta, Oswald R.; Folkerts, Otto; Fei, Zhangjun; Mane, Shrinivasrao P.; Evans, Clive; Martino-Catt, Susan; Bricker, Betsy; Yu, GongXin; Du, Lei; Sobral, Bruno W.

    2008-01-01

    The Brucella abortus strain S19, a spontaneously attenuated strain, has been used as a vaccine strain in vaccination of cattle against brucellosis for six decades. Despite many studies, the physiological and molecular mechanisms causing the attenuation are not known. We have applied pyrosequencing technology together with conventional sequencing to rapidly and comprehensively determine the complete genome sequence of the attenuated Brucella abortus vaccine strain S19. The main goal of this st...

  8. Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis.

    Rossetti, O L; Arese, A I; Boschiroli, M L; Cravero, S L

    1996-01-01

    Brucella spp. are the causative agents of brucellosis in many different hosts, including humans. Most of the serological methods of diagnosis are based on the detection of antilipopolysaccharide antibodies, which makes the differentiation of vaccinated animals from infected animals difficult. By using molecular biology techniques, a gene that encodes a 26-kDa protein (BP26) was isolated from a Brucella abortus S19 genome lambda gt11 library. This protein is in the periplasm of B. abortus and ...

  9. The Brucella abortus Cyclic β-1,2-Glucan Virulence Factor Is Substituted with O-Ester-Linked Succinyl Residues

    Roset, Mara S.; Ciocchini, Andrés E.; Ugalde, Rodolfo A.; Iñón de Iannino, Nora

    2006-01-01

    Brucella periplasmic cyclic β-1,2-glucan plays an important role during bacterium-host interaction. Nuclear magnetic resonance spectrometry analysis, thin-layer chromatography, and DEAE-Sephadex chromatography were used to characterize Brucella abortus cyclic glucan. In the present study, we report that a fraction of B. abortus cyclic β-1,2-glucan is substituted with succinyl residues, which confer anionic character on the cyclic β-1,2-glucan. The oligosaccharide backbone is substituted at C-...

  10. Genome Sequence of Brucella abortus Vaccine Strain S19 Compared to Virulent Strains Yields Candidate Virulence Genes

    Crasta, Oswald R.; Otto Folkerts; Zhangjun Fei; Mane, Shrinivasrao P.; Clive Evans; Susan Martino-Catt; Betsy Bricker; GongXin Yu; Lei Du; Sobral, Bruno W.

    2008-01-01

    The Brucella abortus strain S19, a spontaneously attenuated strain, has been used as a vaccine strain in vaccination of cattle against brucellosis for six decades. Despite many studies, the physiological and molecular mechanisms causing the attenuation are not known. We have applied pyrosequencing technology together with conventional sequencing to rapidly and comprehensively determine the complete genome sequence of the attenuated Brucella abortus vaccine strain S19. The main goal of this st...

  11. Effects of partial deletion of the wzm and wzt genes on lipopolysaccharide synthesis and virulence of Brucella abortus S19.

    Wang, Xiuran; Wang, Lin; Lu, Tiancheng; Yang, Yanling; Chen, Si; Zhang, Rui; Lang, Xulong; Yan, Guangmou; Qian, Jing; Wang, Xiaoxu; Meng, Lingyi; Wang, Xinglong

    2014-06-01

    Brucellosis is a worldwide human and animal infectious disease, and the effective methods of its control are immunisation of animals by vaccination and elimination. Brucella abortus S19 is one of the popular vaccines with virulence in the control of cattle Brucellosis. In the present study, allelic exchange plasmids of wzm and wzt genes and partial knockout mutants of wzm and wzt were constructed to evaluate the resulting difference in virulence of B. abortus S19. PCR analysis revealed that the target genes were knocked out. The mutants were rough mutants and they could be differentiated from natural infection by the Rose Bengal plate and standard agglutination tests. The molecular weights of lipopolysaccharides of the Δwzm and Δwzt mutants were clustered between 25 and 40 kDa, and 30 and 35 kDa separately, and were markedly different from those in B. abortus S19. The virulence of B. abortus Δwzm and Δwzt was decreased compared with that of B. abortus S19 in mice. All these results identified that there were several differences between the wzm and wzt genes on lipopolysaccharide synthesis and on the virulence of B. abortus. PMID:24718931

  12. Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tetánico y diftérico con concentración reducida en adolescentes cubanos

    Rolando Felipe Ochoa.

    2006-08-01

    Full Text Available Se realizó un estudio aleatorizado, controlado y a doble ciegas en 225 adolescentes cubanos entre 13 y 16 años de edad, con el objetivo de evaluar la reactogenicidad y la inmunogenicidad de una nueva vacuna de toxoide tetánico y toxoide diftérico con concentración reducida, producida en el Instituto Finlay, con respecto a su similar comercial IMOVAX dT adult de Aventis Pasteur. Se tomaron muestras de suero antes y 21 días después de la vacunación. La reactogenicidad de ambas vacunas fue similar. Los síntomas y signos, tanto locales como generales fueron moderados y aparecieron principalmente durante las primeras 72 h después de la vacunación. Todos los voluntarios vacunados alcanzaron niveles protectores (³0,1 UI/mL de antitoxina contra el tétanos y la difteria. El 99,25% de los inmunizados con la vacuna experimental y el 98,36% de los voluntarios del grupo control presentaron niveles de antitoxina tetánica correspondientes a una protección de larga duración (³1,0 UI/mL; para la antitoxina diftérica se alcanzaron estos niveles en el 81,20% y 80,33% de los voluntarios en cada grupo. Los títulos medios geométricos de antitoxina tetánica (21,73 UI/mL y antitoxina diftérica (2,55 UI/mL inducidos por la nueva vacuna fueron superiores (p<0,05 a los del grupo control: 15,55 UI/mL y 1,84 UI/Ml respectivamente(p<0.05.

  13. Evaluación de la toxicidad por dosis única de la vacuna antitetánica vax-TET en ratas Sprague Dawley

    Yulieé López.

    2007-12-01

    Full Text Available La vacuna vax-TET® está indicada en la prevención del tétanos y es efectiva si se logra un completo y apropiado esquema de inmunización. Para investigar el potencial tóxico de este producto se realizó una prueba toxicológica con una dosis única, por vía intramuscular, en un volumen de 0,2 mL en ratas Sprague Dawley. La composición de la vacuna de ensayo probada fue la misma de la vacuna comercial. Los animales fueron observados diariamente en busca de síntomas locales y sistémicos de toxicidad. Se realizaron mediciones del consumo de agua y alimento, así como del peso corporal. Dos semanas después de la inoculación las ratas fueron sacrificadas por métodos de eutanasia sin dolor y sometidas a necropsia. No se observaron muertes ni síntomas de toxicidad en los animales estudiados. Tampoco se encontraron diferencias de interés toxicológico entre los grupos experimentales en cuanto a las variables medidas. El estudio anatomopatológico reveló la presencia de formaciones granulomatosas de tipo macrofágico asociadas, fundamentalmente, al hidróxido de aluminio. Estos resultados permitieron concluir que, bajo las condiciones del estudio y según los criterios establecidos, esta vacuna no produce efectos adversos en el modelo animal usado, por lo que se considera potencialmente no tóxica para humanos.

  14. Validation of a PCR Assay for Chlamydophila abortus rRNA gene detection in a murine model

    Francielle Gibson da Silva-Zacarias

    2009-11-01

    Full Text Available Chlamydophila abortus (C. abortus is associated with reproductive problems in cattle, sheep, and goats. Diagnosis of C. abortus using embryonated chicken eggs or immortalized cell lines has a very low sensitivity. Polymerase chain reaction (PCR assays have been used to detect C. abortus infection in clinical specimens and organ fragments, such as placenta, fetal organs, vaginal secretions, and semen. The aim of this study was to develop a PCR assay for the amplification of an 856-bp fragment of the rRNA gene of the Chlamydiaceae family. The PCR assay was evaluated using organs from 15 mice experimentally infected with the S26/3 reference strain of C. abortus. The results of the rRNA PCR were compared to the results from another PCR system (Omp2 PCR that has been previously described for the Omp2 (outer major protein gene from the Chlamydiaceae family. From the 15 C. abortus-inoculated mice, 13 (K=0.84, standard error =0.20 tested positive using the rRNA PCR assay and 9 (K=0.55, standard error=0.18 tested positive using the Omp2 PCR assay. The detection limit, measured using inclusion-forming units (IFU, for C. abortus with the rRNA PCR (1.05 IFU was 100-fold lower than for the Omp2 PCR (105 IFU. The higher sensitivity of the rRNA PCR, as compared to the previously described PCR assay, and the specificity of the assay, demonstrated using different pathogenic microorganisms of the bovine reproductive system, suggest that the new PCR assay developed in this study can be used for the molecular diagnosis of C. abortus in abortion and other reproductive failures in bovines, caprines, and ovines.Chlamydophila abortus (C. abortus é frequentemente associada a distúrbios reprodutivos em bovinos, ovinos e caprinos. Para o diagnóstico, os métodos de cultivo em ovo embrionado de galinha e em células de linhagem contínua apresentam baixa sensibilidade. A reação em cadeia da polimerase (PCR tem sido utilizada em placenta, órgãos fetais, secre

  15. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.

    Wyckoff, John H; Howland, Jeri L; Scott, Catherine M O'Connell; Smith, Robert A; Confer, Anthony W

    2005-11-30

    Augmentation of immunization of cattle Brucella abortus S19 or a B. abortus soluble protein extract (SPEBA) vaccine through administration of recombinant bovine IL 2 (rBoIL 2) was evaluated. Seventy-five heifers were divided among 6 groups that were treated with the following: Group 1, no treatment; Group 2, rBoIL 2 (1microg/kg) on day 0; Group 3, SPEBA (2 mg) on day 0 and week 9; Group 4, SPEBA + rBoIL 2 on day 0, SPEBA on week 9; Group 5, S19 (10(7) CFU) on day 0 and week 9; Group 6, S19 + rBoIL 2 on day 0, S19 only on week 9. Approximately, 6 months after vaccination, cattle were bred by natural service, and at mid-gestation pregnant cattle were challenged intraconjunctivally with 9.1 x 10(5) CFU of virulent B. abortus S2308. Pre- and post-challenge antibody responses were measured by an enzyme-linked immunosorbent assay, a particle concentration fluorescence assay, and the card test. Lymphoproliferation (LP) responses to gamma-irradiated B. abortus and SPEBA antigens were measured in peripheral blood mononuclear cells. After vaccination, antibody responses to B. abortus elevated rapidly in SPEBA- and S19-vaccinates with and without rBoIL 2, however, these responses were significantly (P S19 resulted in significant (P abortus antigens following challenge. Characterization of the cytokine response of bovine monocyte-derived macrophages by real-time polymerase chain reaction indicated that in vitro stimulation of these cells with rBoIL 2 resulted in a profound up-regulation of genes encoding tumor necrosis factor-alpha, IL 12p40, and interferon-gamma reflecting activation of the cells. Overall, rBoIL 2-treatment was associated with fewer infections, sero-conversions and a significant (P = 0.02) level of protection against abortion as compared to vaccination alone or no treatment. PMID:16242273

  16. Valutazione dell’efficacia del vaccino Brucella abortus ceppo RB51 rispetto al vaccino di referenza Brucella abortus ceppo 19 nel bufalo

    Massimo Scacchia

    2010-03-01

    Full Text Available Il patrimonio zootecnico della specie bufalina (Bubalus bubalis della regione Campania, è di 250 000 capi, di questi 150 000 allevati in aziende zootecniche della provincia di Caserta. In queste aziende, nel 2007, l’infezione da Brucella abortus ha avuto la prevalenza media, per allevamento, del 20%. Complessivamente, i 2/3 degli allevamenti positivi hanno evidenziato una prevalenza superiore al 10% e, di questi, i 3/4 una prevalenza superiore al 20%. Prendendo il 20% come valore di riferimento, la metà degli allevamenti infetti (22% degli allevamenti casertani ha evidenziato prevalenze inferiori o uguali al 20%, la restante metà (un altro 22% del totale prevalenze comprese tra il 20 e il 56%. In questo contesto epidemiologico è stato adottato un piano di eradicazione della brucellosi che prevedeva l’abbattimento dei capi infetti e la vaccinazione del restante patrimonio bufalino delle zone con più alta incidenza. Per la profilassi vaccinale della brucellosi, il Manual of diagnostic tests and vaccines for terrestrial animals (OIE prevede l’utilizzo del vaccino B. abortus S19 (S19. Purtroppo, l’utilizzo del vaccino negli animali adulti non è privo di possibili effetti indesiderati. Per superare questo aspetto negativo è stato ipotizzato l’impiego del vaccino di B. abortus RB51 (RB51 anche se in letteratura scientifica, sono risultati disponibili pochi dati relativi alla corretta dose vaccinale, all’efficacia e all’innocuità del vaccino nel bufalo. A tale scopo è stato condotto uno studio comparativo tra i due vaccini. Sono state utilizzate 13 femmine di bufalo di 5 mesi di età provenienti da un allevamento ufficialmente indenne da brucellosi. Un gruppo di 5 animali è stato vaccinato due volte, a distanza di un mese, con una dose di RB51 tre volte superiore a quella prevista per i bovini; un secondo gruppo di 5 bufale con S19 rispettando il dosaggio raccomandato per i bovini e un terzo gruppo, di 3 animali di controllo

  17. Aproximación al uso de hongos entomopatógenos y vacunas para el control sostenible de garrapatas en sistemas ganaderos: revisión

    Ana Carolina Moncada González

    2015-01-01

    Full Text Available La resistencia desarrollada por las garrapatas frente a los acaricidas de síntesis, hace necesario replantear las estrategias utilizadas actualmen - te para su control. Los programas de manejo integrado de parásitos se presentan como una alternativa que, al promover estrategias de con - trol basadas en la ecología y la epidemiología de cada especie de parásito, reducen el riesgo de desarrollo de resistencia. Dichas estrategias incluyen la aplicación de vacunas antigarrapata y hongos entomopatógenos que afectan la viabi - lidad y la reproducción en las garrapatas. Sin embargo, la información obtenida entre estudios sobre hongos y vacunas ha sido inconsistente, por lo que hoy en día ambas representan áreas de investigación bastante activas. El propósito de este trabajo consistió en realizar una revisión descriptiva sobre los mecanismos de acción de la vacuna antigarrapata y los hongos entomopatógenos, en la búsqueda de una po - sible complementariedad que permita el diseño de planes de aplicación conjunta, con miras a mejorar los resultados de control en sistemas ganaderos. En la primera parte del documento se revisa la actual problemática asociada al uso y abuso de los acaricidas de síntesis, haciendo un énfasis particular en el tema de resistencia; posteriormente, se describen los mecanismos de acción de hongos y vacunas que afectan la re - producción y supervivencia en garrapatas, y se incluye información relevante sobre su eficacia. Se espera que la información aquí recolectada, sirva como base para elaborar estudios que permitan identificar la utilidad de los hongos entomopatógenos y las vacunas antigarrapata al interior de los programas de manejo integrado de parásitos en ganadería.

  18. Seroprevalence of Brucella abortus and B. canis in household dogs in southwestern Nigeria: a preliminary report

    S. I. B. Cadmus

    2011-04-01

    Full Text Available A preliminary serological study of 366 household dogs in Lagos and Ibadan, southwestern Nigeria, was carried out to determine antibodies due to exposure to Brucella abortus and B. canis, using the rose bengal test (RBT and the rapid slide agglutination (RSA test, respectively. Results showed that 5.46 % (20/366 and 0.27 % (1/366 of the dogs screened were seropositive to B. abortus and B. canis, respectively.Of all dogs, 36 had a history of being fed foetuses from cows and 11 (30.6 % of these tested positive in the RBT. Our findings, although based on a limited sample size and a dearth of clinical details, revealed that dogs in Nigeria may be infected with Brucella spp. given the wide range of risk factors. Further studies are recommended to elucidate the epidemiology of brucellosis in dogs and its possible zoonotic consequences in the country.

  19. Characterisation of Brucella abortus strain 19 cultures isolated from vaccinated cattle.

    Thomas, E L; Bracewell, C D; Corbel, M J

    1981-01-31

    Thirty-four cultures recovered from material of bovine origin in England, Scotland and Wales were identified unequivocally as Brucella abortus strain 19 (S19). All had the properties of carbon dioxide-independent B abortus biotype 1 strains, were inhibited by penicillin G and thionin blue at standard concentrations and behaved in oxidative metabolism and guinea pig virulence tests as typical S19. Their sensitivity to i-erythritol varied somewhat between cultures as did reference subcultures of S19. Of the total number of isolates, 11 were recovered from abortion material or cyetic products, 10 were from calves which died from a hypersensitivity reaction within 24 hours of S19 vaccination and the remainder were from milk or internal organs. From the evidence available, there is little to suggest that calfhood vaccination with S19 has resulted in persistent systemic infection in other than a very small proportion of the animals inoculated. PMID:6789543

  20. Immunogenic response induced by wzm and wzt gene deletion mutants from Brucella abortus S19.

    Wang, Xiu-Ran; Yan, Guang-Mou; Zhang, Rui; Lang, Xu-Long; Yang, Yan-Ling; Li, Xiao-Yan; Chen, Si; Qian, Jing; Wang, Xing-Long

    2014-02-01

    Brucellosis is an infectious disease affecting humans and animals worldwide. Effective methods of control include inducing immunity in animals by vaccination and elimination. Brucella abortus S19 is one of the popular vaccines for control of cattle brucellosis, as it has low virulence. In this paper, allelic exchange plasmids of wzm and wzt genes were constructed and partially knocked out to evaluate the effects on the induction of immunity to Brucella abortus S19 mutants. Cytokine secretion in vitro, INF-γ induction in vivo and antibody dynamics were evaluated. These data suggested that the immunity-eliciting ability of the wzm and wzt gene deletion mutants was similar, although reduced compared with the S19 strain. The results demonstrated that the wzt gene may be more important in the regulation of the induction of immunity than the wzm gene. PMID:24247358

  1. Brucella abortus Induces the Premature Death of Human Neutrophils through the Action of Its Lipopolysaccharide.

    Barquero-Calvo, Elías; Mora-Cartín, Ricardo; Arce-Gorvel, Vilma; de Diego, Juana L; Chacón-Díaz, Carlos; Chaves-Olarte, Esteban; Guzmán-Verri, Caterina; Buret, Andre G; Gorvel, Jean-Pierre; Moreno, Edgardo

    2015-05-01

    Most bacterial infections induce the activation of polymorphonuclear neutrophils (PMNs), enhance their microbicidal function, and promote the survival of these leukocytes for protracted periods of time. Brucella abortus is a stealthy pathogen that evades innate immunity, barely activates PMNs, and resists the killing mechanisms of these phagocytes. Intriguing clinical signs observed during brucellosis are the low numbers of Brucella infected PMNs in the target organs and neutropenia in a proportion of the patients; features that deserve further attention. Here we demonstrate that B. abortus prematurely kills human PMNs in a dose-dependent and cell-specific manner. Death of PMNs is concomitant with the intracellular Brucella lipopolysaccharide (Br-LPS) release within vacuoles. This molecule and its lipid A reproduce the premature cell death of PMNs, a phenomenon associated to the low production of proinflammatory cytokines. Blocking of CD14 but not TLR4 prevents the Br-LPS-induced cell death. The PMNs cell death departs from necrosis, NETosis and classical apoptosis. The mechanism of PMN cell death is linked to the activation of NADPH-oxidase and a modest but steadily increase of ROS mediators. These effectors generate DNA damage, recruitments of check point kinase 1, caspases 5 and to minor extent of caspase 4, RIP1 and Ca++ release. The production of IL-1β by PMNs was barely stimulated by B. abortus infection or Br-LPS treatment. Likewise, inhibition of caspase 1 did not hamper the Br-LPS induced PMN cell death, suggesting that the inflammasome pathway was not involved. Although activation of caspases 8 and 9 was observed, they did not seem to participate in the initial triggering mechanisms, since inhibition of these caspases scarcely blocked PMN cell death. These findings suggest a mechanism for neutropenia in chronic brucellosis and reveal a novel Brucella-host cross-talk through which B. abortus is able to hinder the innate function of PMN. PMID:25946018

  2. Brucella abortus Induces the Premature Death of Human Neutrophils through the Action of Its Lipopolysaccharide.

    Elías Barquero-Calvo

    2015-05-01

    Full Text Available Most bacterial infections induce the activation of polymorphonuclear neutrophils (PMNs, enhance their microbicidal function, and promote the survival of these leukocytes for protracted periods of time. Brucella abortus is a stealthy pathogen that evades innate immunity, barely activates PMNs, and resists the killing mechanisms of these phagocytes. Intriguing clinical signs observed during brucellosis are the low numbers of Brucella infected PMNs in the target organs and neutropenia in a proportion of the patients; features that deserve further attention. Here we demonstrate that B. abortus prematurely kills human PMNs in a dose-dependent and cell-specific manner. Death of PMNs is concomitant with the intracellular Brucella lipopolysaccharide (Br-LPS release within vacuoles. This molecule and its lipid A reproduce the premature cell death of PMNs, a phenomenon associated to the low production of proinflammatory cytokines. Blocking of CD14 but not TLR4 prevents the Br-LPS-induced cell death. The PMNs cell death departs from necrosis, NETosis and classical apoptosis. The mechanism of PMN cell death is linked to the activation of NADPH-oxidase and a modest but steadily increase of ROS mediators. These effectors generate DNA damage, recruitments of check point kinase 1, caspases 5 and to minor extent of caspase 4, RIP1 and Ca++ release. The production of IL-1β by PMNs was barely stimulated by B. abortus infection or Br-LPS treatment. Likewise, inhibition of caspase 1 did not hamper the Br-LPS induced PMN cell death, suggesting that the inflammasome pathway was not involved. Although activation of caspases 8 and 9 was observed, they did not seem to participate in the initial triggering mechanisms, since inhibition of these caspases scarcely blocked PMN cell death. These findings suggest a mechanism for neutropenia in chronic brucellosis and reveal a novel Brucella-host cross-talk through which B. abortus is able to hinder the innate function of PMN.

  3. Comparison of B.melitensis and B.abortus Bacteremias with Respect to Diagnostic Laboratory Tests

    Hikmet Aliskan

    2016-04-01

    Full Text Available Aim: Brucellosis are most commonly caused by the Brucella species Brucella melitensis and Brucella abortus. This study was aimed to determine the differences in the routine diagnostic tests (serological tests and blood culture positivity that differentiate bacteremias caused by B. melitensis and B. abortus. Material and Method: This study included a total of 42 patients from whose blood cultures Brucella sp. were isolated between January 2010 and April 2014. A 8-10 ml blood sample was put into BACTEC plus/Aerobic F culture bottles after being drawn from patients (n:42 with suspected brucellosis. The obtained samples were incubated in BACTEC 9240 device (BD Diagnostic, Maryland, USA for 21 days. Sera of the blood samples taken simultaneously with the blood culture were studied with the Rose Bengal and Standard Tube Agglutination (STA tests. Results: In patients with acute brucellosis, B. melitensis and B. abortus species showed no significant differences with respect to time to positive signal in blood cultures (for hours p=0.850; for days p=0.696 and the mean time to positivity. The earliest signal in the device was delivered at day 2., 44th hour and the latest at day 6., 123rd hour. No significant difference was noted between the two species with respect to the mean time to positivity. Discussion: This study did not show any significant differences between B. melitensis (n=22 and B. abortus (n=20 bacteremias with respect to age, sex, time to blood culture positivity, and STA test titer level.

  4. Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis

    Langella Philippe

    2006-03-01

    Full Text Available Abstract Background Brucella abortus is a facultative intracellular pathogen that mainly infects cattle and humans. Current vaccines rely on live attenuated strains of B. abortus, which can revert to their pathogenic status and thus are not totally safe for use in humans. Therefore, the development of mucosal live vaccines using the food-grade lactic acid bacterium, Lactococcus lactis, as an antigen delivery vector, is an attractive alternative and a safer vaccination strategy against B. abortus. Here, we report the construction of L. lactis strains genetically modified to produce B. abortus GroEL heat-shock protein, a candidate antigen, in two cellular locations, intracellular or secreted. Results Only the secreted form of GroEL was stably produced in L. lactis, suggesting a detrimental effect of GroEL protein when intracellularly produced in this bacterium. Only trace amounts of mature GroEL were detected in the supernatant fraction of induced lactococcal cultures, and the GroEL precursor remained stacked in the cell fraction. Attempts to raise the secretion yields were made, but even when GroEL was fused to a synthetic propeptide, secretion of this antigen was not improved. Conclusion We found that L. lactis is able to produce, and to secrete, a stable form of GroEL into the extracellular medium. Despite the low secretion efficiency of GroEL, which suggest that this antigen interacts with the cell envelope of L. lactis, secretion seems to be the best way to achieve both production and protein yields, regardless of cellular location. The L. lactis strain secreting GroEL has potential for in vivo immunization.

  5. Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice

    Sublethal irradiation of BALB/c mice 4 hours prior to inoculation with 5 x 10(4) virulent Brucella abortus, caused significant (P less than 0.01) reductions in bacterial numbers in comparison with numbers in unirradiated controls. Numbers of brucellae in the spleen were significantly lower by 5 days after inoculation and decreased thereafter, so that at 2 and 3 weeks after inoculation, there were up to 1,000-fold fewer organisms in the spleen of irradiated mice. The number of brucellae in the spleen increased in irradiated mice thereafter. The course of events in the liver was similar, but developed more slowly, and peak differences in bacterial numbers were about 1 log less. These phenomena were not attributable to differences in implantation of brucellae in the liver or spleen, nor to an abnormal distribution of organisms in other organs of irradiated mice. Irradiation of mice during the plateau phase of infection also resulted in significant (P less than 0.05) reductions in bacterial counts in the spleen during the succeeding 4 weeks. Macrophage activation in the spleen, measured by a Listeria monocytogenes-killing assay, was significantly (P less than 0.01) increased by irradiation alone at 1 week after inoculation and at that time was significantly (P less than 0.01) greater in B abortus-infected, irradiated mice than in B abortus-infected controls. Histologic, cytologic, and immunologic studies revealed that the decrease in numbers of organisms between 1 and 2 weeks after inoculation in irradiated mice occurred at a time when their immune response to B abortus was suppressed and when numbers of neutrophils and monocytes infiltrating the spleen were significantly (P less than 0.01) diminished

  6. Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19

    Kianmehr, Zahra; Kaboudanian Ardestani, Sussan; Soleimanjahi, Hoorieh; Fotouhi, Fatemeh; Alamian, Saeed; Ahmadian, Shahin

    2015-01-01

    Background: Brucella abortus RB51 is a rough stable mutant strain, which has been widely used as a live vaccine for prevention of brucellosis in cattle instead of B. abortus strain S19. B. abortus lipopolysaccharide (LPS) has unique properties in comparison to other bacterial LPS. Objectives: In the current study, two types of LPS, smooth (S-LPS) and rough (R-LPS) were purified from B. abortus S19 and RB51, respectively. The aim of this study was to evaluate biological and immunological properties of purified LPS as an immunogenical determinant. Materials and Methods: Primarily, S19 and RB51 LPS were extracted and purified by two different modifications of the phenol water method. The final purity of LPS was determined by chemical analysis (2-keto-3-deoxyoctonate (KDO), glycan, phosphate and protein content) and different staining methods, following sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). C57BL/6 mice were immunized subcutaneously three times at biweekly intervals with the same amount of purified LPSs. The humoral immunity was evaluated by measuring specific IgG levels and also different cytokine levels, such as IFN-γ, TNF-α, IL-4 and IL-10, were determined for assessing T-cell immune response. Results: Biochemical analysis data and SDS-PAGE profile showed that the chemical nature of S19 LPS is different from RB51 LPS. Both S and R-LPS induce an immune response. T-cell immune response induced by both S and R-LPS had almost the same pattern whereas S19 LPS elicited humoral immunity, which was higher than RB51 LPS. Conclusions: Purified LPS can be considered as a safe adjuvant and can be used as a component in prophylactic and therapeutic vaccines targeting infectious disease, cancer and allergies. PMID:26862376

  7. A rapid cycleave PCR method for distinguishing the vaccine strain Brucella abortus A19 in China.

    Nan, Wenlong; Zhang, Yueyong; Tan, Pengfei; Xu, Zouliang; Chen, Yuqi; Mao, Kairong; Chen, Yiping

    2016-05-01

    Brucellosis is a widespread zoonotic disease caused by Brucella spp. Immunization with attenuated vaccines has proved to be an effective method of prevention; however, it may also interfere with diagnosis. Brucella abortus strain A19, which is homologous to B. abortus strain S19, is widely used for the prevention of bovine brucellosis in China. For effective monitoring of the control of brucellosis, it is essential to distinguish A19 from field strains. Single-nucleotide polymorphism-based assays offer a new approach to such discrimination studies. In the current study, we developed a cycleave PCR assay that successfully distinguished attenuated vaccine strains A19 and S19 from 22 strains of B. abortus and 57 strains of 5 other Brucella species. The assay gave a negative reaction with 4 non-Brucella species. The minimum sensitivity of the assay, evaluated using 10-fold dilutions of chromosomal DNA, was 7.6 fg for the A19 strain and 220 fg for the single non-A19/non-S19 Brucella strain tested (B. abortus 104M). The assay was also reproducible (intra- and interassay coefficients of variation: 0.003-0.01 and 0.004-0.025, respectively). The cycleave assay gave an A19/S19-specific reaction in 3 out of 125 field serum samples, with the same 3 samples being positive in an alternative A19/S19-specific molecular assay. The cycleave assay gave a total of 102 Brucella-specific reactions (3 being the A19/S19-specific reactions), whereas an alternative Brucella-specific assay gave 92 positive reactions (all also positive in the cycleave assay). Therefore, this assay represents a simple, rapid, sensitive, and specific tool for use in brucellosis control. PMID:27075847

  8. Protection against infection in mice vaccinated with a Brucella abortus mutant.

    Boschiroli, M L; Cravero, S L; Arese, A I; Campos, E.; Rossetti, O L

    1997-01-01

    This study determines whether a genetically engineered mutant of Brucella abortus, strain M-1, possesses differences in protective properties compared to the parental strain, vaccine S19. M-1 is a mutant unable to express BP26, a periplasmic protein with potential use in diagnosis. Mice vaccinated with S19 developed antibodies against BP26, while those vaccinated with M-1 did not. However, mice vaccinated with S19 or M-1 were similarly protected against challenge with pathogenic strain 2308, ...

  9. Evaluation of Brucella abortus Phosphoglucomutase (pgm) Mutant as a New Live Rough-Phenotype Vaccine

    Ugalde, Juan Esteban; Comerci, Diego José; Leguizamón, M. Susana; Ugalde, Rodolfo Augusto

    2003-01-01

    Brucella abortus S19 is the vaccine most frequently used against bovine brucellosis. Although it induces good protection levels, it cannot be administered to pregnant cattle, revaccination is not advised due to interference in the discrimination between infected and vaccinated animals during immune-screening procedures, and the vaccine is virulent for humans. Due to these reasons, there is a continuous search for new bovine vaccine candidates that may confer protection levels comparable to th...

  10. Outer Membrane Proteins of Brucella abortus Vaccinal and Field Strains and their Immune Response in Buffaloes

    Rukhshanda Munir*, M. Afzal1, M. Hussain2, S. M. S. Naqvi3 and A. Khanum3

    2010-04-01

    Full Text Available Outer membrane proteins (OMPs of three strains of B. abortus i.e. S19, RB51 and a local field isolate of biotype 1 were isolated through disrupting cells to generate membranes by centrifugation and sodium lauryl sarcosinate solubilisation of inner membrane proteins. Distinct OMP profiles of each strain were seen on SDS-PAGE. SDS-PAGE analysis of S19 and field isolate revealed eight protein bands in each strain. The OMPs of S19 had molecular masses 89.0, 73.0, 53.7, 49.0, 38.0, 27.0, 22.3, and 17.7 kDa, while field isolate had OMPs of 151.3, 89.0, 75.8, 67.6, 37.0, 27.0, 24.0 and 19.0 kDa. B. abortus RB51 yielded 11 OMP bands ranging from 12.5 to 107.1 kDa, with 34.2, 15.8 and 12.5 kDa as additional OMPs. Western immunoblot analysis using antisera raised against all three strains in buffaloes indicated an almost similar pattern of immuno-reactive OMPs in S19 and field strain. Two OMPs of molecular weight 37-38 and 19 kDa were immuno-reactive in all strains in buffaloes. There is possibility of use of these OMPs in a recombinant vaccine for B. abortus. A distinct protein of molecular weight of 151.3 kDa was identified in field strain but not in both vaccine strains of B. abortus. Use of this OMP in a diagnostic assay may differentiate between vaccinated and infected animals.

  11. Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice

    Elzer, P.H.; Rowe, G.E.; Enright, F.M.; Winter, A.J. (Department of Veterinary Microbiology, Immunology and Parasitology, College of Veterinary Medicine, Cornell University, Ithaca, NY (United States))

    1991-06-01

    Sublethal irradiation of BALB/c mice 4 hours prior to inoculation with 5 {times} 10(4) virulent Brucella abortus, caused significant (P less than 0.01) reductions in bacterial numbers in comparison with numbers in unirradiated controls. Numbers of brucellae in the spleen were significantly lower by 5 days after inoculation and decreased thereafter, so that at 2 and 3 weeks after inoculation, there were up to 1,000-fold fewer organisms in the spleen of irradiated mice. The number of brucellae in the spleen increased in irradiated mice thereafter. The course of events in the liver was similar, but developed more slowly, and peak differences in bacterial numbers were about 1 log less. These phenomena were not attributable to differences in implantation of brucellae in the liver or spleen, nor to an abnormal distribution of organisms in other organs of irradiated mice. Irradiation of mice during the plateau phase of infection also resulted in significant (P less than 0.05) reductions in bacterial counts in the spleen during the succeeding 4 weeks. Macrophage activation in the spleen, measured by a Listeria monocytogenes-killing assay, was significantly (P less than 0.01) increased by irradiation alone at 1 week after inoculation and at that time was significantly (P less than 0.01) greater in B abortus-infected, irradiated mice than in B abortus-infected controls. Histologic, cytologic, and immunologic studies revealed that the decrease in numbers of organisms between 1 and 2 weeks after inoculation in irradiated mice occurred at a time when their immune response to B abortus was suppressed and when numbers of neutrophils and monocytes infiltrating the spleen were significantly (P less than 0.01) diminished.

  12. Virulent Brucella abortus Prevents Lysosome Fusion and Is Distributed within Autophagosome-Like Compartments

    Pizarro-Cerdá, Javier; Moreno, Edgardo; Sanguedolce, Veronique; Mege, Jean-Louis; Gorvel, Jean-Pierre

    1998-01-01

    Virulent and attenuated Brucella abortus strains attach to and penetrate nonprofessional phagocytic HeLa cells. Compared to pathogenic Brucella, the attenuated strain 19 hardly replicates within cells. The majority of the strain 19 bacteria colocalized with the lysosome marker cathepsin D, suggesting that Brucella-containing phagosomes had fused with lysosomes, in which they may have degraded. The virulent bacteria prevented lysosome-phagosome fusion and were found distributed in the perinucl...

  13. EXPRESSION OF BACILLUS ANTHRACIS PROTECTIVE ANTIGEN IN VACCINE STRAIN BRUCELLA ABORTUS RB51

    Poff, Sherry Ann

    1997-01-01

    Bacillus anthracis is a facultative intracellular bacterial pathogen that can cause cutaneous, gastrointestinal or respiratory disease in many vertebrates, including humans. Commercially available anthrax vaccines for immunization of humans are of limited duration and do not protect against the respiratory form of the disease. Brucella abortus is a facultative intracellular bacterium that causes chronic infection in animals and humans. As with other intracellular pathogens, cell mediated im...

  14. Detection of antibodies against Chlamydophila abortus in Costa Rican sheep flocks

    R. Villagra-Blanco

    2015-09-01

    Full Text Available A total of 359 sheep samples from 15 flocks were analyzed for the presence of antibodies against Chlamydophila abortus using a commercial Enzyme linked Immunosorbent Assay (ELISA. Antibodies were detected in 19 (5.29% sheep from 12 (80% flocks. Seropositive animals were found in all analyzed regions (Central, Chorotega, Atlantic Huetar, North Huetar and Central Pacific determining prevalence between 0.28% and 4.4%, and intra-flock positivity between 3.7% and 25.0%. The survey revealed two risk factors associated with seropositivity; introducing animals (males and females, embryos, or semen from other farms or from abroad without any sanitary certification, and flocks not having quarantine areas or separated boxes for diseased animals. No clinical signs of disease were observed in positive seroreactors. C. abortus seems to be present in Costa Rica in a very low prevalence in sheep flocks. Further studies, to isolate the bacteria are required. Finally, implementation of control measures to prevent the spread of C. abortus is recommended.

  15. Detection of antibodies against Chlamydophila abortus in Costa Rican sheep flocks.

    Villagra-Blanco, R; Dolz, G; Montero-Caballero, D; Romero-Zúñiga, J J

    2015-01-01

    A total of 359 sheep samples from 15 flocks were analyzed for the presence of antibodies against Chlamydophila abortus using a commercial Enzyme linked Immunosorbent Assay (ELISA). Antibodies were detected in 19 (5.29%) sheep from 12 (80%) flocks. Seropositive animals were found in all analyzed regions (Central, Chorotega, Atlantic Huetar, North Huetar and Central Pacific) determining prevalence between 0.28% and 4.4%, and intra-flock positivity between 3.7% and 25.0%. The survey revealed two risk factors associated with seropositivity; introducing animals (males and females), embryos, or semen from other farms or from abroad without any sanitary certification, and flocks not having quarantine areas or separated boxes for diseased animals. No clinical signs of disease were observed in positive seroreactors. C. abortus seems to be present in Costa Rica in a very low prevalence in sheep flocks. Further studies, to isolate the bacteria are required. Finally, implementation of control measures to prevent the spread of C. abortus is recommended. PMID:26623377

  16. Comparative Brucella abortus antibody prevalence in cattle under contrasting husbandry practices in Uganda

    Gerald Nizeyimana

    2013-02-01

    Full Text Available A study was conducted in the Luwero and Nakasongola districts in central Uganda to determine and compare the prevalence and distribution of antibodies against Brucella abortus in cattle under contrasting husbandry practices, using two serological tests. Three hundred and fifteen serum samples were systematically sampled from 29 farms and subsequently tested using the Rose Bengal plate test (RBPT and Indirect Antibody Enzyme Linked Immunosorbent Assay (I-ELISA. The overall prevalence of antibodies against Brucella abortus in the Nakasongola and Luwero districts was 2.4% and 4.7% on RBPT, compared with 1.2% and 3.34 % on I-ELISA. There was no significant difference between the results obtained by RBPT and indirect antibody ELISA (p > 0.05. It was noted that antibodies against Brucella abortus were widely spread over different farms regardless of the cattle grazing system (p > 0.05. Based on the findings, it is feasible to use RBPT as a cheaper screening alternative for brucellosis. A comprehensive national brucellosis study should be undertaken to study the epidemiology and prevalence of brucellosis in Uganda.

  17. Immunoproteomics of Brucella abortus reveals differential antibody profiles between S19-vaccinated and naturally infected cattle.

    Pajuaba, Ana C A M; Silva, Deise A O; Almeida, Karine C; Cunha-Junior, Jair P; Pirovani, Carlos P; Camillo, Luciana R; Mineo, José R

    2012-03-01

    Brucella abortus is a Gram-negative intracellular bacterium that causes infectious abortion in food-producing animals and chronic infection in humans. This study aimed to characterize a B. abortus S19 antigen preparation obtained by Triton X-114 (TX-114) extraction through immunoproteomics to differentiate infected from vaccinated cattle. Three groups of bovine sera were studied: GI, 30 naturally infected cows; GII, 30 S19-vaccinated heifers; and GIII, 30 nonvaccinated seronegative cows. One-dimensional (1D) and two-dimensional electrophoretic profiles of TX-114 hydrophilic phase antigen revealed a broad spectrum of polypeptides (10-79 kDa). 1D immunoblot showed widespread seroreactivity profile in GI compared with restricted profile in GII. Three antigenic components (10, 12, 17 kDa) were recognized exclusively by GI sera, representing potential markers of infection and excluding vaccinal response. The proteomic characterization revealed 56 protein spots, 27 of which were antigenic spots showing differential seroreactivity profile between GI and GII, especially polypeptides abortus S19 proteins (Invasion protein B, Sod, Dps, Ndk, and Bfr), which were related with antigenicity in naturally infected cattle. In conclusion, immunoproteomics of this new antigen preparation enabled the characterization of proteins that could be used as tools to develop sensitive and specific immunoassays for serodiagnosis of bovine brucellosis, with emphasis on differentiation between S19 vaccinated and infected cattle. PMID:22539433

  18. Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development.

    Connolly, Joseph P; Comerci, Diego; Alefantis, Timothy G; Walz, Alexander; Quan, Marian; Chafin, Ryan; Grewal, Paul; Mujer, Cesar V; Ugalde, Rodolfo A; DelVecchio, Vito G

    2006-07-01

    Brucella abortus is the etiologic agent of bovine brucellosis and causes a chronic disease in humans known as undulant fever. In livestock the disease is characterized by abortion and sterility. Live, attenuated vaccines such as S19 and RB51 have been used to control the spread of the disease in animals; however, they are considered unsafe for human use and they induce abortion in pregnant cattle. For the development of a safer and equally efficacious vaccine, immunoproteomics was utilized to identify novel candidate proteins from B. abortus cell envelope (CE). A total of 163 proteins were identified using 2-DE with MALDI-TOF MS and LC-MS/MS. Some of the major protein components include outer-membrane protein (OMP) 25, OMP31, Omp2b porin, and 60 kDa chaperonin GroEL. 2-DE Western blot analyses probed with antiserum from bovine and a human patient infected with Brucella identified several new immunogenic proteins such as fumarate reductase flavoprotein subunit, F0F1-type ATP synthase alpha subunit, and cysteine synthase A. The elucidation of the immunome of B. abortus CE identified a number of candidate proteins for developing vaccines against Brucella infection in bovine and humans. PMID:16739129

  19. Second generation competitive enzyme immunoassay for detection of bovine antibody to Brucella abortus.

    Nielsen, K; Smith, P; Yu, W L; Elmgren, C; Nicoletti, P; Perez, B; Bermudez, R; Renteria, T

    2007-09-20

    A second generation competitive enzyme immunoassay (CELISA) for detection of bovine antibody to Brucella abortus was developed. This assay was different from previously developed CELISAs in that the detection reagent used was a recombinant combination of the receptor portions of protein A and protein G, labelled with horseradish peroxidase. This eliminates the need for polyclonal anti-mouse-enzyme conjugate reagents for detection thus allowing for true standardization. The assay utilized a monoclonal antibody specific for a common epitope of the O-polysaccharide (OPS) of smooth lipopolysaccharide (SLPS) derived from B. abortus S1119.3 but which did not react with protein A/G. This monoclonal antibody was used to compete with antibody in the bovine test serum. Binding of bovine antibody to the smooth lipopolysaccharide antigen was then measured directly with the protein A/G enzyme conjugate. In this case, development of colour in the reaction was indicative of the presence of bovine antibody. The performance characteristics, sensitivity, specificity and exclusion of B. abortus S19 vaccinated animals, of the assay were very similar to those of the classical CELISA. PMID:17467200

  20. Purification and properties of Cu-Zn superoxide dismutase extracted from Brucella abortus strain 19

    Tabatabai, L.B. (ARS-USDA, Ames, IA (United States))

    1991-03-11

    Recent work showed that a recombinant 20 kDa protein from Brucella abortus expressed in E. coli is a Cu-Zn superoxide dismutase (SOD). Western blot and ELISA results indicated that cattle with brucellosis have antibody to SOD. Here the authors report the purification and properties of the native B. abortus Cu-Zn SOD. SOD was extracted from methanol-killed Brucella abortus strain 19 with 0.1 M sodium citrate-1.0 M sodium chloride solution. The extract was dialyzed and protein precipitated by ammonium sulfate at 70-100% saturation was collected. The SOD was purified by HPLC anion exchange chromatography. SOD activity was assayed with a coupled enzyme assay using xanthine oxidase-cytochrome C reduction assay. The authors determined that the Brucella SOD is present in two molecular forms both inhibitable with KCN with Ki's of 0.32 mM and 4.98 mM, respectively. No other form of SOD was identified in the extract. Polyclonal antibody to SOD and polyclonal antibody to SOD synthetic peptide residues 134-143 inhibited SOD activity by 50% and 13%, respectively. Both SOD and the synthetic peptide inhibited binding of anti-SOD antibody to SOD by 60% and 20%, respectively. Based on these results the SOD and its amphipathic peptide will be considered as candidates for the design of synthetic multiple peptide vaccines and diagnostic reagents for bovine brucellosis.

  1. MÉTODOS MULTIVARIADOS PARA ENCAUZAR LA MEJORA DE LA CALIDAD DE UNA VACUNA CONTRA EL CÁNCER

    Aida Rodríguez Hernández

    2007-09-01

    Full Text Available

    Este trabajo se realizó con el objetivo de encontrar las relaciones entre las variables del proceso productivo y el patrón cromatográfico de una vacuna terapéutica contra el cáncer, característica esta indicativa de la reproducibilidad del producto. Primeramente se empleó el análisis de conglomerados (análisis de cluster para agrupar lotes de producción y posteriormente se empleó el análisis discriminante para encontrar la explicación de estas agrupaciones según las variables del proceso. La determinación de estas relaciones, unida a la búsqueda en la literatura, permitió señalar un camino para mejorar el proceso, dirigiendo el control hacia las variables más influyentes en la variabilidad del producto.

  2. Intranasal infection with Chlamydia abortus induces dose-dependent latency and abortion in sheep.

    David Longbottom

    Full Text Available BACKGROUND: Latency is a key feature of the animal pathogen Chlamydia abortus, where infection remains inapparent in the non-pregnant animal and only becomes evident during a subsequent pregnancy. Often the first sign that an animal is infected is abortion occurring late in gestation. Despite this, little is understood of the underlying mechanisms that control latency or the recrudescence of infection that occurs during subsequent pregnancy. The aim of this study was to develop an experimental model of latency by mimicking the natural route of infection through the intranasal inoculation of non-pregnant sheep with C. abortus. METHODOLOGY/PRINCIPAL FINDINGS: Three groups of sheep (groups 1, 2 and 3 were experimentally infected with different doses of C. abortus (5×10(3, 5×10(5 and 5×10(7 inclusion forming units (IFU, respectively prior to mating and monitored over 2 breeding cycles for clinical, microbiological, pathological, immunological and serological outcomes. Two further groups received either negative control inoculum (group 4a,b or were inoculated subcutaneously on day 70 of gestation with 2×10(6 IFU C. abortus (group 5. Animals in groups 1, 2 and 5 experienced an abortion rate of 50-67%, while only one animal aborted in group 3 and none in group 4a,b. Pathological, microbiological, immunological and serological analyses support the view that the maternal protective immune response is influenced by initial exposure to the bacterium. CONCLUSIONS/SIGNIFICANCE: The results show that intranasal administration of non-pregnant sheep with a low/medium dose of C. abortus results in a latent infection that leads in a subsequent pregnancy to infection of the placenta and abortion. In contrast a high dose stimulates protective immunity, resulting in a much lower abortion rate. This model will be useful in understanding the mechanisms of infection underlying latency and onset of disease, as well as in the development of novel therapeutics and

  3. Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).

    Miranda, Karina Leite; Dorneles, Elaine Maria Seles; Pauletti, Rebeca Barbosa; Poester, Fernando Padilla; Lage, Andrey Pereira

    2015-01-15

    The aim of the present study was to evaluate the use of different mouse strains (BALB/c, Swiss and CD-1) and different challenge strains (Brucella abortus 544 and 2308) in the study of B. abortus vaccine (S19 and RB51) immunogenicity test in the murine model. No significant difference in B. abortus vaccine potency assay was found with the use of B. abortus 544 or B. abortus 2308 as challenge strain. Results of variance analysis showed an interaction between treatment and mouse strain; therefore these parameters could not be compared separately. When CD-1 groups were compared, those vaccinated showed significantly lower counts than non-vaccinated ones (PS19 or RB51). Similar results were observed on BALB/c groups. However, in Swiss mouse groups, S19 was more protective than RB51 (Pabortus strains 544 and 2308, can be used in immunogenicity tests of S19 and RB51 vaccines. PMID:25498211

  4. Prevalence of antibodies to Chlamydophila abortus in ovines in the Londrina area of Paraná state, Brazil

    Bruna Azevedo de Carvalho Lima

    2014-10-01

    Full Text Available The aim of this paper was to estimate the prevalence of antibodies to Chlamydophila abortus in ewes from the Londrina region of Paraná state. Blood samples from 267 adult ewes from eight herds were submitted to complement fixation testing. Tests were considered positive when the titers ? 32. Nineteen animals (7.11% in 7 (87.50% herds tested positive for antibodies against C. abortus. The titers were 32 in 17 animals and were 64 and 128 in the other two animals. The clinical signs recorded were abortion, stillbirth, weak newborns and heat repetition. The high frequency of herds with at least one positive animal and a seroprevalence of 7.11% suggest the presence of Chlamydophila abortus in the animals of studied herds.

  5. La vacuna contra el virus del papiloma humano: una gran arma para la prevención primaria del cáncer de cuello uterino

    Nubia Muñoz

    2008-06-01

    Full Text Available La vacuna profiláctica contra el virus del papiloma humano (VPH constituye la herramienta de salud pública más promisoria para la prevención primaria de cáncer de cuello uterino. La vacunación de mujeres antes de haber adquirido la infección viral tiene un gran impacto en la prevención de lesiones pre-neoplásicas y cáncer de cuello uterino. Las vacunas actuales no eliminan completamente el riesgo de cáncer de cérvix, por lo tanto las mujeres vacunadas como las que no alcancen a recibir la vacuna, se les debe seguir ofreciendo los programas de detección temprana. Las estrategias que incluyen la combinación de vacunación con alta cobertura de adolescentes y tamización con métodos más sensibles que la citología, tales como la prueba de VPH, pueden ser más costo-efectivas que las estrategias actualmente utilizadas. La inefectividad de los actuales programas de tamización en países latinoamericanos incluido Colombia, amerita su evaluación inmediata a la luz de la disponibilidad de nuevos métodos que son costo-efectivos en países en desarrollo tales como la prueba de VPH y la inspección visual y tratamiento inmediato para mujeres con dificultades de acceso oportuno al tratamiento.

  6. Interacción del componente pertussis de células completas con los antígenos tetánico, Haemophilus influenzae tipo B y hepatitis B en ensayos de potencia para vacunas combinadas

    2008-01-01

    Las vacunas combinadas permiten un grado de aceptación mayor entre la población, dado que se requiere de menos inmunizaciones para proteger contra las enfermedades infecciosas. Sin embargo, esto ha generado nuevos retos, ya que se han reportado numerosas interacciones entre los diferentes antígenos que conforman estas vacunas. El propósito del presente trabajo fue evaluar la interferencia potencial del componente pertussis de células completas sobre los ensayos para determinar la actividad bi...

  7. Evaluación de los programas de vacunación mediante estudios serológicos y vacunas distribuidas Evaluation of vaccination programs through serological studies and distributed vaccines

    Pedro Plans

    2005-01-01

    Antecedentes: El objetivo del estudio fue comparar las coberturas vacunales en escolares para la vacuna triple vírica (sarampión-rubéola-parotiditis), DTP (difteria-tétanos-tos ferina) y poliomielitis, obtenidas a partir de las vacunas distribuidas a los centros de vacunación, las vacunaciones declaradas y el análisis serológico de anticuerpos. Métodos: La cobertura vacunal se obtuvo a partir de los antecedentes de vacunación recogidos en un cuestionario y mediante el análisis serológico de a...

  8. Cadena del frío para la conservación de las vacunas en los centros de atención primaria de un área de Madrid: mantenimiento y nivel de conocimientos

    Ortega Molina Paloma; Astasio Arbiza Paloma; Albaladejo Vicente Romana; Gómez Rábago M.ª Luisa; Juanes Pardo José Ramón de; Domínguez Rojas Vicente

    2002-01-01

    Fundamento. Las vacunas son medicamentos termolábiles y para garantizar su inmunogenicidad y eficacia protectora, dentro de los programas de inmunización, es imprescindible mantener la cadena de frío. El elemento fundamental en esta cadena es el personal responsable de las vacunas, que debe conocer las características de estabilidad de cada preparado con el fin de evitar errores durante su manipulación. El objetivo de este trabajo fue conocer cómo se realiza el mantenimiento de la cadena del ...

  9. Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts

    Gamal Wareth

    2016-04-01

    Full Text Available Brucellosis is a debilitating zoonotic disease that affects humans and animals. The diagnosis of brucellosis is challenging, as accurate species level identification is not possible with any of the currently available serology-based diagnostic methods. The present study aimed at identifying Brucella (B. species-specific proteins from the closely related species B. abortus and B. melitensis using sera collected from naturally infected host species. Unlike earlier reported investigations with either laboratory-grown species or vaccine strains, in the present study, field strains were utilized for analysis. The label-free quantitative proteomic analysis of the naturally isolated strains of these two closely related species revealed 402 differentially expressed proteins, among which 63 and 103 proteins were found exclusively in the whole cell extracts of B. abortus and B. melitensis field strains, respectively. The sera from four different naturally infected host species, i.e., cattle, buffalo, sheep, and goat were applied to identify the immune-binding protein spots present in the whole protein extracts from the isolated B. abortus and B. melitensis field strains and resolved on two-dimensional gel electrophoresis. Comprehensive analysis revealed that 25 proteins of B. abortus and 20 proteins of B. melitensis were distinctly immunoreactive. Dihydrodipicolinate synthase, glyceraldehyde-3-phosphate dehydrogenase and lactate/malate dehydrogenase from B. abortus, amino acid ABC transporter substrate-binding protein from B. melitensis and fumarylacetoacetate hydrolase from both species were reactive with the sera of all the tested naturally infected host species. The identified proteins could be used for the design of serological assays capable of detecting pan-Brucella, B. abortus- and B. melitensis-specific antibodies.

  10. Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts

    Wareth, Gamal; Eravci, Murat; Weise, Christoph; Roesler, Uwe; Melzer, Falk; Sprague, Lisa D.; Neubauer, Heinrich; Murugaiyan, Jayaseelan

    2016-01-01

    Brucellosis is a debilitating zoonotic disease that affects humans and animals. The diagnosis of brucellosis is challenging, as accurate species level identification is not possible with any of the currently available serology-based diagnostic methods. The present study aimed at identifying Brucella (B.) species-specific proteins from the closely related species B. abortus and B. melitensis using sera collected from naturally infected host species. Unlike earlier reported investigations with either laboratory-grown species or vaccine strains, in the present study, field strains were utilized for analysis. The label-free quantitative proteomic analysis of the naturally isolated strains of these two closely related species revealed 402 differentially expressed proteins, among which 63 and 103 proteins were found exclusively in the whole cell extracts of B. abortus and B. melitensis field strains, respectively. The sera from four different naturally infected host species, i.e., cattle, buffalo, sheep, and goat were applied to identify the immune-binding protein spots present in the whole protein extracts from the isolated B. abortus and B. melitensis field strains and resolved on two-dimensional gel electrophoresis. Comprehensive analysis revealed that 25 proteins of B. abortus and 20 proteins of B. melitensis were distinctly immunoreactive. Dihydrodipicolinate synthase, glyceraldehyde-3-phosphate dehydrogenase and lactate/malate dehydrogenase from B. abortus, amino acid ABC transporter substrate-binding protein from B. melitensis and fumarylacetoacetate hydrolase from both species were reactive with the sera of all the tested naturally infected host species. The identified proteins could be used for the design of serological assays capable of detecting pan-Brucella, B. abortus- and B. melitensis-specific antibodies. PMID:27144565

  11. The Brucella abortus cyclic beta-1,2-glucan virulence factor is substituted with O-ester-linked succinyl residues.

    Roset, Mara S; Ciocchini, Andrés E; Ugalde, Rodolfo A; Iñón de Iannino, Nora

    2006-07-01

    Brucella periplasmic cyclic beta-1,2-glucan plays an important role during bacterium-host interaction. Nuclear magnetic resonance spectrometry analysis, thin-layer chromatography, and DEAE-Sephadex chromatography were used to characterize Brucella abortus cyclic glucan. In the present study, we report that a fraction of B. abortus cyclic beta-1,2-glucan is substituted with succinyl residues, which confer anionic character on the cyclic beta-1,2-glucan. The oligosaccharide backbone is substituted at C-6 positions with an average of two succinyl residues per glucan molecule. This O-ester-linked succinyl residue is the only substituent of Brucella cyclic glucan. A B. abortus open reading frame (BAB1_1718) homologous to Rhodobacter sphaeroides glucan succinyltransferase (OpgC) was identified as the gene encoding the enzyme responsible for cyclic glucan modification. This gene was named cgm for cyclic glucan modifier and is highly conserved in Brucella melitensis and Brucella suis. Nucleotide sequencing revealed that B. abortus cgm consists of a 1,182-bp open reading frame coding for a predicted membrane protein of 393 amino acid residues (42.7 kDa) 39% identical to Rhodobacter sphaeroides succinyltransferase. cgm null mutants in B. abortus strains 2308 and S19 produced neutral glucans without succinyl residues, confirming the identity of this protein as the cyclic-glucan succinyltransferase enzyme. In this study, we demonstrate that succinyl substituents of cyclic beta-1,2-glucan of B. abortus are necessary for hypo-osmotic adaptation. On the other hand, intracellular multiplication and mouse spleen colonization are not affected in cgm mutants, indicating that cyclic-beta-1,2-glucan succinylation is not required for virulence and suggesting that no low-osmotic stress conditions must be overcome during infection. PMID:16816173

  12. Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts.

    Wareth, Gamal; Eravci, Murat; Weise, Christoph; Roesler, Uwe; Melzer, Falk; Sprague, Lisa D; Neubauer, Heinrich; Murugaiyan, Jayaseelan

    2016-01-01

    Brucellosis is a debilitating zoonotic disease that affects humans and animals. The diagnosis of brucellosis is challenging, as accurate species level identification is not possible with any of the currently available serology-based diagnostic methods. The present study aimed at identifying Brucella (B.) species-specific proteins from the closely related species B. abortus and B. melitensis using sera collected from naturally infected host species. Unlike earlier reported investigations with either laboratory-grown species or vaccine strains, in the present study, field strains were utilized for analysis. The label-free quantitative proteomic analysis of the naturally isolated strains of these two closely related species revealed 402 differentially expressed proteins, among which 63 and 103 proteins were found exclusively in the whole cell extracts of B. abortus and B. melitensis field strains, respectively. The sera from four different naturally infected host species, i.e., cattle, buffalo, sheep, and goat were applied to identify the immune-binding protein spots present in the whole protein extracts from the isolated B. abortus and B. melitensis field strains and resolved on two-dimensional gel electrophoresis. Comprehensive analysis revealed that 25 proteins of B. abortus and 20 proteins of B. melitensis were distinctly immunoreactive. Dihydrodipicolinate synthase, glyceraldehyde-3-phosphate dehydrogenase and lactate/malate dehydrogenase from B. abortus, amino acid ABC transporter substrate-binding protein from B. melitensis and fumarylacetoacetate hydrolase from both species were reactive with the sera of all the tested naturally infected host species. The identified proteins could be used for the design of serological assays capable of detecting pan-Brucella, B. abortus- and B. melitensis-specific antibodies. PMID:27144565

  13. Recomendación sobre la vacuna contra la tosferina para los preadolescentes y adolescentes (Whooping Cough Vaccine Recommendation for Preteens and Teens)

    2015-04-13

    Este podcast proporciona información acerca de la tosferina y la recomendación de que todos los preadolescentes reciban la vacuna Tdap a los 11 o 12 años para ayudar a protegerlos contra esta grave enfermedad.  Created: 4/13/2015 by National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD), Meningitis and Vaccine Preventable Diseases Branch (MVPDB).   Date Released: 4/13/2015.

  14. Evaluación de anticuerpos contra enfermedades prevenibles por vacunas en el binomio madre–recién nacido en hospitales de Ciudad de La Habana

    2007-01-01

    El sistema inmune es inmaduro en los recién nacidos, lo que los hace susceptibles a las enfermedades infecciosas, sin embargo, pueden ser parcialmente protegidos por los anticuerpos adquiridos a través de la placenta. Por ello, nos propusimos evaluar la transferencia transplacentaria de anticuerpos contra algunas enfermedades prevenibles por vacunas. Se realizó un ensayo prospectivo, aleatorio, en el binomio madre–recién nacido. Para ello se analizó un total de 96 pares de muestras de suero, ...

  15. Aproximación al uso de hongos entomopatógenos y vacunas para el control sostenible de garrapatas en sistemas ganaderos: revisión

    Ana Carolina Moncada González; David Villar Argaiz; Jenny Jovanna Chaparro Gutiérrez; Joaquín Angulo Arizala; Liliana María Mahecha Ledesma

    2015-01-01

    La resistencia desarrollada por las garrapatas frente a los acaricidas de síntesis, hace necesario replantear las estrategias utilizadas actualmen - te para su control. Los programas de manejo integrado de parásitos se presentan como una alternativa que, al promover estrategias de con - trol basadas en la ecología y la epidemiología de cada especie de parásito, reducen el riesgo de desarrollo de resistencia. Dichas estrategias incluyen la aplicación de vacunas antigarrapata y hongos e...

  16. Influencia de la edad de vacunación con la vacuna B. abortus S19 en la respuesta serológica inducida en terneras Influence of age of vaccination with Brucella abortus S19 on humoral immune response in beef calf

    G Meglia; M Gastaldo; N Álvarez Rubianes; Oriani, S; Cerutti, D; J Dubarry; C Cisterna; Perea, J.

    2011-01-01

    La brucelosis es una enfermedad infectocontagiosa que afecta a los bovinos, entre otras especies, ocasionando importantes pérdidas por infertilidad. El objetivo del presente trabajo fue determinar el efecto de la vacunación contra brucelosis sobre la respuesta inmunitaria humoral en dos grupos de terneras de diferente edad, como también precisar el grado de concordancia entre la prueba diagnóstica 2 mercapto-etanol (2-ME) y la polarización fluorescente (FPA) en animales BPA positivos. El grup...

  17. Influencia de la edad de vacunación con la vacuna B. abortus S19 en la respuesta serológica inducida en terneras Influence of age of vaccination with Brucella abortus S19 on humoral immune response in beef calf

    G Meglia

    2011-06-01

    Full Text Available La brucelosis es una enfermedad infectocontagiosa que afecta a los bovinos, entre otras especies, ocasionando importantes pérdidas por infertilidad. El objetivo del presente trabajo fue determinar el efecto de la vacunación contra brucelosis sobre la respuesta inmunitaria humoral en dos grupos de terneras de diferente edad, como también precisar el grado de concordancia entre la prueba diagnóstica 2 mercapto-etanol (2-ME y la polarización fluorescente (FPA en animales BPA positivos. El grupo 1 fue vacunado a los 3,5 y el grupo 2 a los 7,5 meses de edad promedio. Los animales se sangraron mensualmente para determinar inmunoglobulinas IgM y/o IgG, e IgG a través de las pruebas de Wright y 2-ME, respectivamente. La concentración sérica de inmunoglobulinas fue significativamente superior en el grupo de terneras vacunadas a mayor edad en relación a las más jóvenes. En terneras BPA (+ FPA, dada su alta especificidad, reveló un número de animales negativos significativamente superior a los detectados por el 2-ME. Inesperadamente la presencia de animales positivos a FPA se mantuvo por más de 90 días en el grupo de terneras vacunadas a menor edad en relación a las de vacunación tardía, evidenciando un comportamiento de difícil explicación.Brucellosis is an infectious disease that affects bovine, among other species, producing loses through infertility. The objective of the present work was to assess the effect of vaccination against brucellosis over the humoral immune response in two groups of different age beef calves, as well as to determine the degree of relationship between 2 mercapto-ethanol and fluorescence polarization assay diagnosis in BPA positive animals. On average, group 1 was vaccinated at 3,5 and group 2 at 7,5 months of age. The animals were bled monthly, and the IgM and/or IgG, and IgG were assessed through Wright and 2-ME, respectively. The serum concentrations of immunoglobulin were significantly higher in the group 2 in relation to group 1. In animals BPA (+, FPA showed significantly lower positive values in relation to 2-ME. Moreover, the group of animals vaccinated at younger age showed positive serum FPA results for a period longer than 90 days in relation to the adult vaccinated ones, exhibiting an unexpected behavior.

  18. Estado actual de la vacuna recombinante contra el virus del papiloma humano State of the art on human papillomavirus vaccine

    Wendy Chan Acón

    2008-12-01

    Full Text Available La infección por el virus del papiloma humano (VPH es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50%. El virus se asocia aproximadamente a un 100% de los casos de cáncer cervical; a un 100% de las neoplasias cervicales intraepiteliales grados 1, 2, 3; a un 40% de los casos de cáncer de vulva, vagina y pene, 100% de las verrugas genitales; a un 100% de las papilomatosis respiratorias recurrentes; a un 90% del cáncer anal y a un 12% del cáncer de cabeza y cuello, predominantemente en orofaringe y amígdala. Actualmente, el uso de dos vacunas está aprobado en diversos países: Gardasil® y Cervarix®. Ambas están compuestas por proteínas L1 de VPH, en forma de partículas no infecciosas similares al virus (VLPs producidas por tecnología de ADN recombinante, adsorbidas en adyuvantes que contienen aluminio. La eficacia hallada en diversos estudios en sujetos no expuestos previamente al virus se encuentran en el rango del 98.8% al 100.0% para la prevención de neoplasias cervicales, vulvares y vaginales intraepiteliales, grados 2 y 3, relacionados con el VPH-16/18, además de los adenocarcinomas in situ y verrugas genitales causadas por VPH- 16/18/6/11 en el caso de Gardasil® y una eficacia del 100% en el caso de Cervarix® para la prevención de neoplasias cervicales grado 2 y 3 relacionados con el VPH-16/18. La eficacia de ambas se mantiene alrededor de los 5 años. Hasta el momento no se le ha atribuido a la vacuna ningún efecto terapéutico, solo se administra con fines profilácticos, sin embargo, esta no debe ser considerada como un sustituto de las pruebas de tamizaje para la prevención del cáncer cervical.Genital human papillomavirus (HPV is one of the most common sexually transmitted infections worldwide. Millions of persons are now infected and the lifetime risk of HPV

  19. Prevalence of antibodies to Chlamydophila abortus in ovines in the Londrina area of Paraná state, Brazil

    Bruna Azevedo de Carvalho Lima; Kledir Anderson Hofstaetter Spohr; Francielle Gibson da Silva Zacarias; Sergio Mangano de Almeida Santos; Mario de Luca Neto; Carlo Turilli; Julio Cesar de Freitas

    2014-01-01

    The aim of this paper was to estimate the prevalence of antibodies to Chlamydophila abortus in ewes from the Londrina region of Paraná state. Blood samples from 267 adult ewes from eight herds were submitted to complement fixation testing. Tests were considered positive when the titers ? 32. Nineteen animals (7.11%) in 7 (87.50%) herds tested positive for antibodies against C. abortus. The titers were 32 in 17 animals and were 64 and 128 in the other two animals. The clinical signs recorded w...

  20. Deletion of znuA Virulence Factor Attenuates Brucella abortus and Confers Protection against Wild-Type Challenge

    Yang, Xinghong; Becker, Todd; Walters, Nancy; Pascual, David W.

    2006-01-01

    znuA is known to be an important factor for survival and normal growth under low Zn2+ concentrations for Escherichia coli, Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida. We hypothesized that the znuA gene present in Brucella melitensis 16 M would be similar to znuA in B. abortus and questioned whether it may also be an important factor for growth and virulence of Brucella abortus. Using the B. melitensis 16 M genome sequence, primers were designed to construct a B. abortu...

  1. Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51

    Elaine M S Dorneles; Lima, Graciela K.; Andréa Teixeira-Carvalho; Araújo, Márcio S S; Martins-Filho, Olindo A; Nammalwar Sriranganathan; Hamzeh Al Qublan; Heinemann, Marcos B; Andrey P. Lage

    2015-01-01

    Brucella abortus S19 and RB51 strains have been successfully used to control bovine brucellosis worldwide; however, currently, most of our understanding of the protective immune response induced by vaccination comes from studies in mice. The aim of this study was to characterize and compare the immune responses induced in cattle prime-immunized with B. abortus S19 or RB51 and revaccinated with RB51. Female calves, aged 4 to 8 months, were vaccinated with either vaccine S19 (0.6-1.2 x 1011 CFU...

  2. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

    Stevens, M G; S. C. Olsen; Pugh, G W; Brees, D

    1995-01-01

    Immune responses and resistance to infection with Brucella abortus 2308 (S2308) were measured in mice following vaccination with B. abortus 19 (S19) or the lipopolysaccharide (LPS) O-antigen-deficient mutant, strain RB51 (SRB51). Live bacteria persisted for 8 weeks in spleens of mice vaccinated with 5 x 10(6) or 5 x 10(8) CFU of SRB51, whereas bacteria persisted for 12 weeks in mice vaccinated with 5 x 10(6) CFU of S19. Mice vaccinated with 5 x 10(6) or 5 x 10(8) CFU of SRB51 had increased re...

  3. Fragmentación del polisacárido de Neisseria meningitidis serogrupo C para su uso en vacunas conjugadas

    Osmir Cabrera

    2001-12-01

    Full Text Available Las infecciones meningocócicas son una causa importante de morbilidad y mortalidad en el mundo. Los serogrupos B y C son los responsables de la mayoría de los casos reportados en muchos países e incluso en países desarrollados. Las vacunas meningocócicas que contienen al polisacárido capsular purificado del meningococo C inducen en adultos protección por la presencia de anticuerpos bactericidas en sueros, pero son pobremente inmunogénicos en niños pequeños y pueden inducir tolerancia. La inmunogenicidad de los polisacáridos o sus fragmentos puede ser mejorada por la conjugación a proteínas transportadoras. El objetivo de este estudio fue obtener oligosacáridos C (Os-C a partir de la depolimerización del polisacárido de Neisseria meningitidis serogrupo C (Ps-C por hidrólisis ácida, calor y peryodato de sodio y evaluar la conservación de sus propiedades antigénicas mediante un ELISA de inhibición. Se determinó la pérdida de grupos O-acetilos, así como, la talla molecular relativa por filtración en gel y se observaron diferencias significativas entre los OS-C obtenidos en cada método. Las propiedades antigénicas fueron dependientes del tamaño molecular de los Os-C, así como de la presencia de los grupos O-acetilos en los oligosacáridos. Los Os-C obtenidos por la hidrólisis ácida mostraron similares propiedades antigénicas a las del polisacárido.

  4. Different resistance patterns of reference and field strains of Brucella abortus

    Karina L. Miranda

    2015-03-01

    Full Text Available The aim of this study was to evaluate the growth of the B. abortus reference strains and field isolates on media containing different inhibitor agents. Reference strains were seeded on tryptose agar containing: i-erythritol (1.0 mg/mL, fuchsin (20 μg/mL and 80 μg/mL, thionin (2.5 μg/mL and 10 μg/mL, rifampicin (200 μg/mL and safranin O (200 μg/mL. Field isolates were tested only on media containing i-erythritol, rifampicin and thionin. Furthermore, each suspension was also inoculated on tryptose agar incubated in air, to test its ability to grow without CO2. Sensitivity to fuchsin was similar among reference strains evaluated. Growth of S19, 544 and 2308 but not RB51 were inhibited on media containing rifampicin. Medium with safranin O showed no inhibition for RB51, 544 and 2308, but it partially inhibited the S19 growth as well as medium containing i-erythritol. Treatment/control growth ratio for 2308 on tryptose agar containing thionin (2.5 μg/mL was approximatelly 1.0, whereas S19 and RB51 showed 0.85 and 0.89 ratios, respectively. Growth of 544, S19 and RB51 but not 2308 was completely inhibited on medium with thionin (10 μg/mL. All field strains grew on medium containing i-erythritol, but were completelly inhibited by rifampicin. With exception of A1 (B. abortus biovar 3 all field isolates grew on medium with thionin, although some strains showed a treatment/control growth ratio of 0.75–0.80 (10 μg/mL. These results showed that tryptose agar with thionin, i-erythritol or rifampicin could be useful for differentiating vaccine, challenge and field strains of B. abortus.

  5. Different resistance patterns of reference and field strains of Brucella abortus

    Miranda, Karina L.; Dorneles, Elaine M. S.; Poester, Fernando P.; Martins, Paulo S.; Pauletti, Rebeca B.; Lage, Andrey P.

    2015-01-01

    The aim of this study was to evaluate the growth of the B. abortus reference strains and field isolates on media containing different inhibitor agents. Reference strains were seeded on tryptose agar containing: i-erythritol (1.0 mg/mL), fuchsin (20 μg/mL and 80 μg/mL), thionin (2.5 μg/mL and 10 μg/mL), rifampicin (200 μg/mL) and safranin O (200 μg/mL). Field isolates were tested only on media containing i-erythritol, rifampicin and thionin. Furthermore, each suspension was also inoculated on tryptose agar incubated in air, to test its ability to grow without CO 2 . Sensitivity to fuchsin was similar among reference strains evaluated. Growth of S19, 544 and 2308 but not RB51 were inhibited on media containing rifampicin. Medium with safranin O showed no inhibition for RB51, 544 and 2308, but it partially inhibited the S19 growth as well as medium containing i-erythritol. Treatment/control growth ratio for 2308 on tryptose agar containing thionin (2.5 μg/mL) was approximatelly 1.0, whereas S19 and RB51 showed 0.85 and 0.89 ratios, respectively. Growth of 544, S19 and RB51 but not 2308 was completely inhibited on medium with thionin (10 μg/mL). All field strains grew on medium containing i-erythritol, but were completelly inhibited by rifampicin. With exception of A1 ( B. abortus biovar 3) all field isolates grew on medium with thionin, although some strains showed a treatment/control growth ratio of 0.75–0.80 (10 μg/mL). These results showed that tryptose agar with thionin, i-erythritol or rifampicin could be useful for differentiating vaccine, challenge and field strains of B. abortus. PMID:26221116

  6. Different resistance patterns of reference and field strains of Brucella abortus.

    Miranda, Karina L; Dorneles, Elaine M S; Poester, Fernando P; Martins Filho, Paulo S; Pauletti, Rebeca B; Lage, Andrey P

    2015-03-01

    The aim of this study was to evaluate the growth of the B. abortus reference strains and field isolates on media containing different inhibitor agents. Reference strains were seeded on tryptose agar containing: i-erythritol (1.0 mg/mL), fuchsin (20 μg/mL and 80 μg/mL), thionin (2.5 μg/mL and 10 μg/mL), rifampicin (200 μg/mL) and safranin O (200 μg/mL). Field isolates were tested only on media containing i-erythritol, rifampicin and thionin. Furthermore, each suspension was also inoculated on tryptose agar incubated in air, to test its ability to grow without CO 2 . Sensitivity to fuchsin was similar among reference strains evaluated. Growth of S19, 544 and 2308 but not RB51 were inhibited on media containing rifampicin. Medium with safranin O showed no inhibition for RB51, 544 and 2308, but it partially inhibited the S19 growth as well as medium containing i-erythritol. Treatment/control growth ratio for 2308 on tryptose agar containing thionin (2.5 μg/mL) was approximatelly 1.0, whereas S19 and RB51 showed 0.85 and 0.89 ratios, respectively. Growth of 544, S19 and RB51 but not 2308 was completely inhibited on medium with thionin (10 μg/mL). All field strains grew on medium containing i-erythritol, but were completelly inhibited by rifampicin. With exception of A1 ( B. abortus biovar 3) all field isolates grew on medium with thionin, although some strains showed a treatment/control growth ratio of 0.75-0.80 (10 μg/mL). These results showed that tryptose agar with thionin, i-erythritol or rifampicin could be useful for differentiating vaccine, challenge and field strains of B. abortus. PMID:26221116

  7. Identification of new IS711 insertion sites in Brucella abortus field isolates

    Moriyón Ignacio

    2011-08-01

    Full Text Available Abstract Background Brucellosis is a zoonosis caused by Brucella spp., a group of highly homogeneous bacteria. The insertion sequence IS711 is characteristic of these bacteria, and occurs in variable numbers and positions, but always constant within a given species. This species-associated polymorphism is used in molecular typing and identification. Field isolates of B. abortus, the most common species infecting cattle, typically carry seven IS711 copies (one truncated. Thus far, IS711 transposition has only been shown in vitro and only for B. ovis and B. pinnipedialis, two species carrying a high number of IS711 copies, but never in other Brucella species, neither in vitro nor in field strains. Results We found several B. abortus strains isolated from milk and aborted fetuses that carried additional IS711 copies in two hitherto undescribed insertion sites: one in an intergenic region near to the 3' end of a putative lactate permease gene and the other interrupting the sequence of a marR transcriptional regulator gene. Interestingly, the second type of insertion was identified in isolates obtained repeatedly from the same herd after successive brucellosis outbreaks, an observation that proves the stability and virulence of the new genotype under natural conditions. Sequence analyses revealed that the new copies probably resulted from the transposition of a single IS711 copy common to all Brucella species sequenced so far. Conclusions Our results show that the replicative transposition of IS711 can occur under field conditions. Therefore, it represents an active mechanism for the emergence of genetic diversity in B. abortus thus contributing to intra-species genetic polymorphism.

  8. Detection of antibodies against Chlamydophila abortus in Costa Rican sheep flocks

    R. Villagra-Blanco; Dolz, G.; Montero-Caballero, D.; Romero-Zúñiga, J.J.

    2015-01-01

    A total of 359 sheep samples from 15 flocks were analyzed for the presence of antibodies against Chlamydophila abortus using a commercial Enzyme linked Immunosorbent Assay (ELISA). Antibodies were detected in 19 (5.29%) sheep from 12 (80%) flocks. Seropositive animals were found in all analyzed regions (Central, Chorotega, Atlantic Huetar, North Huetar and Central Pacific) determining prevalence between 0.28% and 4.4%, and intra-flock positivity between 3.7% and 25.0%. The survey revealed two...

  9. Vector Development for the Expression of Foreign Proteins in the Vaccine Strain Brucella abortus S19

    Diego J Comerci; Pollevick, Guido D.; Vigliocco, Ana M.; Frasch, Alberto C. C.; Ugalde, Rodolfo A.

    1998-01-01

    A vector for the expression of foreign antigens in the vaccine strain Brucella abortus S19 was developed by using a DNA fragment containing the regulatory sequences and the signal peptide of the Brucella bcsp31 gene. This fragment was cloned in broad-host-range plasmid pBBR4MCS, resulting in plasmid pBEV. As a reporter protein, a repetitive antigen of Trypanosoma cruzi was used. The recombinant fusion protein is stably expressed and secreted into the Brucella periplasmic space, inducing a goo...

  10. Different resistance patterns of reference and field strains of Brucella abortus

    Karina L. Miranda; Elaine M S Dorneles; Poester, Fernando P; Paulo S. Martins Filho; Pauletti, Rebeca B.; Andrey P. Lage

    2015-01-01

    The aim of this study was to evaluate the growth of the B. abortus reference strains and field isolates on media containing different inhibitor agents. Reference strains were seeded on tryptose agar containing: i-erythritol (1.0 mg/mL), fuchsin (20 μg/mL and 80 μg/mL), thionin (2.5 μg/mL and 10 μg/mL), rifampicin (200 μg/mL) and safranin O (200 μg/mL). Field isolates were tested only on media containing i-erythritol, rifampicin and thionin. Furthermore, each suspension was also inoculated on ...

  11. Outer Membrane Proteins of Brucella abortus Vaccinal and Field Strains and their Immune Response in Buffaloes

    Rukhshanda Munir*, M. Afzal1, M. Hussain2, S. M. S. Naqvi3 and A. Khanum3

    2010-01-01

    Outer membrane proteins (OMPs) of three strains of B. abortus i.e. S19, RB51 and a local field isolate of biotype 1 were isolated through disrupting cells to generate membranes by centrifugation and sodium lauryl sarcosinate solubilisation of inner membrane proteins. Distinct OMP profiles of each strain were seen on SDS-PAGE. SDS-PAGE analysis of S19 and field isolate revealed eight protein bands in each strain. The OMPs of S19 had molecular masses 89.0, 73.0, 53.7, 49.0, 38.0, 27.0, 22.3, a...

  12. Virulence Criteria for Brucella abortus Strains as Determined by Interferon Regulatory Factor 1-Deficient Mice

    Ko, Jinkyung; Gendron-Fitzpatrick, Annette; Thomas A Ficht; Gary A Splitter

    2002-01-01

    Interferon regulatory factor 1-deficient (IRF-1−/−) mice infected with virulent Brucella abortus 2308 at 5 × 105 CFU developed acute hepatitis similar to many natural hosts but, unlike natural hosts, IRF-1−/− mice were unable to resolve infection and died. In contrast, IRF-1−/− mice survived when infected at 5 × 105 CFU with several attenuated Brucella strains (S19, RB51, cbp, and cyd). The survival of infected IRF-1−/− mice is likely a function of the level of virulence of each Brucella stra...

  13. Investigation of the possible role of Chlamydophila abortus in reproductive failures in nrazilian herds of domestic ruminants

    Francielle Gibson da Silva-Zacarias

    2009-11-01

    Full Text Available Chlamydophila abortus (C. abortus infection is related to reproductive failure in domestic ruminants. Although it has not been well characterized worldwide, this pathogen has already been identified in some European countries and in the USA. In Brazil, preliminary studies have shown serological evidence of C. abortus infection in herds with low antibody prevalence. Until now, the identification of C. abortus in biological samples from females presenting reproductive failures has not been described in Brazilian herds of domestic ruminants. The aim of this study was to evaluate the presence of the C. abortus in a collection of abortions from cattle (n=85, sheep (n=12, and goats (n=8, in samples of vaginal mucus from cows (n=13, sheep (n=90, and goats (n­=20, and in semen from sheep (n=10 and goats (n=5. The specimens (n=243 were evaluated using a PCR assay developed to amplify the 16S-23S rRNA intergenic space of C. abortus. A PCR assay with an internal control, which amplifies a fragment from the ND5 gene of bovine mitochondrial DNA, was used in order to evaluate the efficiency of the DNA extraction and of the PCR reaction. All biological samples (n=243 included in this study were negative for C. abortus in the PCR assay. The internal control enabled the amplification of a product from the bovine mitochondrial ND5 gene in all cattle abortion samples (n=85. Given the serological evidence indicating the presence of C. abortus infection in Brazilian herds of domestic ruminants, and considering the wide sampling evaluated, the failure to identify C. abortus in this survey suggests that the frequency of clinical signs in infected animals may be low or even absent.A infecção pela Chlamydophila abortus (C. abortus em ruminantes domésticos está relacionada com distúrbios reprodutivos. Apesar de ainda pouco estudada em todo o mundo, a infecção já foi identificada em alguns países europeus e também nos EUA. No Brasil, estudos preliminares

  14. La real expedición filantrópica de la vacuna en Canarias (9 de diciembre de 1803 - 6 de enero de 1804

    García Nieto, Víctor

    2005-12-01

    Full Text Available The conditions, circumstances and aftermath of the stay of the Balmis’ Royal Vaccinal Expedition (1803-1806 in the Canary Islands have been studied in this paper. We have focused on reports from canary witnesses rather than official and administrative data. We have records of the spreading of the vaccine out to the isles. Finally, the decisive and determinant part played by the Roman Catholic Church to achieve the objectives of the Royal Expedition has been remarked.

    Se han estudiado las circunstancias y consecuencias de la escala de la Real Expedición Filantrópica de la Vacuna (1803-1806 en el Archipiélago Canario. Nos hemos centrado en los relatos de testigos canarios más que en los datos burocráticos y administrativos. Tenemos constancia de la difusión de la vacuna en las islas. Finalmente, hemos puesto de relieve el papel determinante y decisivo de la Iglesia en la consecución de los objetivos de la Real Expedición.

  15. Post-Abortion Syndrome and nursing approachesPost-Abortus Sendromu ve hemşirelik yaklaşımları

    Yılda Arzu Aba

    2016-02-01

    Full Text Available The relation between the life outputs, are associated especially with the mental health outputs at Abortus and the period that follows it. Post-Abortus Syndrome (PAS is the concept of abortus trauma management that show up with the chronic or delayed symptoms as a result of the hidden emotional reactions that are experienced because of the post-abortus physical and psychological trauma. The individual, the systemic and the social factors that are existing at post-Abortus women affect PAS development. The interventions, in general, that are oriented towards mental problems of the individual at the PAS period, focused on the  individual’s sufficiency and efficiency for coping with all the problems that are faced in her life. There is no any program that is developed for post-Abortus women or their family in our country. It is important for the individual who is diagnosed with PAS to receive consultancy from a health professional for her recovery from the period.   Özet Abortus ve bunu izleyen süreçte yaşam sonuçları arasındaki ilişki özellikle mental sağlık sonuçlarıyla ilişkilendirilmektedir. Post-Abortus Sendromu (PAS, abortus sonrası fiziksel ve psikolojik travma nedeniyle deneyimlenen gizlenmiş duygusal tepkiler sonucu, kronik ya da gecikmiş belirtilerle ortaya çıkan abortus travmasını yönetebilme kavramıdır. Abortus sonrası kadınlarda var olan bireysel, sistemik ve sosyal faktörler PAS gelişimini etkilemektedir. PAS dönemindeki bireyin ruhsal sorunlarına yönelik yapılan müdahaleler genel olarak, bireyin yaşamında karşılaştığı tüm sorunlarla başetmesinde yeterli ve etkili hale gelmesine odaklanır. Ülkemizde abortus sonrası kadınlara ya da ailelerine yönelik geliştirilen herhangi bir program bulunmamaktadır. PAS tanısı alan bireyin süreci atlatabilmesi için sağlık profesyoneli tarafından danışmanlık alması önemlidir.

  16. Genetic stability of Brucella abortus isolates from an outbreak by multiple-locus variable-number tandem repeat analysis (MLVA16)

    Dorneles, Elaine Maria S.; Santana, Jordana A; Telma M. Alves; Pauletti, Rebeca B; Mol, Juliana Pinto da Silva; Marcos B. Heinemann; Andrey P. Lage

    2014-01-01

    Abstract Background Brucellosis caused by Brucella abortus is one of the most important zoonoses in the world. Multiple-locus variable-number tandem repeat analysis (MLVA16) has been shown be a useful tool to epidemiological traceback studies in B. abortus infection. Thus, the present study aimed (i) to evaluate the genetic diversity of B. abortus isolates from a brucellosis outbreak, and (ii) to investigate the in vivo stability of the MLVA16 markers. Results Three-hundred and seventy-five c...

  17. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.

    Tatum, F M; Detilleux, P G; Sacks, J M; Halling, S. M.

    1992-01-01

    Cu-Zn superoxide dismutase (SOD) deletion mutants of Brucella abortus S2308, a virulent strain, and S19, a vaccine strain, were generated by gene replacement. A deletion plasmid, pBA delta sodknr, was constructed by excising the Cu-Zn SOD gene (Cu-Zn sod) from a 2.3-kb B. abortus DNA fragment of plasmid pBA20-1527 and inserting a 1.4-kb DNA fragment encoding kanamycin resistance into the Cu-Zn sod excision site. The deletion plasmid was introduced into B. abortus by electroporation, and South...

  18. Evaluacion de la tecnica de contraimmunoelectroforesis para determinar la potencia antigena de las vacunas antirrabicas Evaluation ot the counterimmunoelectrophoresis technique to determine the antigenic potency of antirrabic vaccines

    Graciela Miceli

    1993-12-01

    Full Text Available El método recomendado por la Organización Mundial de la Salud (OMS para la prueba de potencia de vacunas antirrábicas como producto final es la prueba NIH. Algunas técnicas in vitro se han propuesto para el control durante el proceso de produción y complementan el ensayo in vivo antes mencionado. Este trabajo presenta los resultados obtenidos cuando se utilizó la técnica de contrainmunoelectroforésis (CIE para determinar el contenido de antígenos en muestras de 84 y 40 lotes de vacunas antirrábicas producidas en tejido nervioso de cerebro de ratón lactante mediante cultivo de tejidos, respectivamente. La evaluación de las muestras en, y en torno de, las 0.3 UI por ambos métodos muestran que, en la práctica, un título CIE de 1:4 cumpliría con un mínimo de potencia de la prueba NIH. Un bajo grado de variabilidad de la prueba CIE fue observada en nuestro laboratorio cuando dos lotes de vacunas de referencia de trabajo y 7 lotes de vacunas antirrábicas, de diferente origen y actividad, fueron ensayadas en cinco pruebas independientes. Todos los títulos se ubicaron dentro de una dilución doble, lo que es indicativo de su reproducibilidad. Se observó buena sensibilidad para detectar el deterioro del antígeno en el ensayo de degradación térmica, cuando muestras de 3 lotes de vacuna líquida de cerebro de ratón lactante fueron mantenidas a4 y 37ºC cada una, por 28 días. Se evaluaron semanalmente por los ensayos de CIE y NIH. Finalmente, se observó que el ensayo de CIE podría ser utilizado por los productores para estimar el punto final de los procesos de concentración para que se corresponda con un valor antigénico deseado en la prueba de potencia NIH.The method recommended by the World Health Organization (WHO for the potency assay of human and animal rabies vaccines as final product is the NIH test. Some in vitro techniques have been proposed for in process testing and supplement the in vivo test mentioned above. This

  19. Relevance of Helicobacter pylori virulence factors for vaccine development Relevancia de los factores de virulencia de helicobacter pylori para el desarrollo de vacunas

    Luz del Carmen Hernández-Hernández

    2009-01-01

    í, los individuos infectados por cepas que expresan estos factores de virulencia probablemente desarrollan enfermedades severas como el cáncer gástrico. Sin embargo, la ancestral relación entre H. pylori y los humanos sugiere que algunas cepas pueden ser beneficiosas para la salud humana. Por lo tanto, la administración generalizada de tratamientos con antibiótico podría eventualmente causar problemas. El desarrollo de vacunas con base en factores de virulencia que confieran protección a largo plazo es la mejor estrategia para el control y/o eliminación de cepas patógenas. Los diferentes esquemas y formulaciones de inmunización diseñados para evaluar las vacunas con base en factores de virulencia en modelos animales han dado resultados prometedores. Sin embargo, ha sido necesario probar si estos resultados pueden ser reproducidos en humanos. Este trabajo revisa los recientes estudios de vacunación que han explorado esta posibilidad: vacunas orales usando ureasa o células completas-inactivadas con LT como adyuvante y ureasa expresada en vectores de Salmonella spp.; además de una vacuna intramuscular multicomponente con hidróxido de aluminio como adyuvante. Aunque estos estudios han logrado limitado éxito han establecido las bases para el desarrollo de una vacuna eficaz contra esta infección.

  20. Interacción del componente pertussis de células completas con los antígenos tetánico, Haemophilus influenzae tipo B y hepatitis B en ensayos de potencia para vacunas combinadas

    Mario Landys

    2008-04-01

    Full Text Available Las vacunas combinadas permiten un grado de aceptación mayor entre la población, dado que se requiere de menos inmunizaciones para proteger contra las enfermedades infecciosas. Sin embargo, esto ha generado nuevos retos, ya que se han reportado numerosas interacciones entre los diferentes antígenos que conforman estas vacunas. El propósito del presente trabajo fue evaluar la interferencia potencial del componente pertussis de células completas sobre los ensayos para determinar la actividad biológica de otros antígenos como toxoide tetánico, Haemophilus influenzae tipo b (Hib y hepatitis B. Para ello se estudiaron mediante ensayos de potencia vacunas combinadas que contenían estos antígenos y se compararon con vacunas monovalentes. A su vez se prepararon adyuvaciones experimentales cuya composición permitió estimar adecuadamente la extensión y naturaleza de la interacción entre componentes. Se obtuvo que el componente pertussis incrementó significativamente la actividad biológica de Hib y tétanos, aunque esto puede depender mucho del modelo animal y el diseño experimental utilizado. En cuanto al antígeno de hepatitis B se demostró que pertussis inhibía la potencia de este antígeno, tanto in vitro como in vivo, aunque por mecanismos diferentes y de forma no significativa.

  1. A Live Vaccine from Brucella abortus Strain 82 for Control of Cattle Brucellosis in the Russian Federation

    During the first half of the 20th century, widespread regulatory efforts to control cattle brucellosis (Brucella abortus) in the Union of Soviet Socialist Republics were essentially nonexistent, and control was limited to selective test and slaughter of serologic agglutination reactors. By the 1950...

  2. Comparison of abortion and infection after experimental challenge of pregnant bison and cattle with Brucella abortus strain 2308

    A comparative study was conducted using data from naive bison (n=45) and cattle (n=46) from 8 and 6 studies, respectively, in which a standardized Brucella abortus strain 2308 experimental challenge was administered. The incidence of abortion, fetal infection, uterine or mammary infection, or infec...

  3. Late production of CXCL8 in ruminant oro-nasal turbinate cells in response to Chlamydia abortus infection.

    Doull, L; Wattegedera, S R; Longbottom, D; Mwangi, D; Nath, M; Glass, E J; Entrican, G

    2015-11-15

    Chlamydia abortus is an obligate intracellular bacterium that is an important cause of ovine abortion worldwide. There are reports of abortions in cattle, but these are very rare compared to the reported incidence in sheep. The bacterium is transmitted oro-nasally and can establish a sub-clinical infection until pregnancy, when it can invade the placenta and induce an inflammatory cascade leading to placentitis and abortion. Early host-pathogen interactions could explain differential pathogenesis and subsequent disease outcome in ruminant species. In this study, we assessed the ability of sheep and cattle oro-nasal turbinate cells to sense and respond to C. abortus infection. The cells expressed toll like receptor (TLR) 2, TLR4, nucleotide oligomerization domain (NOD) 1 and NOD-like receptor pyrin domain containing 3 (NLRP3) mRNA. In response to C. abortus infection, both ovine and bovine turbinate cells produce CXCL8 mRNA and protein late in the bacterial developmental cycle, but do not produce IL-1β or TNF-α. The UV-inactivated bacteria did not elicit a CXCL8 response, suggesting that intracellular multiplication of the bacteria is important for activating the signalling pathways. The production of innate immune cytokines from cattle and sheep turbinate cells in response to C. abortus infection was found to be largely similar. PMID:26342452

  4. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.

    Adone, Rosanna; Francia, Massimiliano; Pistoia, Claudia; Petrucci, Paola; Pesciaroli, Michele; Pasquali, Paolo

    2012-06-01

    It has been demonstrated that antibodies specific for O-PS antigen of Brucella smooth strains are involved in the protective immunity of brucellosis. Since the rough strain Brucella melitensis B115 was able to protect mice against wild Brucella strains brucellosis despite the lack of anti-OPS antibodies, in this study we evaluated the biological significance of antibodies induced by this strain, directed to antigens other than O-PS, passively tranferred to untreated mice prior to infection with Brucella abortus 2308 and B. melitensis 16M virulent strains. The protective ability of specific antisera collected from mice vaccinated with B. melitensis B115, B. abortus RB51 and B. abortus S19 strains was compared. The results indicated that antibodies induced by B115 were able to confer a satisfactory protection, especially against B. abortus 2308, similar to that conferred by the antiserum S19, while the RB51 antiserum was ineffective. These findings suggest that antibodies induced by B115 could act as opsonins as well as antibodies anti-O-PS, thus triggering more efficient internalization and degradation of bacteria within phagocytes. This is the first study assessing the efficacy of antibodies directed to antigens other than O-PS in the course of brucellosis infection. PMID:22521283

  5. [Multiplication of Brucella abortus and production of nitric oxide in two macrophage cell lines of different origin].

    Serafino, J; Conde, S; Zabal, O; Samartino, L

    2007-01-01

    Brucella abortus is a bacterium which causes abortions and infertility in cattle and undulant fever in humans. It multiplies intracellularly, evading the mechanisms of cellular death. Nitric oxide (NO) is important in the regulation of the immune response. In the present work, we studied the ability of three B. abortus strains to survive intracellularly in two macrophage cell lines. The bacterial multiplication in both cell lines was determined at two different times in UFC/ ml units. Moreover the inoculated cells were also observed under light-field and fluorescence microscopy stained with Giemsa and acridine orange, respectively. The stain of both cellular lines showed similar results with respect to the UFC/ml determination. The presence of B. abortus was confirmed by electronic microscopy. In both macrophage cell lines inoculated with the rough strain RB51, the multiplication diminished and the level of NO was higher, compared with cells inoculated with smooth strains (S19 and 2308). These results suggest that the absence of O-chain of LPS probably affects the intracellular growth of B. abortus. PMID:18390151

  6. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice.

    Truong, Quang Lam; Cho, Youngjae; Park, Soyeon; Park, Bo-Kyoung; Hahn, Tae-Wook

    2016-06-01

    Brucella abortus RB51 is an attenuated vaccine strain that has been most frequently used for bovine brucellosis. Although it is known to provide good protection in cattle, it still has some drawbacks including resistance to rifampicin, residual virulence and pathogenicity in humans. Thus, there has been a continuous interest on new safe and effective bovine vaccine candidates. In the present study, we have constructed unmarked mutants by deleting singly cydD and cydC genes, which encode ATP-binding cassette transporter proteins, from the chromosome of the virulent Brucella abortus isolate from Korean cow (referred to as IVK15). Both IVK15ΔcydD and ΔcydC mutants showed increased sensitivity to metal ions, hydrogen peroxide and acidic pH, which are mimic to intracellular environment during host infection. Additionally, the mutants exhibited a significant growth defect in RAW264.7 cells and greatly attenuated in mice. Vaccination of mice with either IVK15ΔcydC or IVK15ΔcydD mutant could elicit an anti-Brucella specific immunoglobulin G (IgG) and IgG subclass responses as well as enhance the secretion of interferon-gamma, and provided better protection against challenge with B. abortus strain 2308 than with the commercial B. abortus strain RB51 vaccine. Collectively, these results suggest that both IVK15ΔcydC and IVK15ΔcydD mutants could be an attenuated vaccine candidate against B. abortus. PMID:27057678

  7. Study of some parameters of humoral immunity in asthmatic elderly patients Estudio de algunos parámetros de inmunidad humoral en pacientes asmáticos de la tercera edad

    Dayamí García Torres

    2008-10-01

    Full Text Available Background: Aging process affects the whole body, including the respiratory and immune systems. Reductions of immunoglobulin secretion, together with environmental factors, increases susceptibility of elderly people to a more severe type of asthma. One of the effective ways of evaluating their immune system is the study of humoral immunity through immunoglobulin quantification. Objective: To analyse the characteristics of immunoglobulin G, A and M quantification in a sample of elderly patients. Methods: Descriptive study of two case series: a group of 60 years-old asthmatic patients and a group of patients younger than 60 years. All of them were received in Cienfuegos Allergy External Consultation, during one year and quantities of immunoglobulin G, A and M were measured. Results: There was higher incidence in female patients and patients between 60 and 79 years. We confirmed irregularities in immunoglobulin G quantification, not in IgA and IgM. Conclusions: Knowledge about humoral immunity in asthmatic elderly patients allows being more careful in their treatment.
    Fundamento: El envejecimiento afecta todos los sistemas; el respiratorio y el inmunológico no escapan a ello. La disminución en la secreción de inmunoglobulinas, sumada a factores del ambiente, hace al anciano susceptible de padecer un asma más severa. Una de las medidas eficaces para evaluar su sistema inmunológico es el estudio de la inmunidad humoral a través de la cuantificación de las inmunoglobulinas. Objetivo: Analizar el comportamiento de la cuantificación de las inmunoglobulinas G, A y M en una muestra de pacientes de la tercera edad. Métodos: Estudio descriptivo de dos serie de casos, un grupo de pacientes asmáticos de 60 años y más y un grupo de menos de 60 años, atendidos en la consulta externa municipal de alergia de la

  8. Características de los vídeos en español publicados en YouTube sobre la vacuna contra el virus del papiloma humano

    José Tuells

    2015-01-01

    Full Text Available Fundamentos: Internet constituye un recurso de búsqueda de información relacionada con la salud. El objetivo de este trabajo fue conocer las características de los vídeos en idioma español de YouTube relacionados con la vacuna contra el virus del papiloma humano (VPH. Métodos: Se realizó un estudio observacional a partir de una búsqueda en YouTube el 26 de julio de 2013, con las palabras claves: “vacuna virus papiloma humano”, “vacuna VPH”, “vacuna Gardasil”, “vacuna Cervarix”. Se establecieron categorías por tipo, fuente de publicación y predisposición favorable o no hacia la vacuna. Se registró el número de visitas, tiempo de duración de los videos y origen de los 20 vídeos más visitados. Resultados. Se encontraron 1.080 videos registrados, 170 fueron seleccionados y clasificados como: noticias locales (n=39; 37 favorables, 2 desfavorables; 2:06:29; 42972 visitas, noticias nacionales (n=32; 30/2; 1:49:27; 50138 visitas, creados por subscritores de YouTube (n=21; 13/8; 2:50:35; 144655 visitas, entrevistas (n=21; 20/1; 1:44:39; 10991 visitas, anuncios (n=21; 19/2; 0:27:05; 28435 visitas, conferencias (n=17; 15/2; 3:25:39; 27206 visitas, documentales (n=16; 12/4; 2:11:31; 30629 visitas, y noticias internacionales (n=3; 3/0; 0:11:33; 1667 visitas. De los 20 videos más reproducidos predominan los favorables a la vacunación (n=12; 0:43:43; 161.789 visitas frente a los desfavorables (n=8; 2:44:14; 86.583 visitas. Conclusiones. Predominan los videos que tiene una opinión favorable hacia la vacuna contra el VPH, aunque los videos de contenido negativo son los más extensos y reproducidos-

  9. An evaluation of ELISA using recombinant Brucella abortus bacterioferritin (Bfr) for bovine brucellosis.

    Hop, Huynh Tan; Arayan, Lauren Togonon; Simborio, Hannah Leah; Reyes, Alisha Wehdnesday Bernardo; Min, WonGi; Lee, Hu Jang; Lee, Jin Ju; Chang, Hong Hee; Kim, Suk

    2016-04-01

    To date, detection of antibodies against the lipopolysaccharide portion is the backbone of most serodiagnostic methods for brucellosis screening. However this pose a risk for false positive reactions related to other pathogens especially that of Yersinia enterocolitica O:9 which has the most prominent cross reactivity with Brucella spp. In this study, cloning and expression of Brucella abortus bacterioferritin (Bfr) was accomplished by PCR amplification into an expression vector system, and purification of a recombinant B. abortus Bfr (rBfr). The immunogenicity of rBfr was confirmed by Western blot with Brucella-positive bovine serum. To determine whether rBfr has a potential benefit for use in the serodiagnosis of bovine brucellosis, rBfr-based ELISA was performed. Interestingly, rBfr was able to detect anti-Brucella antibodies in positive sera in a dependent manner of TAT values but did not show an immunoreaction with negative samples. Particularly, average OD492 values at the lowest, medium and highest TAT titer levels were 1.4, 2.2 and 2.6-fold increase compared with the cutoff value, respectively. The accuracy, specificity and sensitivity of rBfr showed 89.09%, 93.6% and 85.33%, respectively. These findings suggest that rBfr might be a good candidate for serological diagnosis development of bovine brucellosis. PMID:27012915

  10. Optimization of production of Brucella abortus S19 culture in bioreactor using soyabean casein digest medium.

    Kamaraj, Govindasamy; Rajendra, Lingala; Shankar, Chinchkar Ramachandra; Srinivasan, Villuppanoor Alwar

    2010-10-01

    A method of cultivating Brucella abortus S19 culture in bioreactor was attempted using three different media. Culture conditions in bioreactor were optimized by varying agitation and aeration parameters. Varying the aeration ranging from 0.5 vvm to 0.8 vvm and agitation rate ranging from 250 rpm to 400 rpm during bacterial growth was found to yield highest viable count within 48 hours of culture period. A count of > 1 x 10(11) CFU per ml within 48 to 60 hours post seeding was obtained consistently in all five consecutive batches (P > 0.05) with 6 x 10(11) CFU per ml being the maximum yield when the organism is grown in soyabean casein digest medium. B. abortus S19 maintained its smooth characteristics throughout its growth in bioreactor. The vaccine prepared with soyabean casein digest medium was found to be potent and safe with a protective index of 3.33 in mice. The vaccine was tested in 10 cattle calves of 3 to 13 months age and all the vaccinated animals were seropositive on 28, 60, 90, 120 and 150 days post-vaccination when analyzed by fluorescence polarization assay (FPA). PMID:21213590

  11. Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome.

    Wang, Qiong; Luo, Lu; Lei, Qiong; Lin, Ming-Mei; Huang, Xuan; Chen, Ming-Hui; Zeng, Yan-Hong; Zhou, Can-Quan

    2016-07-01

    A prospective cohort study was conducted to determine whether chromosome aneuploidy increases the risk of early spontaneous abortions in patients with polycystic ovary syndrome (PCOS). A total of 1461 patients who conceived after IVF and embryo transfer were followed; 100 patients who had experienced clinical spontaneous abortion were recruited, 32 with PCOS and 68 without PCOS. Before 2013, genetic analysis comprised conventional cultured villus chromosome karyotyping and a multiplex ligation-dependent probe amplification subtelomere assay combined with fluorescence in-situ hybridization; since 2013, array-based comparative genomic hybridization technique combined with chromosome karyotyping has been used. Age, BMI, pregnancy history, gestational age and total gonadotrophin dosage did not differ significantly between the PCOS and non-PCOS groups. In the PCOS group, 28.1% of abortuses demonstrated aneuploidy, which was significantly lower (P = 0.001) than in the non-PCOS group (72.1%). Further statistical analyses controlling for maternal age demonstrated that abortuses of women with PCOS were significantly less (P = 0.001) likely to have chromosome aneuploidy. Embryonic aneuploidy does not play a vital role in early spontaneous abortion in women with PCOS. Maternal factors resulting in endometrial disorders are more likely to be responsible for the increased risk of early spontaneous abortion in patients with PCOS. PMID:27157933

  12. Intratracheal infection as an efficient route for testing vaccines against Chlamydia abortus in sheep.

    Álvarez, D; Salinas, J; Buendía, A J; Ortega, N; del Río, L; Sánchez, J; Navarro, J A; Gallego, M C; Murcia-Belmonte, A; Cuello, F; Caro, M R

    2015-09-01

    Pregnant ewes have been widely used to test vaccines against Chlamydia abortus. However, this model entails many disadvantages such as high economic costs and long periods of pregnancy. The murine model is very useful for specific studies but cannot replace the natural host for the later stages of vaccine evaluation. Therefore, a non-pregnant model of the natural host might be useful for a vaccine trial to select the best vaccine candidates prior to use of the pregnant model. With this aim, two routes of infection were assessed in young non-pregnant sheep, namely, intranasal (IN) and intratracheal (IT). In addition, groups of non-vaccinated sheep and sheep immunised with an inactivated vaccine were established to investigate the suitability of the model for testing vaccines. After the experimental infection, isolation of the microorganism in several organs, with pathological and immunohistochemical analyses, antibody production assessment and investigation by PCR of the presence of chlamydia in the vagina or rectum were carried out. Experimental IT inoculation of C. abortus induced pneumonia in sheep during the first few days post-infection, confirming the suitability of the IT route for testing vaccines in the natural host. The course of infection and the resulting pathological signs were less severe in vaccinated sheep compared with non-vaccinated animals, demonstrating the success of vaccination. IN infection did not produce evident lesions or demonstrate the presence of chlamydial antigen in the lungs and cannot be considered an appropriate model for testing vaccines. PMID:26095034

  13. Seroprevalence and molecular characterization of Chlamydia abortus in frozen fetal and placental tissues of aborting ewes in northeastern Algeria.

    Hireche, Sana; Ababneh, Mustafa Mohammed Kheir; Bouaziz, Omar; Boussena, Sabrina

    2016-02-01

    Enzootic abortion of ewes is one of the most serious health problems in sheep flocks worldwide. It has a significant economic impact because abortion, decrease in milk production and weak lambs. Besides, the bacteria is zoonotic. A cross-sectional study was conducted to determine the seroprevalence and risk factors associated with Chlamydia abortus infection in 552 ewes in Constantine using a C. abortus-specific indirect ELISA kit. Chlamydial DNA was investigated in ten ovine fetuses and eight placentas using PCR- restriction fragment length polymorphism (RFLP) and DNA sequencing. The study concluded that 7.2 % of ewes were seropositive and 33.3 % of sheep flocks had at least one seropositive ewe. Adjacent farmworker visits (OR = 7.667, 95 % CI (OR) = 2.307; 27.203) was defined as a risk factor. Deliveries of weak lambs (OR = 2.920, 95 % CI (OR) = 1.022; 8.342) and septicemia in lambs (OR = 9.971, 95 % CI (OR) = 2.383; 41.713) were significantly associated with chlamydial infection. PCR-RFLP analysis revealed positive signals to C. abortus in six fetuses and four placentas. Sequencing of the omp2 gene revealed that the Algerian strain is 96 % similar with C. abortus FAS strain. C. abortus plays a major role in abortion in northeastern Algeria. Appropriate control measures must be implemented to reduce economic losses and to avoid human contamination. PMID:26526957

  14. Infection of C57BL/6 mice by Trypanosoma musculi modulates host immune responses during Brucella abortus cocolonization.

    Lowry, Jake E; Leonhardt, Jack A; Yao, Chaoqun; Belden, E Lee; Andrews, Gerard P

    2014-01-01

    Brucellosis, which results in fetal abortions in domestic and wildlife animal populations, is of major concern in the US and throughout much of the world. The disease, caused by Brucella abortus, poses an economic threat to agriculture-based communities. A moderately efficacious live attenuated vaccine (B. abortus strain RB51) exists. However, even with vaccine use, outbreaks occur. Evidence suggests that elk (Cervus canadensis), a wild host reservoir, are the source of recent outbreaks in domestic cattle herds in Wyoming, USA. Brucella abortus establishes a chronic, persistent infection in elk. The molecular mechanisms allowing the establishment of this persistent infective state are currently unknown. A potential mechanism could be that concurrent pathogen burdens contribute to persistence. In Wyoming, elk are chronically infected with Trypanosoma cervi, which may modulate host responses in a similar manner to that documented for other trypanosomes. To identify any synergistic relationship between the two pathogens, we simulated coinfection in the well-established murine brucellosis model using Trypanosoma musculi and B. abortus S19. Groups of C57BL/6 mice (Mus musculus) were infected with either B. abortus strain 19 (S19) or T. musculi or both. Sera were collected weekly; spleens from euthanized mice were tested to determine bacterial load near the end of normal brucellosis infection. Although changes in bacterial load were observed during the later stages of brucellosis in those mice coinfected with T. musculi, the most significant finding was the suppression of gamma interferon early during the infection along with an increase in interleukin-10 secretion compared with mice infected with either pathogen alone. These results suggest that immune modulatory events occur in the mouse during coinfection and that further experiments are warranted to determine if T. cervi impacts Brucella infection in elk. PMID:24171573

  15. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.

    Vrushabhendrappa; Singh, Amit Kumar; Balakrishna, Konduru; Sripathy, Murali Harishchandra; Batra, Harsh Vardhan

    2014-09-29

    Brucellosis is one of the most prevalent zoonotic diseases of worldwide distribution caused by the infection of genus Brucella. Live attenuated vaccines such as B. abortus S19, B. abortus RB51 and B. melitensis Rev1 are found most effective against brucellosis infection in animals, contriving a number of serious side effects and having chances to revert back into their active pathogenic form. In order to engineer a safe and effective vaccine candidate to be used in both animals and human, a recombinant subunit vaccine molecule comprising the truncated region of glucokinase (r-glk) gene from B. abortus S19 was cloned and expressed in Escherichia coli BL21DE3 host. Female BALB/c mice immunized with purified recombinant protein developed specific antibody titer of 1:64,000. The predominant IgG2a and IgG2b isotypes signified development of Th1 directed immune responses. In vitro cell cytotoxicity assay using anti-r-glk antibodies incubated with HeLa cells showed 81.20% and 78.5% cell viability against lethal challenge of B. abortus 544 and B. melitensis 16M, respectively. The lymphocyte proliferative assay indicated a higher splenic lymphocyte responses at 25μg/ml concentration of protein which implies the elevated development of memory immune responses. In contrast to control, the immunized group of mice intra-peritoneal (I.P.) challenged with B. abortus 544 were significantly protected with no signs of necrosis and vacuolization in their liver and spleen tissue. The elevated B-cell response associated with Th1 adopted immunity, significant in vitro cell viability as well as protection afforded in experimental animals after challenge, supplemented with histopathological analysis are suggestive of r-glk protein as a prospective candidate vaccine molecule against brucellosis. PMID:25131740

  16. Formative research to shape HPV vaccine introduction strategies in Peru Investigación formativa relacionada con el diseño de estrategias para introducir la vacuna contra el VPH en Perú

    Rosario M Bartolini

    2010-06-01

    Full Text Available OBJECTIVE: To understand the sociocultural environment, health systems' capacities, and policy processes related to cervical cancer and HPV vaccines in order to inform HPV vaccine introduction. MATERIAL AND METHODS: Mixed-method formative research using qualitative and quantitative data collection techniques. Participants included girls, parents, community leaders, health and education officials, and policymakers. RESULTS: Respondents, including policymakers, generally supported HPV vaccine introduction, due partly to appreciation for the benefits of vaccination and the desire to prevent cancer. Community-level concerns regarding safety and quality of services will need to be addressed. The immunization system in Peru is strong and has capacity for including the HPV vaccine. CONCLUSION: Formative research provides key insights to help shape an effective program for HPV vaccine introduction.OBJETIVO: Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. MATERIAL Y MÉTODOS: Investigación formativa usando técnicas cualitativas y cuantitativas. Los participantes incluyeron niños, padres, líderes, funcionarios del sector salud y educación, y diseñadores de políticas. RESULTADOS: Generalmente se apoya la introducción de la vacuna contra el VPH, dado que se aprecian los beneficios de la vacunación y se desea prevenir el cáncer. En la comunidad se encontraron preocupaciones sobre seguridad, confianza y calidad de atención. El sistema de inmunizaciones en el Perú es eficiente y tiene la capacidad para incluir la vacuna contra el VPH. CONCLUSIONES: La investigación formativa permite comprender elementos clave que ayudan a diseñar un programa efectivo para la introducción de la vacuna contra el VPH.

  17. Evaluation and Selection of Multilocus Variable-Number Tandem-Repeat Analysis Primers for Genotyping Brucella abortus Biovar 1 Isolated from Human Patients

    Lee, Subok; Hwang, Kyu-Jam; Park, Mi-Yeoun; Hwang, Seon-Do; Chai, Hee-Youl; Chu, Hyuk; Park, Sang-Hee

    2013-01-01

    Objectives Brucellosis is the most common bacterial zoonosis in the world. Multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) is a molecular method for genotyping bacterial species. Brucella abortus biovar I was isolated from most of the brucellosis-suspected patients in Korea. This study was conducted to investigate the ability of various MLVA primers that are used for molecular typing B. abortus isolates and for analyzing their epidemiological data. Methods A total of 80 human ...

  18. Brucella abortus Cyclic β-1,2-Glucan Mutants Have Reduced Virulence in Mice and Are Defective in Intracellular Replication in HeLa Cells

    Briones, Gabriel; Iñón de Iannino, Nora; Roset, Mara; VIGLIOCCO, ANA; Paulo, Patricia Silva; Ugalde, Rodolfo A.

    2001-01-01

    Null cyclic β-1,2-glucan synthetase mutants (cgs mutants) were obtained from Brucella abortus virulent strain 2308 and from B. abortus attenuated vaccinal strain S19. Both mutants show greater sensitivity to surfactants like deoxycholic acid, sodium dodecyl sulfate, and Zwittergent than the parental strains, suggesting cell surface alterations. Although not to the same extent, both mutants display reduced virulence in mice and defective intracellular multiplication in HeLa cells. The B. abort...

  19. Molecular Cloning and Characterization of cgt, the Brucella abortus Cyclic β-1,2-Glucan Transporter Gene, and Its Role in Virulence

    Roset, Mara S.; Ciocchini, Andrés E.; Ugalde, Rodolfo A.; Iñón de Iannino, Nora

    2004-01-01

    The animal pathogen Brucella abortus contains a gene cgt, which complemented Sinorhizobium meliloti nodule development (ndvA) and Agrobacterium tumefaciens chromosomal virulence (chvA) mutants. Complemented strains recovered the presence of anionic cyclic β-1,2-glucan, motility, tumor induction in A. tumefaciens, and nodule occupancy in S. meliloti, all traits strictly associated with the presence of cyclic β-1,2-glucan in the periplasm. Nucleotide sequencing revealed that B. abortus cgt cont...

  20. Identification and Characterization of a Brucella abortus ATP-Binding Cassette Transporter Homolog to Rhizobium meliloti ExsA and Its Role in Virulence and Protection in Mice

    G.M.S. Rosinha; Freitas, Daniela A.; Miyoshi, Anderson; Azevedo, Vasco; Campos, Eleonora; Cravero, Silvio L; Rossetti, Osvaldo; Splitter, Gary; S.C. Oliveira

    2002-01-01

    Brucella abortus is a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. The mechanism of virulence of Brucella spp. is not fully understood yet. Furthermore, genes that allow Brucella to reach the intracellular niche and to interact with host cells need to be identified. Using the genomic survey sequence (GSS) approach, we identified the gene encoding an ATP-binding cassette (ABC) transporter of B. abortus strain S2308. The ded...

  1. MLVA Genotyping of Brucella melitensis and Brucella abortus Isolates from Different Animal Species and Humans and Identification of Brucella suis Vaccine Strain S2 from Cattle in China

    Hai Jiang; Heng Wang; Liqing Xu; Guiying Hu; Junying Ma; Pei Xiao; Weixing Fan; Dongdong Di; Guozhong Tian; Mengguang Fan; Jingchuan Mi; Ruiping Yu; Litao Song; Hongyan Zhao; Dongri Piao

    2013-01-01

    In China, brucellosis is an endemic disease and the main sources of brucellosis in animals and humans are infected sheep, cattle and swine. Brucella melitensis (biovars 1 and 3) is the predominant species, associated with sporadic cases and outbreak in humans. Isolates of B. abortus, primarily biovars 1 and 3, and B. suis biovars 1 and 3 are also associated with sporadic human brucellosis. In this study, the genetic profiles of B. melitensis and B. abortus isolates from humans and animals wer...

  2. TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.

    Gomes, Marco Túlio; Campos, Priscila Carneiro; Pereira, Guilherme de Sousa; Bartholomeu, Daniella Castanheira; Splitter, Gary; Oliveira, Sergio Costa

    2016-05-01

    Brucella abortus is a Gram-negative intracellular bacterial pathogen that causes a zoonosis of worldwide occurrence, leading to undulant fever in humans and abortion in domestic animals. B. abortus is recognized by several pattern-recognition receptors triggering pathways during the host innate immune response. Therefore, here, we determined the cooperative role of TLR9 with TLR2 or TLR6 receptors in sensing Brucella Furthermore, we deciphered the host innate immune response against B. abortus or its DNA, emphasizing the role of TLR9-MAPK/NF-κB signaling pathways in the production of proinflammatory cytokines. TLR9 is required for the initial host control of B. abortus, but this TLR was dispensable after 6 wk of infection. The susceptibility of TLR9(-/-)-infected animals to Brucella paralleled with lower levels of IFN-γ produced by mouse splenocytes stimulated with this pathogen compared with wild-type cells. However, no apparent cooperative interplay was observed between TLR2-TLR9 or TLR6-TLR9 receptors to control infection. Moreover, B. abortus or its DNA induced activation of MAPK/NF-κB pathways and production of IL-12 and TNF-α by macrophages partially dependent on TLR9 but completely dependent on MyD88. In addition, B. abortus-derived CpG oligonucleotides required TLR9 to promote IL-12 and TNF-α production by macrophages. By confocal microscopy, we demonstrated that TLR9 redistributed and colocalized with lysosomal-associated membrane protein-1 upon Brucella infection. Thus, B. abortus induced TLR9 traffic, leading to cell signaling activation and IL-12 and TNF-α production. Although TLR9 recognized Brucella CpG motifs, our results suggest a new pathway of B. abortus DNA-activating macrophages independent of TLR9. PMID:26578650

  3. Granulocyte-Macrophage Colony-Stimulating Factor- and Tumor Necrosis Factor Alpha-Mediated Matrix Metalloproteinase Production by Human Osteoblasts and Monocytes after Infection with Brucella abortus

    Scian, Romina; Barrionuevo, Paula; Giambartolomei, Guillermo H.; Fossati, Carlos A.; Baldi, Pablo C.; Delpino, M. Victoria

    2010-01-01

    Osteoarticular complications are common in human brucellosis, but the pathogenic mechanisms involved are largely unknown. Since matrix metalloproteinases (MMPs) are involved in joint and bone damage in inflammatory and infectious diseases, we investigated the production of MMPs by human osteoblasts and monocytes, either upon Brucella abortus infection or upon reciprocal stimulation with factors produced by each infected cell type. B. abortus infection of the normal human osteoblastic cell lin...

  4. Preparation by ultrafiltration and control by high-performance liquid chromatography of the native hapten of Brucella abortus for use in radial immunodiffusion diagnostic test.

    Zygmunt, M S; Dubray, G

    1987-01-01

    An effective method was developed for the preparation of Brucella abortus native hapten by use of an ultrafiltration system. The membranes PM30 and YM5 were used to separate the lipopolysaccharide and the native hapten. The yield of the native hapten was higher than that obtained by a more complex procedure reported previously. This method is economical for the large-scale preparation of B. abortus native hapten. The effects of ultrafiltration were evaluated by a quick and sensitive high-perf...

  5. Protective immune-response of aluminium hydroxide gel adjuvanted phage lysate of Brucella abortus S19 in mice against direct virulent challenge with B. abortus 544.

    Jain, Lata; Rawat, Mayank; Prajapati, Awadhesh; Tiwari, Ashok Kumar; Kumar, Bablu; Chaturvedi, V K; Saxena, H M; Ramakrishnan, Sarvanan; Kumar, Jatin; Kerketta, Priscilla

    2015-09-01

    The prophylactic efficacies of plain and alum adsorbed lysate were evaluated by direct virulent challenge in mice model. A recently isolated brucellaphage 'ϕLd' was used for generation of lysates. Twenty four h incubated Brucella abortus S19 broth cultures standardized to contain approximately 10(8) CFU/ml were found suitable for generation of lysates. Three lysate batches produced through separate cycles did not show any significant variation with respect to protein and polysaccharide contents, endotoxin level and phage counts, indicating that compositionally stable lysate preparations can be generated through an optimized production process. Three polypeptides of ∼16, 19 and 23 kDa could be identified as immuno-dominant antigens of the lysate which induced both humoral and cell-mediated immune responses in a dose dependent manner. Results of efficacy evaluation trial confirmed dose-dependent protective potencies of lysate preparation. The lysate with an antigenic dose of 0.52 μg protein and 60 μg CHO adsorbed on aluminium gel (0.1 percent aluminium concentration) exhibited the highest protective potency which was greater than that induced by standard S19 vaccine. Phage lysate methodology provides a very viable option through which an improved immunizing preparation with all desirable traits can be developed against brucellosis, and integrated with immunization programmes in a more efficient manner. PMID:26156404

  6. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7.

    Nielsen, K; Smith, P; Widdison, J; Gall, D; Kelly, L; Kelly, W; Nicoletti, P

    2004-05-20

    Sera from cattle naturally infected with Brucella abortus (n = 160), vaccinated with B. abortus S19 (n = 88) or immunized with Yersinia enterocolitica O:9 (n = 25) or Escherichia coli O157:H7 (n = 80) were collected. The sera were compared for antibody content to the same bacteria by indirect enzyme immunoassay (IELISA), fluorescence polarization assay (FPA) and competitive enzyme immunoassay (CELISA). Cattle sera (n = 523) collected randomly from across Canada were tested in the same tests. Sera from the B. abortus infected group reacted positively in the brucellosis IELISA (IELISA(Br)), CELISA and FPA (FPA(Br)) and the Y. enterocolitica IELISA (IELISA(Ye)) while the Y. enterocolitica FPA (FPA(Ye)) detected antibody in 93.8% and the E. coli IELISA (IELISA(Ec)) 86.9% and the E. coli FPA (FPA(Ec)) 48.1%. About 70% of the sera from B. abortus S19 vaccinated animals reacted in the three IELISAs, 45% in the CELISA, and 37.7% in the FPA(Ec), 21.6% in the FPA(Br) and 5.7% in the FPA(Ye). Sera from E. coli O:157 exposed cattle reacted mainly in the IELISA(Ec) and FPA(Ec) although surprisingly 87.5% reacted in the IELISA(Ye) and only 3.8% in the IELISA(Br). No reactions were observed with these sera in the FPA(Br) and FPA(Ye) but one serum gave a low positive reaction in the CELISA. All sera from Y. enterocolitica O:9 exposed cattle reacted in the IELISA(Br) and IELISA(Ye) and 80% in the IELISA(Ec). In the CELISA, 44% gave a positive reaction and 64% were positive in the FPA(Br), 28% in the FPA(Ye) and 12% in the FPA(Ec). Of the 523 Canadian sera, about 50% reacted in the E. coli tests with only minor reactions in the Y. enterocolitica O:9 and B. abortus assays. From the data, the cross reaction between E. coli O157:H7, Y. enterocilitica O:9 and B. abortus is dependent on the test used. Thus, extensive cross reaction was observed with the IELISA with much less reactivity in the FPA and the CELISA. PMID:15135510

  7. Vectores recombinantes basados en el virus modificado de ankara (MVA) como vacunas preventivas y terapéuticas contra el SIDA

    Jonathan L Heeney; Mooij, Petra; Nájera García, José Luis; Jiménez, Victoria; Esteban, Mariano; Gómez, Carmen E.

    2005-01-01

    Vectores Recombinantes basados en el Virus Modificado de Ankara (MVA) como Vacunas Preventivas y Terapéuticas contra el SIDA. Losvirus recombinantes de la invención contienen secuencias que se encuentran insertadas en el mismo sitio de inserción del MVA y permiten la expresión simultánea de varios antígenos, una proteína Env del VIH-I consistente en una proteína gpl20 carente de secuencias correspondientes a la proteína gp41, y una proteína quiméricade fusión de Gag, Pol y Nef. Son virus esta...

  8. Problemas bioéticos en la investigación de nuevas vacunas: ¿obedecen a razones de salud pública?

    Juan Carlos Tealdi

    2015-01-01

    Full Text Available Los problemas éticos de las investigaciones sobre vacunas han crecido en las últimas décadas en frecuencia y magnitud debido a la posición dominante de la industria farmacéutica en el desarrollo de esos estudios. Las tradicionales cuestiones de seguridad y eficacia se han visto agravadas por el conflicto de intereses introducido por la competencia comercial en un mercado a escala global de miles de millones de dólares. La integridad profesional de los investigadores, la responsabilidad moral de los patrocinadores, y la regulación y control por parte de los Estados nacionales, se muestra cuestionada en varios ejemplos. Los resultados de estos cambios son las amenazas a la protección de los derechos de las personas incluidas en estas investigaciones y el discutible progreso que resulta para la salud pública.

  9. Introducción de un ELISA como ensayo alternativo en la determinación de la potencia de vacunas antitetánicas

    Juan Carlos Ramírez; Esther María Fajardo; Beatriz Romeu; Ubel Jesús Ramírez; Eduardo Alvarez; Rolando Ochoa; Alicia Perojo; Regla Sosa; Deolinda Silva; Irma Labrador; Adina García; Pablo González; Luis Izquierdo

    2005-01-01

    Por más de medio siglo de uso, la vacunación con el toxoide tetánico ha mostrado un elevado porcentaje de eficacia en la prevención del tétanos. Este trabajo pretende introducir un ensayo inmunoenzimático en fase sólida (ELISA) como método alternativo a la prueba de seroneutralización in vivo utilizada en la evaluación de la potencia de las vacunas antitetánicas.Se desarrolló un ELISA de tipo indirecto para la cuantificación de antitoxina tetánica en suero de curiel a partir de un estándar co...

  10. Estudios de estabilidad de vida de estante en condiciones de estrés de la vacuna antileptospirósica vax-SPIRAL®

    Maylén Machado

    2007-04-01

    Full Text Available Los estudios de estabilidad constituyen requisito fundamental para avalar el Registro Médico Sanitario de un nuevo medicamento. Por tal motivo se diseñó y llevó a cabo un proyecto de estudio de estabilidad de vida de estante y en condiciones de estrés térmico a la vacuna antileptospirósica cubana vax-SPIRAL®, donde se evaluaron las propiedades físicoquímicas y biológicas fundamentales del producto (características organolépticas, pH, concentración de tiomersal, inocuidad inespecífica, potencia y esterilidad, con el objetivo de recomendar las condiciones de almacenamiento que garantizarán su calidad y se propone la fecha de vencimiento. Para esto, parte de las muestras se conservaron a temperatura de 2-8 ºC durante 30 meses (vida de estante, y las muestras restantes de cada uno de los lotes en estudio se incubaron a 37 ºC por 7 días; 25 ºC por 30 días y 45 ºC por 3 días (temperaturas de estrés. Se concluyó que la vacuna vax-SPIRAL® puede ser considerada un producto estable para los parámetros evaluados en el presente estudio, siempre que se mantenga a la temperatura de 2-8 ºC. Se propone un período de validez de 24 meses para esas condiciones.

  11. Nivel de corte de los ELISAs para cuantificación de anticuerpos inducidos por la vacuna antimeningocócica VA-MENGOC-BC

    Rolando Ochoa

    2001-06-01

    Full Text Available Para medir el grado de protección inducido por vacunas antimeningocócicas se ha establecido el Ensayo Bactericida en Suero (EBS y se perfeccionan otros ensayos inmunobiológicos, sin embargo, es necesario contar con pruebas sencillas como el ELISA, capaz de evaluar un gran número de muestras. Se estimó el nivel de corte de los ELISAs para la cuantificación de IgG humana contra los antígenos de VA-MENGOC-BC, vacuna antimeningocócica compuesta por vesículas proteicas de membrana externa de meningococo B y polisacárido capsular de meningococo C, con respecto a un panel de muestras de suero de lactantes, caracterizado por Ensayo Bactericida en Sangre Total (EBST. Los valores correspondientes a la máxima sensibilidad y especificidad fueron respectivamente; 2 μg/mL y 12 μg/mL para antipolisacárido C, y 1000 U/mL y 7000 U/mL para antiproteínas de membrana externa. La mayor coincidencia se obtuvo con 6 μg/mL y 2500 U/mL. Se evaluó otro panel de muestras de suero de adolescentes entre 14 y 18 años, por ELISA y EBS para Neisseria meningitidis serogrupos B y C, alcanzándose una buena concordancia. Doce años después de la inmunización con VA-MENGOC-BC persiste una importante concentración de anticuerpos contra los antígenos vacunales en los sueros estudiados.

  12. The use of ELISA to detect antibodies to Brucella abortus in naturally infected cattle

    An indirect ELISA using the immunodominant antigen, smooth lipopolysaccharide (SLPS) of Brucella abortus, was used to detect antibodies in a statistically selected dairy cattle population from the Sabana of Bogota (Colombia). Based on the FAO/IAEA Brucella ELISA kit, the test was standardized in terms of plates, reagents and reference sera. Quality control for routine testing was also established. Calculation of the appropriate cut-off optical density (O.D) value for negativity was made after discriminant analysis and examination of the frequency of the sera distributed as positive or negative. The sensitivity and specificity of the ELISA for diagnosis of Brucella infection were compared to the complement fixation (CF) test results and were 94.8% and 96.0% respectively. The use of ELISA for monitoring bovine populations undergoing an eradication of brucellosis is recommended. The application of an ELISA using B. bovis outer membrane proteins (OMP) as antigen is discussed. (author). 38 refs, 3 figs, 4 tabs

  13. An ecological perspective on the changing face of Brucella abortus in the western United States

    Cross, Paul C.; Maichak, Eric J.; Brennan, Angela; Scurlock, Brandon M.; Henningsen, John C.; Luikart, Gordon

    2013-01-01

    After a hiatus during the 1990s, outbreaks of Brucella abortus in cattle are occurring more frequently in some of the western states of the United States, namely, Montana, Wyoming and Idaho. This increase is coincident with increasing brucellosis seroprevalence in elk (Cervus elaphus), which is correlated with elk density. Vaccines are a seductive solution, but their use in wildlife systems remains limited by logistical, financial, and scientific constraints. Cattle vaccination is ongoing in the region. Livestock regulations, however, tend to be based on serological tests that test for previous exposure and available vaccines do not protect against seroconversion. The authors review recent ecological studies of brucellosis, with particular emphasis on the Greater Yellowstone Area, and highlight the management options and implications of this work, including the potential utility of habitat modifications and targeted hunts, as well as scavengers and predators. Finally, the authors discuss future research directions that will help us to understand and manage brucellosis in wildlife.

  14. First report of orchitis in man caused by Brucella abortus biovar 1 in Ecuador.

    Ron-Román, Jorge; Saegerman, Claude; Minda-Aluisa, Elizabeth; Benítez-Ortíz, Washington; Brandt, Jef; Douce, Richard

    2012-09-01

    We present a 44-year-old man from a rural community in northern Ecuador who worked on a cattle farm where he was involved with primary veterinary care, including assistance during births (or calving) and placenta retention and artificial insemination, with minimal precautions. In September of 2009, quite abruptly, he developed asthenia and hypersomnia without any apparent cause or symptoms like fever, chills, or night sweats. On November 14, 2009, he suffered from pain and edema in the right testicle that coincided with pain in the abdomen. Clinical, serological, and bacteriological investigations confirmed the first case of unilateral orchitis in man in Ecuador caused by Brucella abortus biovar 1. Because brucellosis is a neglected disease, special attention should be given to it in the training of medical and veterinary students. PMID:22826490

  15. Endocarditis por Brucella abortus: Reporte del primer caso en C.R

    2011-01-01

    Paciente masculino de 36 años de edad, proveniente de la zona rural de Costa Rica, con un cuadro clínico de 8 meses de evolución de fiebre, mialgias, artralgias, pérdida de peso y lumbalgia; referido por la detección de un soplo de insuficiencia aórtica. El ecocardiograma reveló endocarditis de la válvula aórtica, y se obtuvieron 4 hemocultivos positivos por Brucella abortus biotipo 3, con serologías negativas por brucelosis. Se inició tratamiento con antibióticos y luego se le realizó un ree...

  16. Use of an indirect elisa for Brucella abortus diagnosis in Cuba

    Introducing immunoassays in Brucella diagnosis requires a comparative study with reference techniques such as the complement fixation reaction (CFR). Sensitivity and relative specificity studies allowed us to observe the behaviour of this immunoassay, using samples from free of disease, free by vaccination and affected areas. Sensitivity results for a cut-off point of 40PP and a confidence interval of 95% ranged from 94.8 to 99.5% and the specificity between 94.1 and 97.5%. For free of disease areas a cut-off point of 22 PP was calculated that reached a 99% specificity. This immunoassay for the detection of antibodies against Brucella abortus must be used with two different cut-off points, depending on the epidemiologic conditions of the country, with CFR in affected or vaccinated areas as a confirmative method. (author)

  17. Application and evaluation of the MLVA typing assay for the Brucella abortus strains isolated in Korea

    Jung Suk-Chan

    2009-10-01

    Full Text Available Abstract Background A Brucella eradication program has been executed in Korea. To effectively prevent and control brucellosis, a molecular method for genetic identification and epidemiological trace-back must be established. As part of that, the MLVA typing assay was evaluated and applied to B. abortus isolates for analyzing the characteristics of the regional distribution and relationships of foreign isolates. Results A total of 177 isolates originating from 105 cattle farms for the period 1996 to 2008 were selected as representatives for the nine provinces of South Korea. A dendrogram of strain relatedness was constructed in accordance with the number of tandem repeat units for 17 loci so that it was possible to trace back in the restricted areas. Even in a farm contaminated by one source, however, the Brucella isolates showed an increase or decrease in one TRs copy number at some loci with high DI values. Moreover, those 17 loci was confirmed in stability via in-vitro and in-vivo passage, and found to be sufficiently stable markers that can readily identify the inoculated strain even if minor changes were detected. In the parsimony analysis with foreign Brucella isolates, domestic isolates were clustered distinctively, and located near the Central and Southern American isolates. Conclusion The MLVA assay has enough discrimination power in the Brucella species level and can be utilized as a tool for the epidemiological trace-back of the B. abortus isolates. But it is important to consider that Brucella isolates may be capable of undergoing minor changes at some loci in the course of infection or in accordance with the changes of the host.

  18. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition.

    Conde-Álvarez, Raquel; Arce-Gorvel, Vilma; Iriarte, Maite; Manček-Keber, Mateja; Barquero-Calvo, Elías; Palacios-Chaves, Leyre; Chacón-Díaz, Carlos; Chaves-Olarte, Esteban; Martirosyan, Anna; von Bargen, Kristine; Grilló, María-Jesús; Jerala, Roman; Brandenburg, Klaus; Llobet, Enrique; Bengoechea, José A; Moreno, Edgardo; Moriyón, Ignacio; Gorvel, Jean-Pierre

    2012-01-01

    Innate immunity recognizes bacterial molecules bearing pathogen-associated molecular patterns to launch inflammatory responses leading to the activation of adaptive immunity. However, the lipopolysaccharide (LPS) of the gram-negative bacterium Brucella lacks a marked pathogen-associated molecular pattern, and it has been postulated that this delays the development of immunity, creating a gap that is critical for the bacterium to reach the intracellular replicative niche. We found that a B. abortus mutant in the wadC gene displayed a disrupted LPS core while keeping both the LPS O-polysaccharide and lipid A. In mice, the wadC mutant induced proinflammatory responses and was attenuated. In addition, it was sensitive to killing by non-immune serum and bactericidal peptides and did not multiply in dendritic cells being targeted to lysosomal compartments. In contrast to wild type B. abortus, the wadC mutant induced dendritic cell maturation and secretion of pro-inflammatory cytokines. All these properties were reproduced by the wadC mutant purified LPS in a TLR4-dependent manner. Moreover, the core-mutated LPS displayed an increased binding to MD-2, the TLR4 co-receptor leading to subsequent increase in intracellular signaling. Here we show that Brucella escapes recognition in early stages of infection by expressing a shield against recognition by innate immunity in its LPS core and identify a novel virulence mechanism in intracellular pathogenic gram-negative bacteria. These results also encourage for an improvement in the generation of novel bacterial vaccines. PMID:22589715

  19. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.

    de Souza Filho, Job Alves; de Paulo Martins, Vicente; Campos, Priscila Carneiro; Alves-Silva, Juliana; Santos, Nathalia V; de Oliveira, Fernanda Souza; Menezes, Gustavo B; Azevedo, Vasco; Cravero, Silvio Lorenzo; Oliveira, Sergio Costa

    2015-04-01

    Brucella species can cause brucellosis, a zoonotic disease that causes serious livestock economic losses and represents a public health threat. The mechanism of virulence of Brucella spp. is not yet fully understood. Therefore, it is crucial to identify new molecules that serve as virulence factors to better understand this host-pathogen interplay. Here, we evaluated the role of the Brucella membrane fusogenic protein (Mfp) and outer membrane protein 19 (Omp19) in bacterial pathogenesis. In this study, we showed that B. abortus Δmfp::kan and Δomp19::kan deletion mutant strains have reduced persistence in vivo in C57BL/6 and interferon regulatory factor 1 (IRF-1) knockout (KO) mice. Additionally, 24 h after macrophage infection with a Δmfp::kan or Δomp19::kan strain expressing green fluorescent protein (GFP) approximately 80% or 65% of Brucella-containing vacuoles (BCVs) retained the late endosomal/lysosomal marker LAMP-1, respectively, whereas around 60% of BCVs containing wild-type S2308 were found in LAMP-1-negative compartments. B. abortus Δomp19::kan was attenuated in vivo but had a residual virulence in C57BL/6 and IRF-1 KO mice, whereas the Δmfp::kan strain had a lower virulence in these same mouse models. Furthermore, Δmfp::kan and Δomp19::kan strains were used as live vaccines. Challenge experiments revealed that in C57BL/6 and IRF-1 KO mice, the Δmfp::kan strain induced greater protection than the vaccine RB51 and protection similar that of vaccine S19. However, a Δomp19::kan strain induced protection similar to that of RB51. Thus, these results demonstrate that Brucella Mfp and Omp19 are critical for full bacterial virulence and that the Δmfp::kan mutant may serve as a potential vaccine candidate in future studies. PMID:25644010

  20. Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2.

    Fiorentino, M A; Campos, E; Cravero, S; Arese, A; Paolicchi, F; Campero, C; Rossetti, O

    2008-12-10

    Brucella abortus M1-luc is a mutant strain derived from S19 vaccine strain in which most of bp26 sequence has been replaced by the luciferase coding gene. Strain I2 is a double mutant derived from M1-luc in which most of omp19 has been deleted without introduction of any genetic markers. In BALB/c mice, M1-luc presented equivalent performance to S19 regarding persistence, splenomegaly and protection against challenge. Interestingly, I2 was more attenuated than S19, with no reduction of protection against challenge. In order to evaluate the potential for vaccine use of these strains in the natural host, four groups of 15 heifers, 6-month old, were either non-vaccinated or vaccinated with S19, M1-luc or I2. To at reached 17-month old, heifers were synchronized with two doses of PGF2alpha and received natural service during 60 days with two bulls. Pregnant heifers were challenged at approximately six gestation months with virulent B. abortus S2308. Blood samples post-challenge of heifers were collected for serologic test as well as specimens of aborted fetuses and premature calves for bacterial isolation and histopathological analyses. Protection levels against abortion were 78.6% for S19, 81.8% for M1-luc and 45.5% for I2, compared to the 25% that did not abort from the non-vaccinated group. These results indicate that in bovines BP26 had no influence in protective capacity of S19, correlating with the results obtained in mice. However, contrarily to what was previously observed in mice, lack of expression of Omp19 rendered in less protection capacity of S19 in the natural host. PMID:18565697

  1. Mutant Brucella abortus Membrane Fusogenic Protein Induces Protection against Challenge Infection in Mice

    de Souza Filho, Job Alves; Martins, Vicente de Paulo; Campos, Priscila Carneiro; Alves-Silva, Juliana; Santos, Nathalia V.; de Oliveira, Fernanda Souza; Menezes, Gustavo B.; Azevedo, Vasco; Cravero, Silvio Lorenzo

    2015-01-01

    Brucella species can cause brucellosis, a zoonotic disease that causes serious livestock economic losses and represents a public health threat. The mechanism of virulence of Brucella spp. is not yet fully understood. Therefore, it is crucial to identify new molecules that serve as virulence factors to better understand this host-pathogen interplay. Here, we evaluated the role of the Brucella membrane fusogenic protein (Mfp) and outer membrane protein 19 (Omp19) in bacterial pathogenesis. In this study, we showed that B. abortus Δmfp::kan and Δomp19::kan deletion mutant strains have reduced persistence in vivo in C57BL/6 and interferon regulatory factor 1 (IRF-1) knockout (KO) mice. Additionally, 24 h after macrophage infection with a Δmfp::kan or Δomp19::kan strain expressing green fluorescent protein (GFP) approximately 80% or 65% of Brucella-containing vacuoles (BCVs) retained the late endosomal/lysosomal marker LAMP-1, respectively, whereas around 60% of BCVs containing wild-type S2308 were found in LAMP-1-negative compartments. B. abortus Δomp19::kan was attenuated in vivo but had a residual virulence in C57BL/6 and IRF-1 KO mice, whereas the Δmfp::kan strain had a lower virulence in these same mouse models. Furthermore, Δmfp::kan and Δomp19::kan strains were used as live vaccines. Challenge experiments revealed that in C57BL/6 and IRF-1 KO mice, the Δmfp::kan strain induced greater protection than the vaccine RB51 and protection similar that of vaccine S19. However, a Δomp19::kan strain induced protection similar to that of RB51. Thus, these results demonstrate that Brucella Mfp and Omp19 are critical for full bacterial virulence and that the Δmfp::kan mutant may serve as a potential vaccine candidate in future studies. PMID:25644010

  2. Transcriptome analysis of the Brucella abortus BvrR/BvrS two-component regulatory system.

    Cristina Viadas

    Full Text Available BACKGROUND: The two-component BvrR/BvrS system is essential for Brucella abortus virulence. It was shown previously that its dysfunction alters the expression of some major outer membrane proteins and the pattern of lipid A acylation. To determine the genes regulated by BvrR/BvrS, we performed a whole-genome microarray analysis using B. abortus RNA obtained from wild type and bvrR mutant cells grown in the same conditions. METHODOLOGY/PRINCIPAL FINDINGS: A total of 127 differentially expressed genes were found: 83 were over expressed and 44 were less expressed in the bvrR mutant. Two operons, the phosphotransferase system and the maltose transport system, were down-regulated. Several genes involved in cell envelope or outer membrane biogenesis were differentially expressed: genes for outer membrane proteins (omp25a, omp25d, lipoproteins, LPS and fatty acid biosynthesis, stress response proteins, chaperones, flagellar genes, and twelve genes encoding ABC transport systems. Ten genes related with carbon metabolism (pckA and fumB among others were up-regulated in the bvrR mutant, and denitrification genes (nirK, norC and nosZ were also regulated. Notably, seven transcriptional regulators were affected, including VjbR, ExoR and OmpR that were less expressed in the bvrR mutant. Finally, the expression of eleven genes which have been previously related with Brucella virulence was also altered. CONCLUSIONS/SIGNIFICANCE: All these data corroborate the impact of BvrR/BvrS on cell envelope modulation, confirm that this system controls the carbon and nitrogen metabolism, and suggest a cross-talk among some regulators to adjust the Brucella physiology to the shift expected to occur during the transit from the extracellular to the intracellular niche.

  3. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model

    Monreal, D.; Grillo, M.J. (María Jesús); Gonzalez-fernandez, D.; Marin, C.M.; de Miguel, M. J.; Lopez-Goñi, I. (Ignacio); Blasco, J.M. (José); Cloeckaert, A.; Moriyon, I. (Ignacio)

    2003-01-01

    Brucella abortus rough lipopolysaccharide (LPS) mutants were obtained by transposon insertion into two wbk genes (wbkA [putative glycosyltransferase; formerly rfbU] and per [perosamine synthetase]), into manB (pmm [phosphomannomutase; formerly rfbK]), and into an unassigned gene. Consistent with gene-predicted roles, electrophoretic analysis, 2-keto-3-manno-D-octulosonate measurements, and immunoblots with monoclonal antibodies to O-polysaccharide, outer and inner core epitopes showed no O-po...

  4. Application and evaluation of the MLVA typing assay for the Brucella abortus strains isolated in Korea

    Jung Suk-Chan; Heo Young-Ran; Hwang In-Yeong; Cho Yun-Sang; Cho Dong-Hee; Kang Sung-Il; Her Moon; Yoo Han-Sang

    2009-01-01

    Abstract Background A Brucella eradication program has been executed in Korea. To effectively prevent and control brucellosis, a molecular method for genetic identification and epidemiological trace-back must be established. As part of that, the MLVA typing assay was evaluated and applied to B. abortus isolates for analyzing the characteristics of the regional distribution and relationships of foreign isolates. Results A total of 177 isolates originating from 105 cattle farms for the period 1...

  5. Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response.

    Cora N Pollak

    Full Text Available Outer membrane vesicles (OMVs released by some gram-negative bacteria have been shown to exert immunomodulatory effects that favor the establishment of the infection. The aim of the present study was to assess the interaction of OMVs from Brucella abortus with human epithelial cells (HeLa and monocytes (THP-1, and the potential immunomodulatory effects they may exert. Using confocal microscopy and flow cytometry, FITC-labeled OMVs were shown to be internalized by both cell types. Internalization was shown to be partially mediated by clathrin-mediated endocytosis. Pretreatment of THP-1 cells with Brucella OMVs inhibited some cytokine responses (TNF-α and IL-8 to E. coli LPS, Pam3Cys or flagellin (TLR4, TLR2 and TLR5 agonists, respectively. Similarly, pretreatment with Brucella OMVs inhibited the cytokine response of THP-1 cells to B. abortus infection. Treatment of THP-1 cells with OMVs during IFN-γ stimulation reduced significantly the inducing effect of this cytokine on MHC-II expression. OMVs induced a dose-dependent increase of ICAM-1 expression on THP-1 cells and an increased adhesion of these cells to human endothelial cells. The addition of OMVs to THP-1 cultures before the incubation with live B. abortus resulted in increased numbers of adhered and internalized bacteria as compared to cells not treated with OMVs. Overall, these results suggest that OMVs from B. abortus exert cellular effects that promote the internalization of these bacteria by human monocytes, but also downregulate the innate immune response of these cells to Brucella infection. These effects may favor the persistence of Brucella within host cells.

  6. Biological Properties and Cell Tropism of Chp2, a Bacteriophage of the Obligate Intracellular Bacterium Chlamydophila abortus

    Everson, J. S.; Garner, S. A.; Fane, B.; Liu, B.-L.; Lambden, P R; Clarke, I N

    2002-01-01

    A number of bacteriophages belonging to the Microviridae have been described infecting chlamydiae. Phylogenetic studies divide the Chlamydiaceae into two distinct genera, Chlamydia and Chlamydophila, containing three and six different species, respectively. In this work we investigated the biological properties and host range of the recently described bacteriophage Chp2 that was originally discovered in Chlamydophila abortus. The obligate intracellular development cycle of chlamydiae has prec...

  7. In Vivo Identification and Characterization of CD4+ Cytotoxic T Cells Induced by Virulent Brucella abortus Infection

    Martirosyan, Anna; von Bargen, Kristine; Arce Gorvel, Vilma; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Méresse, Stéphane; Gorvel, Jean-Pierre

    2013-01-01

    CD4+ T cells display a variety of helper functions necessary for an efficient adaptive immune response against bacterial invaders. This work reports the in vivo identification and characterization of murine cytotoxic CD4+ T cells (CD4+ CTL) during Brucella abortus infection. These CD4+ CTLs express granzyme B and exhibit immunophenotypic features consistent with fully differentiated T cells. They express CD25, CD44, CD62L ,CD43 molecules at their surface and produce IFN-γ. Moreover, these cel...

  8. Enhancement of the Brucella AMOS PCR assay for differentiation of Brucella abortus vaccine strains S19 and RB51.

    Bricker, B J; Halling, S. M.

    1995-01-01

    Because the brucellosis eradication program uses slaughter and quarantine as control measures, it would benefit from faster methods of bacterial identification. Distinguishing vaccine strains from strains that cause infections among vaccinated herds in the field is essential. To accomplish this, our PCR-based, species-specific assay (B. J. Bricker and S. M. Halling, J. Clin. Microbiol. 32:2660-2666, 1994) was updated to identify Brucella abortus vaccine strains S19 and RB51. Three new oligonu...

  9. Immune Responses of Elk to Initial and Booster Vaccinations with Brucella abortus Strain RB51 or 19

    S. C. Olsen; Fach, S. J.; Palmer, M. V.; Sacco, R. E.; Stoffregen, W. C.; Waters, W.R.

    2006-01-01

    Previous studies have suggested that currently available brucellosis vaccines induce poor or no protection in elk (Cervus elaphus nelsoni). In this study, we characterized the immunologic responses of elk after initial or booster vaccination with Brucella abortus strains RB51 (SRB51) and 19 (S19). Elk were vaccinated with saline or 1010 CFU of SRB51 or S19 (n = seven animals/treatment) and booster vaccinated with a similar dosage of the autologous vaccine at 65 weeks. Compared to nonvaccinate...

  10. Reaction of Native and Denatured Brucella abortus (S19) Proteins with Antibody Using Affinity Chromatography and Immunoblotting

    Karimi, R.; A Mostafaie; B. Tabaraie; Y. Bahrami; J. Abdolalizadeh

    2005-01-01

    Western blotting or immunoblotting commonly use for study of reaction between antigens and antibodies. Denaturation of many proteins in immunoblotting can affect greatly the reactivity of antibodies and outcome of the procedure.In this study proteins of Brucella abortus (S19) was extracted by a mild method and reaction of the extracted proteins with serum of infected human and goat and immunized rabbit compared by affinity chromatography and immunoblotting. Gamma globulin (m...

  11. Seroprevalence of brucellosis in sheep and isolation of Brucella abortus biovar 6 in Kassala State, Eastern Sudan.

    Gumaa, M M; Osman, H M; Omer, M M; El Sanousi, E M; Godfroid, J; Ahmed, A M

    2014-12-01

    Brucellosis is one of the important zoonotic diseases among livestock. This study was carried out to estimate the prevalence of brucellosis and isolate Brucella spp. in sheep in Kassala State in the east of Sudan. Two thousand and five serum samples were randomly collected from nine different localities. All serum samples were examined by the Rose Bengal plate test (RBPT) and the modified RBPT (mRBPT). Forty-three (2.15%, 95% confidence interval [CI]: 1.6,3.0) and 68 (3.4%, 95% CI: 2.6, 4.2) samples were positive with the RBPT and the mRBPT, respectively. According to a known diagnostic sensitivity of 86.6% and a known diagnostic specificity of 97.6% for the mRBPT, the true prevalence was estimated to be 1.2% (95% CI: 0.3, 2.2). Different tissue samples were collected from 41 mRBPT seropositive animals. Brucella abortus biovar 6 was isolated from a pyometra of a seropositive ewe. It is important to note that B. abortus biovar 6 cannot be differentiated from Brucella melitensis biovar 2 by routine bacteriology. Only phage typing performed in reference laboratories will allow accurate identification of the strain. The fact that B. abortus biovar 6 does not require CO2 for growth, combined with the fact that it has been isolated from a small ruminant in this study, could easily have led to misidentification (as B. melitensis biovar 2), to wrong epidemiological inferences and to the implementation of inappropriate control measures. The results presented here suggest that sheep are spillover hosts, as previously described for camels, and that the actual reservoir of B. abortus biovar 6 is cattle in Kassala State, Eastern Sudan. This study highlights the importance of isolating and identifying Brucella spp. in different livestock species in order to accurately decipher brucellosis epidemiology in sub-Saharan Africa. PMID:25812219

  12. Chlamydiaceae Genomics Reveals Interspecies Admixture and the Recent Evolution of Chlamydia abortus Infecting Lower Mammalian Species and Humans.

    Joseph, Sandeep J; Marti, Hanna; Didelot, Xavier; Castillo-Ramirez, Santiago; Read, Timothy D; Dean, Deborah

    2015-11-01

    Chlamydiaceae are obligate intracellular bacteria that cause a diversity of severe infections among humans and livestock on a global scale. Identification of new species since 1989 and emergence of zoonotic infections, including abortion in women, underscore the need for genome sequencing of multiple strains of each species to advance our knowledge of evolutionary dynamics across Chlamydiaceae. Here, we genome sequenced isolates from avian, lower mammalian and human hosts. Based on core gene phylogeny, five isolates previously classified as Chlamydia abortus were identified as members of Chlamydia psittaci and Chlamydia pecorum. Chlamydia abortus is the most recently emerged species and is a highly monomorphic group that lacks the conserved virulence-associated plasmid. Low-level recombination and evidence for adaptation to the placenta echo evolutionary processes seen in recently emerged, highly virulent niche-restricted pathogens, such as Bacillus anthracis. In contrast, gene flow occurred within C. psittaci and other Chlamydiaceae species. The C. psittaci strain RTH, isolated from a red-tailed hawk (Buteo jamaicensis), is an outlying strain with admixture of C. abortus, C. psittaci, and its own population markers. An average nucleotide identity of less than 94% compared with other Chlamydiaceae species suggests that RTH belongs to a new species intermediary between C. psittaci and C. abortus. Hawks, as scavengers and predators, have extensive opportunities to acquire multiple species in their intestinal tract. This could facilitate transformation and homologous recombination with the potential for new species emergence. Our findings indicate that incubator hosts such as birds-of-prey likely promote Chlamydiaceae evolution resulting in novel pathogenic lineages. PMID:26507799

  13. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.

    Grilló, María Jesús; Manterola, Lorea; de Miguel, María Jesús; Muñoz, Pilar María; Blasco, José María; Moriyón, Ignacio; López-Goñi, Ignacio

    2006-04-01

    The Brucella abortus S19 and RB51 strains are the most widely used live vaccines against bovine brucellosis. However, both can induce abortion and milk excretion, S19 vaccination interferes in serological tests, and RB51 is less effective. We have shown previously that a rough wbkAB. abortus mutant is attenuated and a better vaccine than RB51 in BALB/c mice, and that mutants in the two-component regulatory system bvrS/bvrR are markedly attenuated while keeping a smooth lipopolysaccharide (S-LPS). In this work, we tested whether simultaneous inoculation with live bvrS increases wbkA vaccine efficacy in mice. Even at high doses, the bvrS mutant was cleared much faster from spleens than the wbkA mutant. The splenic persistence of the wbkA mutant increased when inoculated along with the bvrS mutant, but also with inactivated bvrS cells or with purified B. abortus S-LPS, strongly suggesting that S-LPS in the bvrS mutant played a determinant role in the wbkA persistence. When inoculated alone, both mutants protected against virulent B. abortus but less than when inoculated simultaneously, and the protection afforded by the combination was better than that obtained with B. abortus S19. Increased protection was also obtained after simultaneous inoculation of the wbkA mutant and inactivated bvrS cells or purified S-LPS, showing again the role played by the S-LPS in the bvrS cells. In mice, the bvrS-wbkA combination induced an antibody response reduced with respect to B. abortus S19 vaccination. Thus, the simultaneous use of live bvrS and wbkA B. abortus mutants seems a promising approach to overcome the problems of the S19 andRB51 vaccines. PMID:16439039

  14. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.

    Wang, Jing-Yu; Wu, Ning; Liu, Wan-Hua; Ren, Juan-Juan; Tang, Pan; Qiu, Yuan-Hao; Wang, Chi-Young; Chang, Ching-Dong; Liu, Hung-Jen

    2014-01-01

    The commonest ways of diagnosing brucellosis in animals include the Rose-Bengal plate agglutination test, the buffered plate agglutination test (BPA), the slide agglutination test, the complement fixation test, and the indirect enzyme linked immunosorbent assay (I-ELISA). However, these methods cannot discriminate the Brucella vaccine strain (Brucella suis strain 2; B. suis S2) from naturally acquired virulent strains. Of the six common Brucella species, Brucella melitensis, Brucella abortus, and B. suis are the commonest species occurring in China. To develop an ELISA assay that can differentiate between cows inoculated with B. suis S2 and naturally infected with B. abortus and B. melitensis, genomic sequences from six Brucella spp. (B. melitensis, B. abortus, B. suis, Brucella canis, Brucella neotomae and Brucella ovis) were compared using Basic Local Alignment Search Tool software. One particular gene, the repA-related gene, was found to be a marker that can differentiate B. suis from B. abortus and B. melitensis. The repA-related gene of B. suis was PCR amplified and subcloned into the pET-32a vector. Expressed repA-related protein was purified and used as an antigen. The repA-based ELISA was optimized and used as specific tests. In the present study, serum from animals inoculated with the B. suis S2 vaccine strain had positive repA-based ELISA results. In contrast, the test-positive reference sera against B. abortus and B. melitensis had negative repA-based ELISA results. The concordance rate between B. abortus antibody-negative (based on the repA-based ELISA) and the Brucella gene-positive (based on the 'Bruce ladder' multiplex PCR) was 100%. Therefore, the findings suggest that the repA-based ELISA is a useful tool for differentiating cows vaccinated with the B. suis S2 and naturally infected with B. abortus and B. melitensis. PMID:24941369

  15. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen-associated molecular pattern.

    Leyre Palacios-Chaves

    Full Text Available The brucellae are α-Proteobacteria facultative intracellular parasites that cause an important zoonosis. These bacteria escape early detection by innate immunity, an ability associated to the absence of marked pathogen-associated molecular patterns in the cell envelope lipopolysaccharide, lipoproteins and flagellin. We show here that, in contrast to the outer membrane ornithine lipids (OL of other Gram negative bacteria, Brucella abortus OL lack a marked pathogen-associated molecular pattern activity. We identified two OL genes (olsB and olsA and by generating the corresponding mutants found that olsB deficient B. abortus did not synthesize OL or their lyso-OL precursors. Liposomes constructed with B. abortus OL did not trigger IL-6 or TNF-α release by macrophages whereas those constructed with Bordetella pertussis OL and the olsB mutant lipids as carriers were highly active. The OL deficiency in the olsB mutant did not promote proinflammatory responses or generated attenuation in mice. In addition, OL deficiency did not increase sensitivity to polymyxins, normal serum or complement consumption, or alter the permeability to antibiotics and dyes. Taken together, these observations indicate that OL have become dispensable in the extant brucellae and are consistent within the trend observed in α-Proteobacteria animal pathogens to reduce and eventually eliminate the envelope components susceptible of recognition by innate immunity.

  16. Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil

    Barbosa Pauletti, Rebeca; Reinato Stynen, Ana Paula; Pinto da Silva Mol, Juliana; Seles Dorneles, Elaine Maria; Alves, Telma Maria; de Sousa Moura Souto, Monalisa; Minharro, Silvia; Heinemann, Marcos Bryan; Lage, Andrey Pereira

    2015-01-01

    This study aimed to determine the susceptibility profile of Brazilian Brucella abortus isolates from cattle to eight antimicrobial agents that are recommended for the treatment of human brucellosis and to correlate the susceptibility patterns with origin, biotype and MLVA16-genotype of the strains. Screening of 147 B. abortus strains showed 100% sensitivity to doxycycline and ofloxacin, one (0.68%) strain resistant to ciprofloxacin, two strains (1.36%) resistant to streptomycin, two strains (1.36%) resistant to trimethoprim-sulfamethoxazole and five strains (3.40%) resistant to gentamicin. For rifampicin, three strains (2.04%) were resistant and 54 strains (36.73%) showed reduced sensitivity. Two strains were considered multidrug resistant. In conclusion, the majority of B. abortus strains isolated from cattle in Brazil were sensitive to the antimicrobials commonly used for the treatment of human brucellosis; however, a considerable proportion of strains showed reduced susceptibility to rifampicin and two strains were considered multidrug resistant. Moreover, there was no correlation among the drug susceptibility pattern, origin, biotype and MLVA16-genotypes of these strains. PMID:26181775

  17. Detection of antibodies against Brucella abortus, Leptospira spp., and Apicomplexa protozoa in water buffaloes in the Northeast of Argentina.

    Konrad, José L; Campero, Lucía M; Caspe, Gastón S; Brihuega, Bibiana; Draghi, Graciela; Moore, Dadin P; Crudeli, Gustavo A; Venturini, María C; Campero, Carlos M

    2013-11-01

    Water buffalo industry has become a profitable activity worldwide, including the Northeast of Argentina (NEA). However, research on diseases affecting this species is scarce. The aim of the present study was to detect antibodies against Brucella abortus, Leptospira spp., Neospora caninum, Toxoplasma gondii, and Sarcocystis spp. in 500 water buffalo cows from five ranches (100 animals each) in the NEA. Serum samples were tested for B. abortus by fluorescence polarization assay, Leptospira spp. by microagglutination test, and N. caninum, T. gondii, and Sarcocystis spp. by indirect fluorescent antibody tests. Overall, the proportion of seropositive animals was 6.4, 22.2, 42.2, 25.4, and 50.8 % for brucellosis, leptospirosis, neosporosis, toxoplasmosis, and sarcocystosis, respectively. The proportion of seropositive animals for all diseases was statistically different among herds (p < 0.05). Statistical differences were also detected among age groups for brucellosis and neosporosis (p < 0.05). The detection of specific antibodies to B. abortus, Leptospira spp., and several Apicomplexa protozoans in water buffaloes in the NEA is reported in this study. PMID:23765549

  18. Profiling antibody responses to infections by Chlamydia abortus enables identification of potential virulence factors and candidates for serodiagnosis.

    Vera Forsbach-Birk

    Full Text Available Enzootic abortion of ewes (EAE due to infection with the obligate intracellular pathogen Chlamydia (C. abortus is an important zoonosis leading to considerable economic loss to agriculture worldwide. The pathogen can be transmitted to humans and may lead to serious infection in pregnant women. Knowledge about epidemiology, clinical course and transmission to humans is hampered by the lack of reliable diagnostic tools. Immunoreactive proteins, which are expressed in infected animals and humans, may serve as novel candidates for diagnostic marker proteins and represent putative virulence factors. In order to broaden the spectrum of immunogenic C. abortus proteins we applied 2D immunoblot analysis and screening of an expression library using human and animal sera. We have identified 48 immunoreactive proteins representing potential diagnostic markers and also putative virulence factors, such as CAB080 (homologue of the "macrophage infectivity potentiator", MIP, CAB167 (homologue of the "translocated actin recruitment protein", TARP, CAB712 (homologue of the "chlamydial protease-like activity factor", CPAF, CAB776 (homologue of the "Polymorphic membrane protein D", PmpD, and the "hypothetical proteins" CAB063, CAB408 and CAB821, which are predicted to be type III secreted. We selected two putative virulence factors for further characterization, i.e. CAB080 (cMIP and CAB063, and studied their expression profiles at transcript and protein levels. Analysis of the subcellular localization of both proteins throughout the developmental cycle revealed CAB063 being the first C. abortus protein shown to be translocated to the host cell nucleus.

  19. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.

    Zhang, Junbo; Yin, Shuanghong; Guo, Fei; Meng, Ren; Chen, Chuangfu; Zhang, Hui; Li, Zhiqiang; Fu, Qiang; Shi, Huijun; Hu, Shengwei; Ni, Wei; Li, Tiansen; Zhang, Ke

    2014-08-01

    Brucellosis is a globally distributed zoonotic disease that causes animal and human diseases. However, the current Brucella abortus vaccines (S19 and RB51) are deficient; they can cause abortion in pregnant animals. Moreover, when the vaccine S19 is used, tests cannot differentiate natural from vaccinated infection. Therefore, a safer and more potent vaccine is needed. A Brucella abortus 2308 ery promoter mutant (Δery) was constructed to overcome these drawbacks. The growth of the Δery mutant was significantly attenuated in macrophages and mice and induced high protective immunity in mice. Moreover, Δery induced an anti-Brucella-specific IgG (immunoglobulin G) response and stimulated the expression of interferon-gamma (INF-γ) and interleukin-4 (IL-4). Furthermore, the expression of EryA antigen allowed for the serological differentiation between natural and vaccinated infection in mice. These results indicate that the Δery mutant is a potential attenuated live vaccine candidate against virulent Brucella abortus 2308 (S2308) infection. PMID:24994009

  20. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.

    Tabynov, Kaissar; Ryskeldinova, Sholpan; Sansyzbay, Abylai

    2015-07-17

    Brucella melitensis can be transmitted and cause disease in cattle herds as a result of inadequate management of mixed livestock farms. Ideally, vaccines against Brucella abortus for cattle should also provide cross-protection against B. melitensis. Previously we created a novel influenza viral vector B. abortus (Flu-BA) vaccine expressing the Brucella ribosomal proteins L7/L12 or Omp16. This study demonstrated Flu-BA vaccine with adjuvant Montanide Gel01 provided 100% protection against abortion in vaccinated pregnant heifers and good cross-protection of the heifers and their calves or fetuses (90-100%) after challenge with B. melitensis 16M; the level of protection provided by Flu-BA was comparable to the commercial vaccine B. abortus S19. In terms of the index of infection and colonization of Brucella in tissues, both vaccines demonstrated significant (P=0.02 to P<0.0001) protection against B. melitensis 16M infection compared to the negative control group (PBS+Montanide Gel01). Thus, we conclude the Flu-BA vaccine provides cross-protection against B. melitensis infection in pregnant heifers. PMID:26093199

  1. Differential diagnosis of Brucella abortus by real-time PCR based on a single-nucleotide polymorphisms.

    Kim, Ji-Yeon; Kang, Sung-Il; Lee, Jin Ju; Lee, Kichan; Sung, So-Ra; Erdenebaataar, Janchivdorj; Vanaabaatar, Batbaatar; Jung, Suk Chan; Park, Yong Ho; Yoo, Han-Sang; Her, Moon

    2016-05-01

    To diagnose brucellosis effectively, many genus- and species-specific detection methods based on PCR have been developed. With conventional PCR assays, real-time PCR techniques have been developed as rapid diagnostic tools. Among them, real-time PCR using hybridization probe (hybprobe) has been recommended for bacteria with high DNA homology among species, with which it is possible to make an accurate diagnosis by means of an amplification curve and melting peak analysis. A hybprobe for B. abortus was designed from a specific single-nucleotide polymorphism (SNP) on the fbaA gene. This probe only showed specific amplification of B. abortus from approximately the 14th cycle, given a melting peak at 69°C. The sensitivity of real-time PCR was revealed to be 20 fg/µl by 10-fold DNA dilution, and the detection limit was 4 CFU in clinical samples. This real-time PCR showed greater sensitivity than that of conventional PCR and previous real-time PCR based on Taqman probe. Therefore, this new real-time PCR assay could be helpful for differentiating B. abortus infection with rapidity and accuracy. PMID:26666176

  2. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.

    Tadepalli, Ganesh; Singh, Amit Kumar; Balakrishna, Konduru; Murali, Harishchandra Sripathy; Batra, Harsh Vardhan

    2016-03-01

    In this study, the immunogenicity and protective efficacy of recombinant proteins Omp19 (rO) and P39 (rP) from Brucella abortus were evaluated individually and compared with the cocktail protein (rO+rP) against B. abortus 544 and Brucella melitensis 16M infection in BALB/c mouse model. Intra-peritoneal (I.P.) immunization with rO+rP cocktail developed substantially higher antibody titers predominant with Th1 mediated isotypes (IgG2a/2b). Western blot analysis using anti-rO+rP antibodies showed specific reactivity with native Omp19 (19kDa) and P39 (39kDa) among whole cell proteins of B. abortus and B. melitensis. Splenocytes extracted from rO+rP immunized mice induced significantly (P<0.001) higher proliferative responses at 30μg/ml with considerable expression of pro-inflammatory cytokines (IFN-γ, IL-2 and IL-12) than rO and rP. Macrophage cell (RAW 264.7) monolayer supplemented with anti-rO+rP polysera exhibited enhanced viability against challenge with B. abortus 544 (72.27%) and B. melitensis 16M (68.57%). On the other hand, individual anti-rO and anti-rP polysera resulted in relatively lesser protection against the pathogens (64.79%, 54.45% and 47.13%, 45.11%, respectively). Immunized group of mice when I.P. challenged with 5×10(4) CFU of B. abortus 544 and B. melitensis 16M were found significantly (P<0.001) protected in the rO+rP group (log units of protection, spleen: 2.38, 2.12; liver: 1.04, 0.81, respectively) than in rO (spleen: 1.43, 1.21; liver: 0.7, 0.47) and rP (spleen: 1.24, 1.17; liver: 0.65, 0.34). Findings from this study depicted that rO+rP cocktail is highly immunogenic with the Th1 predominant serum antibody titers and T-cell mediated immune protection, would be a valuable intervention in the development of a safer and improved Brucella vaccine. PMID:26826463

  3. Inmunogenicidad y tolerancia de una vacuna contra influenza, en una población mexicana mayor de 55 años de edad Immunogenicity and safety of the influenza vaccine, in a population older than 55-years in Mexico

    Octavio Ayala-Montiel; César Mascareñas; Delfino García-Hernández; Jorge Rendón-Muñiz; Irma López; Luis Felipe Montaño

    2005-01-01

    OBJETIVO: Verificar la inmunogenicidad y tolerancia de una vacuna purificada, inactivada y fraccionada contra influenza, en adultos mexicanos derechohabientes de Petróleos Mexicanos (Pemex). MATERIAL Y MÉTODOS: Se incluyeron 90 adultos mayores de 55 años de edad, derechohabientes de los servicios médicos del Hospital Central Sur Pemex, durante los meses de noviembre y diciembre de 2000. Los criterios evaluados en relación con la inmunogenicidad incluyeron el porcentaje de sujetos protegidos, ...

  4. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers.

    Tabynov, Kaissar; Yespembetov, Bolat; Sansyzbay, Abylai

    2014-10-14

    The present study provides the first information about the protection of a novel influenza viral vector vaccine expressing the Brucella proteins ribosomal L7/L12 or Omp16 containing the adjuvant Montanide Gel01 in pregnant heifers. Immunization of pregnant heifers was conducted via the conjunctival (n=10) or subcutaneous (n=10) route using cross prime and booster vaccination schedules at an interval of 28 days. The vector vaccine was evaluated in comparison with positive control groups vaccinated with Brucella abortus S19 (n=10) or B. abortus RB51 (n=10) and a negative (PBS+Montanide Gel01; n=10) control group. Via both the conjunctival or subcutaneous route, evaluation of protectiveness against abortion, effectiveness of vaccination and index of infection (in heifers and their fetuses or calves) demonstrated the vector vaccine provided good protection against B. abortus 544 infection compared to the negative control group (PBS+Montanide Gel01) and comparable protection to commercial vaccines B. abortus S19 or B. abortus RB51. PMID:25218295

  5. Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines Al encuentro del reto: prevención de la enfermedad neumocócica con vacunas conjugadas

    Irma Gabriela Echániz-Avilés

    2001-08-01

    Full Text Available Streptococcus pneumoniae is one of the leading causes of both invasive and noninvasive diseases in the pediatric population and continues to represent a significant public health burden worldwide. The increasing incidence of antibioticresistant strains of the pathogen has complicated treatment and management of the various pneumococcal disease manifestations. Thus, the best management strategy may be the prevention of pneumococcal diseases through vaccination. Although several pneumococcal conjugate vaccines have been clinically studied in infants and children, only a 7-valent conjugate vaccine (PNCRM7; Prevnar®/Prevenar® is currently approved for the prevention of invasive disease. Vaccination with PNCRM7 is safe and effective in infants and young children. Routine vaccination with the conjugate vaccine could improve outcomes by safeguarding against the development of antibiotic-resistant strains of S. pneumoniae, thus simplifying the management of pneumococcal disease. Additionally, the overall costs associated with the treatment of pneumococcal diseases could be substantially reduced, particularly in developing countries. The time has come for fully applying this new advancement against S. pneumoniae, to benefit the children of the world. The Spanish version of this paper is available at: http://www.insp.mx/salud/index.htmlStreptococcus pneumoniae es uno de los principales agentes causantes de enfermedades invasoras y no invasoras en la población pediátrica y sigue representando uno de los principales problemas de salud pública a nivel mundial. La incidencia creciente de cepas resistentes a diversos antimicrobianos ha complicado el tratamiento y manejo de varias de las manifestaciones de la enfermedad neumocócica. Con éstas consideraciones, la mejor estrategia de manejo es la prevención de éstas enfermedades a través de la vacunación. A pesar de que se han estudiado diversas vacunas neumocócicas conjugadas en niños, solo una

  6. Cadena del frío para la conservación de las vacunas en los centros de atención primaria de un área de Madrid: mantenimiento y nivel de conocimientos

    Ortega Molina Paloma

    2002-01-01

    Full Text Available Fundamento. Las vacunas son medicamentos termolábiles y para garantizar su inmunogenicidad y eficacia protectora, dentro de los programas de inmunización, es imprescindible mantener la cadena de frío. El elemento fundamental en esta cadena es el personal responsable de las vacunas, que debe conocer las características de estabilidad de cada preparado con el fin de evitar errores durante su manipulación. El objetivo de este trabajo fue conocer cómo se realiza el mantenimiento de la cadena del frío en equipos de atención primaria de un área sanitaria de la Comunidad Autónoma de Madrid, así como establecer el grado de información que poseen los responsables de las vacunas con respecto a la termoestabilidad de las mismas. Métodos. Se ha realizado un estudio transversal en 46 puntos de vacunación en atención primaria. La recogida de los datos se realizó mediante entrevista personal por un único investigador. Resultados. La tasa de participación fue del 93,5% (43/46. En todos los casos existía termómetro de máxima y mínima y registro mensual de la temperatura. Se observó una temperatura inadecuada en tres ocasiones (6,97%. El porcentaje de profesionales que conocía el efecto que la congelación producía sobre las vacunas fue muy diverso: 53.5%, 51.2%, 44.2% y 53.5% para difteria-tétanos-pertussis (DTP, hepatitis B (VHB, polio oral (VPO y rubéola-sarampión-paperas (RSP respectivamente. Y sólo el 32% conocía el test de agitación. Conclusión. La formación de los profesionales sobre el efecto que las altas temperaturas ocasionan en las vacunas era correcta, pero es necesario reforzar su formación sobre la inestabilidad que presentan los preparados adsorbidos cuando se someten a congelación.

  7. Administración de vacunas y casos de muerte súbita del lactante en el Perú, 2001: ¿asociación o coincidencia temporal?

    Javier Vargas H

    2006-01-01

    Full Text Available Objetivos: Describir las características clínicas, socioeconómicas, y patológicas de nueve casos de lactantes que fallecieron horas después de administrárseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y métodos: Revisión de la historia clínica, entrevista con el equipo de salud a cargo de la vacunación y con los padres del lactante fallecido. Revisión de los informes del protocolo de autopsia e informes de anatomía patológica y entrevista con los médicos legistas y patólogos. Evaluación de control de calidad de las vacunas administradas. Realización de exámenes de inmunohistoquímica de tejidos pulmonares para el diagnóstico de virus. Resultados: Entre agosto y diciembre de 2001 se notificaron en el Perú, nueve casos de fallecimiento de lactantes entre ocho horas y tres días después de la aplicación de vacunas DPT y antipolio. Después de la vacunación, los síntomas iniciaron entre 30 minutos a tres horas y la muerte se produjo entre ocho a 78 horas. Los síntomas más frecuentes fueron irritabilidad 8/9, llanto persistente 6/9, somnolencia 5/9, sangrado por nariz y boca 5/9. Todos los casos procedieron de familias pobres o muy pobres. El control de calidad se corroboró que las vacunas cumplieron con los estándares establecidos por la OMS. Las causas de la muerte reportadas en las necropsias fueron neumonía en dos casos y edema pulmonar en cinco casos, los informes de anatomía patológica mostraron una neumonitis intersticial y meningitis linfocitaria. No se observaron efectos citopáticos virales en los tejidos pulmonares y los estudios toxicológicos fueron negativos. Conclusiones: No existe evidencia de una asociación causal entre los eventos fatales y la administración de las vacunas.

  8. Vacuna contra la fiebre hemorrágica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad Candid#1 vaccine against Argentine Hemorrhagic Fever produced in Argentina: Immunogenicity and safety

    Delia A. Enria

    2010-06-01

    Full Text Available Se realizó un estudio clínico en 946 voluntarios humanos sanos, donde se comparó la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que había sido utilizada en estudios previos. Como objetivo primario se evaluó la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detección de anticuerpos neutralizantes. Como objetivo secundario se evaluó la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significación clínica y de resolución espontánea o con tratamiento sintomático; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (A clinical study in 946 human volunteers was done to compare Candid #1 vaccine manufactured in Argentina with the vaccine produced in USA that had been previously used. The efficacy was evaluated using immunogenicity measured by the detection of neutralizing antibodies as a subrogate marker. Safety was evaluated comparing the rate of adverse events. Both vaccines showed a comparable rate of seroconversion, slighty higher than the efficacy estimated from previous studies (95.5%. There were no severe adverse events related to the vaccines. The general events considered related to the vaccines were not clinically relevant and disappeared either spontaneously or with symptomatic treatment. Similar rates of adverse events (29.9% for the Argentine vaccine and 35.0% for the USA vaccine were found for both vaccines. These included: headache, weakness, myalgias, mild low blood

  9. Costo-utilidad de la vacuna contra el virus de papiloma humano en mujeres peruanas Cost- utility of the vaccine against the human papiloma virus in peruvian women

    Alfonso Gutiérrez-Aguado

    2011-09-01

    Full Text Available Objetivos. Estimar el costo-utilidad de la vacuna contra el Virus de Papiloma Humano (VPH en las mujeres peruanas luego de la aplicación de la vacuna cuando tenían 10 años de edad. Materiales y métodos. Se realizó un análisis de costo-utilidad empleando el modelo oculto de Markov en una cohorte hipotética de mujeres peruanas, basado en la información de parámetros epidemiológicos, costos asociados al Cáncer de cuello uterino (CCU y la eficacia y los costos de la vacunación contra el VPH. Los costos de la vacunación se estimaron desde la perspectiva del Ministerio de Salud de Perú y se compararon con los años de vida ajustados por calidad (AVAC utilizando una tasa de descuento del 5 %. Resultados. El costo anual de la vacunación fue de USD 16 861 490, para el tamizaje con Papanicolau fue de USD 3 060 793 y los costos asociados al CCU fueron de USD 15 580 000. La razón de costo-utilidad incremental (RCUI fue de 6775 USD/AVAC. Conclusiones. La vacunación contra el VPH puede resultar costo-útil comparada con el no vacunar.Objetives. To estimate the cost-utility of the vaccine against the Human Papiloma Virus (HPV in peruvian women after the application of the vaccine at 10 years of age. Materials and methods. A cost-utility analysis was performed using the Markov´s hidden model in a hypothetical cohort of peruvian women, based on the information on epidemiological parameters, costs associated to uterine cervical cancer (UCC and the efficacy and costs of the vaccine against the HPV. The vaccination costs were estimated from the Peruvian Ministry of Health perspective and were compared against the quality-adjusted life years (QALYs, using a discount rate of 5%. Results. The annual cost of the vaccination was USD 16’861,490, for the Papanicoau screening it was USD 3’060,793 and the costs associated to the UCC were USD 15’580,000. The incremental cost utility ratio (ICUR was 6,775 USD/QALY. Conclusions. Vaccination against HPV

  10. Anti-Brucella abortus antibodies in free-ranging equids from Mossoró, Rio Grande do Norte, BrazilAnticorpos anti-Brucella abortus em equídeos errantes do município de Mossoró, Rio Grande do Norte

    Elaine Maria Seles Dorneles

    2013-06-01

    Full Text Available The aims of the present study were (i to determine the occurrence and (ii to evaluate possible factors associated with infection by Brucella abortus in free-ranging equids from Mossoró, Rio Grande do Norte, Brazil. Sera from 227 free-ranging equids (178 donkeys, 43 horses and 6 mules, captured by the highway police and the prefecture agents, were screened by the rose bengal test (RBT and confirmed for B. abortus-antibodies by the standard tube agglutination (STAT and the 2-mercaptoethanol (2ME tests. Of the 227 equids tested, four (1.76% were positive for B. abortus antibodies. All were horses, which resulted in an observed frequency of infection for this species of 9.30% (4/43. No association was found among seropositivity for B. abortus and the age and sex. Thus, data from the present study showed that infection by B. abortus is present among horses in Mossoró, Rio Grande do Norte, Brazil. Os objetivos deste trabalho foram (i determinar a ocorrência da infecção por Brucella abortus em equídeos de vida livre no município de Mossoró, Rio Grande do Norte e (ii avaliar possíveis fatores associados a esta infecção. Soros de 227 equídeos (178 asininos, 43 equinos e 6 muares, capturados pela polícia rodoviária e funcionários da prefeitura, foram coletados por punção venosa. A pesquisa de anticorpos anti-Brucella abortus foi realizada empregando-se, como triagem, o teste do antígeno acidificado tamponado (AAT e como confirmatório o teste de redução pelo 2-Mercaptoetanol (2ME. Dos animais testados, quatro (1,76% foram positivos para anticorpos anti- B. abortus. Todos os positivos eram equinos (9,30%, 4/43. A análise das variáveis levantadas (sexo e idade como possíveis fatores associados à infecção por B. abortus não revelou a existência de associação entre estas e a soropositividade. Assim, o presente estudo permite concluir que a infecção por B. abortus está presente em equinos do município de Mossoró, Rio Grande

  11. Utilización de indicadores metabólicos en la valoración de la transferencia de inmunidad pasiva en neonatos bovinos Assessment of the passive transference of immunity in calves through metabolic indicators

    Angie Fairut Carrillo

    2009-07-01

    Full Text Available Resumen Para determinar la utilidad de la actividad sérica de la fosfatasa alcalina (FA y las proteínas séricas totales (PST como indicadores de transferencia de inmunidad en terneros por el consumo de calostro en sus primeros días de vida, en un hato del trópico bajo de Colombia se escogieron al azar 15 vacas de las razas Gyr, Brahaman y el cruce Gyr x Holstein y sus respectivos terneros. En las vacas se recolectaron aproximadamente 300 ml de calostro el primer día del parto para determinar sólidos totales, proteína total y cenizas. En los terneros se tomaron muestras de sangre sin anticoagulante mediante venipunción yugular los días 0, 4, 12 y 30 posnacimiento. La concentración de las PST se determinó por refractometría y la FA mediante colorimetría enzimática. Se encontró relación alta y significativa (P Fifteen bovines and their calves were chosen randomly in order to determine the usefulness of the Alkaline phosphatase's (ALP seric activity and the total seric proteins (TSP as indicators of transference of immunity in calves through colostrums' consumption in their first days of life. Three hundred ml (300 ml of colostrums of the first day after delivery were collected from the cows. In it total solids, crude protein and ashes were found. Blood samples without anticoagulant and through jugular venipuncture were taken from the calves on the 0, 4, 12, and 30th day after delivery. The concentration of the TSP was determined through refractometry, while the ALP was determined through the enzymatic colourimetric assay. A high and statistically significant relationship between the percentages of crude protein of the colostrums and the total solids was found, thus, it can be concluded that just one measurement is valid in order to study both indicators. The effect of time on the concentrations of TSP as well as on the enzymatic activity was evaluated through the use of ANOVA (Analysis of Variance. In the TSP there was a

  12. Evaluación de la inmunidad celular en caninos: prueba de proliferación de linfocitos in vitro Evaluation of cellular immunity in dogs: in vitro lymphocyte proliferation test

    L. G Ramayo

    2005-12-01

    Full Text Available La prueba de proliferación de linfocitos inducida por mitógenos in vitro se utiliza para evaluar la inmunidad celular. En el presente trabajo, se comparan los resultados obtenidos con el método tradicional, que utiliza linfocitos purificados para el cultivo y la captación de timidina tritiada como método de medición de la proliferación (LP- ³H, con otras dos metodologías: el uso de sangre entera con revelado por captación de timidina tritiada (SE-³H y el uso de linfocitos purificados con revelado por ensayo colorimétrico con MTT (LP-MTT. Se trabajó sobre muestras de 12 caninos clínicamente sanos que fueron procesadas por las tres metodologías. Se utilizó Concanavalina A como mitógeno y el Indice de Estimulación (IE como expresión de los resultados. El método de SE-³H arrojó valores de IE significativamente mayores que la técnica clásica, por lo que resultaría útil para evaluar la proliferación linfocitaria en caninos en nuestras condiciones de trabajo. El método de LP-MTT mostró valores de IE significativamente menores, por lo que se requieren más estudios para evaluar su posible uso en la medición de la funcionalidad linfocitaria. Sobre la base de los resultados obtenidos se estableció un rango normal de valores de IE para cada método.In vitro mitogen induced lymphocyte proliferation test is widely used for evaluation of cellmediated immunity. In the present work, we compare the results of the traditional method, which uses gradient isolated lymphocytes as the source of cells for the culture and tritiated thymidine incorporation to measure proliferative response (LP- ³H, with other two methods: culture of whole blood and proliferation measure with ³H- thymidine (SE-³H, and culture of isolated lymphocytes and proliferation evaluation with a colorimetric assay using MTT (LP-MTT. Blood samples of twelve adult, healthy dogs were processed by the three mentioned methods, using Concanavalin- A as mitogen and the

  13. DETECTION OF Leptospira spp. AND Brucella abortus ANTIBODIES IN FREE-LIVING JAGUARS (Panthera onca IN TWO PROTECTED AREAS OF NORTHERN PANTANAL, BRAZIL

    Selma Samiko Miyazaki ONUMA

    2015-04-01

    Full Text Available This study aimed to assess the exposure of free-living jaguars (Panthera onca to Leptospira spp. and Brucella abortus in two conservation units in the Pantanal of Mato Grosso, Brazil. The presence of antibodies in blood samples of eleven jaguars was investigated using autochthonous antigens isolated in Brazil added to reference antigen collection applied to diagnosis of leptospirosis by Microscopic Agglutination Test (MAT. The Rose Bengal test was applied for B. abortus antibodies. Two (18.2% jaguars were seroreactive for the Leptospira spp. antigen and the serovar considered as most infective in both animals was a Brazilian isolate of serovar Canicola (L01. All jaguars were seronegative for B. abortus. These data indicate that the inclusion of autochthonous antigens in serological studies can significantly increase the number of reactive animals, as well as modify the epidemiological profile of Leptospira spp. infection.

  14. Improving the molecular diagnosis of Chlamydia psittaci and Chlamydia abortus infection with a species-specific duplex real-time PCR.

    Opota, Onya; Jaton, Katia; Branley, James; Vanrompay, Daisy; Erard, Veronique; Borel, Nicole; Longbottom, David; Greub, Gilbert

    2015-10-01

    Chlamydia psittaci and Chlamydia abortus are closely related intracellular bacteria exhibiting different tissue tropism that may cause severe but distinct infection in humans. C. psittaci causes psittacosis, a respiratory zoonotic infection transmitted by birds. C. abortus is an abortigenic agent in small ruminants, which can also colonize the human placenta and lead to foetal death and miscarriage. Infections caused by C. psittaci and C. abortus are underestimated mainly due to diagnosis difficulties resulting from their strict intracellular growth. We developed a duplex real-time PCR to detect and distinguish these two bacteria in clinical samples. The first PCR (PCR1) targeted a sequence of the 16S-23S rRNA operon allowing the detection of both C. psittaci and C. abortus. The second PCR (PCR2) targeted the coding DNA sequence CPSIT_0607 unique to C. psittaci. The two PCRs showed 100 % detection for ≥ 10 DNA copies per reaction (1000 copies ml(- 1)). Using a set of 120 samples, including bacterial reference strains, clinical specimens and infected cell culture material, we monitored 100 % sensitivity and 100 % specificity for the detection of C. psittaci and C. abortus for PCR1. When PCR1 was positive, PCR2 could discriminate C. psittaci from C. abortus with a positive predictive value of 100 % and a negative predictive value of 88 %. In conclusion, this new duplex PCR represents a low-cost and time-saving method with high-throughput potential, expected to improve the routine diagnosis of psittacosis and pregnancy complication in large-scale screening programs and also during outbreaks. PMID:26297212

  15. Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection.

    Jake E Lowry

    Full Text Available Current vaccines used for the prevention of brucellosis are ineffective in inducing protective immunity in animals that are chronically infected with Brucella abortus, such as elk. Using a gene discovery approach, in vivo-induced antigen technology (IVIAT on B. abortus, we previously identified ten loci that encode products up-regulated during infection in elk and consequently may play a role in virulence. In our present study, five of the loci (D15, 0187, VirJ, Mdh, AfuA were selected for further characterization and compared with three additional antigens with virulence potential (Hia, PrpA, MltA. All eight genes were PCR-amplified from B. abortus and cloned into E. coli. The recombinant products were then expressed, purified, adjuvanted, and delivered subcutaneously to BALB/c mice. After primary immunization and two boosts, mice were challenged i.p. with 5 x 10⁴ CFU of B. abortus strain 19. Spleens from challenged animals were harvested and bacterial loads determined by colony count at various time points. While vaccination with four of the eight individual proteins appeared to have some effect on clearance kinetics, mice vaccinated with recombinant Mdh displayed the most significant reduction in bacterial colonization. Furthermore, mice immunized with Mdh maintained higher levels of IFN-γ in spleens compared to other treatment groups. Collectively, our in vivo data gathered from the S19 murine colonization model suggest that vaccination with at least three of the IVIAT antigens conferred an enhanced ability of the host to respond to infection, reinforcing the utility of this methodology for the identification of potential vaccine candidates against brucellosis. Mechanisms for immunity to one protein, Mdh, require further in vitro exploration and evaluation against wild-type B. abortus challenge in mice, as well as other hosts. Additional studies are being undertaken to clarify the role of Mdh and other IVI antigens in B. abortus virulence

  16. Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection.

    Lowry, Jake E; Isaak, Dale D; Leonhardt, Jack A; Vernati, Giulia; Pate, Jessie C; Andrews, Gerard P

    2011-01-01

    Current vaccines used for the prevention of brucellosis are ineffective in inducing protective immunity in animals that are chronically infected with Brucella abortus, such as elk. Using a gene discovery approach, in vivo-induced antigen technology (IVIAT) on B. abortus, we previously identified ten loci that encode products up-regulated during infection in elk and consequently may play a role in virulence. In our present study, five of the loci (D15, 0187, VirJ, Mdh, AfuA) were selected for further characterization and compared with three additional antigens with virulence potential (Hia, PrpA, MltA). All eight genes were PCR-amplified from B. abortus and cloned into E. coli. The recombinant products were then expressed, purified, adjuvanted, and delivered subcutaneously to BALB/c mice. After primary immunization and two boosts, mice were challenged i.p. with 5 x 10⁴ CFU of B. abortus strain 19. Spleens from challenged animals were harvested and bacterial loads determined by colony count at various time points. While vaccination with four of the eight individual proteins appeared to have some effect on clearance kinetics, mice vaccinated with recombinant Mdh displayed the most significant reduction in bacterial colonization. Furthermore, mice immunized with Mdh maintained higher levels of IFN-γ in spleens compared to other treatment groups. Collectively, our in vivo data gathered from the S19 murine colonization model suggest that vaccination with at least three of the IVIAT antigens conferred an enhanced ability of the host to respond to infection, reinforcing the utility of this methodology for the identification of potential vaccine candidates against brucellosis. Mechanisms for immunity to one protein, Mdh, require further in vitro exploration and evaluation against wild-type B. abortus challenge in mice, as well as other hosts. Additional studies are being undertaken to clarify the role of Mdh and other IVI antigens in B. abortus virulence and induction of

  17. Brucella abortus choloylglycine hydrolase affects cell envelope composition and host cell internalization.

    María Inés Marchesini

    Full Text Available Choloylglycine hydrolase (CGH, E.C. 3.5.1.24 is a conjugated bile salt hydrolase that catalyses the hydrolysis of the amide bond in conjugated bile acids. Bile salt hydrolases are expressed by gastrointestinal bacteria, and they presumably decrease the toxicity of host's conjugated bile salts. Brucella species are the causative agents of brucellosis, a disease affecting livestock and humans. CGH confers Brucella the ability to deconjugate and resist the antimicrobial action of bile salts, contributing to the establishment of a successful infection through the oral route in mice. Additionally, cgh-deletion mutant was also attenuated in intraperitoneally inoculated mice, which suggests that CGH may play a role during systemic infection other than hydrolyzing conjugated bile acids. To understand the role CGH plays in B. abortus virulence, we infected phagocytic and epithelial cells with a cgh-deletion mutant (Δcgh and found that it is defective in the internalization process. This defect along with the increased resistance of Δcgh to the antimicrobial action of polymyxin B, prompted an analysis of the cell envelope of this mutant. Two-dimensional electrophoretic profiles of Δcgh cell envelope-associated proteins showed an altered expression of Omp2b and different members of the Omp25/31 family. These results were confirmed by Western blot analysis with monoclonal antibodies. Altogether, the results indicate that Brucella CGH not only participates in deconjugation of bile salts but also affects overall membrane composition and host cell internalization.

  18. Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus.

    Barquero-Calvo, Elías; Martirosyan, Anna; Ordoñez-Rueda, Diana; Arce-Gorvel, Vilma; Alfaro-Alarcón, Alejandro; Lepidi, Hubert; Malissen, Bernard; Malissen, Marie; Gorvel, Jean-Pierre; Moreno, Edgardo

    2013-02-01

    Polymorphonuclear neutrophils (PMNs) are the first line of defense against microbial pathogens. In addition to their role in innate immunity, PMNs may also regulate events related to adaptive immunity. To investigate the influence of PMNs in the immune response during chronic bacterial infections, we explored the course of brucellosis in antibody PMN-depleted C57BL/6 mice and in neutropenic mutant Genista mouse model. We demonstrate that at later times of infection, Brucella abortus is killed more efficiently in the absence of PMNs than in their presence. The higher bacterial removal was concomitant to the: i) comparatively reduced spleen swelling; ii) augmented infiltration of epithelioid histiocytes corresponding to macrophages/dendritic cells (DCs); iii) higher recruitment of monocytes and monocyte/DCs phenotype; iv) significant activation of B and T lymphocytes, and v) increased levels of INF-γ and negligible levels of IL4 indicating a balance of Th1 over Th2 response. These results reveal that PMNs have an unexpected influence in dampening the immune response against intracellular Brucella infection and strengthen the notion that PMNs actively participate in regulatory circuits shaping both innate and adaptive immunity. PMID:23458832

  19. Identification of Brucella abortus virulence proteins that modulate the host immune response.

    Wang, Yufei; Chen, Zeliang; Qiu, Yefeng; Ke, Yuehua; Xu, Jie; Yuan, Xitong; Li, Xianbo; Fu, Simei; Cui, Mingquan; Xie, Yongfei; Du, Xinying; Wang, Zhoujia; Huang, Liuyu

    2012-01-01

    Brucellosis is an important zoonotic disease of almost worldwide distribution. One significant immune phenomenon of this disease is the ability of the pathogen to hide and survive in the host, establishing long lasting chronic infections. Brucella was found to have the ability to actively modulate the host immune response in order to establish chronic infections, but the mechanism by which the pathogen achieves this remains largely unknown. In our screening for protective antigens of Brucella abortus, 3 proteins (BAB1_0597, BAB1_0917, and BAB2_0431) were found to induce significantly higher levels of gamma interferon (IFNγ) in splenocytes of PBS immunized mice than those immunized with S19. This finding strongly implied that these three proteins inhibit the production of IFNγ. Previous studies have shown that LPS, PrpA, and Btp1/TcpB are three important immunomodulatory molecules with the capacity to interfere with host immune response. They have been shown to have the ability to inhibit the secretion of IFNγ, or to increase the production of IL-10. Due to the role of these proteins in virulence and immunomodulation, they likely offer significant potential as live, attenuated Brucella vaccine candidates. Understanding the mechanisms by which these proteins modulate the host immune responses will deepen our knowledge of Brucella virulence and provide important information on the development of new vaccines against Brucellosis. PMID:22743689

  20. Immune Modulation of Recombinant OmpA against Brucella abortus 544 Infection in Mice.

    Simborio, Hannah Leah Tadeja; Reyes, Alisha Wehdnesday Bernardo; Hop, Huynh Tan; Arayan, Lauren Togonon; Min, Wongi; Lee, Hu Jang; Lee, Jin Ju; Chang, Hong Hee; Kim, Suk

    2016-03-28

    Brucellosis affects a wide range of host species, including humans and many livestock animals. Chronic infections of the disease make antibiotic treatment costly, and the current vaccine used in livestock has not been approved for human use. This study investigated the possible use of the Brucella abortus outer membrane protein A (OmpA) as a candidate subunit vaccine in an infected mouse model. The ompA gene was cloned and overexpressed, and the recombinant OmpA (rOmpA) protein fused to maltose binding protein (MBP) was purified in Escherichia coli. Immunogenicity was verified through western blotting, and mice were immunized and challenged to evaluate its protective effect. Mice treated with rOmpA exhibited induced humoral and host cell-mediated responses, with a significant increase in immunoglobulin G (IgG1 and IgG2a) and cytokine levels, especially TNF-α and IL-12, compared with the control groups treated with either MBP or PBS. In conclusion, rOmpA should be highly considered as a future subunit vaccine for brucellosis, and further studies regarding rOmpA and its protective ability are suggested. PMID:26699748

  1. Endocarditis por Brucella abortus: Reporte del primer caso en C.R

    Manuel Antonio Villalobos-Zúñiga

    2011-09-01

    Full Text Available Paciente masculino de 36 años de edad, proveniente de la zona rural de Costa Rica, con un cuadro clínico de 8 meses de evolución de fiebre, mialgias, artralgias, pérdida de peso y lumbalgia; referido por la detección de un soplo de insuficiencia aórtica. El ecocardiograma reveló endocarditis de la válvula aórtica, y se obtuvieron 4 hemocultivos positivos por Brucella abortus biotipo 3, con serologías negativas por brucelosis. Se inició tratamiento con antibióticos y luego se le realizó un reemplazo valvular aórtico; 4 meses después ingresó con dolor torácico que se atribuyó a una oclusión de la arteria descendente anterior, demostrada angiográficamente, por posible embolismo. En la actualidad cursa clínicamente estable con manejo médico para su cardiopatía, sin recaída infecciosa.

  2. Vaccination with Brucella abortus Recombinant In Vivo-Induced Antigens Reduces Bacterial Load and Promotes Clearance in a Mouse Model for Infection

    Jake E Lowry; Isaak, Dale D.; Leonhardt, Jack A.; Giulia Vernati; Jessie C Pate; Andrews, Gerard P.

    2011-01-01

    Current vaccines used for the prevention of brucellosis are ineffective in inducing protective immunity in animals that are chronically infected with Brucella abortus, such as elk. Using a gene discovery approach, in vivo-induced antigen technology (IVIAT) on B. abortus, we previously identified ten loci that encode products up-regulated during infection in elk and consequently may play a role in virulence. In our present study, five of the loci (D15, 0187, VirJ, Mdh, AfuA) were selected for ...

  3. Otpornost na antimikrobne tvari, fenotipska obilježja i fagotipovi sojeva vrste B. abortus izdvojenih iz goveda i azijskih bivola (Bubalus bubalis) u Trinidadu.

    Adesiyun, Abiodun A.; Baird, Kadian; Stewart-Johnson, Alva

    2011-01-01

    Određivana su fenotipska obilježja, fagotipovi i otpornost na antimikrobna sredstva sojeva bakterije Brucella abortus izdvojenih iz goveda i azijskog bivola (Bubalus bubalis) u Trinidadu i Tobagu. Ukupno je 86 izolata bilo izdvojeno iz limfnih čvorova 14 klinički zdravih serološki pozitivnih goveda i 17 indijskih bivola, iz ozljeda kože devet bivola te tkiva pobačenih plodova 16 bivola. Analizirana su bila i dva cjepna soja bakterije B. abortus, soj 19 (S19) i RB51 (SRB51). Svi analizirani so...

  4. Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.

    Stevens, M G; S. C. Olsen; Pugh, G W

    1995-01-01

    Mice vaccinated with Brucella abortus 19 (S19) or RB51 (SRB51) had spleen cells which proliferated in response to proteins of 32, 27, 18, and < 18 kDa but not in response to proteins of 106, 80, and 49 kDa from B. abortus 2308 (S2308) following vaccination and challenge infection with S2308. Spleen cells from mice vaccinated with S19 but not with SRB51 had increased proliferation in response to S2308 lipopolysaccharide (LPS) following challenge infection with S2308. We previously reported tha...

  5. Variables Associated with Infections of Cattle by Brucella abortus., Leptospira spp. and Neospora spp. in Amazon Region in Brazil.

    Chiebao, D P; Valadas, S Y O B; Minervino, A H H; Castro, V; Romaldini, A H C N; Calhau, A S; De Souza, R A B; Gennari, S M; Keid, L B; Soares, R M

    2015-10-01

    The frequency of Neospora spp., Leptospira spp. and Brucella abortus infections in adult cattle was determined in herds of the State of Pará, Brazil, which is an important region for cattle production located in the Amazon region. A total of 3466 adult female cattle from 176 herds were tested, leading to a frequency of seropositive animals of 14.7%, 3.7% and 65.5% and a herd positivity of 87.4%, 41.3% and 98.8% for infections caused by Neospora spp., B. abortus and Leptospira spp., respectively. The five most frequently diagnosed serologic responses to Leptospira spp. were those against serovars hardjo, wolfii, grippotyphosa, hebdomadis and shermani. The following associations were found: practice of artificial insemination, large farm size, large herd size, large number of dogs and high number of total abortions per year with the presence of antibodies against serovar hardjo; positive results to serovar grippotyphosa with the presence of dogs; inappropriate disposal of aborted foetuses with positivity to serovar hebdomadis. Serovar grippotyphosa was also associated with number of episodes of abortions. Neospora spp. positive herds were associated with episodes of abortion and B. abortus infection with the disposal of dead animals and aborted foetuses on pastures and with the use of artificial insemination. In conclusion, the high frequency of brucellosis, leptospirosis and neosporosis in the region may be a consequence of social, natural and raising conditions as: (i) climate conditions that favour the survival and spread of pathogens in the environment; (ii) farms located in regions bordering forest areas; (iii) farms in areas of difficult access to the veterinary service; (iv) extensive beef herds raised at pastures with different age and productive groups inter-mingled; and (v) minimal concerns regarding hygiene practices and disease prevention measures. PMID:26302373

  6. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.

    Kianmehr, Zahra; Soleimanjahi, Hoorieh; Ardestani, Susan Kaboudanian; Fotouhi, Fatemeh; Abdoli, Asghar

    2015-04-01

    Brucella abortus lipopolysaccharide (LPS) has less toxicity and no pyrogenic properties in comparison with other bacterial LPS. It is a toll-like receptor 4 agonist and has been shown to have the potential use as a vaccine adjuvant. In this study, the immunostimulatory properties of LPS from smooth and rough strains of B. abortus (S19 and RB51) as adjuvants were investigated for the human papillomavirus type 16 (HPV16) L1 virus-like particles (L1VLPs) vaccines. C57BL/6 mice were immunized subcutaneously three times either with HPV-16 L1VLPs alone, or in combination with smooth LPS (S-LPS), rough LPS (R-LPS), aluminum hydroxide or a mixture of them as adjuvant. The humoral immunity was evaluated by measuring the specific and total IgG levels, and also the T-cell immune response of mice was evaluated by measuring different cytokines such as IFN-γ, TNF-α, IL-4, IL-10 and IL-17. Results showed that serum anti-HPV16 L1VLP IgG antibody titers was significantly higher in mice immunized with a combination of VLPs and R-LPS or S-LPS compared with other immunized groups. Co-administration of HPV-16 L1VLPs with R-LPS elicited the highest levels of splenocytes cytokines (IFN-γ, IL-4, IL-17 and TNF-α) and also effectively induced improvement of a Th1-type cytokine response characterized with a high ratio of IFN-γ/IL-10. The data indicate that B. abortus LPS particularly RB51-LPS enhances the immune responses to HPV-16 L1VLPs and suggests its potential as an adjuvant for the development of a potent prophylactic HPV vaccine and other candidate vaccines. PMID:25187406

  7. Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection.

    Simei Fu

    Full Text Available Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection. Identification of Brucella antigens that present T-cell epitopes to the host could enable development of such vaccines. In this study, 45 proven or putative pathogenesis-associated factors of Brucella were selected according to currently available data. After expressed and purified, 35 proteins were qualified for analysis of their abilities to stimulate T-cell responses in vitro. Then, an in vitro gamma interferon (IFN-γ assay was used to identify potential T-cell antigens from B. abortus. In total, 7 individual proteins that stimulated strong IFN-γ responses in splenocytes from mice immunized with B. abortus live vaccine S19 were identified. The protective efficiencies of these 7 recombinant proteins were further evaluated. Mice given BAB1_1316 (CobB or BAB1_1688 (AsnC plus adjuvant could provide protection against virulent B. abortus infection, similarly with the known protective antigen Cu-Zn SOD and the license vaccine S19. In addition, CobB and AsnC could induce strong antibodies responses in BALB/c mice. Altogether, the present study showed that CobB or AsnC protein could be useful antigen candidates for the development of subunit vaccines against brucellosis with adequate immunogenicity and protection efficacy.

  8. Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection.

    Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Qiu, Yefeng; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Yu, Yaqing; Peng, Guangneng; Huang, Kehe; Huang, Liuyu; Wang, Yufei; Chen, Zeliang

    2012-01-01

    Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection. Identification of Brucella antigens that present T-cell epitopes to the host could enable development of such vaccines. In this study, 45 proven or putative pathogenesis-associated factors of Brucella were selected according to currently available data. After expressed and purified, 35 proteins were qualified for analysis of their abilities to stimulate T-cell responses in vitro. Then, an in vitro gamma interferon (IFN-γ) assay was used to identify potential T-cell antigens from B. abortus. In total, 7 individual proteins that stimulated strong IFN-γ responses in splenocytes from mice immunized with B. abortus live vaccine S19 were identified. The protective efficiencies of these 7 recombinant proteins were further evaluated. Mice given BAB1_1316 (CobB) or BAB1_1688 (AsnC) plus adjuvant could provide protection against virulent B. abortus infection, similarly with the known protective antigen Cu-Zn SOD and the license vaccine S19. In addition, CobB and AsnC could induce strong antibodies responses in BALB/c mice. Altogether, the present study showed that CobB or AsnC protein could be useful antigen candidates for the development of subunit vaccines against brucellosis with adequate immunogenicity and protection efficacy. PMID:22383953

  9. Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes.

    Crasta, Oswald R; Folkerts, Otto; Fei, Zhangjun; Mane, Shrinivasrao P; Evans, Clive; Martino-Catt, Susan; Bricker, Betsy; Yu, GongXin; Du, Lei; Sobral, Bruno W

    2008-01-01

    The Brucella abortus strain S19, a spontaneously attenuated strain, has been used as a vaccine strain in vaccination of cattle against brucellosis for six decades. Despite many studies, the physiological and molecular mechanisms causing the attenuation are not known. We have applied pyrosequencing technology together with conventional sequencing to rapidly and comprehensively determine the complete genome sequence of the attenuated Brucella abortus vaccine strain S19. The main goal of this study is to identify candidate virulence genes by systematic comparative analysis of the attenuated strain with the published genome sequences of two virulent and closely related strains of B. abortus, 9-941 and 2308. The two S19 chromosomes are 2,122,487 and 1,161,449 bp in length. A total of 3062 genes were identified and annotated. Pairwise and reciprocal genome comparisons resulted in a total of 263 genes that were non-identical between the S19 genome and any of the two virulent strains. Amongst these, 45 genes were consistently different between the attenuated strain and the two virulent strains but were identical amongst the virulent strains, which included only two of the 236 genes that have been implicated as virulence factors in literature. The functional analyses of the differences have revealed a total of 24 genes that may be associated with the loss of virulence in S19. Of particular relevance are four genes with more than 60 bp consistent difference in S19 compared to both the virulent strains, which, in the virulent strains, encode an outer membrane protein and three proteins involved in erythritol uptake or metabolism. PMID:18478107

  10. Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes.

    Oswald R Crasta

    Full Text Available The Brucella abortus strain S19, a spontaneously attenuated strain, has been used as a vaccine strain in vaccination of cattle against brucellosis for six decades. Despite many studies, the physiological and molecular mechanisms causing the attenuation are not known. We have applied pyrosequencing technology together with conventional sequencing to rapidly and comprehensively determine the complete genome sequence of the attenuated Brucella abortus vaccine strain S19. The main goal of this study is to identify candidate virulence genes by systematic comparative analysis of the attenuated strain with the published genome sequences of two virulent and closely related strains of B. abortus, 9-941 and 2308. The two S19 chromosomes are 2,122,487 and 1,161,449 bp in length. A total of 3062 genes were identified and annotated. Pairwise and reciprocal genome comparisons resulted in a total of 263 genes that were non-identical between the S19 genome and any of the two virulent strains. Amongst these, 45 genes were consistently different between the attenuated strain and the two virulent strains but were identical amongst the virulent strains, which included only two of the 236 genes that have been implicated as virulence factors in literature. The functional analyses of the differences have revealed a total of 24 genes that may be associated with the loss of virulence in S19. Of particular relevance are four genes with more than 60 bp consistent difference in S19 compared to both the virulent strains, which, in the virulent strains, encode an outer membrane protein and three proteins involved in erythritol uptake or metabolism.

  11. Overexpression of Brucella putative glycosyltransferase WbkA in B. abortus RB51 leads to production of exopolysaccharide

    Neha eDabral

    2015-06-01

    Full Text Available Brucella spp. are Gram-negative, facultative intracellular bacteria that cause brucellosis in mammals. Brucella strains containing the O-polysaccharide in their cell wall structure exhibit a smooth phenotype whereas the strains devoid of the polysaccharide show rough phenotype. B. abortus strain RB51 is a stable rough attenuated mutant which is used as a licensed live vaccine for bovine brucellosis. Previous studies have shown that the wboA gene, which encodes a glycosyltransferase required for the synthesis of O-polysaccharide, is disrupted in B. abortus RB51 by an IS711 element. Although complementation of strain RB51 with a functional wboA gene results in O-polysaccharide synthesis in the cytoplasm, it does not result in smooth phenotype. The aim of this study was to determine if overexpression of Brucella WbkA or WbkE, two additional putative glycosyltransferases essential for O-polysaccharide synthesis, in strain RB51 would result in the O-polysaccharide synthesis and smooth phenotype. Our results demonstrate that overexpression of wbkA or wbkE gene in RB51 does not result in O-polysaccharide expression as shown by Western blotting with specific antibodies. However, wbkA, but not wbkE, overexpression leads to the development of a clumping phenotype and the production of exopolysaccharide(s containing mannose, galactose, N-acetylglucosamine and N-acetylgalactosamine. Moreover, we found that the clumping recombinant strain displays increased adhesion to polystyrene plates. The recombinant strain was similar to strain RB51 in its attenuation characteristic and in its ability to induce protective immunity against virulent B. abortus challenge in mice.

  12. Circulating strains of Brucella abortus in cattle in the province of Santo Domingo de los Tsáchilas - Ecuador.

    Richar Ivan Rodríguez Hidalgo

    2015-03-01

    Full Text Available In Ecuador, the Province of Santo Domingo de los Tsáchilas represents the largest informal market of livestock due to its strategic position in the country; thus, given the high mobility of cattle in this region, the aim of this study was to determine the strain variation of Brucella sp.. Part of the study was the isolation, biotyping and genotyping of Brucella species isolated from milk and supra-mammary lymph nodes of sero-positive bovines. Protocols used for isolation, biotyping and genotyping of Brucella species were selective Farrell medium, biochemical assays and IS711-PCR, AMOS-PCR and HOOF-Prints techniques, respectively. In total, 656 animals from sero-positive dairy herds and from the slaughterhouse of the province were diagnosed by Rose Bengal and Wright’s Slow Agglutination test with EDTA. From these animals, 50 animals were found sero-positive for brucellosis. Twenty-five lymph nodes and 25 milk samples from each group of positive reactors were cultured and growth. Isolation was possible in 4 (16% and 9 (36%, respectively; and of these, 10 isolates were diagnosed as Brucella sp. All 4 isolates of lymphatic tissue corresponded to Brucella abortus biotype 1, confirmed as field strains by molecular analysis. Milk isolations, biochemically showed a more dispersed pattern in which B. abortus biotypes 1 and 4 were found; yet four samples gave a pattern similar to B. abortus biotype 2; however, only biotypes 1 and 4 were confirmed by molecular analysis. The concordance between biochemical and molecular diagnostic tests reached 76.9%.

  13. DNA vaccine encoding L7/L12-P39 of Brucella abortus induces protective immunity in BALB/c mice

    LUO De-yan; LI Peng; XING Li; ZHAO Guang-yu; SHI Wei; ZHANG Song-le; WANG Xi-liang

    2006-01-01

    @@ Brucella abortus is a gram-negative, facultative, intracellular bacterium that infects both cattle and humans, causing abortion and infertility in the former and undulant fever, endocarditis, arthritis, and osteomyelitis. Resistance to Brucella depends on acquired cell-mediated immunity (CMI).1 Live attenuated vaccines can stimulate strong CMI response, which are usually very effective against brucellosis and are used to control brucellosis in domestic animals. However, there is no safe and effective vaccine available for human because the vaccine strains used for animals are considered too virulent for humans. A vaccine that will be noninfectious to humans but effective in stimulating a broad protective immune response is needed.2

  14. VACINAS: PROGRESSOS E NOVOS DESAFIOS PARA O CONTROLE DE DOENÇAS IMUNOPREVENÍVEIS Vacunas: Progresos y Nuevos Retos para el Control de Enfermedades Prevenibles Vaccines: Progress nnd Challenges for the Control of Preventable Diseases

    Fonseca Pinto Eduardo

    2011-12-01

    Full Text Available RESUMO Há mais de 200 anos a vacinação tem sido uma ferramenta muito efetiva na prevenção de doenças infecciosas e juntamente com o saneamento básico, o efeito prático da vacinação pode ser considerado o maior benefício à saúde pública do século XX. No entanto, o desenvolvimento de vacinas permanece um objetivo importante no campo da imunologia e na última década observa-se uma mudança em direção a uma abordagem mais racional, baseada em uma compreensão molecular da patogenicidade microbiana, na utilização de novas tecnologias recombinantes e no desenvolvimento de sistemas de liberação de vacinas mais efetivos. Este trabalho descreve o progresso no desenvolvimento de vacinas a partir dos primeiros relatos das práticas de vacinação, passando pelo estado atual de desenvolvimento de vacinas, pelas novas estratégias vacinais e pelo impacto da vacinação no controle das doenças imunopreveníveis. Palavras chave: doenças imunopreveníveis, novas estratégias, vacinas. RESUMEN Desde hace más de 200 años la vacunación ha sido una herramienta muy efectiva en la prevención de enfermedades infecciosas, junto con el saneamiento, el efecto práctico de la vacunación puede ser considerado como el mayor beneficio para la salud pública del siglo XX. Sin embargo, el desarrollo de vacunas sigue siendo un objetivo importante en el campo de la inmunología y en la última década ha habido un cambio hacia un enfoque más racional, basada en los hallazgos moleculares de la patogenia microbiana, el uso de nuevas tecnologías recombinantes y el desarrollo de sistemas de suministro de las vacunas más eficaces. En este trabajo se describen los progresos en el desarrollo de vacunas, partiendo de los primeros informes de prácticas de vacunación, hasta el estado actual del desarrollo de vacunas, las nuevas estrategias de vacunas y el impacto de la vacunación en el control de enfermedades prevenibles. Palabras

  15. El desafío del cambio de la vacuna inactivada contra poliomielitis en América Latina: Declaración de la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE

    Luiza Helena Falleiros-Arlant

    2014-10-01

    Full Text Available A pesar de que ya se ha recorrido el 99% del camino para erradicar la poliomielitis (polio del mundo, esta enfermedad continúa causando parálisis en niños. Su erradicación no sólo significa el fin de la circulación del poliovirus salvaje, sino también del virus derivado de la vacunación. La Sociedad Latinoamericana de Infectología Pediátrica (SLIPE, tomando en cuenta diferentes factores tales como: los datos epidemiológicos actuales, los eventos adversos de la vacuna oral atenuada (OPV contra polio, la disponibilidad de una vacuna inactivada (IPV inyectable que no tiene el potencial de causar los eventos adversos graves de la OPV, la eficacia y la efectividad de la IPV en varios países del mundo donde es utilizada desde hace varios años, el racional del cambio del esquema de vacunación en diferentes países de la América Latina; hace pública su recomendación del cambio a la IPV para América Latina, a través de la presente Declaración con un Plan de Acción para el período 2014-2015 con respecto a las políticas de vacunación contra la polio en Latinoamérica. 1. El esquema óptimo propuesto son cuatro dosis de IPV (tres dosis en el esquema primario más un refuerzo, ya sea IPV combinada o no combinada con otras vacunas indicadas en el programa de inmunización del país. Es aceptable un esquema alternativo durante la etapa de transición de la vacuna OPV a la IPV; 2. Los países deben plantear las estrategias óptimas para mantener y mejorar las coberturas de vacunación e implementar el registro nominal de vacunas; 3. Mejorar la vigilancia epidemiológica de la Parálisis Flácida Aguda (PFA y establecer un programa de vigilancia ambiental; 4. Establecer estrategias para la introducción de IPV en los Programas Nacionales de Inmunización, como comunicación adecuada con la población y otras; 5. Acercamiento de las sociedades científicas a los tomadores de decisión; 6. Asegurar el abastecimiento y precios óptimos para

  16. Isolation of two biologically active cell surface proteins from Brucella abortus by chromatofocusing

    Brucella abortus contains a group of immunogenic cell surface proteins which have potential value as a vaccine or as a diagnostic reagent for the prevention and diagnosis of bovine brucellosis. Under nondenaturing conditions, these proteins range in molecular weight from 10,000-124,000, as determined by high performance liquid chromatography (HPLC) on TSK 3000sw. By analytical isoelectrofocusing, 6 major protein bands could be distinguished with pI's ranging from 4.0 to 6.0 and 3 additional major proteins with pI's of 7.5, 9.5, and 10. By chromatofocusing on Polybuffer Exchanger 94 with a pH gradient from 6-4, two of the six proteins from pI 4-6 were separated, a pI 4.9 and a pI 4.7 protein; a third fraction contained the high pI proteins. The former two proteins were homogeneous by analytical isoelectrofocusing, and a molecular weight of 54,000 daltons was found for both protein species by HPLC on TSK 3000sw. The pI 4-6 and not the pI 9.5 and 10 proteins, could be radiolabeled when intact cells were radioiodinated with diazotized (125I)-iodosulfanilic acid. Biological activity of the proteins as assessed in lemmings indicated that immunization with the pI 4.7 and 4.9 proteins afforded better protection against experimental brucellosis than immunization with the high pI proteins. These results support our view that a single surface protein may be sufficient for the prevention of experimental brucellosis

  17. Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice.

    Afley, Prachiti; Dohre, Sudhir K; Prasad, G B K S; Kumar, Subodh

    2015-09-01

    Brucellae are Gram-negative intracellular bacteria that cause an important zoonotic disease called brucellosis. The animal vaccines are available but have disadvantage of causing abortions in a proportion of pregnant animals. The animal vaccines are also pathogenic to humans. Recent trend in vaccine design has shifted to epitope-based vaccines that are safe and specific. In this study, efforts were made to identify MHC-I- and MHC-II-restricted T cell epitopes of Brucella abortus and evaluate their vaccine potential in mice. The peptides were designed using online available immunoinformatics tools, and five MHC-I- and one MHC-II-restricted T cell peptides were selected on the basis of their ability to produce interferon gamma (IFN-γ) in in vivo studies. The selected peptides were co-administered with poly DL-lactide-co-glycolide (PLG) microparticles and evaluated for immunogenicity and protection in BALB/c mice. Mice immunized with peptides either entrapped in PLG microparticles (EPLG-Pep) or adsorbed on PLG particles (APLG-Pep) showed significantly higher splenocyte proliferation and IFN-γ generation to all selected peptides than the mice immunized with corresponding irrelevant peptides formulated PLG microparticles or phosphate-buffered saline (PBS). A significant protection compared to PBS control was also observed in EPLG-Pep and APLG-Pep groups. A plasmid DNA vaccine construct (pVaxPep) for peptides encoding DNA sequences was generated and injected to mice by in vivo electroporation. Significant protection was observed (1.66 protection units) when compared with PBS and empty vector control group animals. Overall, the MHC-I and MHC-II peptides identified in this study are immunogenic and protective in mouse model and support the feasibility of peptide-based vaccine for brucellosis. PMID:26150246

  18. Isolation of two biologically active cell surface proteins from Brucella abortus by chromatofocusing

    Tabatabai, L.B.; Deyoe, B.L.

    1983-01-01

    Brucella abortus contains a group of immunogenic cell surface proteins which have potential value as a vaccine or as a diagnostic reagent for the prevention and diagnosis of bovine brucellosis. Under nondenaturing conditions, these proteins range in molecular weight from 10,000-124,000, as determined by high performance liquid chromatography (HPLC) on TSK 3000sw. By analytical isoelectrofocusing, 6 major protein bands could be distinguished with pI's ranging from 4.0 to 6.0 and 3 additional major proteins with pI's of 7.5, 9.5, and 10. By chromatofocusing on Polybuffer Exchanger 94 with a pH gradient from 6-4, two of the six proteins from pI 4-6 were separated, a pI 4.9 and a pI 4.7 protein; a third fraction contained the high pI proteins. The former two proteins were homogeneous by analytical isoelectrofocusing, and a molecular weight of 54,000 daltons was found for both protein species by HPLC on TSK 3000sw. The pI 4-6 and not the pI 9.5 and 10 proteins, could be radiolabeled when intact cells were radioiodinated with diazotized (/sup 125/I)-iodosulfanilic acid. Biological activity of the proteins as assessed in lemmings indicated that immunization with the pI 4.7 and 4.9 proteins afforded better protection against experimental brucellosis than immunization with the high pI proteins. These results support our view that a single surface protein may be sufficient for the prevention of experimental brucellosis.

  19. Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strains RB51 or RB51 overexpressing superoxide dismutase and Glycosyltransferase genes

    Vaccination is a tool that could be beneficial in managing the high prevalence of brucellosis in free-ranging bison in Yellowstone National Park. In this study, we characterized immunologic responses and protection against experimental challenge after vaccination of bison with Brucella abortus stra...

  20. Molecular cloning and characterization of cgt, the Brucella abortus cyclic beta-1,2-glucan transporter gene, and its role in virulence.

    Roset, Mara S; Ciocchini, Andrés E; Ugalde, Rodolfo A; Iñón de Iannino, Nora

    2004-04-01

    The animal pathogen Brucella abortus contains a gene cgt, which complemented Sinorhizobium meliloti nodule development (ndvA) and Agrobacterium tumefaciens chromosomal virulence (chvA) mutants. Complemented strains recovered the presence of anionic cyclic beta-1,2-glucan, motility, tumor induction in A. tumefaciens, and nodule occupancy in S. meliloti, all traits strictly associated with the presence of cyclic beta-1,2-glucan in the periplasm. Nucleotide sequencing revealed that B. abortus cgt contains a 1,797-bp open reading frame coding for a predicted membrane protein of 599 amino acids (65.9 kDa) that is 58.5 and 59.9% identical to S. meliloti NdvA and A. tumefaciens ChvA, respectively. Additionally, B. abortus cgt, like S. meliloti ndvA and A. tumefaciens chvA possesses ATP-binding motifs and the ABC signature domain features of a typical ABC transporter. Characterization of Cgt was carried out by the construction of null mutants in B. abortus 2308 and S19 backgrounds. Both mutants do not transport cyclic beta-1,2-glucan to the periplasm, as shown by the absence of anionic cyclic glucan, and they display reduced virulence in mice and defective intracellular multiplication in HeLa cells. These results suggest that cyclic beta-1,2-glucan must be transported into the periplasmatic space to exert its action as a virulence factor. PMID:15039351

  1. The efficacy of the skin delayed-type hypersensitivity using a brucellin prepared from a mucoid strain of Brucella abortus to detect brucellosis

    Bercovich, Z.; Muskens, J.A.M.

    1998-01-01

    Eight-hundred-and-ninety-six cattle belonging to herds officially designated Brucella-free, and 190 cattle belonging to infected herds were tested with the skin delayed-type hypersensitivity (SDTH) test, using brucellin (273) prepared from a rnucoid strain of Brucella abortus. An increase in skinfol

  2. The Assessment of Cytokine and Antibody Responses to Recombinant 31kDa Brucella Cell-Surface Protein in Brucella Abortus Infected Mouse Model

    Nima Khoramabadi

    2014-06-01

    Conclusion: These findings suggest that specific humoral and cell-mediated responses to BCSP31 is formed during murine host infection with B. abortus. Based on these findings, rBCSP31 can be used in further design of immunogenic strategies for vaccination against brucellosis.

  3. The Dutch Brucella abortus monitoring programme for cattle: the impact of false-positive serological reactions and comparison of serological tests

    Emmerzaal, A.; Wit, de J.J.; Dijkstra, T.; Bakker, D.; Ziiderveld, van F.G.

    2002-01-01

    The Dutch national Brucella abortus eradication programme for cattle started in 1959. Sporadic cases occurred yearly until 1995; the last infected herd was culled in 1996. In August 1999 the Netherlands was declared officially free of bovine brucellosis by the European Union. Before 1999, the progra

  4. Entre controversias científico-médicas y movilizaciones populares. Población epidémica y vacunas contra la fiebre hemorrágica argentina 1958-1990

    Agnese, Graciela

    2013-06-01

    Full Text Available The emergence and gradual extension of a new epidemic disease, as it has been the Haemorrhagic Fever Argentina, from the Decade of the ‘ 50s, prompted the medical scientific research with the aim of finding a vaccine. In the period 1959-1990 developed three projects of vaccines with different results. This article aims to consider the behavior assumed by the epidemic population around the three vaccines in response to the tensions that exist between population and physicians and researchers in charge of vaccination campaigns; the struggles between the various scientific groups; the role of the press and the State.La irrupción y la progresiva extensión de una nueva enfermedad epidémica, como ha sido la Fiebre Hemorrágica Argentina, a partir de la década del ’50, impulsó la investigación científica médica con el objetivo fundamental de encontrar una vacuna. En el período 1959-1990 se desarrollaron tres proyectos de vacunas con distintos resultados. El objetivo de este artículo es considerar las conductas asumidas por la población epidémica en torno a las tres vacunas atendiendo a las tensiones existentes entre la población y los médicos e investigadores a cargo de las campañas de vacunación; las pugnas entre los distintos grupos científicos; el rol de la prensa y del estado.

  5. Glial Cell-Elicited Activation of Brain Microvasculature in Response to Brucella abortus Infection Requires ASC Inflammasome-Dependent IL-1β Production.

    Miraglia, M Cruz; Costa Franco, Miriam M; Rodriguez, Ana M; Bellozi, Paula M Q; Ferrari, Carina C; Farias, Maria I; Dennis, Vida A; Barrionuevo, Paula; de Oliveira, Antonio C P; Pitossi, Fernando; Kim, Kwang Sik; Delpino, M Victoria; Oliveira, Sergio Costa; Giambartolomei, Guillermo H

    2016-05-01

    Blood-brain barrier activation and/or dysfunction are a common feature of human neurobrucellosis, but the underlying pathogenic mechanisms are largely unknown. In this article, we describe an immune mechanism for inflammatory activation of human brain microvascular endothelial cells (HBMEC) in response to infection with Brucella abortus Infection of HBMEC with B. abortus induced the secretion of IL-6, IL-8, and MCP-1, and the upregulation of CD54 (ICAM-1), consistent with a state of activation. Culture supernatants (CS) from glial cells (astrocytes and microglia) infected with B. abortus also induced activation of HBMEC, but to a greater extent. Although B. abortus-infected glial cells secreted IL-1β and TNF-α, activation of HBMEC was dependent on IL-1β because CS from B. abortus-infected astrocytes and microglia deficient in caspase-1 and apoptosis-associated speck-like protein containing a CARD failed to induce HBMEC activation. Consistently, treatment of CS with neutralizing anti-IL-1β inhibited HBMEC activation. Both absent in melanoma 2 and Nod-like receptor containing a pyrin domain 3 are partially required for caspase-1 activation and IL-1β secretion, suggesting that multiple apoptosis-associated speck-like protein containing CARD-dependent inflammasomes contribute to IL-1β-induced activation of the brain microvasculature. Inflammasome-mediated IL-1β secretion in glial cells depends on TLR2 and MyD88 adapter-like/TIRAP. Finally, neutrophil and monocyte migration across HBMEC monolayers was increased by CS from Brucella-infected glial cells in an IL-1β-dependent fashion, and the infiltration of neutrophils into the brain parenchyma upon intracranial injection of B. abortus was diminished in the absence of Nod-like receptor containing a pyrin domain 3 and absent in melanoma 2. Our results indicate that innate immunity of the CNS set in motion by B. abortus contributes to the activation of the blood-brain barrier in neurobrucellosis and IL-1β mediates

  6. In Vivo Identification and Characterization of CD4+ Cytotoxic T Cells Induced by Virulent Brucella abortus Infection

    Martirosyan, Anna; Von Bargen, Kristine; Arce Gorvel, Vilma; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Méresse, Stéphane; Gorvel, Jean-Pierre

    2013-01-01

    CD4+ T cells display a variety of helper functions necessary for an efficient adaptive immune response against bacterial invaders. This work reports the in vivo identification and characterization of murine cytotoxic CD4+ T cells (CD4+ CTL) during Brucella abortus infection. These CD4+ CTLs express granzyme B and exhibit immunophenotypic features consistent with fully differentiated T cells. They express CD25, CD44, CD62L ,CD43 molecules at their surface and produce IFN-γ. Moreover, these cells express neither the co-stimulatory molecule CD27 nor the memory T cell marker CD127. We show here that CD4+ CTLs are capable of cytolytic action against Brucella-infected antigen presenting cells (APC) but not against Mycobacterium-infected APC. Cytotoxic CD4+ T cell population appears at early stages of the infection concomitantly with high levels of IFN-γ and granzyme B expression. CD4+ CTLs represent a so far uncharacterized immune cell sub-type triggered by early immune responses upon Brucella abortus infection. PMID:24367519

  7. In vivo identification and characterization of CD4⁺ cytotoxic T cells induced by virulent Brucella abortus infection.

    Martirosyan, Anna; Von Bargen, Kristine; Arce Gorvel, Vilma; Zhao, Weidong; Hanniffy, Sean; Bonnardel, Johnny; Méresse, Stéphane; Gorvel, Jean-Pierre

    2013-01-01

    CD4(+) T cells display a variety of helper functions necessary for an efficient adaptive immune response against bacterial invaders. This work reports the in vivo identification and characterization of murine cytotoxic CD4(+) T cells (CD4(+) CTL) during Brucella abortus infection. These CD4(+) CTLs express granzyme B and exhibit immunophenotypic features consistent with fully differentiated T cells. They express CD25, CD44, CD62L ,CD43 molecules at their surface and produce IFN-γ. Moreover, these cells express neither the co-stimulatory molecule CD27 nor the memory T cell marker CD127. We show here that CD4(+) CTLs are capable of cytolytic action against Brucella-infected antigen presenting cells (APC) but not against Mycobacterium-infected APC. Cytotoxic CD4(+) T cell population appears at early stages of the infection concomitantly with high levels of IFN-γ and granzyme B expression. CD4(+) CTLs represent a so far uncharacterized immune cell sub-type triggered by early immune responses upon Brucella abortus infection. PMID:24367519

  8. Mouse cytokine profile skewed towards Th2 in pregnancy during infection with Brucella abortus S19 strain.

    Wamonje, Francis O; Waihenya, Rebecca K; Ng'ang'a, Zipporah; Ngeranwa, Joseph N

    2011-04-01

    The two classes of cytokines Th1 and Th2 determine the type of immune response elicited. The Th2 immune response is associated with successful pregnancy. Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species. This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy. Forty-eight Swiss white mice were used in this murine model and the S19 strain of Brucella abortus was used in as the infective agent. Pregnant mice in the test group were injected intraperitoneally with 10(5-8) CFU of Brucella and cytokine profile evaluated over the three trimesters of pregnancy. Pregnant mice in the control group were left to go through normal pregnancy and their cytokine profile evaluated over the three trimesters of pregnancy. Cytokines in serum samples were analyzed by Cytometric Bead Array. The data was analyzed using the Paired T- test and p Brucella abortus cannot cause spontaneous abortion by altering the mouse cytokine profile towards Th1 in pregnancy. Elevated IL-4 levels with corresponding suppression of IFN-γ can be used as a marker for successful pregnancy in Brucellosis. PMID:25566611

  9. Pseudorabies Virus and Brucella abortus from an Expanding Wild Pig ( Sus scrofa ) Population in Southern Oklahoma, USA.

    Gaskamp, Joshua A; Gee, Kenneth L; Campbell, Tyler A; Silvy, Nova J; Webb, Stephen L

    2016-04-28

    Wild pigs ( Sus scrofa ) are causing increasing ecologic and economic damage at a global scale. Because wild pigs can carry ≥65 diseases that affect livestock, their widespread expansion threatens native wildlife and livestock. We screened wild pigs from south-central Oklahoma, US for antibodies against Brucella abortus , pseudorabies virus (PRV), and porcine reproductive and respiratory syndrome virus (PRRS). These pathogens were chosen because they are part of eradication programs in the US and could have large economic impacts on domestic livestock if transmitted from wild animals. We tested 282 serum samples during spring 2010 (n=149) and 2011 (n=133) and found an overall exposure rate to PRV of 24.1% (n=68); PRV was detected at two of three study sites. Two wild pigs had detectable antibody to B. abortus , and one had detectable antibody to PRRS. On average, 27% of wild pigs within a sounder were positive for PRV antibody, with 44% of the sounders (16/36) having at least one positive individual. These data highlight that wild pigs could carry pathogens that affect domestic livestock. Because the US is free of these pathogens in commercial livestock operations, continued surveillance and vaccination of domestic livestock are needed. Commercial livestock producers at the wildlife-livestock interface may benefit from spatial prioritization of risk zones to facilitate strategic control efforts. PMID:27124329

  10. Summary of field trials using the direct and competitive enzyme immunoassays for detection of antibody to brucella abortus

    Two indirect and two competitive enzyme immunoassays for detection of antibody to Brucella abortus, validated elsewhere, were field tested in five different Latin American laboratories. Testing was performed according to standardised protocols using sera obtained in each area. Sera from B. abortus infected herds, from vaccinated (but serologically negative in a screening test) and non-vaccinated cattle were tested in each assay and compared to the results obtained with conventional diagnostic tests used for diagnosis of brucellosis in each country. Relative sensitivity and specificity values were calculated for each country as well as a weighted summary combining the data from all the participating laboratories. The result demonstrate that all ELISAs performed as well as, or better than, the conventional aerological tests. Given the inherent errors in the use of the latter in the diagnosis of brucellosis, it is recommended that the ELISAs described here be considered as replacements for the conventional tests. The CELISA using the lipopolysaccharide antigen with the competing monoclonal antibody M84, should be considered as the most useful because of cross-species and vaccination considerations. (author)

  11. Recomendación sobre la vacuna contra la tosferina para los bebés y niños pequeños (Whooping Cough Vaccine Recommendation for Babies and Young Children)

    2015-04-13

    Este podcast proporciona información acerca de la tosferina y la recomendación de que todos los niños reciban la vacuna DTaP según el calendario recomendado por los CDC para ayudar a protegerlos contra esta grave enfermedad.  Created: 4/13/2015 by National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD), Meningitis and Vaccine Preventable Diseases Branch (MVPDB).   Date Released: 4/13/2015.

  12. Modelo matemático predictivo del crecimiento de Escherichia coli O157 en carne vacuna Mathematical model to predict the growth of Escherichia coli O157 in beef

    M.L. Signorini

    2008-01-01

    El objetivo del estudio fue modelar el crecimiento microbiano de Escherichia coli O157 en carne vacuna (hamburguesas) como parte de una evaluación cuantitativa de riesgos. Se seleccionaron artículos científicos que exponían de manera completa modelos predictivos de crecimiento del patógeno en carne en función de la temperatura y dos modelos predictivos terciarios. A partir de éstos se generaron datos sobre el tiempo de latencia (ë) y tasa de crecimiento (μ) en un rango de temperaturas (5...

  13. VACUNAS CONTRA EL HERPESVIRUS BOVINO-1: UNA MIRADA DESDE EL PASADO HACIA EL FUTURO DE LA INMUNIZACIÓN Bovine Herpesvirus-1 Vaccine’s: A Look From The Past To The Immunization Future

    JULIÁN RUIZ-SAENZ

    Full Text Available El herpesvirus Bovino-1 (BHV-1 es uno de los principales patógenos que afecta el ganado; la infección primaria se acompaña de varias manifestaciones clínicas tales como la rinotraqueitis, aborto, vulvovaginitis/balanopostitis pustular y en algunos casos, enfermedad neurológica. Luego de la recuperación, la infección persiste durante toda la vida del individuo en un estado de latencia en ganglios nervioso trigémino o sacro. La Organización Mundial de Sanidad Animal (OIE reporta que la vacunación contra el BHV-1 puede ser efectiva en reducir las manifestaciones clínicas y en consecuencia las pérdidas económicas, pero no logra proteger completamente de la infección. Es por esto que durante los últimos años se han desarrollado gran cantidad de agentes vacunales que van desde las vacunas clásicas inactivadas hasta aquellas que usan tecnología de DNA recombinante. El presente artículo se enfoca en presentar una actualización acerca de las vacunas más usadas desde hace ya varios años y resumir los avances más importantes en la generación de nuevas vacunas contra el BHV-1; tratando así de abrir un nuevo panorama para la generación de vacunas en Colombia.Bovine herpesvirus-1 is one of the most important pathogens of cattle; the primary infection is characterized by clinical manifestations such as infectious bovine rhinotracheitis, abortion, infectious pustular vulvovaginitis and in some cases, neurological signs. After recovering, the virus establishes viral latency in sensory neurons of trigeminal or sacral ganglia. The World Organization for Animal Health (OIE reports that vaccination against BHV-1 could be useful to reduce the clinical manifestations and in consequence the economic looses, but it can not protect against the infection. Therefore, a huge amount of vaccines have been developed that includes from classic inactivation to recombinant DNA technologies. This paper makes an updated review about the most used vaccines

  14. Isabel Morgan y el grupo de investigación sobre vacunas de la Universidad Johns Hopkins (1940-1960): un modelo de análisis de la trayectoria de una mujer en el mundo de la ciencia

    Ballester Añón, Rosa

    2007-01-01

    La historia acerca de la presencia y características de las mujeres en los ámbitos de la ciencia y la tecnología son analizados en este trabajo recurriendo a un estudio de casos: el de la investigadora norteamericana Isabel Morgan, quien participó activamente en los trabajos de laboratorio llevados a cabo para encontrar una vacuna eficaz contra la poliomielitis. Sus contribuciones fueron fundamentales pero su carrera científica quedó truncada y fueron otros los que obtuviero...

  15. Estudio histopatológico entre ratones infectados con Salmonella typhi sin vacunar y vacunados por diferentes vías con las vacunas polisacarídica y de células enteras

    Juan F. Infante

    2000-12-01

    Full Text Available La fiebre tifoidea constituye una enfermedad propia del hombre. La misma es causada por Salmonella typhi y produce una respuesta inflamatoria en el tracto intestinal. Con el fin de establecer su control por vacunación el Instituto Finlay ha desarrollado una vacuna a partir del polisacárido capsular Vi. Para su estudio experimental no existe un modelo animal que reproduzca los síntomas y la patogenia de la enfermedad. El desarrollo de modelos experimentales y los estudios histopatológicos aportan informaciones al conocimiento de la enfermedad y a la interpretación de los procesos inmunológicos. Nos propusimos caracterizar el cuadro histopatológico en los ratones utilizados en las pruebas de potencia de la vacuna antitifoídica basada en polisacárido Vi purificado y su comparación con la vacuna de células enteras. Se utilizaron 240 ratones de ambos sexos pertenecientes a la línea C57BL/6 procedentes del Centro Nacional para la Producción de Animales de Laboratorio (CENPALAB, con un peso comprendido entre 18 y 22 g. Se evaluó la protección comparativa entre las vías intraperitoneal y subcutánea utilizando dos inmunógenos, a partir del polisacárido Vi y con la variante de células enteras. Se logró una considerable eficacia en ratón C57BL/6 para reproducir las lesiones compatibles con Salmonella typhi en hígado y bazo. La sobrevivencia del grupo no vacunado fue de un 15%. La sobrevivencia de los ratones correspondientes al grupo vacunado con polisacárido Vi osciló entre 90% y 100% para ambas vías, mientras que los vacunados con células enteras variaron entre 50% y 100% para la vía subcutánea y entre 60% y 100% para la vía intraperitoneal todo lo cual evidencia la superioridad de la vacuna a partir del polisacárido capsular Vi sobre la variante de células enteras en la especie ratón C57BL/6

  16. ESTRUCTURA MOLECULAR Y ANTIGÉNICA DE LA VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO 16 (VPH 16 Antigenic and Molecular Structure of Human Papillomavirus (HPV 16 Vaccine

    VÍCTOR ANDRÉS VANEGAS

    Full Text Available La proteína L1 del Virus del Papiloma Humano (VPH constituye el 80% de la cápside viral. Las vacunas profilácticas contra el VPH son sintetizadas a partir de la proteína L1 ensamblada en Partículas similares al Virus (del inglés VLP, las cuales son altamente inmunogénicas generando anticuerpos específicos de tipo y en algunos casos pueden presentar reacción cruzada entre tipos de VPH filogenéticamente próximos. La estructura de la proteína L1 del VPH es importante porque confiere estabilidad a la cápside mediante el establecimiento de interacciones intra e intercapsoméricas lo que asegura la integridad viral y antigénicamente porque contiene los epítopes que inducen la respuesta inmune protectora. En estudios en los que se evaluó la antigenicidad de la proteína L1 se determinó que los epítopes inmunodominantes de la cápside viral se encuentran en los bucles B-C, D-E, F-G, H-I y en el extremo C-terminal. Estos bucles son poco conservados entre los diferentes genotipos y se encuentran en segmentos de la proteína expuestos en la superficie de la cápside. Los aminoácidos situados en los bucles B-C, F-G y H-I son primordiales para el reconocimiento por los anticuerpos neutralizantes. Los diferentes subtipos y variantes presentan cambios en estos aminoácidos o en residuos que conforman otros epítopes. En esta revisión se presentará un estado del arte de la proteína L1 del VPH genotipo 16, la estructura y su importancia en el desarrollo de vacunas contra la infección producida por este virus.Human Papillomavirus L1 protein makes up 80% of the viral capsid and self assembles in Virus-like Particles (VLP; these particles are immunogenic, generate type-specific antibodies and can induce very limited cross-reactivity among highly homologous HPV types. In addition to its structural function, it confers the stability to the capsid by establishing disulfide bonds and other intra and intercapsomeric interactions, and also contains

  17. Efecto de una vacuna anticoccidial sobre parámetros fisiológicos e inmunológicos de pollos de engorda

    Marco Antonio Juárez Estrada

    2007-01-01

    Full Text Available Se evaluó el efecto de una vacuna anticoccidial en pollos de engorda desafi ados al día 21 de edad con 6.0 x 104 E. acervulina; 5.0 x 103 E. maxima y 4.0 x 104 E. tenella ooquistes esporulados/ave. De manera aleatoria se asignaron 20 aves de un día de edad a cada uno de cuatro grupos: 1 testigo no vacunado, no desafi ado (NVND; 2 testigo no vacunado, desafi ado (NVD; 3 vacunado desafi ado (VD; y 4 vacunado no desafi ado (VND. Las aves se pesaron semanalmente. A los siete días posdesafío (PD se observó la ganancia porcentual de peso (GPP, el pH intestinal, el peso total del intestino (PTI, la concentración intestinal de IgA (CIIgA, el grado de severidad de las lesiones (GSL, la eliminación de ooquistes (EOH y el porcentaje de la especie específi ca de coccidia (PEEC en heces. A los días 14 y 26 se midió la velocidad de tránsito gástrico (VTG. Al día 21, el peso del grupo VD (544.8 ± 105 y VND (504.9 ± 88 fueron menores (P < 0.05 al grupo NVND (615.6 ± 100. Al día 28, el grupo NVND fue el más pesado (923.3 ± 126 y con mayor GPP (49.97%. El grupo NVD obtuvo la menor GPP (24.60% y al día 26 la menor VTG (212.4 ± 31, diferente (P < 0.05 al grupo VND con 43.81% de GPP y 158.4 ±52 de VTG. Los grupos no fueron diferentes en pH y PTI. El grupo NVND presentó la menor CIIgA en sacos ciegos. El grupo NVD mostró el mayor GSL, el NVND y el VND, el menor; el grupo VD presentó mayor GSL de E. maxima y E. tenella que los grupos NVND y VND. Al día 28, el grupo NVD mostró la mayor EOH, el VD tuvo mayor EOH que los grupos NVND y VND. A los siete días PD, el PEEC para E. acervulina del grupo VD fue menor al grupo NVND y VND, aun cuando el PEEC para E. maxima y E. tenella se incrementó. Con la fi nalidad de entender las diferencias antigénicas, debe efectuarse la caracterización molecular de las cepas de campo y compararse con las vacunas comerciales.

  18. Early Transcriptional Responses of Bovine Chorioallantoic Membrane Explants to Wild Type, ΔvirB2 or ΔbtpB Brucella abortus Infection

    Mol, Juliana P. S.; Costa, Erica A.; Carvalho, Alex F.; Sun, Yao-Hui; Tsolis, Reneé M.; Paixão, Tatiane A.; Santos, Renato L.

    2014-01-01

    The pathogenesis of the Brucella-induced inflammatory response in the bovine placenta is not completely understood. In this study we evaluated the role of the B. abortus Type IV secretion system and the anti-inflammatory factor BtpB in early interactions with bovine placental tissues. Transcription profiles of chorioallantoic membrane (CAM) explants inoculated with wild type (strain 2308), ΔvirB2 or ΔbtpB Brucella abortus were compared by microarray analysis at 4 hours post infection. Transcripts with significant variation (>2 fold change; P<0.05) were functionally classified, and transcripts related to defense and inflammation were assessed by quantitative real time RT-PCR. Infection with wild type B. abortus resulted in slightly more genes with decreased than increased transcription levels. Conversely, infection of trophoblastic cells with the ΔvirB2 or the ΔbtpB mutant strains, that lack a functional T4SS or that has impaired inhibition of TLR signaling, respectively, induced more upregulated than downregulated genes. Wild type Brucella abortus impaired transcription of host genes related to immune response when compared to ΔvirB and ΔbtpB mutants. Our findings suggest that proinflammatory genes are negatively modulated in bovine trophoblastic cells at early stages of infection. The virB operon and btpB are directly or indirectly related to modulation of these host genes. These results shed light on the early interactions between B. abortus and placental tissue that ultimately culminate in inflammatory pathology and abortion. PMID:25259715

  19. Early transcriptional responses of bovine chorioallantoic membrane explants to wild type, ΔvirB2 or ΔbtpB Brucella abortus infection.

    Juliana P S Mol

    Full Text Available The pathogenesis of the Brucella-induced inflammatory response in the bovine placenta is not completely understood. In this study we evaluated the role of the B. abortus Type IV secretion system and the anti-inflammatory factor BtpB in early interactions with bovine placental tissues. Transcription profiles of chorioallantoic membrane (CAM explants inoculated with wild type (strain 2308, ΔvirB2 or ΔbtpB Brucella abortus were compared by microarray analysis at 4 hours post infection. Transcripts with significant variation (>2 fold change; P<0.05 were functionally classified, and transcripts related to defense and inflammation were assessed by quantitative real time RT-PCR. Infection with wild type B. abortus resulted in slightly more genes with decreased than increased transcription levels. Conversely, infection of trophoblastic cells with the ΔvirB2 or the ΔbtpB mutant strains, that lack a functional T4SS or that has impaired inhibition of TLR signaling, respectively, induced more upregulated than downregulated genes. Wild type Brucella abortus impaired transcription of host genes related to immune response when compared to ΔvirB and ΔbtpB mutants. Our findings suggest that proinflammatory genes are negatively modulated in bovine trophoblastic cells at early stages of infection. The virB operon and btpB are directly or indirectly related to modulation of these host genes. These results shed light on the early interactions between B. abortus and placental tissue that ultimately culminate in inflammatory pathology and abortion.

  20. Serological response to an indirect and a competitive elisa in heifers vaccinated with Brucella abortus strain 19

    The different serologic techniques for bovine brucellosis diagnosis have different abilities to detect antibodies after vaccination with Brucella abortus strain 19. The humoral response in heifers vaccinated with Brucella abortus strain 19 was evaluated by using several serologic techniques. In the experimental field of INTA, Pilcaniyeu, Rio Negro province, sixteen 5 months old heifers were vaccinated subcutaneously with a standard dose (2ml, containing 20x109 to 10x109 living organisms) of Brucella abortus strain 19. Sera from all the heifers were obtained on 18 occasions (one 87 days before vaccination, one immediately before vaccination and on 16 occasions after vaccination, during 488 days) and analyzed by buffered plate antigen test, rose bengal test, standard tube agglutination test, 2-mercaptoetanol test, complement fixation test, indirect ELISA, and competitive ELISA. Prior vaccination, 100% of the heifers gave negative results in all the techniques used, while 100% of them gave positive reaction in the first sampling after vaccination to all the techniques, with the exception of standard tube agglutination test that showed agglutinating titters of 1/100 or higher (positive threshold) in only 71.4% of the heifers. The indirect ELISA technique showed a reducing percentage of positive animals up until 316 days after vaccination, after which positive results were obtained. The competitive ELISA gave positive results in a variable number of heifers up to 253 days after vaccination when 100% of the sera were negative to this technique. Buffered plate antigen test was the technique that gave positive results for a longest period, being 100% of the animals negative to this technique at 450 days after vaccination. The other serological techniques assayed gave positive results during variable periods of time, intermediate between standard tube agglutination test and buffered plate antigen test. Although the present results were obtained from a limited number of

  1. Vacunas:: progresos y nuevos retos para el control de enfermedades prevenibles VACINAS:: PROGRESSOS E NOVOS DESAFIOS PARA O CONTROLE DE DOENÇAS IMUNOPREVENÍVEIS Vaccines:: Progress and Challenges for the Control of Preventable Diseases

    EDUARDO FONSECA PINTO

    Full Text Available Desde hace más de 200 años la vacunación ha sido una herramienta efectiva en la prevención de enfermedades infecciosas junto con el saneamiento ambiental. El efecto práctico de la vacunación puede ser considerado como el mayor beneficio para la salud pública del siglo XX. Sin embargo, el desarrollo de vacunas sigue siendo un objetivo importante en inmunología y en la última década ha habido un cambio hacia un enfoque más racional, basada en los hallazgos moleculares de patogenia microbiana, el uso de nuevas tecnologías recombinantes y el desarrollo de sistemas de suministro de las vacunas más eficaces. En este trabajo se describen los progresos en el desarrollo de vacunas, partiendo de los primeros informes de prácticas de vacunación, hasta el estado actual del desarrollo de vacunas, las nuevas estrategias de vacunas y el impacto de la vacunación en el control de enfermedades prevenibles.Há mais de 200 anos a vacinação tem sido uma ferramenta muito efetiva na prevenção de doenças infecciosas e juntamente com o saneamento básico, o efeito prático da vacinação pode ser considerado o maior benefício à saúde pública do século XX. No entanto, o desenvolvimento de vacinas permanece um objetivo importante no campo da imunologia e na última década observa-se uma mudança em direção a uma abordagem mais racional, baseada em uma compreensão molecular da patogenicidade microbiana, na utilização de novas tecnologias recombinantes e no desenvolvimento de sistemas de liberação de vacinas mais efetivos. Este trabalho descreve o progresso no desenvolvimento de vacinas a partir dos primeiros relatos das práticas de vacinação, passando pelo estado atual de desenvolvimento de vacinas, pelas novas estratégias vacinais e pelo impacto da vacinação no controle das doenças imunopreveníveis.For over 200 years, vaccination has been a very effective tool to prevent infectious diseases along with sanitation. In practical

  2. Diagnóstico sorológico da brucelose bovina em animais adultos vacinados com dose reduzida da cepa 19 de Brucella abortus Serological diagnosis of bovine brucellosis in adult herd vaccinated with Brucella abortus strain 19 reduced dose

    Gustavo Coelho Jardim

    2006-09-01

    Full Text Available Com o presente trabalho avaliou-se o uso de dose reduzida da vacina produzida com a amostra 19 de Brucella abortus, em rebanho adulto negativo para a enfermidade, por meio de técnicas de diagnóstico sorológico preconizadas pelo Programa Nacional de Controle e Erradicação da Brucelose e Tuberculose Animal e por um ensaio indireto de imunoadsorção enzimática (ELISA ID. A prova de fixação de complemento detectou 46,77% de positivos, o antígeno acidificado tamponado 67,74%, o 2-mercaptoetanol com soroaglutinação lenta 87,09% e o ELISA ID 100%. A dose reduzida interferiu no diagnóstico sorológico. Nenhuma das técnicas apresentou especificidade adequada para uso em rebanho nestas condições, até 3 meses após a vacinação.The study evaluated the use of a reduced dose of the Brucella abortus strain 19 vaccine, in an adult herd negative for the disease, by serological diagnostic techniques, advocated by the Brazilian Program for Animal Brucellosis and Tuberculosis Control and Eradication, and by an indirect ELISA. The complement fixation test detecteed 46.77% positives, the rose bengal test 67.74%, the mercaptoethanol with standard agglutination test 87.09% and the ELISA ID 100%. The reduced dose influenced the serological diagnosis. None of the techniques reached a suitable specificity for use in the herd under those conditions, up to 3 months after vaccination.

  3. Crystallographic and kinetic study of riboflavin synthase from Brucella abortus, a chemotherapeutic target with an enhanced intrinsic flexibility

    This work reports crystal structures of trimeric riboflavin synthase from the pathogen B. abortus both as the apo protein and in complex with several ligands of interest. It is shown that ligand binding drives the assembly of the unique active site of the trimer, and these findings are complemented by a detailed kinetic study on this enzyme, in which marked inhibition by substrate and product was observed. Riboflavin synthase (RS) catalyzes the last step of riboflavin biosynthesis in microorganisms and plants, which corresponds to the dismutation of two molecules of 6,7-dimethyl-8-ribityllumazine to yield one molecule of riboflavin and one molecule of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione. Owing to the absence of this enzyme in animals and the fact that most pathogenic bacteria show a strict dependence on riboflavin biosynthesis, RS has been proposed as a potential target for antimicrobial drug development. Eubacterial, fungal and plant RSs assemble as homotrimers lacking C3 symmetry. Each monomer can bind two substrate molecules, yet there is only one active site for the whole enzyme, which is located at the interface between two neighbouring chains. This work reports the crystallographic structure of RS from the pathogenic bacterium Brucella abortus (the aetiological agent of the disease brucellosis) in its apo form, in complex with riboflavin and in complex with two different product analogues, being the first time that the structure of an intact RS trimer with bound ligands has been solved. These crystal models support the hypothesis of enhanced flexibility in the particle and also highlight the role of the ligands in assembling the unique active site. Kinetic and binding studies were also performed to complement these findings. The structural and biochemical information generated may be useful for the rational design of novel RS inhibitors with antimicrobial activity

  4. Crystallographic and kinetic study of riboflavin synthase from Brucella abortus, a chemotherapeutic target with an enhanced intrinsic flexibility

    Serer, María I.; Bonomi, Hernán R. [IIBBA–CONICET, Avenida Patricias Argentinas 435, C1405BWE Buenos Aires (Argentina); Guimarães, Beatriz G. [Synchrotron SOLEIL, L’Orme des Merisiers, Saint-Aubin BP 48, 91192 Gif-sur-Yvette CEDEX (France); Rossi, Rolando C. [Universidad de Buenos Aires, Junín 956, C1113AAD Buenos Aires (Argentina); Goldbaum, Fernando A.; Klinke, Sebastián, E-mail: sklinke@leloir.org.ar [IIBBA–CONICET, Avenida Patricias Argentinas 435, C1405BWE Buenos Aires (Argentina)

    2014-05-01

    This work reports crystal structures of trimeric riboflavin synthase from the pathogen B. abortus both as the apo protein and in complex with several ligands of interest. It is shown that ligand binding drives the assembly of the unique active site of the trimer, and these findings are complemented by a detailed kinetic study on this enzyme, in which marked inhibition by substrate and product was observed. Riboflavin synthase (RS) catalyzes the last step of riboflavin biosynthesis in microorganisms and plants, which corresponds to the dismutation of two molecules of 6,7-dimethyl-8-ribityllumazine to yield one molecule of riboflavin and one molecule of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione. Owing to the absence of this enzyme in animals and the fact that most pathogenic bacteria show a strict dependence on riboflavin biosynthesis, RS has been proposed as a potential target for antimicrobial drug development. Eubacterial, fungal and plant RSs assemble as homotrimers lacking C{sub 3} symmetry. Each monomer can bind two substrate molecules, yet there is only one active site for the whole enzyme, which is located at the interface between two neighbouring chains. This work reports the crystallographic structure of RS from the pathogenic bacterium Brucella abortus (the aetiological agent of the disease brucellosis) in its apo form, in complex with riboflavin and in complex with two different product analogues, being the first time that the structure of an intact RS trimer with bound ligands has been solved. These crystal models support the hypothesis of enhanced flexibility in the particle and also highlight the role of the ligands in assembling the unique active site. Kinetic and binding studies were also performed to complement these findings. The structural and biochemical information generated may be useful for the rational design of novel RS inhibitors with antimicrobial activity.

  5. Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice.

    Lacerda, Thaís Lourdes Santos; Cardoso, Patrícia Gomes; Augusto de Almeida, Leonardo; Camargo, Ilana Lopes Baratella da Cunha; Afonso, Daniela Almeida Freitas; Trant, Cyntia Cardoso; Macedo, Gilson Costa; Campos, Eleonora; Cravero, Silvio L; Salcedo, Suzana P; Gorvel, Jean-Pierre; Oliveira, Sérgio Costa

    2010-08-01

    Rough mutants of Brucella abortus were generated by disruption of wbkC gene which encodes the formyltransferase enzyme involved in LPS biosynthesis. In bone marrow-derived macrophages the B. abortusDeltawbkC mutants were attenuated, could not reach a replicative niche and induced higher levels of IL-12 and TNF-alpha when compared to parental smooth strains. Additionally, mutants exhibited attenuation in vivo in C57BL/6 and interferon regulatory factor-1 knockout mice. DeltawbkC mutant strains induced lower protective immunity in C56BL/6 than smooth vaccine S19 but similar to rough vaccine RB51. Finally, we demonstrated that Brucella wbkC is critical for LPS biosynthesis and full bacterial virulence. PMID:20580469

  6. Real-time PCR Detection of Brucella Abortus: A Comparative Study of SYBR Green I, 5'-exonuclease, and Hybridization Probe Assays

    Newby, Deborah Trishelle; Hadfield, Ted; Roberto, Francisco Figueroa

    2003-08-01

    Real-time PCR provides a means of detecting and quantifying DNA targets by monitoring PCR product accumulation during cycling as indicated by increased fluorescence. A number of different approaches can be used to generate the fluorescence signal. Three approaches—SYBR Green I (a double-stranded DNA intercalating dye), 5'-exonuclease (enzymatically released fluors), and hybridization probes (fluorescence resonance energy transfer)—were evaluated for use in a real-time PCR assay to detect Brucella abortus. The three assays utilized the same amplification primers to produce an identical amplicon. This amplicon spans a region of the B. abortus genome that includes portions of the alkB gene and the IS711 insertion element. All three assays were of comparable sensitivity, providing a linear assay over 7 orders of magnitude (from 7.5 ng down to 7.5 fg). However, the greatest specificity was achieved with the hybridization probe assay.

  7. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.

    Neha Dabral

    Full Text Available Brucella spp. are Gram-negative, facultative intracellular coccobacilli that cause one of the most frequently encountered zoonosis worldwide. Humans naturally acquire infection through consumption of contaminated dairy and meat products and through direct exposure to aborted animal tissues and fluids. No vaccine against brucellosis is available for use in humans. In this study, we tested the ability of orally inoculated gamma-irradiated B. neotomae and B. abortus RB51 in a prime-boost immunization approach to induce antigen-specific humoral and cell mediated immunity and protection against challenge with virulent B. abortus 2308. Heterologous prime-boost vaccination with B. abortus RB51 and B. neotomae and homologous prime-boost vaccination of mice with B. neotomae led to the production of serum and mucosal antibodies specific to the smooth LPS. The elicited serum antibodies included the isotypes of IgM, IgG1, IgG2a, IgG2b and IgG3. All oral vaccination regimens induced antigen-specific CD4(+ and CD8(+ T cells capable of secreting IFN-γ and TNF-α. Upon intra-peritoneal challenge, mice vaccinated with B. neotomae showed the highest level of resistance against virulent B. abortus 2308 colonization in spleen and liver. Experiments with different doses of B. neotomae showed that all tested doses of 10(9, 10(10 and 10(11 CFU-equivalent conferred significant protection against the intra-peritoneal challenge. However, a dose of 10(11 CFU-equivalent of B. neotomae was required for affording protection against intranasal challenge as shown by the reduced bacterial colonization in spleens and lungs. Taken together, these results demonstrate the feasibility of using gamma-irradiated B. neotomae as an effective and safe oral vaccine to induce protection against respiratory and systemic infections with virulent Brucella.

  8. Oral Immunization of Mice with Gamma-Irradiated Brucella neotomae Induces Protection against Intraperitoneal and Intranasal Challenge with Virulent B. abortus 2308

    Dabral, Neha; Martha-Moreno-Lafont,; Sriranganathan, Nammalwar; Vemulapalli, Ramesh

    2014-01-01

    Brucella spp. are Gram-negative, facultative intracellular coccobacilli that cause one of the most frequently encountered zoonosis worldwide. Humans naturally acquire infection through consumption of contaminated dairy and meat products and through direct exposure to aborted animal tissues and fluids. No vaccine against brucellosis is available for use in humans. In this study, we tested the ability of orally inoculated gamma-irradiated B. neotomae and B. abortus RB51 in a prime-boost immuniz...

  9. Characterization of the heat shock response in Brucella abortus and isolation of the genes encoding the GroE heat shock proteins.

    Lin, J.; Adams, L G; Ficht, T A

    1992-01-01

    In an effort to define the heat shock response in the bovine intracellular pathogen Brucella abortus, a rough variant lacking extensive lipopolysaccharide was pulse-labeled with [35S]methionine following exposure to elevated temperatures. The major heat shock proteins observed following sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography migrate at 70, 62, 18, and 10 kDa. The maximum response was observed between 42 and 46 degrees C and within 2 to 3 h of the shif in...

  10. Validation of the Abbreviated Brucella AMOS PCR as a Rapid Screening Method for Differentiation of Brucella abortus Field Strain Isolates and the Vaccine Strains, 19 and RB51

    Ewalt, Darla R; Bricker, Betsy J.

    2000-01-01

    The Brucella AMOS PCR assay was previously developed to identify and differentiate specific Brucella species. In this study, an abbreviated Brucella AMOS PCR test was evaluated to determine its accuracy in differentiating Brucella abortus into three categories: field strains, vaccine strain 19 (S19), and vaccine strain RB51/parent strain 2308 (S2308). Two hundred thirty-one isolates were identified and tested by the conventional biochemical tests and Brucella AMOS PCR. This included 120 isola...

  11. The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23

    Mario Weinhold; Martin Eisenblätter; Edith Jasny; Michael Fehlings; Antje Finke; Hermine Gayum; Ursula Rüschendorf; Pablo Renner Viveros; Verena Moos; Kristina Allers; Thomas Schneider; Schaible, Ulrich E; Schumann, Ralf R.; Martin E Mielke; Ralf Ignatius

    2013-01-01

    Background: Bacterial vectors have been proposed as novel vaccine strategies to induce strong cellular immunity. Attenuated strains of Brucella abortus comprise promising vector candidates since they have the potential to induce strong CD4+ and CD8+ T-cell mediated immune responses in the absence of excessive inflammation as observed with other Gram-negative bacteria. However, some Brucella strains interfere with the maturation of dendritic cells (DCs), which is essential for antigen-speci...

  12. Potential Role of Fibroblast-Like Synoviocytes in Joint Damage Induced by Brucella abortus Infection through Production and Induction of Matrix Metalloproteinases ▿

    Scian, Romina; Barrionuevo, Paula; Giambartolomei, Guillermo H.; De Simone, Emilio A.; Silvia I. Vanzulli; Fossati, Carlos A.; Baldi, Pablo C.; Delpino, M. Victoria

    2011-01-01

    Arthritis is one of the most common complications of human brucellosis, but its pathogenic mechanisms have not been elucidated. Fibroblast-like synoviocytes (FLS) are known to be central mediators of joint damage in inflammatory arthritides through the production of matrix metalloproteinases (MMPs) that degrade collagen and of cytokines and chemokines that mediate the recruitment and activation of leukocytes. In this study we show that Brucella abortus infects and replicates in human FLS (SW9...

  13. virB-Mediated Survival of Brucella abortus in Mice and Macrophages Is Independent of a Functional Inducible Nitric Oxide Synthase or NADPH Oxidase in Macrophages

    Sun, Yao-Hui; den Hartigh, Andreas B.; de Lima Santos, Renato; Adams, L. Garry; Tsolis, Renée M.

    2002-01-01

    The Brucella abortus virB locus is required for establishing chronic infection in the mouse. Using in vitro and in vivo models, we investigated whether virB is involved in evasion of the bactericidal activity of NADPH oxidase and the inducible nitric oxide synthase (iNOS) in macrophages. Elimination of NADPH oxidase or iNOS activity in macrophages in vitro increased recovery of wild-type B. abortus but not recovery of a virB mutant. In mice lacking either NADPH oxidase or iNOS, however, B. abortus infected and persisted to the same extent as it did in congenic C57BL/6 mice up until 60 days postinfection, suggesting that these host defense mechanisms are not critical for limiting bacterial growth in the mouse. A virB mutant did not exhibit increased survival in either of the knockout mouse strains, indicating that this locus does not contribute to evasion of nitrosative or oxidative killing mechanisms in vivo. PMID:12183526

  14. Expression of MPB83 from Mycobacterium bovis in Brucella abortus S19 induces specific cellular immune response against the recombinant antigen in BALB/c mice.

    Sabio y García, Julia V; Bigi, Fabiana; Rossetti, Osvaldo; Campos, Eleonora

    2010-12-01

    Immunodominant MPB83 antigen from Mycobacterium bovis was expressed as a chimeric protein fused to either β-galactosidase, outer membrane lipoprotein OMP19 or periplasmic protein BP26 in gram-negative Brucella abortus S19, in all cases driven by each gene's own promoter. All fusion proteins were successfully expressed and localized in the expected subcellular fraction. Moreover, OMP19-MPB83 was processed as a lipoprotein when expressed in B. abortus. Splenocytes from BALB/c mice immunized with the recombinant S19 strains carrying the genes coding for the heterologous antigens in replicative plasmids, showed equally specific INF-γ production in response to MPB83 stimulation. Association to the lipid moiety of OMP19 presented no advantage in terms of immunogenicity for MPB83. In contrast, fusion to BP26, which was encoded by an integrative plasmid, resulted in a weaker immune response. None of the constructions affected the survival rate or the infection pattern of Brucella. We concluded that B. abortus S19 is an appropriate candidate for the expression of M. bovis antigens both associated to the membrane or cytosolic fraction and may provide the basis for a future combined vaccine for bovine brucellosis and tuberculosis. PMID:20888425

  15. MLVA genotyping of Brucella melitensis and Brucella abortus isolates from different animal species and humans and identification of Brucella suis vaccine strain S2 from cattle in China.

    Hai Jiang

    Full Text Available In China, brucellosis is an endemic disease and the main sources of brucellosis in animals and humans are infected sheep, cattle and swine. Brucella melitensis (biovars 1 and 3 is the predominant species, associated with sporadic cases and outbreak in humans. Isolates of B. abortus, primarily biovars 1 and 3, and B. suis biovars 1 and 3 are also associated with sporadic human brucellosis. In this study, the genetic profiles of B. melitensis and B. abortus isolates from humans and animals were analyzed and compared by multi-locus variable-number tandem-repeat analysis (MLVA. Among the B. melitensis isolates, the majority (74/82 belonged to MLVA8 genotype 42, clustering in the 'East Mediterranean' group. Two B. melitensis biovar 1 genotype 47 isolates, belonging to the 'Americas' group, were recovered; both were from the Himalayan blue sheep (Pseudois nayaur, a wild animal. The majority of B. abortus isolates (51/70 were biovar 3, genotype 36. Ten B. suis biovar 1 field isolates, including seven outbreak isolates recovered from a cattle farm in Inner Mongolia, were genetically indistinguishable from the vaccine strain S2, based on MLVA cluster analysis. MLVA analysis provided important information for epidemiological trace-back. To the best of our knowledge, this is the first report to associate Brucella cross-infection with the vaccine strain S2 based on molecular comparison of recovered isolates to the vaccine strain. MLVA typing could be an essential assay to improve brucellosis surveillance and control programs.

  16. MLVA genotyping of Brucella melitensis and Brucella abortus isolates from different animal species and humans and identification of Brucella suis vaccine strain S2 from cattle in China.

    Jiang, Hai; Wang, Heng; Xu, Liqing; Hu, Guiying; Ma, Junying; Xiao, Pei; Fan, Weixing; Di, Dongdong; Tian, Guozhong; Fan, Mengguang; Mi, Jingchuan; Yu, Ruiping; Song, Litao; Zhao, Hongyan; Piao, Dongri; Cui, Buyun

    2013-01-01

    In China, brucellosis is an endemic disease and the main sources of brucellosis in animals and humans are infected sheep, cattle and swine. Brucella melitensis (biovars 1 and 3) is the predominant species, associated with sporadic cases and outbreak in humans. Isolates of B. abortus, primarily biovars 1 and 3, and B. suis biovars 1 and 3 are also associated with sporadic human brucellosis. In this study, the genetic profiles of B. melitensis and B. abortus isolates from humans and animals were analyzed and compared by multi-locus variable-number tandem-repeat analysis (MLVA). Among the B. melitensis isolates, the majority (74/82) belonged to MLVA8 genotype 42, clustering in the 'East Mediterranean' group. Two B. melitensis biovar 1 genotype 47 isolates, belonging to the 'Americas' group, were recovered; both were from the Himalayan blue sheep (Pseudois nayaur, a wild animal). The majority of B. abortus isolates (51/70) were biovar 3, genotype 36. Ten B. suis biovar 1 field isolates, including seven outbreak isolates recovered from a cattle farm in Inner Mongolia, were genetically indistinguishable from the vaccine strain S2, based on MLVA cluster analysis. MLVA analysis provided important information for epidemiological trace-back. To the best of our knowledge, this is the first report to associate Brucella cross-infection with the vaccine strain S2 based on molecular comparison of recovered isolates to the vaccine strain. MLVA typing could be an essential assay to improve brucellosis surveillance and control programs. PMID:24124546

  17. Anafilaxia associada à vacina contra sarampo, caxumba e rubéola Anafilaxia asociada a la vacuna contra sarampión, varicela y rubéola Anaphylaxis associated with the vaccine against measles, mumps and rubella

    Iolanda Maria Novadzki

    2010-04-01

    Full Text Available Estudo do tipo caso-controle cujo objetivo foi descrever os casos e as causas de anafilaxia associada à vacina contra sarampo, caxumba e rubéola. Foram estudados 22 casos notificados em crianças de Curitiba, PR, durante Campanha Nacional de Vacinação de 2004, que apresentaram manifestações mucocutâneas. Para o controle, foram selecionadas 66 crianças vizinhas dos casos, que não apresentaram sintomatologia após a aplicação vacinal. Foram realizadas dosagens séricas de anticorpos para os antígenos vacinais, IgE total e específicas para diversos alérgenos, e testes cutâneos. A resposta vacinal foi adequada, a dosagem de IgE específica e os testes cutâneos mostraram que os alérgenos potenciais constituintes da vacina e a atopia não foram relacionados às reações anafiláticas. Os testes cutâneos com a vacina e o dextrano foram positivos somente nos casos, sugerindo sensibilização por algum componente residual da vacina e possível reação cruzada com o dextrano.Estudio del tipo caso-control cuyo objetivo fue describir los casos y las causas de anafilaxia asociada a la vacuna contra sarampión, varicela y rubéola. Fueron estudiados 22 casos notificados en niños de Curitiba, Sureste de Brasil, durante Campaña Nacional de Vacunación de 2004, que presentaron manifestaciones mococutáneas. Para el control, fueron seleccionados 66 niños vecinos de los casos, que no presentaron sintomatología posterior a la aplicación vacunal. Fueron realizadas dosificaciones séricas de anticuerpos para los antígenos vacunales, IgE total y específicas para diversos alérgenos, y pruebas cutáneas. La respuesta vacunal fue adecuada, la dosificación de IgE específica y las pruebas cutáneas mostraron que los alérgenos potenciales constituyentes de la vacuna y la atopia no fueron relacionados a las reacciones anafilácticas. Las pruebas cutáneas con la vacuna y el dextrano fueron positivas solamente en los casos, sugiriendo

  18. Estudio comparativo del efecto protector de dos esquemas de inmunización con una vacuna recombinante contra la Hepatitis B en estudiantes del área de ciencias de la salud susceptibles

    L Marocho

    2005-10-01

    Full Text Available Objetivo: Demostrar que el efecto protector contra la Hepatitis B en estudiantes menores de 30 años del área de Ciencias de la Salud susceptibles es similar luego de completar los dos esquemas de vacunación (acortado y convencional en menor tiempo y con menos dosis. Hipotesis: Los 3 esquemas de dosificación en la vacuna contra la hepatitis B generan anticuerpos por encima de 10 ug/100 ml generando igual efecto de protección. Diseño: Analítico, experimental, longitudinal, prospectivo y de cohortes concurrentes. Material y Métodos: Un total de 100 alumnos de ambos sexos de Tecnología Médica de la Facultad de Medicina de la UNMSM susceptibles fueron enrolados, quedaron para el análisis final, 89 alumnos tomando en cuenta los criterios de inclusión y exclusión de acuerdo al objetivo de estudio. Se administró la vacuna a la dosis de 20 ug del antigeno de superficie en 1 mL, en tres esquemas de dosificación; 0, 1, 6 meses, 0,1,2 meses y 0,1 meses y se tomaron muestras de sangre antes y a 1,2, 6 y 7 meses de la primera dosis de vacuna para determinación de anti.HBs. Se definió como seroprotección un valor o = a 10 mUI/mL de anti-HBs. Resultados: en base a los 89 alumnos menores de 30 años, cuya edad promedio fue 23.5 años, siendo el 51.7% (46 del sexo masculino y 48.3% (43 sexo femenino. A los 30 días de la primera dosis el 12.4% alcanzó protección, a los 30 días posterior a la segunda dosis el 98.8% y a los 180 días el 100% de protección. Después de la segunda dosis los tres grupos alcanzaron títulos protectores, y al final del estudio los niveles promedios de anticuerpos estuvieron entre 532.7 mUI/mL y 1237.2 mUI/mL Conclusiones: En el presente estudio se logró alcanzar hasta los 7 meses después de la primera dosis, igual efecto protector contra la Hepatitis B mediante la administración de la vacuna con tres esquemas de vacunación diferentes: esquema convencional de tres dosis (0,1,6 meses, esquema acortado de dos

  19. Lactancia materna y respuesta humoral contra vacunas de toxoide tetánico y diftérico en niños de 2 años

    Deyanira La Rosa; Soamy Montesino; Lenia Bezos; Enrique Gómez; Tania Valmaseda; Alina Alerm; Rolando Ochoa

    2011-01-01

    Teniendo en cuenta que el impacto de la lactancia materna sobre la respuesta a la vacunación es controversial, se evaluó la influencia de la lactancia materna sobre la respuesta humoral a las vacunas con toxoide tetánico y diftérico en niños de 2 años de edad que culminaron la etapa básica de inmunización del esquema de vacunación infantil. Se seleccionaron 44 niños que se diferenciaron en dos grupos de estudios, de acuerdo con el tiempo que fueron amamantados. Para la determinación de las co...

  20. Evaluación productiva de un programa de inyección sin aguja para la administración de vacunas contra Circovirus porcino tipo 2 y Mycoplasma hyopneumoniae en un plantel porcino intensivo tipo destete-venta

    C Gutiérrez

    2015-01-01

    Full Text Available La vacunación contra PCV2 y Mycoplasma hyopneumoniae (M. hyo juega un rol fundamental en la industria porcina global. Nuevas vacunas y metodologías de administración han sido introducidas en los últimos cinco años. El objetivo del presente estudio fue describir bajo condiciones de campo el impacto de dos vacunas monodosis de PCV2 y M. hyo administradas mezcladas mediante una sola inyección con y sin aguja. Durante tres réplicas, tres cohortes de animales de 21 días de edad fueron dividas al azar en tres grupos experimentales para inyección intramuscular: 240 animales (Grupo A fueron vacunados mediante un dispositivo de inyección sin aguja, 240 animales (Grupo B fueron vacunados mediante inyección con aguja y 60 animales controles no vacunados (Grupo C fueron inyectados con suero salino usando agujas. Los animales vacunados tuvieron un mejor rendimiento productivo de destete a venta con hasta 6,6 kg de peso vivo adicional a los grupos de animales no vacunados y una mejora en la GDP de hasta 48 gramos (P < 0,005. Adicionalmente los animales vacunados tuvieron una reducción en la incidencia de inyecciones terapéuticas con cuatro veces menos dosis de fármacos por animal y por ende menor costo de producción por este concepto, así como una reducción en la pérdida de animales por mortalidad y desechos del orden de 1 a 8 puntos porcentuales. Bajo las condiciones del presente estudio la tecnología de inyección sin aguja fue una herramienta tan segura y efectiva como la inyección tradicional. La vacunación mejoró el rendimiento productivo de los animales hasta edad de faena.

  1. Vacuna anti-Ornithodoros erraticus

    Manzano Román, Raúl

    2002-01-01

    169 págs.-- Tesis doctoral de la Facultad de Biología de la Universidad de Salamanca, Departamento de Biología Animal, Ecología, Edafología y Parasitología y del Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA-CSIC).-- Fecha de lectura: 19/07/2002.-- Calificación: Sobresaliente "Cum laude".

  2. Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.

    Dorneles, Elaine M S; Lima, Graciela K; Teixeira-Carvalho, Andréa; Araújo, Márcio S S; Martins-Filho, Olindo A; Sriranganathan, Nammalwar; Al Qublan, Hamzeh; Heinemann, Marcos B; Lage, Andrey P

    2015-01-01

    Brucella abortus S19 and RB51 strains have been successfully used to control bovine brucellosis worldwide; however, currently, most of our understanding of the protective immune response induced by vaccination comes from studies in mice. The aim of this study was to characterize and compare the immune responses induced in cattle prime-immunized with B. abortus S19 or RB51 and revaccinated with RB51. Female calves, aged 4 to 8 months, were vaccinated with either vaccine S19 (0.6-1.2 x 1011 CFU) or RB51 (1.3 x 1010 CFU) on day 0, and revaccinated with RB51 (1.3 x 1010 CFU) on day 365 of the experiment. Characterization of the immune response was performed using serum and peripheral blood mononuclear cells. Blood samples were collected on days 0, 28, 210, 365, 393 and 575 post-immunization. Results showed that S19 and RB51 vaccination induced an immune response characterized by proliferation of CD4+ and CD8+ T-cells; IFN-ɣ and IL-17A production by CD4+ T-cells; cytotoxic CD8+ T-cells; IL-6 secretion; CD4+ and CD8+ memory cells; antibodies of IgG1 class; and expression of the phenotypes of activation in T-cells. However, the immune response stimulated by S19 compared to RB51 showed higher persistency of IFN-ɣ and CD4+ memory cells, induction of CD21+ memory cells and higher secretion of IL-6. After RB51 revaccination, the immune response was chiefly characterized by increase in IFN-ɣ expression, proliferation of antigen-specific CD4+ and CD8+ T-cells, cytotoxic CD8+ T-cells and decrease of IL-6 production in both groups. Nevertheless, a different polarization of the immune response, CD4+- or CD8+-dominant, was observed after the booster with RB51 for S19 and RB51 prime-vaccinated animals, respectively. Our results indicate that after prime vaccination both vaccine strains induce a strong and complex Th1 immune response, although after RB51 revaccination the differences between immune profiles induced by prime-vaccination become accentuated. PMID:26352261

  3. Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51

    Dorneles, Elaine M. S.; Lima, Graciela K.; Teixeira-Carvalho, Andréa; Araújo, Márcio S. S.; Martins-Filho, Olindo A.; Sriranganathan, Nammalwar; Al Qublan, Hamzeh; Heinemann, Marcos B.; Lage, Andrey P.

    2015-01-01

    Brucella abortus S19 and RB51 strains have been successfully used to control bovine brucellosis worldwide; however, currently, most of our understanding of the protective immune response induced by vaccination comes from studies in mice. The aim of this study was to characterize and compare the immune responses induced in cattle prime-immunized with B. abortus S19 or RB51 and revaccinated with RB51. Female calves, aged 4 to 8 months, were vaccinated with either vaccine S19 (0.6–1.2 x 1011 CFU) or RB51 (1.3 x 1010 CFU) on day 0, and revaccinated with RB51 (1.3 x 1010 CFU) on day 365 of the experiment. Characterization of the immune response was performed using serum and peripheral blood mononuclear cells. Blood samples were collected on days 0, 28, 210, 365, 393 and 575 post-immunization. Results showed that S19 and RB51 vaccination induced an immune response characterized by proliferation of CD4+ and CD8+ T-cells; IFN-ɣ and IL-17A production by CD4+ T-cells; cytotoxic CD8+ T-cells; IL-6 secretion; CD4+ and CD8+ memory cells; antibodies of IgG1 class; and expression of the phenotypes of activation in T-cells. However, the immune response stimulated by S19 compared to RB51 showed higher persistency of IFN-ɣ and CD4+ memory cells, induction of CD21+ memory cells and higher secretion of IL-6. After RB51 revaccination, the immune response was chiefly characterized by increase in IFN-ɣ expression, proliferation of antigen-specific CD4+ and CD8+ T-cells, cytotoxic CD8+ T-cells and decrease of IL-6 production in both groups. Nevertheless, a different polarization of the immune response, CD4+- or CD8+-dominant, was observed after the booster with RB51 for S19 and RB51 prime-vaccinated animals, respectively. Our results indicate that after prime vaccination both vaccine strains induce a strong and complex Th1 immune response, although after RB51 revaccination the differences between immune profiles induced by prime-vaccination become accentuated. PMID:26352261

  4. Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.

    Elaine M S Dorneles

    Full Text Available Brucella abortus S19 and RB51 strains have been successfully used to control bovine brucellosis worldwide; however, currently, most of our understanding of the protective immune response induced by vaccination comes from studies in mice. The aim of this study was to characterize and compare the immune responses induced in cattle prime-immunized with B. abortus S19 or RB51 and revaccinated with RB51. Female calves, aged 4 to 8 months, were vaccinated with either vaccine S19 (0.6-1.2 x 1011 CFU or RB51 (1.3 x 1010 CFU on day 0, and revaccinated with RB51 (1.3 x 1010 CFU on day 365 of the experiment. Characterization of the immune response was performed using serum and peripheral blood mononuclear cells. Blood samples were collected on days 0, 28, 210, 365, 393 and 575 post-immunization. Results showed that S19 and RB51 vaccination induced an immune response characterized by proliferation of CD4+ and CD8+ T-cells; IFN-ɣ and IL-17A production by CD4+ T-cells; cytotoxic CD8+ T-cells; IL-6 secretion; CD4+ and CD8+ memory cells; antibodies of IgG1 class; and expression of the phenotypes of activation in T-cells. However, the immune response stimulated by S19 compared to RB51 showed higher persistency of IFN-ɣ and CD4+ memory cells, induction of CD21+ memory cells and higher secretion of IL-6. After RB51 revaccination, the immune response was chiefly characterized by increase in IFN-ɣ expression, proliferation of antigen-specific CD4+ and CD8+ T-cells, cytotoxic CD8+ T-cells and decrease of IL-6 production in both groups. Nevertheless, a different polarization of the immune response, CD4+- or CD8+-dominant, was observed after the booster with RB51 for S19 and RB51 prime-vaccinated animals, respectively. Our results indicate that after prime vaccination both vaccine strains induce a strong and complex Th1 immune response, although after RB51 revaccination the differences between immune profiles induced by prime-vaccination become accentuated.

  5. Valutazione della produzione di gamma interferone in bovini vaccinati con Brucella abortus ceppo RB51 mediante un test ELISA

    Manuela Tittarelli

    2009-06-01

    Full Text Available In questo lavoro sono presentati i risultati di un test ELISA messo a punto per rilevare la produzione di gamma interferone (g-interferone in bovini vaccinati con Brucella abortus ceppo RB51 (RB51. Come stimolo antigenico per il sangue intero è stata utilizzata una frazione proteica purificata derivante da RB51 (brucellina RB51. La prova è stata valutata nell’arco di 300 giorni in 10 manze vaccinate in età prepubere con 10×109 Unità Formanti Colonia di RB51 e in cinque manze di controllo, provenienti da allevamenti ufficialmente indenni da brucellosi bovina. I capi vaccinati hanno cominciato a fornire risultati positivi a partire dal 17° giorno post vaccinazione (p.v. fino al giorno 239 p.v. Tutti i capi vaccinati hanno fornito almeno una volta un risultato positivo (indice di stimolazione, IS, superiore a 2,5. Tuttavia, se si esclude il prelievo al giorno 20 p.v. (90% di animali vaccinati risultati positivi, la sensibilità del test oscilla tra il 20% e il 70%, con una media del 40%. IS superiore a 2,5 è stato rilevato anche in tre animali di controllo. Sulla scorta dei risultati ottenuti, si ritiene che il test del g-interferone non fornisce garanzie sufficienti per consigliarne l’impiego ai fini di riconoscere i bovini vaccinati con RB51, sia come prova individuale, sia come prova d’allevamento.

  6. An ELISA for the evaluation of gamma interferon production in cattle vaccinated with Brucella abortus strain RB51

    Manuela Tittarelli

    2009-06-01

    Full Text Available The results of an enzyme-linked immunosorbent assay (ELISA implemented for the detection of gamma interferon (g-interferon production in cattle vaccinated with Brucella abortus strain RB51 are presented. A purified protein fraction derived from RB51 (RB51 brucellin has been used as antigenic stimulus for whole blood. The test was evaluated for 300 days in ten heifers vaccinated at calfhood with 10 × 109 colony-forming units of RB51 and in five control heifers. All animals came from officially brucellosis-free herds. Vaccinated animals started to give positive results from day 17 post vaccination (pv until day 239 pv. All vaccinated animals gave a positive reaction at least once (with a stimulation index exceeding 2.5. Nevertheless, if sampling on day 20 pv is excluded (90% of vaccinated animals gave positive results, the sensitivity of the test varies from 20% to 70%, with a 40% average. A stimulation index over 2.5 was also recorded in three control animals. The results suggest that the g-interferon test is not suitable for the detection of cattle vaccinated with RB51, either at the individual or at the herd level.

  7. Development of immunochromatographic strip test using fluorescent, micellar silica nanosensors for rapid detection of B. abortus antibodies in milk samples.

    Vyas, Swati S; Jadhav, Sushma V; Majee, Sharmila B; Shastri, Jayanthi S; Patravale, Vandana B

    2015-08-15

    Presence of bacteria such as Brucella spp. in dairy products is an immense risk to public health. Point of care immunoassays are rapid in that they can quickly screen various samples in a relatively short amount of time, are sensitive, specific and offer a great advantage in accurate and fast diagnosis of infectious diseases. We have fabricated a point of care rapid diagnostic assay that employs fluorescent, micellar silica nanosensors capable of specifically detecting Brucella IgG antibodies in milk samples of afflicted animals. Currently, point of care detection assays are not commercially available for field testing of farm animals using milk samples. The nanosensing allows precise detection of antibodies with low sample volumes (50 μl). We demonstrate recognition of B. abortus antibodies through capture by fluorescent silica nanosensors using spiked and raw milk samples validated by ELISA and PCR. The test results are accurate and repeatable with high sensitivity and specificity, and a short assay time of 10 min for antigenic recognition and do not require any sample processing procedures such as isolation and separation. Additionally, well defined antigenic components and surface biomarkers of various disease causing microbes can be broadly incorporated within the purview of this technology for accurate and rapid detection of suspected bovine pathological conditions, and can largely enable rapid field testing that can be implemented in farms and food industry. PMID:25829223

  8. Reaction of Native and Denatured Brucella abortus (S19 Proteins with Antibody Using Affinity Chromatography and Immunoblotting

    R. Karimi

    2005-01-01

    Full Text Available Western blotting or immunoblotting commonly use for study of reaction between antigens and antibodies. Denaturation of many proteins in immunoblotting can affect greatly the reactivity of antibodies and outcome of the procedure.In this study proteins of Brucella abortus (S19 was extracted by a mild method and reaction of the extracted proteins with serum of infected human and goat and immunized rabbit compared by affinity chromatography and immunoblotting. Gamma globulin (mostly IgG fraction of the sera was precipitated by half saturation of ammonium sulfate and linked to activated sepharose 4B. The extracted proteins were loaded on the affinity column. Attached proteins was eluted by low pH and analyzed by SDS-PAGE. Reaction of the total extract and eluted fractions with IgG fraction of sera was evaluated by Western blotting.Upon the results of affinity chromatography and immunoblotting, Brucella proteins can be classified in four groups: 1- The proteins that adsorbed to the affinity column and react with IgG in westernblotting. 2- Proteins that react with IgG in native state but no in denatured state. 3- Proteins that do not react with IgG in native state but react in denatured state. 4- Proteins that do not react with IgG in native and denatured state.

  9. Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

    Manuela Tittarelli

    2008-01-01

    Full Text Available Immune response to Brucella abortus strain RB51 vaccine was measured in cattle vaccinated at calfhood. After an increase at day 6 post-vaccination (pv, the antibody level recorded in the 10 vaccinated animals remained constant for two months, and then progressively decreased. All vaccinated animals remained negative from day 162 pv to the end of the study (day 300 pv. Only at days 13 and 14 pv the RB51-CFT showed 100% sensitivity (credibility interval (CI 76.2%–100%. The results indicate that the possibility to use RB51-CFT for the identification of cattle vaccinated at calfhood with RB51 is limited in time. A field investigation was carried out on 26,975 sera collected on regional basis from the Italian cattle population. The study outcomes indicate that in case of RB51-CFT positive results observed in officially Brucellosis-free (OBF areas and, in any case, when an illegal use of RB51 vaccine is suspected, the use of the RB51-CFT alone is not sufficient to identify all the vaccinated animals. The design of a more sophisticated diagnostic protocol including an epidemiological investigation, the use of RB51-CFT, and the use of the skin test with RB51 as antigen is deemed more appropriate for the identification of RB51 vaccinated animals.

  10. Latent class regression models for simultaneously estimating test accuracy, true prevalence and risk factors for Brucella abortus.

    Campe, A; Abernethy, D; Menzies, F; Greiner, M

    2016-07-01

    In 2003/2004 a field trial was conducted in Northern Ireland to assess the diagnostic accuracy of six serological tests for bovine brucellosis caused by Brucella abortus. Whereas between-test comparisons have been used to calculate test performances so far, the present study used a latent class approach to estimate diagnostic test accuracy parameters in the absence of a gold standard for these six tests simultaneously and to estimate the true prevalence, while accounting for clustering in the study population and risk factors for true prevalence. Results obtained in this study with regard to prevalence, sensitivity and specificity were largely in accordance with previous findings. Screening tests (SAT and EDTA) appeared to be the most sensitive; however, at low prevalences the EDTA and CFT showed the highest positive predictive values of all investigated tests. The specificities and negative predictive values of all diagnostic tests were found to be very high. Differences of prevalence between three groups of the study population with different risk of exposure could be attributed to the mode of sampling indicating that a more risk-based sampling will result in a higher prevalence than a cross-sectional sampling mode. Age, dairy status and history of abortion were shown to influence the prediction of the latent true infection status. PMID:27245291

  11. The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23.

    Mario Weinhold

    Full Text Available Bacterial vectors have been proposed as novel vaccine strategies to induce strong cellular immunity. Attenuated strains of Brucella abortus comprise promising vector candidates since they have the potential to induce strong CD4(+ and CD8(+ T-cell mediated immune responses in the absence of excessive inflammation as observed with other Gram-negative bacteria. However, some Brucella strains interfere with the maturation of dendritic cells (DCs, which is essential for antigen-specific T-cell priming. In the present study, we investigated the interaction of human monocyte-derived DCs with the smooth attenuated B. abortus strain (S 19, which has previously been employed successfully to vaccinate cattle.We first looked into the potential of S19 to hamper the cytokine-induced maturation of DCs; however, infected cells expressed CD25, CD40, CD80, and CD86 to a comparable extent as uninfected, cytokine-matured DCs. Furthermore, S19 activated DCs in the absence of exogeneous stimuli, enhanced the expression of HLA-ABC and HLA-DR, and was able to persist intracellularly without causing cytotoxicity. Thus, DCs provide a cellular niche for persisting brucellae in vivo as a permanent source of antigen. S19-infected DCs produced IL-12/23p40, IL-12p70, and IL-10, but not IL-23. While heat-killed bacteria also activated DCs, soluble mediators were not involved in S19-induced activation of human DCs. HEK 293 transfectants revealed cellular activation by S19 primarily through engagement of Toll-like receptor (TLR2.Thus, as an immunological prerequisite for vaccine efficacy, B. abortus S19 potently infects and potently activates (most likely via TLR2 human DCs to produce Th1-promoting cytokines.

  12. Aglutininas anti-Brucella abortus no soro e em secreção de bursite cervical em eqüinos

    Ribeiro M.G.

    2003-01-01

    Full Text Available Fistulous wither secretions from three horses were tested by the plate agglutination (PAT, tube agglutination (SAT, buffered plate-Rose Bengal (RBPT and 2-mercaptoethanol (2-ME tests, comparatively with standard agglutination tests. In the modified tests, titers were increased in the PAT, SAT and 2-ME tests and positive reaction was observed in RBPT. Brucella abortus was isolated from the secretion of fistulous withers collected from one animal. These results suggest that the modified tests may be used as alternative tests to diagnose brucellosis in horses with fistulous withers.

  13. Prueba de inmunodifusión radial con hapteno nativo para diferenciar bovinos con revacunaciones repetidas con la cepa S19 de Brucella abortus

    Esperanza González Miranda; Laura Hernández Andrade; Efrén Díaz Aparicio

    2006-01-01

    El objetivo del estudio fue establecer la capacidad de la inmunodifusión radial (IDR) con hapteno nativo, para diferenciar anticuerpos post-vacunales de anticuerpos por infección, en bovinos con revacunaciones repetidas de cepa S19. Se trabajó en un establo del estado de México, con presencia de abortos, retención de placenta, expulsiones y fetos momificados. Las becerras se vacunaban con dosis clásica de cepa S19 de B. abortus, y ya adultas revacunaciones anuales repetidas con dosis reducida...

  14. Evaluation of DNA extraction protocols for Brucella abortus pcr detection in aborted fetuses or calves born from cows experimentally infected with strain 2308 Avaliação de diferentes protocolos de extração de DNA para detecção de Brucella abortus a partir de abortos ou de bezerros nascidos de vacas experimentalmente infectadas com estirpe 2308

    M. Matrone

    2009-09-01

    Full Text Available The objective of the present study was to improve the detection of B. abortus by PCR in organs of aborted fetuses from infected cows, an important mechanism to find infected herds on the eradication phase of the program. So, different DNA extraction protocols were compared, focusing the PCR detection of B. abortus in clinical samples collected from aborted fetuses or calves born from cows challenged with the 2308 B. abortus strain. Therefore, two gold standard groups were built based on classical bacteriology, formed from: 32 lungs (17 positives, 26 spleens (11 positives, 23 livers (8 positives and 22 bronchial lymph nodes (7 positives. All samples were submitted to three DNA extraction protocols, followed by the same amplification process with the primers B4 and B5. From the accumulated results for organ, the proportion of positives for the lungs was higher than the livers (p=0.04 or bronchial lymph nodes (p=0.004 and equal to the spleens (p=0.18. From the accumulated results for DNA extraction protocol, the proportion of positives for the Boom protocol was bigger than the PK (pO objetivo do presente estudo foi aperfeiçoar a detecção de Brucella abortus pela PCR em homogeneizados de órgãos de fetos abortados por vacas infectadas, importante mecanismo para descobrir focos da doença na fase de erradicação. Assim, foram comparados diferentes protocolos de extração de DNA, visando à detecção de B. abortus pela PCR em amostras clínicas colhidas de abortos ou de bezerros oriundos de vacas desafiadas com a estirpe 2308 de B. abortus. Para tanto, foram construídos dois grupos padrão ouro com base na bacteriologia clássica, constituídos por: 32 pulmões (17 positivos, 26 baços (11 positivos, 23 fígados (8 positivos e 22 linfonodos bronquiais (7 positivos. Todas essas amostras foram submetidas a três protocolos de extração de DNA, seguidos do mesmo processo de amplificação com os primers B4 e B5. Nos resultados acumulados por

  15. Francisco Xavier Balmis y las Juntas de Vacuna, un ejemplo pionero para implementar la vacunación Francisco Xavier Balmis and the vaccine network, a pioneering example of vaccination implementation

    José Tuells

    2011-04-01

    Full Text Available La primera campaña mundial de vacunación organizada fue efectuada en América y las Filipinas por la Real Expedición Filantrópica de la Vacuna (1803-1810. La labor de Balmis como director y de Salvany, subdirector, no se limitó al mero transporte del fluido vacunal a través de los niños vacuníferos sino también al sistema organizativo que aplicaron. Las Juntas de Vacuna fueron una red de centros creados para preservar y transportar el fluido vacuno en buenas condiciones hasta los lugares de vacunación. Disponían de un Reglamento con instrucciones sobre las características del puesto de vacunación o cómo efectuar el censo de vacunados. Para mejorar la aceptabilidad vacunal integraron a los sanitarios locales y utilizaron la prensa para difundir noticias. La estrategia desarrollada constituye un antecedente que, transcurridos doscientos años, guarda una indudable similitud con modelos de planificación sanitaria como el de Pineault y Daveluy utilizados en los modernos programas de inmunización.The first organised global immunization campaign was undertaken in America and the Philippines by the 'Royal Philanthropic Expedition of the Vaccine' (1803-1810. The work of Balmis as director of the Expedition and Salvany, his Assistant Director, not only included vaccinating children but also the development of an organised model for its application. The model was based on a network of centres created to protect and transport the vaccine fluids in good condition until they reached their vaccination sites and how to conduct a census of vaccinated people. In order to improve vaccine acceptability, local health workers were incorporated and the press was used to disseminate news. The strategy developed served as an antecedent that, two hundred years later, is unquestionably similar to health planning models such as Pineault and Daveluy, used in modern vaccination campaigns.

  16. Validación de un ELISA tipo inhibición para cuantificar polisacárido Vi en la vacuna antitifoídica cubana vax-TyVi

    Esther María Fajardo

    2006-08-01

    Full Text Available Se describe la validación de un ELISA tipo inhibición, reportado por primera vez en la literatura científica para cuantificar un antígeno vacunal: el polisacárido Vi de Salmonella Typhi, para ser empleado en el control de la calidad de la vacuna antitifoídica cubana vax- TyViâ. El ensayo consta de seis pasos: 1 Recubrimiento de placa de reacción con poli-L-lisina y posteriormente polisacárido Vi; 2 Bloqueo con leche descremada; 3 Inhibición o neutralización en tubos de suero anti-Vi de conejo, respectivamente, con polisacárido Vi de Curva de Calibración (concentraciones desde 1–32 μg/mL, control positivo y muestras de vacuna (3 diluciones; 4 Neutralización de anticuerpos anti-Vi libres, presentes en las mezclas anteriores, por el Polisacárido de Recubrimiento; 5 Reconocimiento de anticuerpos anti-Vi unidos a la placa (conjugado anti-IgG de conejo-fosfatasa alcalina y 6 Revelado por reacción enzima-sustrato. Los parámetros de validación estudiados y sus resultados fueron: 1 Precisión, expresada como coeficiente de variación a tres niveles de concentración de polisacárido, comprendidos en el rango de su especificación (35, 50 y 70 μg/mL y evaluada en términos de repetibilidad; precisión intraensayos (cuatro analistas y reproducibilidad (seis analistas: £ 20%; 2 Linealidad (100*R2: 99,68 %; 3 Límite de detección: 0,5 μg/mL; 4 Exactitud (recuperación para las tres diluciones de la muestra: entre 100 y 118%, y 5 Robustez: no influye 1,5 h de bloqueo (p = 0,52 ni ± 5 min para leer placa (p = 0,56; influye grandemente la calidad del agua (p = 0,026, a favor del agua para inyección. El ensayo es adecuado para los fines propuestos y es una medida de la inmunogenicidad in vitro del polisacárido Vi.

  17. Allotypic and idiotypic specificities of anti-Salmonella abortus-equi antibodies produced by rabbits subjected to successive irradiations

    Three out of five rabbits subjected to successive irradiations and immunized against Salmonella abortus-equi produced IgG which, transiently, were not precipitated by anti-a3 anti-allotypic sera, although they carried all the determinants of the a3 allotypic pattern. As a3 IgG from normal rabbits are precipitated by anti-a3 sera, it appeared that the molecular distribution of the a3 allotypic determinants was different on the IgG produced by these irradiated rabbits compared to IgG produced by normal rabbits. After a second irradiation, one of these rabbits produced a high level (50 mg per ml) of anti-Salmonella antibodies of restricted heterogeneity. An anti-idiotypic serum prepared against anti-Salmonella antibodies produced by this rabbit after the first irradiation precipitated the idiotypes it recognised in the serum collected after the first irradiation, while it did not precipitate the idiotypes it recognised in the serum collected after the second irradiation, although they carried all the determinants of the idiotypes of the serum collected after the first irradiation. That probably means that there is a different molecular distribution of the idiotypic determinants between antibodies produced after the first irradiation and antibodies produced after the second irradiation. An antiidiotypic serum prepared against anti-Salmonella antibodies produced after the second irradiation did not distinguish by precipitation in gel medium or by radioimmunoassay between the idiotypes it recognised in antibodies produced after the first irradiation and those in antibodies produced after the second irradiation. The idiotypic similarity thus detected, and the fact that unexpected allotypes were not detected, is in better agreement with the expression of the potentiality of radiation-resistant cells than with the expression of new antibody producing cell clones arising from virgin stem cells. (author)

  18. Immune responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19.

    Olsen, S C; Fach, S J; Palmer, M V; Sacco, R E; Stoffregen, W C; Waters, W R

    2006-10-01

    Previous studies have suggested that currently available brucellosis vaccines induce poor or no protection in elk (Cervus elaphus nelsoni). In this study, we characterized the immunologic responses of elk after initial or booster vaccination with Brucella abortus strains RB51 (SRB51) and 19 (S19). Elk were vaccinated with saline or 10(10) CFU of SRB51 or S19 (n=seven animals/treatment) and booster vaccinated with a similar dosage of the autologous vaccine at 65 weeks. Compared to nonvaccinates, elk vaccinated with SRB51 or S19 had greater (PS19 after initial vaccination and after booster vaccination. Compared to nonvaccinated elk, greater (PS19 (22 weeks) treatment groups. In general, proliferative responses of vaccinates to nonautologous antigens did not differ (P>0.05) from the responses of nonvaccinated elk. Gamma interferon production in response to autologous or nonautologous Brucella antigens did not differ (P>0.05) between controls and vaccinates after booster vaccination. Flow cytometric techniques suggested that proliferation occurred more frequently in immunoglobulin M-positive cells, with differences between vaccination and control treatments in CD4+ and CD8+ subset proliferation detected only at 22 weeks after initial vaccination. After booster vaccination, one technique ([3H]thymidine incorporation) suggested that proliferative responses to SRB51 antigen, but not S19 antigen, were greater (PBrucella antigens in S19 or SRB51 vaccinates after booster vaccination. Although some cellular immune responses were detected after initial or booster vaccination of elk with SRB51 or S19, our data suggest that responses tend to be transient and much less robust than previously reported in SRB51-vaccinated cattle (Bos taurus) or bison (Bison bison). These data may explain why the vaccination of elk with S19 and SRB51 induces poor protection against brucellosis. PMID:17028213

  19. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping.

    Miranda, Karina Leite; Poester, Fernando Padilla; Minharro, Silvia; Dorneles, Elaine Maria Seles; Stynen, Ana Paula Reinato; Lage, Andrey Pereira

    2013-06-24

    Live attenuated Brucella abortus S19 is the most effective vaccine against brucellosis in cattle. The assessment of the immunological parameters is essential to guarantee the biological quality of live anti-bacteria vaccines. The evaluation of genetic stability of live bacterial vaccines is also important in quality control. The aims of the present study were to compare (i) the immunogenicity and residual virulence, and (ii) the genotypic profile (MLVA15) of the eight S19 vaccines commercialized in Brazil to the USDA S19 reference strain. Two batches of each of the eight S19 commercial vaccines used in Brazil (A-H) were tested. They were submitted to the potency and residual virulence in vivo tests recommended by OIE and typed by the multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) described for Brucella spp. Our results demonstrated that all S19 vaccines commercialized in Brazil would be approved by Brazilian and OIE recommendations for potency and residual virulence. Furthermore, the S19 vaccine is genetically very homogeneous, as all but two batches (from the same manufacturer) tested showed identical MLVA15 profile. The two batches with different profiles presented six repeat units in locus Bruce07, instead of the five found in all other strains, including the USDA S19 reference strain. Although presenting a slightly different profile, this vaccine was also protective, as demonstrated by the immunogenicity and residual virulence assays performed. Therefore, the commercial Brazilian S19 vaccines were in accordance to Brazilian and international standards for immunogenicity and residual virulence tests. Moreover, our results also show that MLVA could be a useful inclusion to the list of in vitro tests required by the official control authorities to be applied to the commercial S19 vaccines, as an efficient assay to guarantee the quality and stability of the vaccine strains. PMID:23664986

  20. T cell regulation of the thymus-independent antibody response to trinitrophenylated-Brucella abortus (TNP-BA)

    Tanay, A.; Strober, S.

    1985-06-01

    The authors have previously observed a reduction of the T cell-dependent primary antibody response to dinitrophenylated keyhole limpet hemocyanin, and an enhancement of the T cell-independent response to trinitrophenylated Brucella abortus (TNP-BA) in BALB/c mice after treatment with total lymphoid irradiation (TLI). To elucidate the relative contribution of T and B cells to the enhanced T cell-independent antibody responses after TLI, a syngeneic primary adoptive transfer system was utilized whereby irradiated hosts were reconstituted with unfractionated spleen cells or a combination of purified T and B cells from TLI-treated and untreated control mice. Antibody responses of purified splenic B cells from TLI-treated BALB/c mice (TLI/B) to TNP-BA were enhanced 10-fold as compared with those of unfractionated (UF) spleen cells or B cells from normal (NL) BALB/c mice (NL/UF and NL/B, respectively). Splenic T cells from normal animals (NL/T) suppressed the anti-TNP-BA response of TLI/B by more than 100-fold. NL/T neither suppressed nor enhanced the response of NL/B. On the other hand, T cells from TLI-treated mice (TLI/T) enhanced by 100-fold the anti-TNP-BA response of NL/B, but neither suppressed nor enhanced the response of TLI/B. Thus, T cells can regulate the T cell-independent antibody response to TNP-BA. However, experimental manipulation of the T and B cell populations is needed to demonstrate the regulatory functions.

  1. SNP Research on Brucella abortus Vaccine Strain A19%中国牛种布鲁氏菌疫苗株A19 SNP位点的研究

    谭鹏飞; 南文龙; 彭大新; 毛开荣; 陈义平

    2014-01-01

    To distinguish Brucella abortus vaccine strain A19 from field strains, the single nucleotide polymorphism (SNP) signatures for B. abortus A19 were initially analyzed using bioinformatics method and gene sequencing. Then, the specificity of several SNPs was verified, by comparing the nucleotide sequences of these SNPs with common species and biovars of Brucella and three Brucella vaccines. The results showed 29 SNPs were successfully screened from genome of B. abortus A19. Furthermore, ClpX G825-C825,LysR A605-C605and Omp2b G503-A503were confirmed to be specific to B. abortus A19 (or B. abortus S19). Our study systematically revealed the SNP distribution of B. abortus A19, which provided a molecular basis for differentiating B. abortus A19 from field strains.%为鉴别我国牛种布鲁氏菌疫苗株A19与野生菌株,运用生物信息学方法结合基因测序,对疫苗株A19基因组单核苷酸多态性( SNP )位点分析筛选,选取其中部分SNP位点,通过与布鲁氏菌常见种、生物型标准参考菌株和疫苗株基因组SNP 位置核苷酸测序比较,验证SNP 位点的A19特异性。结果表明,共筛选获得A19基因组29个SNP 位点,验证ClpX G825-C825、LysR A605-C605、Omp2b G503-A503这3个SNP位点为A19(或S19)特异,揭示了A19基因组SNP位点分布情况,为疫苗株A19与野生菌株鉴别提供了分子依据。

  2. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.

    Lalsiamthara, Jonathan; Gogia, Neha; Goswami, Tapas K; Singh, R K; Chaudhuri, Pallab

    2015-05-21

    Brucella abortus S19 is a smooth strain used as live vaccine against bovine brucellosis. Smooth lipopolysaccharide (LPS) is responsible for its residual virulence and serological interference. Rough mutants defective of LPS are more attenuated but confers lower level of protection. We describe a modified B. abortus S19 strain, named as S19Δper, which exhibits intermediate rough phenotype with residual O-polysaccharide (OPS). Deletion of perosamine synthetase gene resulted in substantial attenuation of S19Δper mutant without affecting immunogenic properties. It mounted strong immune response in Swiss albino mice and conferred protection similar to S19 vaccine. Immunized mice produced higher levels of IFN-γ, IgG2a and thus has immune response inclined towards Th1 cell mediated immunity. Sera from immunized animals did not show agglutination reaction with RBPT antigen and thus could serve as DIVA (Differentiating Infected from Vaccinated Animals) vaccine. S19Δper mutant displayed more susceptibility to serum complement mediated killing and sensitivity to polymyxin B. Pregnant guinea pigs injected with S19Δper mutant completed full term of pregnancy and did not cause abortion, still birth or birth of weak offspring. S19Δper mutant with intermediate rough phenotype displayed remarkable resemblance to S19 vaccine strain with improved properties of safety, immunogenicity and DIVA capability for control of bovine brucellosis. PMID:25869887

  3. Vaccination of adult animals with a reduced dose of Brucella abortus S19 vaccine to control brucellosis on dairy farms in endemic areas of India.

    Chand, Puran; Chhabra, Rajesh; Nagra, Juhi

    2015-01-01

    Bovine brucellosis is an economically important disease which seriously affects dairy farming by causing colossal losses. It can be controlled by practicing vaccination of animals with Brucella abortus S19 vaccine (S19 vaccine). In the present study, adult bovines were vaccinated on seven dairy farms with a reduced dose of S19 vaccine to control brucellosis. Serological screening of adult animals (N = 1,082) by Rose Bengal test (RBT) and ELISA prior to vaccination revealed the presence and absence of brucellosis on five and two farms, respectively. The positive animals (N = 171) were segregated and those which tested negative (N = 911) were vaccinated by conjunctival route with a booster after 4 months. The conjunctival vaccination induced weak antibody response in animals, which vanished within a period of 9 to 12 weeks. Abortion in 12 animals at various stages of pregnancy and post-vaccination was recorded, but none was attributed to S19 vaccine. However, virulent B. abortus was incriminated in six heifers, and the cause of abortion could not be established in six animals. The six aborted heifers perhaps acquired infection through in utero transmission or from the environment which remained undetected until abortion. These findings suggested that vaccination of adult animals with a reduced dose of S19 vaccine by conjunctival route did not produce adverse effects like abortion in pregnant animals and persistent vaccinal antibody titers, which are the major disadvantages of subcutaneous vaccination of adult animals. PMID:25274621

  4. Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16).

    Dorneles, Elaine Maria Seles; de Faria, Ana Paula Paiva; Pauletti, Rebeca Barbosa; Santana, Jordana Almeida; Caldeira, George Afonso Vítor; Heinemann, Marcos Bryan; Titze-de-Almeida, Ricardo; Lage, Andrey Pereira

    2013-10-01

    The aims of the present study were (i) to assess the in vitro genetic stability of S19 and RB51 Brucella abortus vaccines strains and (ii) to evaluate the ability of multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) as a tool to be used in the quality control of live vaccines against brucellosis. Sixty-three batches of commercial S19 (n=53) and RB51 (n=10) vaccines, produced between 2006 and 2009, were used in this study. S19 and RB51 vaccines were obtained from, respectively, seven and two different manufacturers. Ten in vitro serial passages were performed on reference strains and on selected batches of commercial vaccines. All batches, reference strains and strains of serial passages were typed by the MLVA16. The results demonstrated that B. abortus S19 and RB51 vaccine strains are genetically stable and very homogeneous in their respective groups. Anyway, batches of S19 from one manufacturer and batches of RB51 from another presented genotypes distincts from the reference vaccine strains. In both cases, differences were found on locus Bruce07, which had addition of one repeat unit in the case of S19 batches and the deletion of one repeat unit in the case of RB51 batches. In summary, MLVA16 proved to be a molecular tool capable of discriminating small genomic variations and should be included in in vitro official tests. PMID:23933375

  5. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.

    Yu, Da-Hai; Hu, Xi-Dan; Cai, Hong

    2007-06-01

    We constructed a combined DNA vaccine comprising genes encoding the antigens BCSP31, superoxide dismutase (SOD), and L7/L12 and evaluated its immunogenicity and protective efficacy. Immunization of mice with the combined DNA vaccine offered high protection against Brucella abortus (B. abortus) infection. The vaccine induced a vigorous specific immunoglobulin G (IgG) response, with higher IgG2a than IgG1 titers. Cytokine profiling performed at the same time showed a biased Th1-type immune response with significantly increased interferon-gamma and tumor necrosis factor-alpha stimulation. CD8(+), but not CD4(+), T cells accumulated at significantly higher levels after administration of the vaccine. Granzyme B-producing CD8(+) T cells were significantly higher in number in samples prepared from combined DNA-vaccinated mice compared with S19-vaccinated mice, demonstrating that the cytotoxicity lysis pathway is involved in the response to Brucella infection. The success of our combined DNA vaccine in a mouse model suggests its potential efficacy against brucellosis infection in large animals. PMID:17570767

  6. Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.

    Bosseray, N; Plommet, M

    1990-10-01

    Live attenuated Brucella suis S2 vaccine was compared to living vaccines B. abortus S19 and B. melitensis Rev. 1 in mice. Residual virulence was estimated by ability to multiply and persist in spleen and lymph nodes. Immunogenicity was estimated by spleen counts of control and vaccinated mice challenged either with the reference B. abortus 544 strain or with virulent B. melitensis H38 and B. suis 1330 strains. S2 vaccine had lower residual virulence; expressed as 50% recovery time, persistence was 4.3 weeks, compared to 7.1 and 9.0 weeks for S19 and Rev. 1 vaccines. Immunity induced by the three vaccines was similar 45 days after vaccination. At 150 days, immunity by S19 and Rev.1 was still similar against the three challenge strains. In contrast, immunity induced by S2 had declined against the B. melitensis strain. Thus, a recall vaccination may be required for vaccination of sheep to confer a long-lasting immunity. PMID:2123586

  7. Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model

    Kim, Won K.; Moon, Ja Y.; Kim, Suk; Hur, Jin

    2016-01-01

    Live, attenuated Salmonella Typhimurium vaccine candidate expressing BCSP31, Omp3b, and SOD proteins of Brucella abortus was constructed. Thirty BALB/c mice were divided equally into three groups, Group A, were intraperitoneally (IP) inoculated with 100 μl of approximately 1.2 × 106 colony-forming units (CFUs)/ml of the Salmonella containing vector only in 100 μl as a control. And groups B and C mice were orally and IP immunized with approximately 1.2 × 109 CFU/ml of the mixture of three delivery strains in 10 μl and IP immunized with approximately 1.2 × 106 CFU/ml of the mixture in 100 μl, respectively. The serum IgG, TNF-α and IFN-γ concentrations in groups B (except Omp3b) and C were significantly higher than those in group A. Following challenge with B. abortus strain 544; challenge strain was detected <103 CFU from the spleen of all mice of group C. These results suggest that IP immunization with the mixture of the vaccine candidate can induce immune responses, and can effectively protect mice against brucellosis. PMID:27148232

  8. Epidemiological aspects of an infection by Brucella abortus in risk occupational groups in the microregion of Araguaína, Tocantins

    Taciana Rabelo Ramalho Ramos

    2008-04-01

    Full Text Available The aim of this paper was to study some epidemiological aspects of the infection by Brucella abortus in risk occupational groups in the microregion of Araguaína, Tocantins. For antibody research, 645 serum samples were analyzed by the complement fixation test (CF. A 4.0% frequency was found (26/645 in patients' serum and among those 4.1% (23/551 were slaughterhouses employees and 8.1% (3/37 rural workers. Of the total positive samples, three (2.0% were women and 23 (4.7% men; ten (2.9% were between the ages of 18 and 30, six (3.4% between 31 and 40, and nine (8.0% were above 41 years of age. Risk factors for brucellosis in the study groups were age, background (OR = 2.45; CI 95% = 0.98 to 6.10 and previous work conducted with production animals (OR 2.36; CI 95% = 0.95 to 6.02. It was concluded that the infection by Brucella abortus is found in some risk occupational groups in the microregion of Araguaína, Tocantins, and control and prophylactic measures must be implemented emphasizing risk factors identified in the study.

  9. Characterization of recombinant B. abortus strain RB51SOD towards understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51

    Jianguo eZhu

    2011-11-01

    Full Text Available Brucella abortus is a Gram-negative, facultative intracellular pathogen for several mammals, including humans. Live attenuated B. abortus strain RB51 is currently the official vaccine used against bovine brucellosis in the United States and several other countries. Overexpression of protective B. abortus antigen Cu/Zn superoxide dismutase (SOD in a recombinant strain of RB51 (strain RB51SOD significantly increases its vaccine efficacy against virulent B. abortus challenge in a mouse model. An attempt has been made to better understand the mechanism of the enhanced protective immunity of RB51SOD compared to its parent strain RB51. We previously reported that RB51SOD stimulated enhanced Th1 immune response. In this study, we further found that T effector cells derived from RB51SOD-immunized mice exhibited significantly higher cytotoxic T lymphocyte (CTL activity than T effector cells derived from RB51-immunized mice against virulent B. abortus-infected target cells. Meanwhile, the macrophage responses to these two strains were also studied. Compared to RB51, RB51SOD cells had a lower survival rate in macrophages and induced lower levels of macrophage apoptosis and necrosis. The decreased survival of RB51SOD cells correlates with the higher sensitivity of RB51SOD, compared to RB51, to the bactericidal action of either Polymyxin B or sodium dodecyl sulfate (SDS. Furthermore, a physical damage to the outer membrane of RB51SOD was observed by electron microscopy. Possibly due to the physical damage, overexpressed Cu/Zn SOD in RB51SOD was found to be released into the bacterial cell culture medium. Therefore, the stronger adaptive immunity induced by RB51SOD did not correlate with the low level of innate immunity induced by RB51SOD compared to RB51. This unique and apparently contradictory profile is likely associated with the differences in outer membrane integrity and Cu/Zn SOD release.

  10. Desenvolvimento e avaliação de uma cepa knockout de Brucella abortus obtida pela deleção do gene virB10 Development and evaluation of a strain of Brucella abortus gotten by the knockout of the virB10 gene

    Fabiane G. de Souza

    2009-11-01

    Full Text Available Brucella spp. são bactérias gram-negativas, intracelulares facultativas que são patogênicas para muitas espécies de mamíferos causando a brucelose, uma zoonose difundida mundialmente. Por isso a busca de alternativas de controle mais eficientes se faz necessário como o desenvolvimento de novas cepas que possam ser testadas como potenciais imunógenos. Neste estudo realizou-se a deleção do gene virB10 da cepa S2308 de Brucella abortus gerando uma cepa knockout provavelmente incapaz de produzir a proteína nativa correspondente. O gene virB10 faz parte de um operon que codifica para um sistema de secreção do tipo IV, essencial para a sobrevivência intracelular e multiplicação da bactéria em células hospedeiras. A deleção foi realizada pela construção do plasmídeo suicida pBlue:virB10:kan e eletroporação deste em células eletrocompetentes de B. abortus S2308, ocorrendo a troca do gene selvagem pelo gene interrompido, com o gene de resistência a canamicina, por recombinação homóloga dupla. Camundongos BALB/c foram inoculados com as cepas S19, RB-51, ΔvirB10 de B. abortus e B. abortus S2308 selvagem; os resultados demonstraram que camundongos BALB/c inoculados com S19 e camundongos BALB/c inoculados com S2308 apresentaram queda mais rápida de linha de tendência, quando comparadas aos demais grupos, para recuperação bacteriana (RB e peso esplênico (PE respectivamente. Os grupos que receberam ΔvirB10 S2308 de B. abortus e RB-51 demonstraram comportamento semelhante para ambas as características. Na sexta semana após a inoculação, os resultados para RB (log de UFC ± desvio padrão e PE (peso esplênico ± desvio padrão, respectivamente, mostraram: grupos inoculados com as cepas S2308 (4,44±1,97 e 0,44±0,11, S19 (1,83±2,54 e 0,31±0,04, RB-51 (0,00±0,00 e 0,20±0,01 e ΔvirB10 S2308 (1,43±1,25 e 0,19±0,03. Considerado o clearance bacteriano, todos os grupos diferiram estatisticamente do grupo que recebeu S

  11. A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects: A dose-response, double-blind, placebo-controlled, randomized pilot trial Una mezcla de Lactobacillus plantarum CECT 7315 y CECT 7316 mejora la inmunidad sistémica en ancianos: Un ensayo aleatorio piloto, de dosis-respuesta, doble ciego y controlado con placebo

    J. Mañé

    2011-02-01

    Full Text Available Background & aim: Immunosenescence can increase morbi-mortality. Lactic acid producing bacteria may improve immunity and reduce morbidity and mortality in the elderly. We aimed to investigate the effects of a mixture of two new probiotic strains of Lactobacillus plantarum-CECT 7315 and 7316- on systemic immunity in elderly. Methods: 50 institutionalized elderly subjects were randomized, in a double-blind fashion, to receive for 12 weeks 1 5·10(8 cfu/day of L. plantarum CECT7315/7316 ("low probiotic dose" (n = 13, 2 5·10(9 cfu/day of the probiotic mixture ("high probiotic dose" (n = 19, or 3 placebo (n = 15. Leukocyte subpopulations, and cytokine levels (IL-1 , IL-10, TGF-β1 were measured in venous blood at baseline, end of treatment (week 12, and end of follow-up (week 24. Infection and survival rates were recorded. Results: After treatment, high probiotic dose resulted in significant increases in the percentages of activated potentially T-suppressor (CD8+CD25+ and NK (CD56+ CD16+ cells, while low probiotic dose increased activated T-helper lymphocytes (CD4+CD25+, B lymphocytes (CD19+, and antigen presenting cells (HLA-DR+. Also, plasma TGF-β1 concentration significantly decreased after treatment with both probiotic doses. Most of these changes remained 12 weeks after probiotic discontinuation. Incidence of infections during treatment showed a significant trend to be lower in the high probiotic dose group. In addition, there was a significant trend for mortality to be greater in the placebo group vs. both probiotic groups. Conclusions: Depending on the dose, L. plantarum CECT7315/7316 have different immune-enhancing effects in elderly subjects. These effects might result in a better clinical outcome.Introducción y objetivos: La inmunosenescencia puede aumentar la morbi-mortalidad. Las bacterias productoras de ácido láctico pueden mejorar la inmunidad y disminuir la morbilidad y mortalidad en los ancianos. Nuestro objetivo fue investigar

  12. Desenvolvimento e avaliação de uma cepa knockout de Brucella abortus obtida pela deleção do gene virB10 Development and evaluation of a strain of Brucella abortus gotten by the knockout of the virB10 gene

    Fabiane G. de Souza; Ana L.A.R. Osório; Bárbara G. Csordas; Rafael Q. Prado; Carina Elisei; Cleber O. Soares; Araújo, Flábio R; Stênio P Fragoso; Grácia M.S. Rosinha

    2009-01-01

    Brucella spp. são bactérias gram-negativas, intracelulares facultativas que são patogênicas para muitas espécies de mamíferos causando a brucelose, uma zoonose difundida mundialmente. Por isso a busca de alternativas de controle mais eficientes se faz necessário como o desenvolvimento de novas cepas que possam ser testadas como potenciais imunógenos. Neste estudo realizou-se a deleção do gene virB10 da cepa S2308 de Brucella abortus gerando uma cepa knockout provavelmente incapaz de produzir ...

  13. Papel de los anticuerpos en la protección contra micobacterium tuberculosis

    Nesty Olivares

    2006-12-01

    Full Text Available Convencionalmente se asume que la defensa del hospedero contra Mycobacterium tuberculosis se basa en los mecanismos de inmunidad celular exclusivamente y se descarta el papel de los anticuerpos en la protección. En este trabajo se analizan evidencias recientes que retan este dogma y sugieren la importancia de considerar la manipulación de la respuesta inmune humoral como una alternativa en la investigación de vacunas contra la tuberculosis.

  14. HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors Introducción de la vacuna contra el VPH en niveles locales de un país en vías de desarrollo: actitudes y criterios de actores clave

    Marion Piñeros

    2010-05-01

    Full Text Available In most developing countries, HPV vaccines have been licensed but there are no national policy recommendations, nor is it clear how decisions on the introduction of this new vaccine are made. Decentralization processes in many Latin American countries favor decision-making at the local level. Through a qualitative study we explored knowledge regarding the HPV vaccine and the criteria that influence decision-making among local health actors in four regions of Colombia. We conducted a total of 14 in-depths interviews with different actors; for the analysis we performed content analysis. Results indicate that decision-making on the HPV vaccine at the local level has mainly been driven by pressure from local political actors, in a setting where there is low technical knowledge of the vaccine. This increases the risk of initiatives that may foster inequity. Local decisions and initiatives need to be strengthened technically and supported by national-level decisions, guidelines and follow-up.En gran parte de los países en vías de desarrollo, las vacunas contra el VPH tienen aprobación para su comercialización. Sin embargo, no hay recomendaciones y tampoco hay claridad sobre la forma en la que se toman las decisiones para su introducción. La reforma del sistema de salud en muchos países latinoamericanos permite la toma de decisiones en el nivel local. Mediante un estudio cualitativo con actores claves del sector salud en cuatro regiones de Colombia, exploramos el conocimiento sobre la vacuna del VPH y los criterios que influyen en la toma de decisiones. Se realizaron 14 entrevistas en profundidad y análisis de contenido. Los resultados indican que en el nivel local la toma de decisiones sobre la introducción de la vacuna está determinada en gran parte por la presión ejercida por figuras políticas locales. Esto, sumado a un bajo nivel de conocimiento técnico, incrementa la posibilidad de iniciativas con implicaciones éticas considerables

  15. Evaluation of the HOOF-Print assay for typing Brucella abortus strains isolated from cattle in the United States: results with four performance criteria

    Ewalt Darla R

    2005-06-01

    Full Text Available Abstract Background A fundamental question that arises during epidemiological investigations of bacterial disease outbreaks is whether the outbreak strain is genetically related to a proposed index strain. Highly discriminating genetic markers for characterizing bacterial strains can help in clarifying the genetic relationships among strains. Under the auspices of the European Society of Clinical Microbiology and Infectious Diseases, the European Study Group for Epidemiological Markers (ESGEM established guidelines for evaluating the performance of typing systems based of a number of criteria. Recently, HOOF-Print genotype analysis, a new method for typing Brucella abortus strains based on hypervariability at eight tandem repeat loci, was described. This paper evaluates the HOOF-Print assay by four of the criteria set out by the ESGEM: typeability, reproducibility, power of discrimination, and concordance with other typing methods. Results The HOOF-Print Assay was evaluated with a test population composed of 97 unrelated field isolates and 6 common laboratory strains of B. abortus. Both typeability and reproducibility of the assay were excellent. Allele diversity and frequency varied widely among the eight loci, ranging from 1 to 13 alleles. The power of discrimination, measured by the Hunter-Gaston discrimination index (HGDI, varied by locus ranging from 0 to 0.89, where a maximal value of 1.0 indicates discrimination of all strains. The HGDI values calculated for subgroups sorted by biovar were similar to the values determined for the whole population. None of the individual loci achieved the recommended HGDI threshold of 0.95, but the HGDI of the composite profiles was 0.99 (93 unique genotypes from 97 field strains evaluated, well above the recommended threshold. By comparison, the HGDI value for biovar typing was 0.61 in a test population biased with disproportionate numbers of the less common biovars. Cluster analysis based on HOOF

  16. Aborto enzoótico dos ovinos: pesquisa de Chlamydophila abortus por PCR em ovinos Serra da Estrela após aborto

    Cristóvão, Luís Filipe Dinis

    2014-01-01

    O aborto enzoótico dos ovinos é um importante problema nas explorações, provocando um elevado impacto económico na maioria dos países produtores. Tem como agente etiológico Chlamydophila abortus, uma bactéria Gram-negativa que induz infeção subclínica persistente em ovelhas não-gestantes, podendo ser posteriormente causa de aborto, sobretudo no último terço de gestação. Foram colhidas vinte zaragatoas vaginais de ovinos após aborto, em explorações na região da Serra da Estrela. As amostras...

  17. Vacina contra influenza: conhecimentos, atitudes e práticas de idosos em Teresina Vacuna contra gripe: conocimiento, actitudes y práctica de ancianos en Teresina Vaccine influenza: knowledge, attitudes and practices of elderly in Teresina

    Telma Maria Evangelista de Araújo

    2007-08-01

    Full Text Available Este estudo objetiva levantar os conhecimentos, atitudes e práticas dos idosos de uma área do Programa de Saúde da Família (PSF sobre a vacina contra influenza e identificar os motivos que levaram alguns a não se vacinarem. Consiste em um inquérito domiciliar, em uma área do PSF de Teresina, com 74 idosos a partir de 60 anos. Os resultados evidenciaram que não obstante 85,3% tenham conhecimento inadequado sobre a vacina, 89,1% são favoráveis. Os motivos mais freqüentes para a não vacinação foram doença e temor dos eventos adversos. Conclui-se que a atitude favorável a respeito da vacinação pode modificar a prática frente a ela, instaurando comportamento de autoproteção e maior adesão.Este estudio objetivo para levantar el conocimiento, práctico y actitudes envejecidos de un área del programa de la salud de Familia (PSF en la vacuna cuenta gripe e identificar las razones que habían tomado alguno para no ser vaccined. Consiste en una investigación domiciliaria, un área del PSF de Teresina, con 74 envejeció unos a partir de 60 años. El resultado había evidenciado que sin embargo 85.3% tienen conocimiento inadecuado en la vacuna, 89.1% es favorable. Las razones más frecuentes para la vacunación no habían sido enfermedad y miedo de los acontecimientos adversos. Se concluye que la actitud favorable con respecto a la vacunación puede modificar el frente práctico él, restaurando el comportamiento de la uno mismo-protección y de la mayor adherencia.This objective study to raise the knowledge, practical and attitudes of the aged ones of an area of the Program of Health of Família (PSF on the vaccine it counts influenza and to identify the reasons that had taken some not to be vaccined. It consists of a domiciliary inquiry, an area of the PSF of Teresina, with 74 aged ones from 60 years. The result had evidenced that even so 85.3% have inadequate knowledge on the vaccine, 89.1% is favorable. The reasons most frequent

  18. Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer Vacunas contra virus del papiloma humano y perspectivas para la prevención y el control del cáncer cervicouterino

    Alejandro García-Carrancá

    2003-01-01

    Full Text Available Today, "persistent" infections by certain types of human papillomavirus (HPV are considered necessary for developing cervical cancer. Producing efficient vaccines against these viruses may eventually lead to a great reduction in incidence and mortality rates of this cancer. In the case of HPV, the production of traditional vaccines usually based in dead or attenuated viruses is not possible due in part to the lack of systems where large quantities of viral particles could be obtained. Fortunately, the expression of the late L1 protein alone, or in combination with L2, leads to the generation of structures resembling true virions that have been called virus-like particles (VLPs and constitute excellent candidates as prophylactic vaccines. VLPs have shown to be very immunogenic, and have prevented development of natural or challenged infections in both animal systems and humans. Recently, HPV16 VLPs were shown to be very efficient to prevent the development of "persistent" infections, as determined by PCR assays, in a large group of vaccinated women. Therapeutic vaccines, on the other hand, are expected to have an impact on advanced lesions and residual illness, by taking advantaje of the fact that early E6 and E7 genes are thought to be constitutively expressed in cervical tumors and precursor lesions. Finally, DNA-based vaccines could represent a useful alternative for preventing infections by genital HPV.Actualmente, las infecciones "persistentes" por algunos tipos del virus del papiloma humano se consideran como necesarias para desarrollar cáncer cervicouterino. Por ello, el desarrollo de vacunas eficientes contra estos virus se ha considerado de suma importancia para poder eventualmente ayudar a controlar esta enfermedad, en países donde los programas de detección oportuna no han dado aún los resultados deseados. En el caso de estos virus no es posible el desarrollo de vacunas tradicionales, las cuales están basadas generalmente en el

  19. Cromatografía de adsorción para purificar el disacárido espaciador del ingrediente farmacéutico activo de la vacuna QuimiHib®

    Belinda Díaz,

    2013-04-01

    Full Text Available En este trabajo se estudiaron las condiciones de la cromatografía de adsorción en Silicagel 60 para la purificación del disacárido espaciador (DSE, componente del ingrediente farmacéutico activo de la vacuna QuimiHib®. Para ello se realizó un desescalado a una escala analítica que representó el 1,8% del proceso industrial. Se logró reproducibilidad en términos de calidad de empaque, pureza y recobrado entre ambas escalas. Se determinó que la capacidad dinámica de carga de la resina Silicagel 60 por el DSE fuera de aproximadamente 125±0,2 mg/mL de resina empacada; 3,4 veces superior al proceso base. El perfil de elución que se obtuvo indicó la posibilidad de colectar una fracción única en el rango 195±2 y 260±2 min. Si se mantiene un correcto empaque de la resina cromatográfica, determinado por un factor de asimetría entre 0,8 y 1,2 se garantiza un recobrado de 58,9±4,5% y una pureza equivalente a la del patrón de referencia en el análisis por cromatografía de capa delgada. El ajuste de la condición de adsorción incrementa la productividad de la operación en 3,5 veces, indicando que la propuesta es económicamente factible.

  20. Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice.

    Li, Xianbo; Xu, Jie; Xie, Yongfei; Qiu, Yefeng; Fu, Simei; Yuan, Xitong; Ke, Yuehua; Yu, Shuang; Du, Xinying; Cui, Mingquan; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Yu, Yaqing; Huang, Kehe; Huang, Liuyu; Peng, Guangneng; Chen, Zeliang; Wang, Yufei

    2012-12-28

    Brucella has been considered as a non-motile, facultative intracellular pathogenic bacterium. However, the genome sequences of different Brucella species reveal the presence of the flagellar genes needed for the construction of a functional flagellum. Due to its roles in the interaction between pathogen and host, we hypothesized that some of the flagellar proteins might induce protective immune responses and these proteins will be good subunit vaccine candidates. This study was conducted to screening of protective antigens among these flagellar proteins. Firstly, according to the putative functional roles, a total of 30 flagellar genes of Brucella abortus were selected for in vitro expression. 15 of these flagellar genes were successfully expressed as his-tagged recombinant proteins in Escherichia coli ER2566. Then, these proteins were purified and used to analyze their T cell immunity induction activity by an in vitro gamma interferon (IFN-γ) assay. Five of the flagellar proteins could stimulate significantly higher levels of IFN-γ secretion in splenocytes from S19 immunized mice, indicating their T cell induction activity. Finally, immunogenicity and protection activity of these 5 flagellar proteins were evaluated in BALB/c mice. Results showed that immunization with FlgJ (BAB1_0260) or FliN (BAB2_0122) plus adjuvant could provide protection against B. abortus 544 infection. Furthermore, mice immunized with FlgJ and FliN developed a vigorous immunoglobulin G response, and in vitro stimulation of their splenocytes with immunizing proteins induced the secretion of IFN-γ. Altogether, these data suggest that flagellar proteins FlgJ and FliN are protective antigens that could produce humoral and cell-mediated responses in mice and candidates for use in future studies of vaccination against brucellosis. PMID:22854331

  1. Oral vaccination with microencapsuled strain 19 vaccine confers enhanced protection against Brucella abortus strain 2308 challenge in red deer (Cervus elaphus elaphus).

    Arenas-Gamboa, Angela M; Ficht, Thomas A; Davis, Donald S; Elzer, Philip H; Kahl-McDonagh, Melissa; Wong-Gonzalez, Alfredo; Rice-Ficht, Allison C

    2009-10-01

    Bison (Bison bison) and elk (Cervus elaphus nelsoni) in the Greater Yellowstone Area (GYA), USA, are infected with Brucella abortus, the causative agent of bovine brucellosis, and they serve as a wildlife reservoir for the disease. Bovine brucellosis recently has been transmitted from infected elk to cattle in Montana, Wyoming, and Idaho and has resulted in their loss of brucellosis-free status. An efficacious Brucella vaccine with a delivery system suitable for wildlife would be a valuable tool in a disease prevention and control program. We evaluated Strain 19 (S19) in a sustained release vehicle consisting of alginate microspheres containing live vaccine. In a challenge study using red deer (Cervus elaphus elaphus) as a model for elk, alginate, a naturally occurring polymer combined with a protein of Fasciola hepatica vitelline protein B was used to microencapsulate S19. Red deer were orally or subcutaneously immunized with 1.5 x 10(10) colony-forming units (CFUs) using microencapsulated S19. Humoral and cellular profiles were analyzed bimonthly throughout the study. The vaccinated red deer and nonvaccinated controls were challenged 1 yr postimmunization conjunctivally with 1 x 10(9) CFUs of B. abortus strain 2308. Red deer vaccinated with oral microencapsulated S19 had a statistically significant lower bacterial tissue load compared with controls. These data indicate for the first time that protection against Brucella-challenge can be achieved by combining a commonly used vaccine with a novel oral delivery system such as alginate-vitelline protein B microencapsulation. This system is a potential improvement for efficacious Brucella-vaccine delivery to wildlife in the GYA. PMID:19901378

  2. El papel de la inmunidad innata en la obesidad

    Ángeles Fortis; Rebeca García-Macedo; Carmen Maldonado-Bernal; Francisco Alarcón-Aguilar; Miguel Cruz

    2012-01-01

    La obesidad en México es un problema de salud preocupante por el incremento en la prevalencia en adultos y niños, y se considera un factor de riesgo para el desarrollo de resistencia a la insulina, así como de otras alteraciones metabólicas. En esta patología se ha observado un incremento en la expresión de los receptores tipo Toll (TLRs) en el adipocito, receptores con participación crucial en la respuesta inmune innata. Se propone que los TLRs están implicados en la inflamación sistémica y ...

  3. Immunogenicity and tolerability of inactivated flu vaccine In high risk and healthy children Inmunogenicidad y tolerancia de la vacuna inactivada anti-influenza en niños en alto riesgo y en controles sanos

    Maria Luisa Avila Aguero

    2007-08-01

    Full Text Available We conducted this open study to evaluate the immunogenicity and safety of the inactivated influenza vaccine, Imovax Gripe® in 154 children between 6 and 36 months of age at high risk of influenza- related complications, and in a reference group of 64 healthy children. The study was conducted over two flu seasons, in which the vaccine contained the same A strains but different B strains. The results for the A/H3N2 and A/H1N1 strains from the two flu seasons were pooled, but those for the B strains were not. Anti-hemagglutinin (HA antibody titers were determined before, and one month after each vaccination, and safety was evaluated based on diary card reporting any adverse event observed, either included or not in the list of "solicited events". Within each group of vaccines, the seroconversion rates, seroprotection rates, and ratio of post- to prevaccination geometric mean titers (GMTR for the A/H3N2 and the A/H1N1 strains fulfilled all requirements of the criteria of the European Union Committee for Proprietary Medicinal Products (CPMP. The immune responses in high-risk and in healthy children were similar, and consistent with those observed in previous studies conducted in healthy children. The vaccine was equally well tolerated by all study groups. Reactogenicity was low and similar in both high-risk and healthy children. Overall from 9.5% to 15.4% of at-risk children and 12% of healthy children reported a solicited local reaction; 23.0 to 28.8% of high-risk and 25.3% of healthy children reported a solicited systemic reaction. The study results provide support for vaccination of children at high-risk of influenza related complications.Se realizó un estudio clínico abierto para evaluar la inmunogenícidad y la seguridad de la vacuna inactivada anti-influenza, Imovax Gripe®, en 154 niños entre 6 y 36 meses de edad con alto riesgo de complicaciones ligadas a la influenza, y en un grupo de referencia de 64 niños sanos. El estudio fue

  4. Imunodifusão em gel de ágar com polissacarídeos de membrana de Brucella abortus 1119-3 no diagnóstico da brucelose bovina Membrane polysaccharides of Brucella abortus 1119-3 in agar gel immunodifusion test in diagnosis of bovine brucellosis

    J. Megid

    1999-10-01

    Full Text Available Comparou-se a prova de imunodifusão em gel de ágar (IDGA, utilizando extrato polissacarídico (POLI O, obtido da amostra de B. abortus 1119-3, com os testes de soroaglutinação rápida em placa, de soroaglutinação lenta em tubos, de antígeno acidificado e de 2-mercaptoetanol para o diagnóstico da brucelose bovina. O IDGA mostrou alta especificidade, porém sensibilidade inferior aos métodos convencionais.An agar gel immunodiffusion (AGID test using the polysaccharide (POLIO O extract obtained from Brucella abortus strain 1119-3, was compared to plate agglutination, tube agglutination, rose bengal plate and mercaptoethanol tests in the diagnosis of bovine brucellosis. The AGID assay with B. aborturs polysaccharide antigens, presented a greater specificity but lower sensitivity for detecting brucellosis infected animals as compared to the conventional methods of antibody detection.

  5. Herd-level prevalence and associated risk factors for Toxoplasma gondii, Neospora caninum, Chlamydia abortus and bovine viral diarrhoea virus in commercial dairy and beef cattle in eastern, northern and northeastern China.

    Sun, Wu-Wen; Meng, Qing-Feng; Cong, Wei; Shan, Xiao-Feng; Wang, Chun-Feng; Qian, Ai-Dong

    2015-11-01

    Although the seroprevalence of Toxoplasma gondii, Neospora caninum, Chlamydia abortus and bovine viral diarrhea virus infection in cattle have been reported in some areas in China, most of them were conducted with small number of cattle samples and very limited districts and neglected the assessment of herd management factors associated with herd-level prevalence of these pathogen infections. Thus, from September 2013 to December 2014, a large-scale seroprevalence study was conducted to determine the animal-level and herd-level seroprevalence and identify herd-level risk factors associated with these pathogen infections in 4487 cattle from 134 herds in five provinces (Heilongjiang, Jilin, Liaoning, Shandong, Hebei) and Inner Mongolia Autonomous Region of China. At animal level, the true prevalence of antibodies against T. gondii, N. caninum, C. abortus and bovine viral diarrhoea virus (BVDV) was 10.48, 17.14, 11.92 and 50.10%, respectively. At herd level, the true prevalence of antibodies against T. gondii, N. caninum, C. abortus and BVDV was 27.16, 29.10, 37.31 and 40.30%, respectively. Multivariate analysis of these characteristics showed that source of water and presence of felids were significantly associated with T. gondii infection in the studied cattle herds. Source of water was significantly associated with N. caninum infection in the studied cattle herds. While herd size and management system were significantly associated with BVDV infection in the studied cattle herds, this is the first report of herd-level prevalence and associated risk factors of T. gondii, N. caninum, C. abortus and BVDV infection in cattle in China. PMID:26231838

  6. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.

    Tabynov, Kaissar; Kydyrbayev, Zhailaubay; Ryskeldinova, Sholpan; Yespembetov, Bolat; Zinina, Nadezhda; Assanzhanova, Nurika; Kozhamkulov, Yerken; Inkarbekov, Dulat; Gotskina, Tatyana; Sansyzbay, Abylai

    2014-04-11

    This paper presents the results of a study of the immunogenicity and protectiveness of new candidate vector vaccine against Brucella abortus - a bivalent vaccine formulation consisting of a mixture of recombinant influenza A subtype H5N1 or H1N1 (viral constructs vaccine formulation) viruses expressing Brucella ribosomal protein L7/L12 and Omp16, in cattle. To increase the effectiveness of the candidate vaccine, adjuvants such as Montanide Gel01 or chitosan were included in its composition. Immunization of cattle (heifers aged 1-1.5 years, 5 animals per group) with the viral constructs vaccine formulation only, or its combination with adjuvants Montanide Gel01 or chitosan, was conducted via the conjunctival method using cross prime (influenza virus subtype H5N1) and booster (influenza virus subtype H1N1) vaccination schedules at an interval of 28 days. Vaccine candidates were evaluated in comparison with the positive (B. abortus S19) and negative (PBS) controls. The viral constructs vaccine formulations, particularly in combination with Montanide Gel01 adjuvant promoted formation of IgG antibodies (with a predominance of antibodies of isotype IgG2a) against Brucella L7/L12 and Omp16 proteins in ELISA. Moreover, these vaccines in cattle induced a strong antigen-specific T-cell immune response, as indicated by a high number of CD4(+) and CD8(+) cells, as well as the concentration of IFN-γ, and most importantly provided a high level of protectiveness comparable to the commercial B. abortus S19 vaccine and superior to the B. abortus S19 vaccine in combination with Montanide Gel01 adjuvant. Based on these findings, we recommended the bivalent vaccine formulation containing the adjuvant Montanide Gel01 for practical use in cattle. PMID:24598723

  7. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

    Pasquevich, Karina A; Estein, Silvia M; García Samartino, Clara; Samartino, Clara García; Zwerdling, Astrid; Coria, Lorena M; Barrionuevo, Paula; Fossati, Carlos A; Giambartolomei, Guillermo H; Cassataro, Juliana

    2009-01-01

    Available vaccines against Brucella spp. are live attenuated Brucella strains. In order to engineer a better vaccine to be used in animals and humans, our laboratory aims to develop an innocuous subunit vaccine. Particularly, we are interested in the outer membrane proteins (OMPs) of B. abortus: Omp16 and Omp19. In this study, we assessed the use of these proteins as vaccines against Brucella in BALB/c mice. Immunization with lipidated Omp16 (L-Omp16) or L-Omp19 in incomplete Freund's adjuvant (IFA) conferred significant protection against B. abortus infection. Vaccination with unlipidated Omp16 (U-Omp16) or U-Omp19 in IFA induced a higher degree of protection than the respective lipidated versions. Moreover, the level of protection induced after U-Omp16 or U-Omp19 immunization in IFA was similar to that elicited by live B. abortus S19 immunization. Flow cytometric analysis showed that immunization with U-Omp16 or U-Omp19 induced antigen-specific CD4(+) as well as CD8(+) T cells producing gamma interferon. In vivo depletion of CD4(+) or CD8(+) T cells in mice immunized with U-Omp16 or U-Omp19 plus IFA resulted in a loss of the elicited protection, indicating that both cell types are mediating immune protection. U-Omp16 or U-Omp19 vaccination induced a T helper 1 response, systemic protection in aluminum hydroxide formulation, and oral protection with cholera toxin adjuvant against B. abortus infection. Both immunization routes exhibited a similar degree of protection to attenuated Brucella vaccines (S19 and RB51, respectively). Overall these results indicate that U-Omp16 or U-Omp19 would be a useful candidate for a subunit vaccine against human and animal brucellosis. PMID:18981242

  8. Evaluation of Indirect Enzyme-Linked Immunosorbent Assays and IgG Avidity Assays Using a Protein A-Peroxidase Conjugate for Serological Distinction between Brucella abortus S19-Vaccinated and -Infected Cows ▿

    Pajuaba, Ana C. A. M.; Deise A O Silva; Mineo, José R.

    2010-01-01

    This study aimed to evaluate the use of protein A-peroxidase (horseradish peroxidase [HRPO]) in indirect enzyme-linked immunosorbent assays (iELISAs) and IgG avidity assays for serological distinction between Brucella abortus S19-vaccinated and -infected cows. Four groups were analyzed: GI, 41 nonvaccinated seropositive cows; GII, 79 S19-vaccinated heifers analyzed at 3 months postvaccination; GIII, 105 S19-vaccinated cows analyzed after 24 months of age; and GIV, 278 nonvaccinated seronegati...

  9. Caracterização epidemiológica e fatores de risco associados à infecção por Chlamydophila abortus em ovinos deslanados do semiárido brasileiro

    Areano E.M. Farias

    2013-03-01

    Full Text Available O objetivo do presente trabalho foi determinar as prevalências de propriedades positivas e animais soropositivos para Chlamydophila abortus em ovinos deslanados da região semiárida do Nordeste do Brasil, bem como identificar fatores de risco. Foram colhidas amostras de sangue de 476 ovinos procedentes de 72 propriedades em 14 municípios na mesorregião do Sertão, Estado da Paraíba. Para o diagnóstico sorológico da infecção por Chlamydophila abortus foi utilizada a reação de fixação de complemento (RFC. Uma propriedade foi considerada positiva quando apresentou pelo menos um animal soropositivo. Das 72 propriedades usadas 38 (52,8% apresentaram pelo menos um animal soropositivo, e dos 476 animais 94 (19,7% foram soropositivos. Participação em exposições (odds ratio =4,31; IC 95% =1,80-10,35; p=0,011 foi identificada como fator de risco. Sugere-se que a infecção por Chlamydophila abortus encontra-se disseminada em ovinos da região, e baseando-se na análise de fatores de risco, recomenda-se o controle sanitário nas exposições de animais.

  10. Validación del método de Ellman para la determinación de la concentración de grupos sulfhidrilosa muestras de la producción de la vacuna sintética contra el Haemophilus influenzae tipo b

    Mayra Wood-Duque

    2014-08-01

    Full Text Available e validó el método de Ellman para la determinación de grupos sulfhidrilos de la producción del Ingrediente Farmacéutico Activo de la vacuna contra el Haemophilusinfluenzaetipo b (Hib. Se evaluaron los parámetros: linealidad, rango de trabajo, especificidad, exactitud y precisión. El método fue lineal en el rango de 0,25-4 mM/L. Se demostró que la técnica fue específica con una exactitud entre 95 y 105%. La repetibilidad y la precisión intermedia mostraron coeficientes de variación inferiores al 5% y 10% respectivamente, por debajo de los criterios de aceptación requeridos para estos parámetros. Se estableció el reactivo hidrocloruro de L-cisteína monohidratado como control positivo del método. Este ensayo por su precisión, especificidad y exactitud se convierte en una eficaz herramienta para el control del proceso de obtención de esta vacuna.

  11. La supuesta asociación entre la vacuna triple vírica y el autismo y el rechazo a la vacunación The putative link between the MMR vaccine and autism and refusal to vaccinate

    Andreu Segura Benedicto

    2012-08-01

    Full Text Available La publicación del artículo de Wakefield et al. en The Lancet desencadenó una reacción de rechazo a la vacuna triple vírica, a pesar de que se trataba solo de una serie de casos y la asociación entre la vacunación y el autismo hubiera podido muy bien ser anecdótica. Sin embargo, más tarde se comprobó que tal asociación era espuria, debido no solo a sesgos ocultados sino también a alteraciones interesadas de los datos y a otros comportamientos impropios de dos de los autores que por ello fueron expulsados del colegio de médicos. Finalmente el artículo fue retirado de la revista. Este episodio invita a reflexionar sobre la credibilidad y la confianza que merecen las autoridades y los profesionales a la población, así como sobre los recelos que pueden plantearse cuando se producen potenciales conflictos de intereses entre los profesionales, la industria, las revistas y la población. Un aspecto de particular interés es el de las expectativas distorsionadas sobre las posibilidades de las intervenciones sanitarias, incluida la vacunación, especialmente respecto de la dimensión individual y la colectiva de la prevención.The paper of Wakefield et al. in The Lancet, triggered a negative reaction to the MMR vaccine, even though it was just a series of cases and the association between vaccination and autism could well be anecdotal. However, it was found that this association was spurious, not only because of hidden biases but also to alterations of the data and other improper behavior of the two authors that they were expelled from medical council. Finally, the article was removed from the magazine. This episode invites to think about the credibility and trust in the authorities and professionals to the population, as well as the suspicions that may arise when there are potential conflicts of interest among professionals, industry magazines and the population. A special area of interest is on the distorted expectations of health

  12. Los nuevos escenarios de transmisión de la fiebre hemorrágica Argentina desde la introducción de la vacuna a virus junín vivo atenuado (Candid#1: una experiencia en trabajadores golondrinas

    Ana Briggiler

    2015-01-01

    Full Text Available La fiebre hemorrágica Argentina (FHA es una enfermedad viral aguda grave causada por el virus Junín, de la familia Arenaviridae. El área endémica de la FHA coincide geográficamente con el mayor complejo agroindustrial cerealero de exportación del Argentina. Desde la implementación de la vacunación con Candid#1, se logró una importante reducción de la incidencia y se modificaron los patrones de riesgo. Un estudio previo permitió caracterizar estos cambios e identificar tres escenarios de transmisión: clásico, emergente-reemergente y viajero. Dentro de este último escenario se incluyen los trabajadores migrantes estacionales que se desplazan cada año, principalmente desde la provincia de Santiago del Estero, al área endémica para trabajar en el despanojado de maíz. Con el objetivo de brindar protección a este grupo de trabajadores se inició una campaña de prevención que incluyó: capacitación de personal de salud de esta provincia, educación para la salud e inmunización con vacuna Candid#1. Se vacunaron 3021 trabajadores. Previo a la vacunación, se tomaron muestras de suero en un grupo de 104 voluntarios. Se realizó la detección de anticuerpos neutralizantes específicos para virus Junín en el total de las mismas y 6 (5,76% arrojaron resultado positivo. El inesperado hallazgo de un elevado porcentaje de trabajadores con anticuerpos, nos sugiere la necesidad de valorar varias hipótesis: a que el resultado sea producto de un muestreo no probabilístico; b que podría tratarse de personas que enfermaron en viajes previos, c o que se vacunaron en viajes previos; d considerar esta región como un escenario emergente.

  13. Los nuevos escenarios de transmisión de la fiebre hemorrágica Argentina desde la introducción de la vacuna a virus junín vivo atenuado (Candid#1: una experiencia en trabajadores golondrinas

    Ana Briggiler

    2015-03-01

    Full Text Available La fiebre hemorrágica Argentina (FHA es una enfermedad viral aguda grave causada por el virus Junín, de la familia Arenaviridae. El área endémica de la FHA coincide geográficamente con el mayor complejo agroindustrial cerealero de exportación del Argentina. Desde la implementación de la vacunación con Candid#1, se logró una importante reducción de la incidencia y se modificaron los patrones de riesgo. Un estudio previo permitió caracterizar estos cambios e identificar tres escenarios de transmisión: clásico, emergente-reemergente y viajero. Dentro de este último escenario se incluyen los trabajadores migrantes estacionales que se desplazan cada año, principalmente desde la provincia de Santiago del Estero, al área endémica para trabajar en el despanojado de maíz. Con el objetivo de brindar protección a este grupo de trabajadores se inició una campaña de prevención que incluyó: capacitación de personal de salud de esta provincia, educación para la salud e inmunización con vacuna Candid#1. Se vacunaron 3021 trabajadores. Previo a la vacunación, se tomaron muestras de suero en un grupo de 104 voluntarios. Se realizó la detección de anticuerpos neutralizantes específicos para virus Junín en el total de las mismas y 6 (5,76% arrojaron resultado positivo. El inesperado hallazgo de un elevado porcentaje de trabajadores con anticuerpos, nos sugiere la necesidad de valorar varias hipótesis: a que el resultado sea producto de un muestreo no probabilístico; b que podría tratarse de personas que enfermaron en viajes previos, c o que se vacunaron en viajes previos; d considerar esta región como un escenario emergente.

  14. Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide.

    Aragón, V; Díaz, R; Moreno, E; Moriyón, I

    1996-02-01

    Brucella native haptens (NHs) extracted with hot water from smooth (S)-type B. abortus and B. melitensis were purified to high levels of serological activity and compared with the polysaccharide obtained by acid hydrolysis (PS) of the S lipopolysaccharide (S-LPS). By 13C nuclear magnetic resonance analysis, NHs showed the spectrum of a homopolymer of alpha-1,2- or alpha-1,2- plus alpha-1,3-linked 4-formamido-4,6-dideoxy-D-mannose (N-formylperosamine) previously reported for the LPS O chain. However, while PS contained up to 0.6% 3-deoxy-D-manno-2-octulosonate, this LPS-core marker was absent from NH. High performance liquid chromatography and thin-layer chromatography showed heterogeneity in NH purified from whole cells but not in PS. By immunoprecipitation, polysaccharides indistinguishable from NH were demonstrated in extracts obtained with phenol-water, saline at 60 degrees C, and ether-water treatments, and none of these treatments caused S-LPS hydrolysis detectable with antibodies to the O chain and lipid A. Two lines of evidence showed that NH was in the cell surface. First, NH became biotinylated when B. abortus live cells were labelled with biotin-hydrazide, and the examination of cell fractions and electron microscopy sections with streptavidin-peroxidase and streptavidin-coloidal gold, respectively, showed that labelling was extrinsic. Moreover, whereas only traces of NH were found in cytosols, the amount of NH was enriched in cell envelopes and in the outer membrane blebs spontaneously released by brucellae during growth. Interactions between NH and S-LPS were observed in crude cell extracts, and such interactions could be reconstituted by using purified NH and LPS. The results demonstrate that NH is not a hydrolytic product of S-LPS and suggest a model in which LPS-independent O-type polysaccharides (NH) are intertwined with the O chain in the outer membrane of S-type brucellae. PMID:8576040

  15. FREQÜÊNCIA DE AGLUTININAS ANTI-Brucella abortus EM CAPRINOS E OVINOS DO SERTÃO DO ESTADO DE PERNAMBUCO, BRASIL FREQUENCY OF ANTI-Brucella abortus AGGLUTININS IN GOATS AND sheep OF THE “SERTÃO” (BACKLANDS OF THE STATE OF PERNAMBUCO, BRAZIL

    Vânia Lúcia de Assis Santana

    2008-12-01

    Full Text Available Objetivou-se investigar a freqüência de aglutininas anti-Brucella abortus em caprinos e ovinos do Sertão do Estado de Pernambuco, Brasil. Foram processadas 700 amostras de soros sangüíneos, das quais 340 eram da espécie caprina (115 machos e 225 fêmeas e 360 (136 machos e 224 fêmeas ovina. Empregou-se a técnica do antígeno acidificado tamponado (AAT corado com rosa bengala (RB. Das 340 amostras de caprinos avaliadas, duas (0,6% foram reagentes ao AAT. Não se observaram associações significativas para as variáveis faixa etária (p= 0,430, raça (p= 0,936 e sexo (p= 0,562. Das 360 amostras de ovinos, nove (2,5% foram reagentes. Também não houve associação significativa entre as variáveis analisadas e a soropositividade para brucelose: faixa etária (p= 0,522; raça (p= 0,576 e sexo (p= 0,461. Verificou-se associação significativa (p= 0,042 entre as espécies estudadas e soropositividade para brucelose nos animais investigados. A soropositividade para Brucella abortus em caprinos e ovinos foi descrita pela primeira vez no Sertão de Pernambuco, fato que pode dificultar o sucesso do Programa Nacional de Controle e Erradicação da Brucelose, tendo em vista que nessa região é comum a criação consorciada de pequenos ruminantes com bovinos, além de representar riscos à Saúde Pública.

    PALAVRAS-CHAVES: Brucelose, ovinos, caprinos, pequenos ruminantes, sorodiagnóstico. The objective was to investigate the frequency of anti-Brucella abortus agglutinins in goats and sheep of the backlands of the State of Pernambuco, Brazil. 700 samples of sanguine serums were processed, of which 340 were of the goat (115 males and 225 females and 360 (136 males and 224 females sheep. The technique of the Tamponed Acidified Antigen (AAT dyed with Bengalese Rose (BR was used. Of the 340 samples of goat evaluated two (0.6% were reactive to AAT. Significant associations were not observed for the variable age group (p = 0.430; race (p = 0

  16. Eficácia e segurança da vacina brasileira contra hepatite B em recém-nascidos Eficiencia y seguridad de la vacuna brasilera contra hepatitis B en recién-nacidos Efficacy and safety of the Brazilian vaccine against Hepatitis B in newborns

    Expedito José de Albuquerque Luna

    2009-12-01

    Full Text Available OBJETIVO: Analisar a eficácia e segurança de vacina recombinante contra hepatite B em recém-nascidos. MÉTODOS: O estudo foi conduzido em hospital geral do município de Guarulhos, SP, entre 2002 e 2005. A vacina recombinante contra hepatite B do Instituto Butantan (VrHB-IB foi analisada em dois ensaios clínicos. Em ambos os ensaios, os recém-nascidos foram alocados aleatoriamente ao grupo experimental ou controle (vacina de referência. Os recém-nascidos receberam três doses das vacinas, uma em até 24 h após o nascimento e as subseqüentes 30 e 180 dias após. No primeiro ensaio 538 recém-nascidos completaram o protocolo e no segundo ensaio, 486. Considerou-se critério de equivalência a diferença na soroproteção inferior a 5%. RESULTADOS: A soroproteção no primeiro ensaio (anti HBs > 10mUI/ml foi de 92,5% (247/267 no grupo experimental, comparada a 98,5% (267/271 no grupo controle (p = 0,001. Com este resultado, a VrHB-IB não atingiu o critério de equivalência estabelecido. Após o aumento da concentração de antígeno na vacina para 25¼g, a soroproteção no segundo ensaio foi de 100% no grupo experimental e 99,2% no grupo controle. Nenhum evento adverso grave foi registrado. CONCLUSÕES: A vacina VrHB-IB modificada foi considerada equivalente à vacina de referência e seu uso recomendado à vacinação de recém-nascidos.OBJETIVO: Analizar la eficiencia y seguridad de vacuna recombinante contra hepatitis B en recién-nacidos. MÉTODOS: El estudio fue conducido en hospital general del municipio de Guarulhos, Sureste de Brasil, entre 2002 y 2005. La vacuna recombinante contra hepatitis B del Instituto Butantan (VrHB-IB fue analizada en dos ensayos clínicos. En ambos ensayos, los recién-nacidos fueron distribuidos aleatoriamente en el grupo experimental o control (vacuna de referencia. Los recién-nacidos recibieron tres dosis de las vacunas, una en máximo 24 h posterior al nacimiento y las subsecuentes 30 y 180 d

  17. Inmunogenicidad y tolerancia de una vacuna contra influenza, en una población mexicana mayor de 55 años de edad Immunogenicity and safety of the influenza vaccine, in a population older than 55-years in Mexico

    Octavio Ayala-Montiel

    2005-04-01

    Full Text Available OBJETIVO: Verificar la inmunogenicidad y tolerancia de una vacuna purificada, inactivada y fraccionada contra influenza, en adultos mexicanos derechohabientes de Petróleos Mexicanos (Pemex. MATERIAL Y MÉTODOS: Se incluyeron 90 adultos mayores de 55 años de edad, derechohabientes de los servicios médicos del Hospital Central Sur Pemex, durante los meses de noviembre y diciembre de 2000. Los criterios evaluados en relación con la inmunogenicidad incluyeron el porcentaje de sujetos protegidos, cuantificados por medio de anticuerpos antihemaglutininas superior o igual a 1:40, así como por el porcentaje de seroconversión determinado por el título inicial de anticuerpos multiplicado por un factor 4X. Los criterios secundarios fueron la frecuencia de reacciones adversas tanto locales como sistémicas. Se realizaron estudios de afinidad antígeno-anticuerpo para determinar la respuesta policlonal de anticuerpos y de anticuerpos de alta afinidad prevacunación y posvacunación. Se calcularon frecuencias y porcentajes. RESULTADOS: Se identificó una seroprotección en 95.6% de los sujetos a la cepa H1N1, de 98.9% a la cepa H3N2 y de 100% a la cepa B/ Yamanashi. En cuanto a los porcentajes de seroconversión, se identificó un incremento 4X de 74.4 para la cepa H1N1, de 88.9 para la cepa H3N2, y de 82.2 para la cepa B / Yamanashi. Un total de 18 individuos (20% presentaron reacciones locales, mientras que 17 (18.8% presentaron reacciones sistémicas a los cinco días posvacunación y nueve sujetos (10% a los 28 días. Las reacciones locales a los cinco días consistieron en dolor, en 10 individuos (11.1%; enrojecimiento, en ocho (8.8%, e induración, en seis (6.6%. Malestar general, cefalea y fiebre se presentaron a los cinco días en 10, 8.8, y 0% de individuos, respectivamente, y en 4.4, 6.6, y 0%, respectivamente, a los 28 días. CONCLUSIONES: Esta vacuna contra influenza demostró ser altamente inmunogénica en adultos mexicanos mayores de 55 a

  18. La retirada de una campaña publicitaria para promoción de la vacuna tetravalente del virus del papiloma humano en España Withdrawal of an advertising campaign to promote the quadrivalent human papilloma virus vaccine in Spain

    Marta Martín-Llaguno

    2010-01-01

    Full Text Available La inclusión de la vacuna tetravalente del virus del papiloma humano (VPH en el Sistema Nacional de Salud aviva el debate sobre Gardasil®, presentada ante la opinión pública como «la vacuna contra el cáncer de cérvix». En este contexto, Sanofi Pasteur MSD es demandada por publicidad engañosa por la campaña cuentaselo.org. Pese a que la querella no se admite a trámite, la acción desencadena cinco cambios en la titularidad del dominio de la web que, avalada por sociedades científicas, queda sin razón legal. Por vulnerar la Ley de la Sociedad de Servicios de la Información, y ante la sospecha de que detrás está la farmacéutica (que no puede hacer publicidad de su producto, la plataforma para la moratoria de la vacuna del virus del papiloma humano reclama a la Sociedad Española de Ginecología y Obstetricia (presente en la web ante Autocontrol. Sanofi Pasteur MSD, anunciante no mencionado, «acepta la reclamación y da de baja la web», corroborando así su implicación.The inclusion of the quadrivalent human papilloma virus (HPV vaccine in the schedule of the Spanish National Health System sparked the debate over Gardasil®, which was presented to the public as a "vaccine against cervical cancer". In this context, Sanofi Pasteur MSD was sued for misleading advertising in the campaign "cuentaselo.org". Although the complaint was not admitted, the lawsuit triggered five changes in the ownership of the web domain which, although backed by scientific societies, was not supported by law. Because of the violation of the Law of the Society of Information Services, and prompted by the suspicion that the pharmaceutical company was behind these changes (as it could not advertise the product, the platform for the moratorium on the HPV vaccine filed a complaint against the Spanish Society of Gynecology and Obstetrics (whose logo appeared on the webpage for breaching the code of advertising self-regulation. Sanofi Pasteur MSD, the advertiser

  19. Transmission of the allergy reaction of a delayed type against Salmonella abortus ovis through blood plasma of gamma-irradiated guinea pigs

    Use is made of blood plasma taken from guinea pigs (sensibilized with a live culture of Salmonella abortus ovis and then irradiated with 800 rad gamma-rays) to transmit the skin allergy reaction to normal, nonsensibilized guinea pigs. The allergy reaction has been demonstrated in the recipients of plasma as early as the 3-4th hour following the injection of the allergen into the skin. It reaches its peak at the 12-24th hour and later on strongly diminishes, remaining in few of the animals only up to the 48th hour. The infiltrate at the site of injection in the skin of positively reacting animals contains at the 24th hour cells of the polymorphonuclear type, which predominate, while the cells of the mononuclear type are few in number. There are no precipitins in the plasma of the donors, and the titer of the agglutinins and the cytophile antibodies is very low. Regardless of these findings it is concluded that the transmitted allergy reaction is of the fast type (after Arthuss), and not of the delayed one. (author)

  20. A serological prevalence survey of Brucella abortus in cattle of rural communities in the province of KwaZulu-Natal, South Africa : article

    U.W. Hesterberg

    2008-05-01

    Full Text Available A serological survey of Brucella abortus in cattle originating from communal grazing areas of Kwa Zulu Natal was carried out between March 2001 and December 2003. The survey was designed as a 2-stage survey, considering the diptank as the primary sampling unit. In total 46 025 animals from 446 diptanks of 33 magisterial districts were sampled and tested using the Rose Bengal test and Complement Fixation Test. The apparent prevalence at district level was adjusted for clustering, diagnostic test sensitivity and specificity, and mapped using ArcView version 3.3. The prevalence of brucellosis in communal grazing areas of Kwa-Zulu Natal was found to be 1.45 % (0.84-2.21 % and varied from 0 to 15.6% between magisterial districts. In 19 of the 33 magisterial districts no serological reactors were observed. A large variation in prevalence was found within diptank areas. Brucellosis was found to be most prevalent in the northeastern area of the province. The findings of the survey are discussed.

  1. Serological profile of buffalo (Bubalus bubalis) female calves vaccinated with standard Brucella abortus strain 19 vaccine using rose bengal, 2-mercaptoethanol and complement fixation tests.

    Nardi, G Júnior; Ribeiro, M G; Jorge, A M; Megid, J; Silva, L M P

    2012-03-01

    The serological profiles of 21 female buffaloes vaccinated between 3 and 8 months of age using Brucella abortus strain 19 (S19) were evaluated by rose bengal (RBT), 2-mercaptoethanol (2ME) and complement fixation (CFT) tests. The serum strains were collected in day zero, 15, 30, 45, 60th days and subsequently to each 30 months, until 720th day after vaccination. No animal showed reaction in day zero. In 15th day above 95% of animals revealed reaction in all tests. All the animals presented absence of reactions in CFT, RBT and 2ME tests at 270, 300 and 360 days after vaccination, respectively. Our finding highlighted early response in CFT compared than other conventional agglutination tests. None of animals presented oscillation of titers or reactions in any test after 360 day of study, which enables the use of these tests after this period without interference of antibodies from S19 vaccine origin between 3 and 8 months in buffalo heifers. PMID:22284623

  2. Brucella melitensis Biovar 1 and Brucella abortus S19 Vaccine Strain Infections in Milkers Working at Cattle Farms in the Khartoum Area, Sudan

    Osman, Amira E. F.; Hassan, Abdullahi N.; Ali, Ali E.; Abdoel, Theresia H.; Smits, Henk L.

    2015-01-01

    Background Human brucellosis is a preventable zoonoses that may become persistent, causing, if left untreated, severe localized disease. Occupational exposure to infected animals or animal products and consumption of fresh contaminated dairy are main risk factors. Methods One hundred farmworkers employed at two cattle farms one in Khartoum North and one in Omdurman were screened for the presence of specific antibodies and seropositive workers were invited to donate a blood sample for blood culture. Molecular typing was used to characterize Brucella isolates. Results Ten percent of farmworkers tested seropositive and while Brucella melitensis biovar 1 was isolated from the blood of three individuals, an isolate identical to the B. abortus S19 vaccine strain was isolated from a fourth person. All four bacteremic individuals were employed as milkers and did not have obvious disease. Conclusions The isolation of the highly infectious pathogen B. melitensis from seropositive workers is consistent with the notion that the pathogen may persist in the blood without causing overt disease. While vaccination with strain S19 is essential for the control of bovine brucellosis the vaccine strain may be transmitted to the human population and protective measures remain important to prevent exposure also in view of the presence of B. melitensis. To create awareness for this potentially severe disease more information on the prevalence of the pathogen in different risk groups and in livestock in the Sudan is needed. PMID:25938483

  3. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice.

    Mukherjee, Falguni; Jain, Jainendra; Grilló, Maria Jesús; Blasco, José María; Nair, Mrinalini

    2005-09-01

    Two Brucella abortus S19 commercial vaccine strains used for vaccination against brucellosis in India and three S19 strains available as international reference were examined by microbiological assays and molecular analysis of the ery loci involved in erythritol metabolism, and tested for residual virulence in BALB/c mice. According to the sensitivity to penicillin and i-erythritol, the five strains tested had the phenotypic characteristics of strain S19. However, on culture medium containing i-erythritol, all strains developed spontaneous i-erythritol resistant colonies at mutation rates ranging from 1.42x10(-2) to 1.33x10(-6). The S19 characteristic 702 bp deletion in the erythrulose 1-phosphate dehydrogenase gene of the ery locus was present only in the three reference strains but not in the two commercial vaccines. Both commercial strains and one of the reference strains showed reduced virulence in BALB/c mice. The presence or absence in S19 strains of the 702 bp deletion in the ery locus had no correlation with either the rates of spontaneous mutation to erythritol resistance or the residual virulence in mice. PMID:16081301

  4. Mass vaccination as a complementary tool in the control of a severe outbreak of bovine brucellosis due to Brucella abortus in Extremadura, Spain.

    Sanz, Cristina; Sáez, José Luis; Alvarez, Julio; Cortés, María; Pereira, Gema; Reyes, Aurelia; Rubio, Félix; Martín, Javier; García, Nerea; Domínguez, Lucas; Hermoso-de-Mendoza, María; Hermoso-de-Mendoza, Javier

    2010-11-01

    We report the evolution of an outbreak of bovine brucellosis (Brucella abortus) in the region of Extremadura (Spain) involving more than 1000 herds and nearly 40,000 animals. S19 vaccination of young cattle combined with a test and slaughter strategy did not result in a rapid decrease in herd prevalence and animal incidence; these parameters showed a constant decreasing trend only when a combination of restriction of cattle movements, increased test frequency, S19 vaccination and mass RB51 vaccination (with yearly revaccinations) were applied to all susceptible populations. These measures were applied for 5 years; abortions following RB51 vaccination of pregnant cows were limited to the first inoculation and the involvement of the vaccine strain could only be demonstrated in 78 out of 897 abortions. Our results demonstrate the usefulness - and lack of significant side effects - of RB51 mass vaccination as a complementary tool to control bovine brucellosis outbreaks in areas where the disease cannot be contained using more conservative approaches. PMID:20833439

  5. Structural and functional insights into the stationary-phase survival protein SurE, an important virulence factor of Brucella abortus.

    Tarique, K F; Abdul Rehman, S A; Devi, S; Tomar, Priya; Gourinath, S

    2016-05-01

    The stationary-phase survival protein SurE from Brucella abortus (BaSurE) is a metal-dependent phosphatase that is essential for the survival of this bacterium in the stationary phase of its life cycle. Here, BaSurE has been biochemically characterized and its crystal structure has been determined to a resolution of 1.9 Å. BaSurE was found to be a robust enzyme, showing activity over wide ranges of temperature and pH and with various phosphoester substrates. The active biomolecule is a tetramer and each monomer was found to consist of two domains: an N-terminal domain, which forms an approximate α + β fold, and a C-terminal domain that belongs to the α/β class. The active site lies at the junction of these two domains and was identified by the presence of conserved negatively charged residues and a bound Mg(2+) ion. Comparisons of BaSurE with its homologues have revealed both common features and differences in this class of enzymes. The number and arrangement of some of the equivalent secondary structures, which are seen to differ between BaSurE and its homologues, are responsible for a difference in the size of the active-site area and the overall oligomeric state of this enzyme in other organisms. As it is absent in mammals, it has the potential to be a drug target. PMID:27139831

  6. Confirmação de infecção por Brucella abortus em um rebanho bovino certificado livre em Minas Gerais: relato de caso

    P.M. Soares Filho

    2012-10-01

    Full Text Available Relata-se a ocorrência de um surto de brucelose em um rebanho de aproximadamente 1000 animais, livre da doença há 18 anos, certificado pelo Ministério da Agricultura, Pecuária e Abastecimento desde 2006. Dois animais reagiram aos testes sorológicos de diagnóstico por ocasião dos procedimentos de recertificação em 2008. Após o sacrifício deles, Brucella abortus, biovariedade 1, amostra não vacinal, foi isolada e identificada por meio de provas bioquímicas e de biologia molecular (PCR AMOS. A origem do agente no rebanho é de difícil determinação. No entanto, a adoção de procedimentos preconizados pelo Programa Nacional de Controle e Erradicação da Brucelose permitiu evitar a disseminação da enfermidade. Ocorrências como essas, em que rebanhos livres foram infectados após anos sem a ocorrência de brucelose, nunca haviam sido relatadas no Brasil.

  7. Brucella melitensis Biovar 1 and Brucella abortus S19 Vaccine Strain Infections in Milkers Working at Cattle Farms in the Khartoum Area, Sudan.

    Amira E F Osman

    Full Text Available Human brucellosis is a preventable zoonoses that may become persistent, causing, if left untreated, severe localized disease. Occupational exposure to infected animals or animal products and consumption of fresh contaminated dairy are main risk factors.One hundred farmworkers employed at two cattle farms one in Khartoum North and one in Omdurman were screened for the presence of specific antibodies and seropositive workers were invited to donate a blood sample for blood culture. Molecular typing was used to characterize Brucella isolates.Ten percent of farmworkers tested seropositive and while Brucella melitensis biovar 1 was isolated from the blood of three individuals, an isolate identical to the B. abortus S19 vaccine strain was isolated from a fourth person. All four bacteremic individuals were employed as milkers and did not have obvious disease.The isolation of the highly infectious pathogen B. melitensis from seropositive workers is consistent with the notion that the pathogen may persist in the blood without causing overt disease. While vaccination with strain S19 is essential for the control of bovine brucellosis the vaccine strain may be transmitted to the human population and protective measures remain important to prevent exposure also in view of the presence of B. melitensis. To create awareness for this potentially severe disease more information on the prevalence of the pathogen in different risk groups and in livestock in the Sudan is needed.

  8. Fermentación de alto rendimiento de haemophilus influenzae no tipificable y expresión de la proteína p6: un acercamiento a la producción de una vacuna purificada. parte I High yield fermentation of haemophilus influenzae and protein p6 expression: an approach to the production of a purified vaccine. part I

    Zuluaga D.

    1998-06-01

    Full Text Available

    EI presente artículo describe una metodología eficiente, simple y económica para la obtención de altas densidades celulares de Haemophilus influenzae, con el fin de producir vacunas tanto celulares como acelulares. Se describe un método de cultivo en líquido para este microorganismo, el cual no había sido implementado en el país. Después de varios años de investigación por parte de varios grupos, principalmente debido a los bajos rendimientos obtenidos o a los altos costos de las formulaciones más exitosas. Se evalúa el sistema, con respecto a medios sólidos y líquidos de referencia, teniendo en cuenta la cinética de crecimiento, los costos y la expresión de los antígenos más promisorios como vacuna purificada.

    The present article describes an efficient, simple and unexpensive method for the production of high cellular densities of Haemophilus influenzae for cellular and cell free vaccine production. We present here a liquid culture-based method that had not been successfully implemented in Colombia, so far having given low yields and high costs. The kinetics, costs and production of the most promisory antigen candidates for vaccine production were evaluated in liquid and solid reference media.

  9. Vacuna idiotípica en el tratamiento del linfoma folicular: situación actual y perspectivas futuras Idiotype vaccines in the treatment of follicular lymphoma: current status and future perspectives

    N. Zabalegui

    2009-04-01

    Full Text Available El linfoma folicular (LF está considerado como el segundo tipo de linfoma no-Hodgkin más común, representando más del 20% del total de los linfomas. Es una enfermedad de progresión lenta y curso indolente en la que, a pesar de la buena respuesta al tratamiento, las recaídas son muy frecuentes y cada vez es más difícil conseguir respuestas completas. Por ello, se puede considerar que hasta el momento, el LF es incurable. La búsqueda continua de nuevas estrategias terapéuticas en enfermedades neoplásicas, junto con un mejor conocimiento del sistema inmunitario, ha llevado a la aparición de una nueva disciplina, conocida con el nombre de inmunoterapia, que aprovecha la capacidad del sistema inmunitario de atacar lo extraño sin dañar lo propio. El LF es un tumor muy apropiado para este tipo de tratamiento por presentar un antígeno específico de tumor: el idiotipo de la inmunoglobulina monoclonal expresada en la membrana de todas las células tumorales. Se han realizado diversos estudios en los que se ha probado la inmunoterapia como tratamiento complementario al tratamiento convencional. Recientemente, nuestro grupo ha publicado un estudio en el que se observa claramente que los resultados que se obtienen tras la vacunación idiotípica, cuando se consigue la inmunización adecuada del paciente, son mejores que los obtenidos con quimioterapia sola. En este sentido, es necesario seguir investigando para aclarar si la vacunación idiotípica pudiera no sólo mantener remisiones completas duraderas en los pacientes vacunados, sino incluso conseguir la curación de los mismos. Por ello, resulta interesante abordar un mejor planteamiento de los ensayos clínicos, la mejora de la producción de la vacuna y el estudio de mecanismos de la célula tumoral capaces de modificar la inmunoglobulina específica del tumor.Follicular lymphoma is the second most prevalent non-Hodgkin lymphoma, representing 20% of all lymphomas. Follicular lymphoma is

  10. Incidencia de la gripe y efectividad de la vacuna antigripal en la temporada 2004-2005 Incidence of influenza and influenza vaccine effectiveness in the 2004-2005 season

    J. Castilla

    2006-04-01

    Full Text Available Fundamento. Cuantificar la incidencia de gripe en distintos grupos de la población de Navarra en la temporada 2004-2005 y evaluar la efectividad de la vacunación antigripal. Métodos. El análisis de los casos de gripe del sistema de enfermedades de declaración obligatoria se ha complementado con las notificaciones individualizadas de la red de médicos centinela que atiende a una población de 22.339 habitantes. Se estudió la cobertura y efectividad de la vacuna. Resultados. La cobertura vacunal en ≥65 años alcanzó el 62%. La incidencia de gripe fue de 42,6 casos por 1.000 habitantes. Alcanzó el máximo a mediados de enero, superando 750 casos semanales por 100.000 habitantes y 1.900 casos por 100.000 niños. La mayor tasa de gripe se observó en menores de 15 años (49,4 casos por 1.000 habitantes y la menor en ≥65 años no institucionalizados (2,6 por 1.000 habitantes, aunque fue mayor en residencias geriátricas (62,1 por 1.000; pBackground. To quantify the incidence of flu in different groups of the population of Navarra in the 2004-2005 season, and to evaluate the effectiveness of anti-flu vaccination. Methods. The analysis of influenza cases in the system of compulsory notificable diseases was complemented by the individualised notifications in the network of sentinel doctors that covers a population of 22,339 inhabitants. The coverage and effectiveness of the vaccine was studied. Results. Vaccine coverage in ≥65 year olds reached 62%. The incidence of influenza was 42.6 cases per 1,000 inhabitants. It reached a maximum in mid-January, exceeding 750 weekly cases per 100,000 inhabitants and 1,900 cases per 100,000 children. The highest rate of influenza was observed in under-15 year olds (49.4 cases per 1,000 inhabitants and the lowest in non-institutionalised ≥65 year olds (2.6 per 1,000 inhabitants, although it was higher in geriatric residences (62.1 per 1,000; p<0.0001. Seventy-nine percent of the cases from 5 to 64

  11. Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

    Pasquevich, Karina A.; Estein, Silvia M.; Samartino, Clara García; Zwerdling, Astrid; Coria, Lorena M.; Barrionuevo, Paula; Fossati, Carlos A.; Giambartolomei, Guillermo H.; Cassataro, Juliana

    2009-01-01

    Available vaccines against Brucella spp. are live attenuated Brucella strains. In order to engineer a better vaccine to be used in animals and humans, our laboratory aims to develop an innocuous subunit vaccine. Particularly, we are interested in the outer membrane proteins (OMPs) of B. abortus: Omp16 and Omp19. In this study, we assessed the use of these proteins as vaccines against Brucella in BALB/c mice. Immunization with lipidated Omp16 (L-Omp16) or L-Omp19 in incomplete Freund's adjuvan...

  12. Use of S-[2,3-Bispalmitoyiloxy-(2R)-Propyl]-R-Cysteinyl-Amido-Monomethoxy Polyethylene Glycol as an Adjuvant Improved Protective Immunity Associated with a DNA Vaccine Encoding Cu,Zn Superoxide Dismutase of Brucella abortus in Mice

    Retamal-Díaz, Angello; Riquelme-Neira, Roberto; Sáez, Darwin; Rivera, Alejandra; Fernández, Pablo; Cabrera, Alex; Guzmán, Carlos A.; Oñate, Angel

    2014-01-01

    This study was conducted to evaluate the immunogenicity and protective efficacy of a DNA vaccine encoding Brucella abortus Cu,Zn superoxide dismutase (SOD) using the Toll-like receptor 2/6 agonist S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol (BPPcysMPEG) as an adjuvant. Intranasal coadministration of BPPcysMPEG with a plasmid carrying the SOD-encoding gene (pcDNA-SOD) into BALB/c mice elicited antigen-specific humoral and cellular immune responses. Hu...

  13. Prevalência e fatores de risco associados à infecção por Chlamydophila abortus em granjas suinícolas tecnificadas no Estado de Alagoas, Brasil

    Rômulo M. B. Valença

    2011-01-01

    Full Text Available Objetivou-se com este estudo calcular a prevalência e identificar os fatores de risco associados à infecção por Chlamydophila abortus em suínos criados em granjas tecnificadas no Estado de Alagoas, Brasil. Para compor a amostra do estudo foram utilizados 342 suínos, sendo 312 matrizes e 30 varrões oriundos de sete granjas de ciclo completo e distribuídas em cinco municípios do Estado de Alagoas. O diagnóstico sorológico da infecção por C. abortus foi realizado através da microtécnica de Fixação do Complemento (RFC. A análise dos fatores de risco foi realizada por meio da aplicação de questionários investigativos, constituídos por perguntas objetivas referentes ao criador, às características gerais da propriedade, ao manejo produtivo, reprodutivo e sanitário. Observou-se prevalência de 10,5% (36/342 de suínos soropositivos para a infecção por C. abortus, com 85,8% das granjas analisadas com animais positivos. As variáveis que demonstraram associação significativa foram: utilização de bebedouros comuns para jovens e adultos (p=0,024; OR=10,83; IC=1,36-86,03 e método de cobertura de monta natural associada à inseminação artificial (p=0,05; OR=7,62; IC=1,00-58,31. Relata-se a primeira ocorrência de anticorpos anti-C. abortus em suínos no Brasil. Fatores como a introdução de reprodutores nos plantéis e a forma de fornecimento de água foram evidenciados como facilitadores da infecção das matrizes neste estudo. Dessa forma, medidas de controle da infecção devem ser enfocadas nesse aspecto para evitar a disseminação do agente nas granjas suinícolas e em outros plantéis da região.

  14. Chlamydophilose abortive ovine : études à propos d'une suspicion de résistance de Chlamydophila abortus au vaccin vivant thermosensible dans des élevages ovins laitiers du rayon de Roquefort

    Uhart, Maia

    2009-01-01

    Des cas d'avortements imputés à Chlamydophila abortus ont été décrits dans des élevages de brebis du rayon Roquefort (France, 12) alors que ces élevages pratiquaient la vaccination contre la chlamydophilose avec un vaccin vivant depuis plusieurs années. De brefs rappels bibliographiques concernant la chlamydophilose et la vaccination contre cette maladie sont présentés en première partie. Une enquête menée auprès de neuf éleveurs est ensuite exposée afin d'expliquer la persistance d'avortemen...

  15. Vacuna de la desconfiança

    Bueno i Torrens, David, 1965-

    2009-01-01

    Les persones som un niu de contradiccions. D'una banda, volem gaudir de bona salut, i llevat de comptades excepcions demanem que la ciència ens proveeixi de tot el que cal per aconseguir-ho. D'altra banda però, tendim a desconfiar dels seus resultats i de les recomanacions dels especialistes, però tanmateix acostumem a fer-ho per motius aliens a la ciència [...].

  16. Estratégias de campo em ensaios clínicos com novas vacinas produzidas no Brasil Estrategias de campo en ensayos clínicos con nuevas vacunas producidas en Brasil Clinical trials field strategies with novel vaccines produced in Brazil

    Emília de Faria Carniel

    2012-06-01

    Full Text Available OBJETIVO: Relatar as estratégias de campo utilizadas em dois ensaios clínicos com vacinas desenvolvidas pelo Instituto Butantan, em 2004 e 2006. MÉTODOS: Estudo do tipo relato de experiência, em que se descreve o planejamento e a operacionalização dos ensaios clínicos, que avaliaram a imunogenicidade e a segurança da vacina BCG combinada com a vacina da hepatite B (VrHB-IB e da tetravalente bacteriana modificada pela extração do lipopolissacarídeo (LPS do componente pertussis (DTPm/Hib. RESULTADOS: As principais estratégias de campo utilizadas foram: a Parceria entre os pesquisadores e os gestores da Secretaria Municipal de Saúde e b Realização dos procedimentos da pesquisa nos domicílios ou nos Centros de Saúde frequentados pelos participantes. No primeiro estudo, foram vacinados 552 recém-nascidos na maternidade com a BCG/VrHB-IB (combinadas ou separadas e nos domicílios, com as duas doses subsequentes de VrHB-IB. O segundo estudo incluiu 241 lactentes em Centros de Saúde da rede municipal, vacinados com tetravalente bacteriana (com componente pertussis total ou modificado. Em ambos os estudos, amostras de sangue foram colhidas nas residências. Não houve relatos de eventos adversos. A adesão foi de 90,2% para o primeiro estudo e 93,8%, para o segundo. As vacinas foram administradas nas datas preconizadas pelo Programa Nacional de Imunizações e as coletas de sangue, de acordo com o cronograma dos estudos. CONCLUSÕES: As estratégias utilizadas facilitaram o recrutamento das crianças e garantiram cumprir o protocolo da pesquisa com alta adesão, sem interferir no vínculo da família com o Serviço de Saúde, no calendário vacinal ou no seguimento pediátrico dos participantes.OBJETIVO: Relatar las estrategias de campo utilizadas en dos ensayos clínicos con vacunas desarrolladas por el Instituto Butantan, en 2004 y 2006. MÉTODOS: Estudio de tipo relato de experiencia, en que se describe la planificación y la

  17. Influenza pandemic (H1N1 2009 activity during summer 2009: Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain Actividad de la gripe pandémica (H1N1 2009 durante el verano de 2009: Efectividad de la vacuna trivalente 2008-9 frente a la gripe pandémica en España

    Amparo Larrauri

    2011-02-01

    Full Text Available Introduction: The Spanish influenza surveillance system (SISS maintained its activity during the summer of 2009 to monitor the influenza pandemic. Objectives: To describe pandemic influenza activity from May to September 2009 and to estimate the effectiveness of the 2008-9 seasonal influenza vaccine against laboratory-confirmed pandemic (H1N1 2009 influenza. Methods: Data from the SISS were used to identify the trend of pandemic (H1N1 2009 influenza outside the influenza season. For the effectiveness study, we compared the vaccination status of notified cases [influenza-like illnesses (ILI laboratory confirmed as pandemic influenza] with that of the test-negative controls. Results: The first laboratory-confirmed case of the pandemic virus was notified in the system in week 20/2009. The ILI rate increased gradually in the study period, exceeding basic activity in week 38. The proportion of pandemic (H1N1 2009 influenza viruses detected by the system represented 14% in week 20/2009 and rapidly increased to 90% in week 34. The adjusted vaccine effectiveness of the 2008-9 seasonal vaccine against laboratory-confirmed pandemic influenza was 12% (-30; 41. Conclusions: The SISS became an essential tool for pandemic monitoring in Spain. The improved SISS will provide more accurate information on influenza activity in future seasonal or pandemic waves. Using surveillance data, we could not demonstrate the effectiveness of the seasonal 2008-9 vaccine against laboratory-confirmed pandemic influenza.Introducción: El Sistema de Vigilancia de Gripe en España (SVGE continuó y reforzó su actividad durante el verano de 2009 con el objetivo de vigilar la evolución de la pandemia en España. Objetivos: Describir la actividad de la gripe pandémica en España de mayo a septiembre de 2009 y estimar la efectividad de la vacuna antigripal estacional 2008-2009 frente a casos confirmados de gripe pandémica (H1N1 2009. Métodos: Se utilizaron datos del SVGE para

  18. Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows.

    Pajuaba, Ana C A M; Silva, Deise A O; Mineo, José R

    2010-04-01

    This study aimed to evaluate the use of protein A-peroxidase (horseradish peroxidase [HRPO]) in indirect enzyme-linked immunosorbent assays (iELISAs) and IgG avidity assays for serological distinction between Brucella abortus S19-vaccinated and -infected cows. Four groups were analyzed: GI, 41 nonvaccinated seropositive cows; GII, 79 S19-vaccinated heifers analyzed at 3 months postvaccination; GIII, 105 S19-vaccinated cows analyzed after 24 months of age; and GIV, 278 nonvaccinated seronegative cows. IgG levels and avidity to B. abortus smooth lipopolysaccharide (S-LPS) were determined using anti-bovine IgG-HRPO or protein A-HRPO conjugates. Similar levels of IgG anti-S-LPS were found with GI using both conjugates. Lower IgG levels were detected with GII, GIII, and GIV using protein A-HRPO. Both conjugates showed high performance in discriminating GI from GIII, with high sensitivity (Se; 97.6%) and specificity (Sp; 97.1%). Protein A-HRPO was better in distinguishing GI from GIV (Se, 97.6%; Sp, 94.6%) and GI from GII (Se, 80.5%; Sp, 94.9%). Protein A-HRPO excluded a higher number of positive samples with GII and GIV. IgG avidity showed that protein A-HRPO, but not anti-IgG-HRPO, was able to distinguish nonvaccinated from vaccinated cattle, showing a higher avidity index (AI) with GI than with GII, with 78% of serum samples in GII showing an AI of abortus S-LPS antigen and protein A-HRPO conjugate for preferential detection of the IgG2 subclass was shown to be suitable for serological distinction between S19-vaccinated and -infected cows. Also, antibodies generated after vaccination showed lower avidity, suggesting a role for the IgG2 subclass as an antibody of higher-affinity maturation after infection, constituting an additional tool for differentiating vaccinated from infected cattle. PMID:20147498

  19. Respuesta serológica a la vacunación contra brucelosis en bovinos provenientes de un rebaño libre vacunados con dos dosis de vacuna Cepa RB-51 Serological response to brucellosis vaccination in bovines from a free herd vaccinated with two doses of RB-51

    C Ramírez

    2009-01-01

    Full Text Available Se realizó una encuesta prospectiva con la finalidad de determinar la respuesta serológica a las pruebas oficiales aplicadas en Chile para la detección de brucelosis bovina que son Rosa de Bengala (RB, Fijación de Complemento (FC y Elisa de Competencia (C-Elisa, en hembras adultas vacunadas con dos dosis de vacuna Cepa RB-51 provenientes de un rebaño libre de la enfermedad con certificación vigente otorgada por el Servicio Agrícola y Ganadero (SAG del Ministerio de Agricultura de Chile. Se seleccionaron 100 hembras bovinas mayores de 18 meses con la finalidad de tener una confianza de un 90% de que la proporción de positivos no será mayor a un 2,95% si todos los animales muestreados resultan negativos. Los bovinos fueron vacunados vía subcutánes con vacuna Cepa RB-51 en dosis de 1-3.4 x 10(10 UFC con una diferencia de 30 días entre la primera y segunda aplicación; la fecha de la primera vacunación correspondió al día cero del estudio. Los días 0, 30 y 60 se tomaron muestras de 10 ml de sangre por venopunción coccígea de cada animal seleccionado. Las muestras se procesaron en el Laboratorio de Referencia de Brucelosis Bovina del SAG, Osorno, X Región, Chile. Ningún animal presentó reacción serológica atribuible a la vacunación con RB-51 que puedan interferir con las pruebas diagnósticas actualmente utilizadas para la detección de la brucelosis bovina.A prospective study was carried out in order to determine the serological response to the official tests used in Chile for the detection of bovine brucellosis which are Rose Bengal (RB, Complement Fixation (CF and Competing Elisa (C-ELISA, in adult cows vaccinated with two doses of vaccine strain RB-51 from a brucellosis free herd as certified by the Servicio Agrícola y Ganadero (SAG of the Ministry of Agriculture of Chile. A total of 100 female bovines older than 18 months were selected in order to be 90% confident that the proportion of positives in cows vaccinated twice

  20. El proceso de revisión a la traducción de Francisco Xavier Balmis del Tratado histórico y práctico de la vacuna, de Moreau de la Sarthe The revision process of Francisco Xavier Balmis' translation of Moreau de la Sarthe's Historical and Practical Treatise on Vaccines

    José Tuells

    2012-08-01

    Full Text Available El Tratado histórico y práctico de la vacuna de Moreau de la Sarthe, traducido por Francisco Xavier de Balmis y publicado en 1803, fue uno de los protagonistas de la Real Expedición Filantrópica de la Vacuna, convirtiéndose en el primer Manual de Vacunaciones oficial reconocido así por un gobierno. En 1801, Balmis decide traducirlo, y se suma a la primera hornada de difusores del método de Edward Jenner en España. Analizamos el procedimiento a que fue sometido desde su envío para revisión hasta su edición final, en el que transcurren 16 meses. Tras una remisión incompleta, el revisor señala a Balmis errores en el estilo, en la propia traducción y omisiones a pasajes de la obra original. La decisión final tras las correcciones fue de aceptación, aunque no obtuvo la autorización deseada por Balmis para incluir una dedicatoria a la Reina, hecho que incrementaría su impacto, justificado en la consideración de que no era una obra singular en su género o de un mérito sobresaliente. Finalmente, Balmis lo dedica a las madres de familia. Con una tirada inicial de 500 ejemplares y una inmediata posterior de 2000, tuvo una amplia difusión en la América latina. El estudio destaca la influencia de los evaluadores en la calidad de la producción científica.Moreau de la Sarthe's Traité historique et pratique de la vaccine, translated by Francisco Xavier de Balmis and published in 1803, was one of the protagonists of the Royal Philanthropic Expedition of the Vaccine, and became the first official vaccination manual recognized by a government. Balmis decided to translate Moreau's work in 1801, joining the first generation of disseminators of Edward Jenner's method in Spain. The translation process from return for review to final publication 16 months later is analyzed in this article. After Balmis submitted the still-incomplete work, the reviewer pointed out errors in style and in the translation itself, and omissions of passages from

  1. Análise dos eventos adversos pós-vacinais ocorridos em Teresina Análisis de los eventos adversos pós vacunas ocurridos en Teresina Analysis of after-vacination side-effects occurred in Teresina

    Telma Maria Evangelista de Araújo

    2007-08-01

    Full Text Available Este estudo trata do perfil dos eventos adversos pós-vacinais ocorridos em Teresina em 2006. Os dados foram coletados mediante a aplicação de formulário com 73 participantes em 18 Unidades Básicas de Saúde. Os resultados mostram que as vacinas que mais produziram eventos adversos foram a tetravalente, BCG e DPT. Os eventos mais freqüentes foram: febre, episódio hipotônico hiporresponsivo, irritabilidade e manifestações locais moderadas. Dentre as condutas adotadas pelos profissionais de saúde, aproximadamente 80% foram adequadas. Os menores de ano foram os mais acometidos pelos eventos. Todos os eventos evoluíram para a cura. Conclui-se que a ação de vacinação ainda continua requerendo capacitação constante dos profissionais da área. Sugere-se aprofundar o conhecimento com relação ao manejo, diagnóstico, investigação e tratamento.El presente estudio trata del perfil de las ocurrencias adversas de la después-vacuna en Teresina en 2006. Los datos fueron recogidos por medio del uso un formulário a lo cual participaran 73 personas en 18 unidades básicas de salud. Los resultados demuestraran que las vacunas que tenían más ocurrencias adversas fueran la tetravalente, BCG y DPT. Las ocurrencias más frecuentes fueran: fiebre, episodio hipotônico hiporresponsivo, irritabilidad moderada y manifestaciones locales. Entre los comportamientos adoptados por los profesionales de salud, 80% fueran ajustados aproximadamente. Los menores de edad del año habían sido acometidos por los acontecimientos. Todos los acontecimientos fueran desarrollados para la cura. Se hay concluydo que la acción de la vacunación todavía continúa requiriendo la calificación constante de los profesionales de la área. Se sugiere para profundizar el conocimiento en relación a la dirección, a la diagnosis, a la investigación y al tratamiento.This study focuses the profile of the adverse events after-vaccine occurrences in Teresina in 2006. The data

  2. Respuesta de anticuerpos inducidos por la vacuna antimeningocócica cubana VA-MENGOC-BC® frente a la cepa de Neisseria meningitidis B:4:P1.19,15 en adolescentes después de 12 años de inmunizados

    María A. Camaraza

    2006-12-01

    Full Text Available Se estudió la respuesta de anticuerpos inducida por la vacuna antimeningocócica cubana VA-MENGOC-BC® contra la cepa de Neisseria meningitidis B:4:P1.19,15 mediante el Ensayo Bactericida del Suero (EBS y ELISA de tipo indirecto, para medir anticuerpos contra vesículas de membrana externa (VME de N. meningitidis B a 184 adolescentes de un politécnico de Ciego de Ávila que fueron inmunizados en campañas masivas 12 años antes. Se realizaron extracciones de sangre antes de aplicar la primera dosis (T0, 4 semanas después de ésta (T1 y 4 semanas después de la segunda dosis (T2. Transcurridos 12 años de esta vacunación el 42% de los adolescentes presentó títulos bactericidas ≥ 1:4 frente a la cepa homóloga (B:4:P1.19,15 y el 98% mostró anticuerpos detectables contra las VME. En el EBS; el porcentaje de seroconversión T1/T0 fue del 57% y T2/T0 del 60%. Mediante ELISA la seroconversión fue del 59% y 54%, respectivamente, por lo que se demostró que la aplicación de una sola dosis después de 12 años indujo una respuesta inmune importante que puede sugerir una respuesta anamnésica.

  3. Cloning and prokaryotic expression of virB8 gene of Brucella abortus%牛布氏菌virB8基因的克隆及原核表达

    张瑞; 王秀然; 夏力亮; 李晓艳; 王兴龙; 王景龙; 冉会玲; 钱晶

    2012-01-01

    Objective To clone the virBS gene of Brucella abortus and express in E. coli . Methods The virBS gene was amplified by PCR from genomic DNA of B. abortus S19 and inserted into pEASY-El vector. The constructed recombinant plasmid pEASY-virB8 was transformed to E. coli BL21 (DE3) for expression under induction of IPTG. The expressed product was purified by HisTrap, FF chromatography and identified by SDS-PAGE and Western blot. Resultus The length of amplified virBS gene was 720 bp. Restriction analysis and sequencing proved that recombinant plasmid pEASY-virB8 was constructed correctly. The expressed recombinant protein,with a relative molecular mass of about 30 000,contained 17. 3% of total somatic protein and reached a purity of 85% after purification. At a protein concentration of 1. 52 mg/ml determined by Lowry method,the expressed product showed specific binding to mouse monoclonal antibody against His. Conclusion The virB8 gene of B. abortus was successfully cloned and expressed in E. coli,which provided an effective candidate antigen for development of novel vaccines.%目的 克隆牛布氏菌virB8基因并在大肠杆菌中进行表达.方法 从牛布氏菌S19基因组DNA中PCR扩增virB8基因片段,插入pEASY-E1载体中,构建重组表达质粒pEASY-virB8,转化E. coli BL.21(DE3),IPTG诱导表达.表达产物经HisTrapTM FF纯化后,进行SDS-PAGE分析和Western blot鉴定.结果 扩增的virB8基因大小为720 bp;重组表达质粒pEASY-virB8经双酶切及测序证实构建正确;表达的重组蛋白相对分子质量约为30000,表达量占菌体总蛋白的17.3%;纯化的重组蛋白纯度为85%,Lowry法测定蛋白浓度为1.52 mg/ml,可与鼠抗His单抗特异性结合.结论 成功克隆了牛布氏菌virB8基因,并在大肠杆菌中表达了重组蛋白,为新型疫苗的研发及布氏菌鉴别诊断方法的建立提供了有效的候选抗原.

  4. Ocorrência de anticorpos anti-Brucella abortus e anti-Brucella canis em cães rurais e urbanos do Município de Monte Negro, Rondônia, Brasil

    Aguiar Daniel Moura de

    2005-01-01

    Full Text Available Foram avaliados 304 cães de ambiente rural e urbano do município de Monte Negro, Rondônia, através do Antígeno Acidificado Tamponado (AAT, Soroaglutinação Lenta em Tubos (SAL e 2-Mercaptoetanol (2-ME para a pesquisa de anticorpos anti-Brucella abortus e da Imunodifusão em gel de ágar (IDGA e Imunodifusão em gel de ágar com soro tratado com 2-Mercaptoetanol (IDGA-ME para Brucella canis. Foram consideradas positivas as amostras reagentes nas provas confirmatórias do 2-ME e IDGA-ME. Verificaram-se 56 (18,4% animais reagentes ao AAT e 12 (4,0% reagentes a SAL. Apenas um cão (0,3% foi considerado positivo, confirmado pela prova do 2-ME. Foram observadas 11 (3,6% reações á IDGA, porém não houve confirmação na prova do IDGA-ME. Ressalta-se a baixa ocorrência de cães positivos ao 2-ME e a ausência de animais reagentes á IDGA-ME.

  5. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.

    Pasquevich, Karina A; García Samartino, Clara; Coria, Lorena M; Estein, Silvia M; Zwerdling, Astrid; Ibañez, Andrés E; Barrionuevo, Paula; Oliveira, Fernanda Souza de; Carvalho, Natalia Barbosa; Borkowski, Julia; Oliveira, Sergio Costa; Warzecha, Heribert; Giambartolomei, Guillermo H; Cassataro, Juliana

    2010-05-01

    Knowing the inherent stimulatory properties of the lipid moiety of bacterial lipoproteins, we first hypothesized that Brucella abortus outer membrane protein (Omp)16 lipoprotein would be able to elicit a protective immune response without the need of external adjuvants. In this study, we demonstrate that Omp16 administered by the i.p. route confers significant protection against B. abortus infection and that the protective response evoked is independent of the protein lipidation. To date, Omp16 is the first Brucella protein that without the requirement of external adjuvants is able to induce similar protection levels to the control live vaccine S19. Moreover, the protein portion of Omp16 (unlipidated Omp16 [U-Omp16]) elicits a protective response when administered by the oral route. Either systemic or oral immunization with U-Omp16 elicits a Th1-specific response. These abilities of U-Omp16 indicate that it is endowed with self-adjuvanting properties. The adjuvanticity of U-Omp16 could be explained, at least in part, by its capacity to activate dendritic cells in vivo. U-Omp16 is also able to stimulate dendritic cells and macrophages in vitro. The latter property and its ability to induce a protective Th1 immune response against B. abortus infection have been found to be TLR4 dependent. The facts that U-Omp16 is an oral protective Ag and possesses a mucosal self-adjuvanting property led us to develop a plant-made vaccine expressing U-Omp16. Our results indicate that plant-expressed recombinant U-Omp16 is able to confer protective immunity, when given orally, indicating that a plant-based oral vaccine expressing U-Omp16 could be a valuable approach to controlling this disease. PMID:20351187

  6. Socioeconomic profile of children who did not join the rotavirus vaccine schedule Perfil socioeconómico de niños que no cumplieron con el régimen de una vacuna contra el rotavirus Perfil socioeconômico das crianças que não aderiram ao esquema da vacina contra o rotavírus

    Gabriella Miranda Martins

    2011-12-01

    enfermedad. Objetivo: Evaluar el perfil socio-económico de las familias de los niños que no cumplan con el régimen de la vacuna contra el rotavirus. Métodos: A través de la tarjeta de sombra, el uso de la salud de la comunidad en el Centro de Salud Cecy Fortes, se analizó el estado de vacunación de los niños nacidos entre abril de 2009 a enero de 2011. Los registros de la familia de los niños que no realizaron la descripción completa de la vacuna contra el rotavirus fue evaluado sobre la base de los datos sentados en la misma en relación a su perfil socioeconómico. Resultados y discusión: De 183 tarjetas de sombra evaluados, 25 fueron incompletos o ausentes en un régimen de la vacuna y los registros de la familia fueron evaluados. Sesenta y ocho por ciento de las familias perciben ingresos inferiores a dos salarios mínimos, lo que representa un riesgo de lesión a causa de enfermedades diarreicas. Sin embargo, el 96% de los padres saben leer y escribir, y el 100% de las familias viven en casas con condiciones adecuadas de saneamiento, lo que infiere un buen pronóstico. Conclusión: Las familias de estos niños son en su mayoría compuestas por padres que saben leer y escribir, tienen ingresos familiares inferiores a dos salarios mínimos y las condiciones de la vivienda y el saneamiento son satisfactorias.

    Introdução: O rotavírus apresenta distribuição universal, determinando episódios de gastrenterite aguda, endêmica em regiões de clima tropical. A forma mais eficaz de evitá-la é por meio da imunização. Crianças vindas de ambiente com melhores condições e mais elevado nível sociocultural tendem a ter melhor prognóstico, enquanto aquelas vindas de famílias carentes apresentam maior risco de gravidade da doença. Objetivo: Avaliar o perfil socioeconômico das famílias das crianças que não aderiram ao esquema da vacina contra o rotav

  7. El papel de la inmunidad innata en la obesidad The role of innate immunity in obesity

    Ángeles Fortis

    2012-04-01

    Full Text Available La obesidad en México es un problema de salud preocupante por el incremento en la prevalencia en adultos y niños, y se considera un factor de riesgo para el desarrollo de resistencia a la insulina, así como de otras alteraciones metabólicas. En esta patología se ha observado un incremento en la expresión de los receptores tipo Toll (TLRs en el adipocito, receptores con participación crucial en la respuesta inmune innata. Se propone que los TLRs están implicados en la inflamación sistémica y en el desarrollo de la resistencia a la insulina. La activación de los TLRs es mediada por ácidos grasos y su expresión está regulada por leptina, adiponectina y PPAR. El conocimiento de la función de los TLRs, tanto en la inflamación como en la diferenciación del adipocito es importante en la búsqueda de nuevos blancos terapéuticos antiinflamatorios que coadyuven en el tratamiento de la obesidad.Obesity in Mexico is alarmingly increasing in prevalence in adults and children, and it is a risk factor for the development of insulin resistance, as well as, of other metabolic alterations. The discovery of the expression of the Toll-like receptors (TLRs in adipocytes, suggests an important role in innate immunity. In different models of obesity, there has been observed an increase of TLRs expression in the fat tissue, therefore TLRs could be involved in systemic inflammation in this disease, and in the development of insulin resistance. TLR activation is mediated by fatty acids and their expression is regulated by leptin, adiponectin and PPARs. Knowledge of the role of TLRs in inflammation and adipocyte differentiation and their regulation, then it is important to try to develop new therapeutic anti-inflammatory targets that contribute in the treatment of obesity.

  8. La acumulación de reservas y la inmunidad financiera (o durmiendo con el enemigo)

    Perichinsky, Leonardo

    2008-01-01

    Cerca del 90% de las reservas internacionales se encuentran colocadas en títulos públicos (fundamentalmente norteamericanos) y depósitos a plazo en los centros financieros internacionales. Resulta bastante inconsistente el argumento de que estas reservas son las que nos resguardan de las perturbaciones financieras en el exterior. Por ello, cabria interrogarse cuales son las razones por las cuales desde agosto del 2007, la crisis de subprime en EE. UU. no han tenido efectos en la economía arge...

  9. Relación de la inmunidad en mucosas y la microbiota con las enfermedades inflamatorias

    Martínez de Castro, Sara

    2015-01-01

    Existe un equilibrio perfecto entre el ser humano y la comunidad bacteriana que lo coloniza, denominada microbiota. Nuestro organismo está habitado por millones de bacterias establecidas en comunidades que sobreviven gracias al microambiente que las personas le proporcionamos, a cambio de que cumplan sus funciones en el mantenimiento de la homeostasis. El reciente descubrimiento de esta compleja interacción y su importancia en el desarrollo de enfermedades ha abierto un importante camino en l...

  10. Estudio de mecanismos de la inmunidad innata en la patogénesis de la leptospirosis

    Cedola, Maia Tatiana

    2014-01-01

    El trabajo de tesis consta de tres bloques: 1) la caracterización de dos proteínas (BatA y BatB) codificadas en el genoma de Leptospira interrogans; 2) el estudio del rol de los neutrófilos durante la infección con Leptospira interrogans, utilizando un modelo de leptospirosis murina experimental; 3) el análisis de la relación entre el polimorfismo Arg753Gln del TLR2 humano y la leptospirosis.

  11. El papel de la inmunidad innata en la obesidad The role of innate immunity in obesity

    Ángeles Fortis; Rebeca García-Macedo; Carmen Maldonado-Bernal; Francisco Alarcón-Aguilar; Miguel Cruz

    2012-01-01

    La obesidad en México es un problema de salud preocupante por el incremento en la prevalencia en adultos y niños, y se considera un factor de riesgo para el desarrollo de resistencia a la insulina, así como de otras alteraciones metabólicas. En esta patología se ha observado un incremento en la expresión de los receptores tipo Toll (TLRs) en el adipocito, receptores con participación crucial en la respuesta inmune innata. Se propone que los TLRs están implicados en la inflamación sistémica y ...

  12. Efecto booster de una inmunización activa con Leptospira interrogans serogrupo Ballum en hámsters vacunados con vax-SPIRAL®

    Andrés González

    2003-06-01

    Full Text Available Se evaluó en hámsters la inmunidad cruzada y capacidad protectora conferidas por la vacuna antileptospirósica trivalente vax-SPIRAL® frente a Leptospira interrogans serogrupo Ballum, así como el efecto de una inmunización activa con preparación vacunal monovalente de Ballum en animales previamente inmunizados con la vacuna trivalente. La respuesta IgG específica a Ballum, Canicola, Icterohaemorrhagiae y Pomona inducida tras cada inmunización se determinó mediante un sistema ELISA cuantitativo de células enteras. La capacidad de protección heteróloga de vax-SPIRAL® se evaluó frente al reto con 100 y 10 000 DL50 de dos cepas clínicas de Ballum altamente virulentas. Tras 14 días de culminado el esquema de inmunización la vacuna trivalente indujo un 100% de seroconversión de IgG específica a Ballum en los animales inmunizados y una total protección cruzada frente a la infección letal y la prevalencia de leptospiras en hígado y riñón. La aplicación de una única dosis de preparación monovalente de Ballum tras 6 semanas de culminado el esquema de inmunización de vax-SPIRAL® reforzó la inmunidad frente a los cuatro serogrupos de Leptospira de mayor circulación en humanos en Cuba.

  13. Evaluación del Programa de Acción de la Ganadería Vacuna de algunas Provincias de la Región Oriental (Cuba - Evaluation of the action program of the cattle industry of some provinces of the Oriental Region (Cuba.

    Ramírez, W .

    2008-03-01

    Full Text Available ResumenLa concepción esencial de la legislación, ha estado dirigida a preservar la salud animal, muy particularmente en lo referente a las enfermedades infecciosas y parasitarias. La situación sanitaria del país ha mejorado sustancialmente, particularmente en los últimos años y ello ha inducido a modificar la concepción curativa por la productiva. Tomándose en cuenta el uso racional de los recursos. El objetivo del presente trabajo, consiste en evaluar el Programa de Acción de la Ganadería Vacuna en sus primeros cuatro años de ejecución en tres de las provincias orientales del país. Para el presente trabajo, se tomaron los datos de los Boletines Estadísticos del IMV del 2002 al 2005 por meses de las provincias orientales denominadas A, B y C. Se llevó a cabo un análisis de varianza de clasificación simple, totalmente aleatorizado para determinar la posible diferencia entre sus medias; también se aplicó el modelo de regresión lineal simple (T = β0 + β1 x para determinar su comportamiento en el tiempo. En general, los resultados no son los esperados, por tanto, se concluye que los programas con medidas no del todo especificas y probablemente también, por la falta de una mayor exigencia en su ejecutoria, debe implicar una consecuente revisión. AbstractThe essential conception legislation has been directed to preserved animal health, particularly in reference to infections and parasitic diseases. The sanitary situation of the country has improved substantially, particularly in the last years and has induced a modification of the curative conception by the production, taking in account the rational use of the resources. The objective of the present investigation, consist in the evaluation of the action program of the cattle industry en it’s first four years of utilization in three of the oriental provinces of the country. For the present work datas from statistical records of the Veterinary Medicine Institute were collected

  14. Hallazgo de antígenos en un tumor murino espontáneo no inmunogénico mediante el uso de una vacuna basada en células dendríticas Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell-based vaccine

    Verónica L. Reffo

    2008-08-01

    Full Text Available La inmunoterapia sería un tratamiento ideal contra el cáncer porque combina eficacia y especificidad, pero hasta hoy no ha dado resultados exitosos contra tumores establecidos. En este trabajo abordamos el problema de la falta de inmunogenicidad de los tumores espontáneos como una posible causa del fracaso de la inmunoterapia. Nos preguntamos si esta falta de inmunogenicidad se debe a la ausencia de antígenos o a la existencia de mecanismos tolerogénicos que impiden a esos antígenos iniciar una respuesta inmune. Para deslindar entre ambas alternativas, utilizamos dos tumores murinos -uno espontáneo y no inmunogénico (linfoma LB y otro inducido por metilcolantreno y fuertemente inmunogénico (fibrosarcoma MC-C- y la técnica de inmunización con células dendríticas (DC estimuladas con extracto acelular de tumor. Al estimular DC in vitro con extracto de LB, las DC no exhibieron maduración ni inmunizaron in vivo contra implantes de LB. Por otro lado, extractos de MC-C, hicieron madurar las DC y las convirtieron en poderosas vacunas contra implantes de MC-C pero no de LB, indicando que MC-C y LB no tienen antígenos compartidos. Por último, cuando DC fueron estimuladas con una mezcla de los extractos de LB y MC-C, expresaron marcadores de maduración y exhibieron capacidad vacunante contra LB. Estos resultados sugieren que el tumor LB tiene antígenos específicos de tumor pero carece de otras señales necesarias para la maduración de las DC. Estas señales serían aportadas por el extracto de MC-C, permitiendo de este modo iniciar una respuesta inmune contra LB.Up to date, most attempts to use immunotherapy to cause the regression of animal and human established tumors have not been successful. Former experiments have postulated that this failure could be attributed, at least in part, to a lack of immunogenicity of spontaneous tumors. In this paper, we have investigated whether this lack of immunogenicity can be attributed to the

  15. Epidemiology, reemergence of pertussis and vaccine development in Latin America: an overview

    Celso Pérez-Bolaños

    2011-01-01

    Full Text Available Pertussis o tosferina es una enfermedad bacteriana aguda del tracto respiratorio, causada principalmente por Bordetella pertussis y en menor medida por Bordetella parapertussis. Bordetella pertussis ocupa el quinto lugar en la lista de muertes atribuidas a enfermedades prevenibles por vacunas en niños menores de cinco años en todo el mundo. Se ha reportado que provoca morbilidad y mortalidad significativa, tanto en países desarrollados como en países en desarrollo. La enfermedad es más severa en niños pequeños, pero su prevalencia ha sido observada en todo el mundo en todos los grupos de edad, aún después del desarrollo de vacunas a partir de células completas contra pertussis en los años cuarenta del pasado siglo. Desde la última década ha sido reportada una re-emergencia de pertussis en muchos países desarrollados, incluidos aquellos con una elevada cobertura de vacunación por años. Varios factores pudieran provocar la re-emergencia de pertussis, por ejemplo, una mayor conciencia del problema, un mejor diagnóstico mediante la implementación de técnicas de PCR, disminución de la cobertura de vacunación, la utilización de vacunas de baja protección, baja inmunidad inducida por vacunas y adaptación del patógeno. Este trabajo revisa el estado actual de la epidemiología y la re-emergencia de la enfermedad en América Latina y enfoca la situación actual en Cuba, para dar un panorama de la aplicación de estrategias novedosas en el desarrollo de vacunas futuras, así como medidas generales, recomendadas para el tratamiento de la enfermedad.

  16. Desarrollo de vacunas para el control de garrapatas.

    Canales García-Menocal, Mario Manuel

    2010-01-01

    Las garrapatas Rhipicephalus (Boophilus) spp. afectan a la ganadería de los países de zonas tropicales y subtropicales provocando perdidas millonarias a la industria. Los métodos de control para combatirlas emplean baños garrapaticidas que contaminan el medio ambiente, la carne y la leche, y seleccionan garrapatas cada vez más resistentes. La vacunación, empleando la proteína rBm86 aislada del intestino de Rhipicephalus microplus como antígeno, controló eficazmente infestaciones por R. microp...

  17. Construction of mutant Brucella Abortus S19 strain and evaluation of immunization in mice%流产布氏杆菌S19突变株构建及在小鼠感染模型中的免疫保护评估

    郑孝辉; 胡森; 王加兰; 刘林涛; 高红霞; 步志高

    2009-01-01

    通过构建标记疫苗株来解决流产布氏杆菌(B.abortus)鉴别诊断方面的缺陷,本研究以bp26基因作为重组靶住点,S19为亲本,利用bp26基因ORF外侧序列作为同源重组序列,卡那霉素抗性基因(Kanr)为抗性筛选标记,通过双交叉重组筛选获得bp26基因缺失突变的重组S19株,命名为S19-△26.小鼠感染结果表明,突变株S19-△26的残留毒力与亲本株S19相比较没有发生明显改变,康复时间约为15周,突变株S19-△26、亲本株S19和B.abortus强毒株S544接种小鼠后的第3周能检测出"O"抗原的特异性抗体,而第6周开始S19和S544接种小鼠BP26特异性抗体明显升高,S19-△26接种的小鼠一直没检测到BP26特异性抗体.小鼠免疫保护试验显示,脾脏分离CFU数比空白对照要低310g10,S544攻击后脾脏细菌分离数表明突变株具有与亲本疫苗株免疫保护性无明显差异.结果表明,S19-△26免疫能够通过血清学方法与野生型B.abortus感染后的免疫反应相区别,具备作为标记疫苗的潜力.%Brucella abortus strain S19 played an important role in preventing and monitoring brucellosis with high protective rate. S19-△26, a Mutant bp26 gene of B. Abortus S19 strain was constructed by replacing the bp26 gene of attenuated S19 with kanamycin resistence gene. Compared with Si9, mutant S19-△26 possessed the same recover time (15 weeks) and residual virulence in mice, However it did not induce anti-bp26 antibody production in Mice, which would differentiate animals infected with S19-△26 from those infected by S19 and S544. The mutant S19-△26 possesses the same protective ability as S19, which could reduce CFU number of strain S544 infection in mice by 31og10. Altogether, these results indicate that B. Abortus S19-△26 could be a promising vaccine strain in preventing brucellosis.

  18. 西藏职业技术学院实验农场牛布病与结核病的净化措施%Discussion on the Cleaning Measures of Tibet Vocational Technology College Test Farm Brucellosis Brucella Abortus and Tuberculosis

    金红岩; 封家旺

    2011-01-01

    牛布病和结核病分别是由布鲁氏杆菌和结核分枝杆菌引起的人畜共患传染病,严重危害养牛业可持续发展和人民身体健康,危害公共卫生安全.一旦发生,如不能采取有效的净化措施,不仅给畜牧养殖业造成很大损失,而且也严重威胁人体健康.随着奶牛业在全国各地迅速发展,奶牛交易流通的增加,及奶产品在人们饮食结构中的比例越来越大,奶牛的布氏杆菌病、结核病发病率已在悄然上升,饮用未经消毒的牛奶易使人感染布氏杆菌病和牛型结核病[1].%Bovine brocellosis and tuberculosis are the anthropozoonosis caused by bmcellsis leucosis and myeobaeterium tuberculosis which seriously harms the sustainable development of cattle industry and people's health and the public health security. Once happened, if no proper effective cleaning measures are adopted, it will result in the big loss for livestock breeding industry as well as people's health. With the rapid development of dairy industry and the increase in number of cow trade and the the big proportion of milk at people's daily food, the brucellosis brucella abortus and tuberculosis have increased quietly. Drinking the unsterilized milk will make people infect the brucellosis brucella abortus and tuberculosis.

  19. Valoración del contenido de hierro y sodio, del estado microbiológico y aceptabilidad de la carne vacuna kosher, en la ciudad de Rosario, 2009 Valuation of the content of iron and sodium, microbiological state and preference of kosher meat kosher, in rosario city, 2009

    P Chaín

    2010-12-01

    Full Text Available La carne vacuna para ser denominada kosher, es sometida a un método ritual donde la sangre se derrama rápidamente. El presente estudio fue realizado con el objetivo de evaluar el contenido de hierro (Fe++ y sodio (Na+; Salmonella Typhimurium, Listeria Monocytogenes y el pH para cotejarlos con estándares establecidos; y asimismo evaluar la aceptabilidad de dicha carne. Para el análisis de Fe++ y Na+; Salmonella Typhimurium, Listeria Monocytogenes y pH se llevó a cabo un estudio de tipo cuantitativo descriptivo analítico. Se tomaron tres muestras del corte tapa de asado Kosher. La determinación del contenido de Fe++, Na+ y pH se realizó según Normas Association of Analytical Communities (AOAC OFF. METHOD 990.08, 966.16 y 981.12 respectivamente. La valoración microbiológica de: Salmonella Typhimurium y Listeria Monocytogenes se efectuó según Food and Drug Administration- Bacteriological Analitiycal Manual (FDA B.A.M 8th. Luego los resultados de Fe++ y Na+ se compararon con lo establecido según la tabla de Composición Química de Alimentos del Centro de Endocrinología Experimental y Aplicada (CENEXA,1995. Los resultados microbiológicos se compararon con parámetros establecidos por el Código Alimentario Argentino (CAA y Organización de las Naciones Unidas para la Agricultura y la Alimentación/ Organización Mundial de la Salud (FAO/OMS y Los resultados de pH se cotejaron con los valores en los cuales puede existir crecimiento de microorganismo (pH=6,5. Además, se llevó a cabo un estudio de tipo cuantitativo participativo transversal para la realización de la evaluación sensorial. En la misma participaron alumnos de 3er año de la Licenciatura en Nutrición de la Facultad de Química de Universidad del Centro Educativo Latinoamericano (UCEL. El valor promedio hallado para el Fe++ fue de 1,85 miligramos: mg/100 g, para el Na+ de 266 mg/100 g, produciéndose una remoción del 6 % y un incremento de 3,4 veces respectivamente

  20. Etika vrlin, moralne dileme in abortus

    Logar, Tea

    2012-01-01

    Etika vrlin si v zadnjih nekaj desetletjih skuša izboriti enakopravno mesto poleg deontologije in utilitarizma, dveh osrednjih filozofskih moralnih teorij. Rosalind Hursthouse, ena najvidnejših predstavnic etike vrlin, zagovarja tezo, da lahko ta teorija usmerja in vrednoti posameznikovo ravnanje prav tako zanesljivo in dosledno kot njeni tekmici. Še več, Hursthousova trdi, da lahko etika vrlin nudi napotke za etično ravnanje celo v situacijah, ki jim ostale moralne teorije niso kos; to naj b...

  1. Factores asociados a una respuesta inadecuada a la vacunación contra la hepatitis B en personal sanitario

    Tolosa Martínez Natividad

    1998-01-01

    Full Text Available FUNDAMENTO: La vacuna recombinante contra la hepatitis B confiere inmunidad aproximadamente en el 95 % de los casos, pero existe un porcentaje que responde insuficientemente. El objetivo de este trabajo es evaluar los factores que se asocian con una inadecuada respuesta inmunitaria. MÉTODOS: Se trata de un estudio observacional y analítico en el que se sigue retrospectivamente una cohorte de sujetos vacunados frente al virus de la hepatitis B (VHB. Se recogieron las variables de interés del personal sanitario que cumplía los criterios de inclusión, del Área de Salud 9 de la Comunidad Valenciana (n=827. Tras la vacunación se determinó la titulación de anticuerpos de superficie (antiHBs para comprobar la respuesta, considerándose niveles protectores los superiores a 10 mUI/ml. RESULTADOS: Se produjo una adecuada seroconversión en el 94,4% de los vacunados. La baja o nula respuesta a la vacuna se asoció significativamente y de forma independiente con variables como el sexo masculino, la edad, el índice de masa corporal (IMC y el tabaquismo. El consumo de alcohol y los niveles de GPT, aunque no se relacionaron de forma significativa con la respuesta a la vacuna, actuaron como posibles factores de confusión. CONCLUSIONES: La inmunogenicidad de la vacuna es satisfactoria. Es importante cuantificar los niveles de antiHBs, sobretodo cuando hay factores predictivos de mala respuesta. De esta manera, es posible identificar a aquellos que precisan dosis de recuerdo y a los no respondedores, evitándose así situaciones de falsa sensación de protección frente al VHB.

  2. Validación del ensayo bactericida en suero para los serogrupos A, C y W135 de Neisseria meningitidis

    2012-01-01

    El ensayo bactericida en suero se considera la herramienta más eficaz para medir el estado de la inmunidad en individuos vacunados contra N. meningitidis y constituye el soporte analítico para el desarrollo de las vacunas a base de polisacáridos. Las normas de Buenas Prácticas de Fabricación y control de la calidad de productos farmacéuticos plantean que la validación debe aplicarse tanto a los procesos de fabricación como a los métodos de análisis y de control. Es de particular interés en el...

  3. Anestesia em criança com síndrome de Guillain-Barré após vacina de sarampo: relato de caso Anestesia en un niño con síndrome de Guillain-Barré después de la vacuna de sarampión: relato de caso Anesthesia in Guillain-Barré pediatric patient after measles vaccination: case report

    Deoclécio Tonelli

    2005-12-01

    Full Text Available JUSTIFICATIVA E OBJETIVOS: A síndrome de Guillain-Barré após vacina de sarampo é rara. O diagnóstico muitas vezes é tardio, o que leva a um aumento da morbidade. O presente relato apresenta um caso avançado e os cuidados especiais exigidos durante a anestesia. RELATO DO CASO: Paciente do sexo masculino, com quatro anos de idade com síndrome de Guillain-Barré desde um ano de idade, foi submetido a gastrostomia sob anestesia geral sem intercorrências, com sevoflurano e sem bloqueadores neuromusculares. CONCLUSÕES: O caso ilustra a raridade etiológica de uma síndrome importante na prática anestésica assim como os eventos adversos pós-vacinação, a melhor escolha para a equipe anestésica e as complicações da síndrome de Guillain-Barré na infância.JUSTIFICATIVA Y OBJETIVOS: El síndrome de Guillain-Barré después de la vacuna de sarampión es rara. El diagnóstico en la mayoría de las veces es tardío, lo que lleva a un aumento de la morbidez. Este actual relato presenta un caso avanzado y todas las atenciones especiales exigidas durante la anestesia. RELATO DEL CASO: Paciente del sexo masculino, con cuatro años de edad con síndrome de Guillain-Barré desde hace un año de edad, fue sometido a gastrostomía bajo anestesia general sin intercurrencias, con sevoflurano y sin bloqueadores neuromusculares. CONCLUSIONES: El caso ilustra la rareza etiológica de una síndrome importante en la práctica anestésica, así como los eventos adversos pos-vacunación, la mejor elección para el equipo anestésico y las complicaciones de la síndrome de Guillain-Barré en la infancia.BACKGROUND AND OBJECTIVES: Guillain-Barré syndrome following measles vaccination is uncommon. Diagnosis is often delayed, leading to increased morbidity. This report describes an advanced Guillain-Barré case and the special approaches required during anesthesia. CASE REPORT: Male patient, four years old, with Guillain-Barré syndrome diagnosed at 1 year of

  4. Polyarteritis nodosa related with influenza vaccine = Poliarteritis nodosa relacionada con vacuna contra la influenza

    Restrepo Escobar, Mauricio

    2013-01-01

    Full Text Available Vasculitis can be secondary to various processes, among them infections, malignancies, connective tissue diseases or medications, or primary, generally idiopathic. The reported adverse events after vaccination can be mild and transient or more serious such as autoimmune diseases. Possibly the most frequently described autoimmune phenomena after influenza vaccination are different forms of vasculitis. We report the case of a patient who presented a clinical picture of vasculitis classified as polyarteritis nodosa that began two weeks after receiving the influenza vaccine. After critically reviewing the literature, this would be the first clearly documented case of polyarteritis nodosa associated with vaccination against influenza.

  5. "Necesita una vacuna": what Spanish-speakers want in text-message immunization reminders.

    Ahlers-Schmidt, Carolyn R; Chesser, Amy; Brannon, Jennifer; Lopez, Venessa; Shah-Haque, Sapna; Williams, Katherine; Hart, Traci

    2013-08-01

    Appointment reminders help parents deal with complex immunization schedules. Preferred content of text-message reminders has been identified for English-speakers. Spanish-speaking parents of children under three years old were recruited to develop Spanish text-message immunization reminders. Structured interviews included questions about demographic characteristics, use of technology, and willingness to receive text reminders. Each participant was assigned to one user-centered design (UCD) test: card sort, needs analysis or comprehension testing. Respondents (N=54) were female (70%) and averaged 27 years of age (SD=7). A card sort of 20 immunization-related statements resulted in identification of seven pieces of critical information, which were compiled into eight example texts. These texts were ranked in the needs assessment and the top two were assessed for comprehension. All participants were able to understand the content and describe intention to act. Utilizing UCD testing, Spanish-speakers identified short, specific text content that differed from preferred content of English-speaking parents. PMID:23974378

  6. Viejos y nuevos enfoques para el desarrollo de vacunas contra la tuberculosis.

    H. Bercovier

    2000-03-01

    Full Text Available Do we need renewed efforts to develop new vaccines to fight tuberculosis? Epidemiological data show that the decrease of the already low incidence of tuberculosis has stopped in developed countries. In certain Western countries the incidence of tuberculosis has even increased in the last ten years. In Africa and in Asia, a high incidence of tuberculosis is found similar to that of the Western world in the 1930s. Can we predict from the history of tuberculosis in Western Europe that the epidemic of tuberculosis in developing countries has reached his peak or is still developing? Revisited data from Europe show that the epidemic of tuberculosis started at least three centuries before it reached its apogee in the middle of the 19th century. The reasons for the decrease of tuberculosis in the first half of the 20th century in the Western world are still not well understood. Will public health measures and proper antibiotic treatment reduce and stop tuberculosis in Africa and in Asia or will the incidence of tuberculosis increase? Our ability to control the spread of the disease is complicated by the appearance of antibiotic resistant strains and HIV. Therefore, a better understanding of the molecular basis for the interaction between the bacilli and the hosts is necessary for the development of improved approaches for treatment and immunization. Cellular immunity and delayed type hypersensitivity (DTH are key processes in the course of mycobacterial infection and are involved in both primary and secondary infection as well as in the induction of protective immunity in the host. The different types of tuberculosis vaccines being reevaluated comprise: BCG with booster, oral BCG, modified BCG (multivalent, auxotrophic M. tuberculosis attenuated strains, M. tuberculosis secreted proteins or recombinant proteins with or without immunomodulators and DNA vaccines. These new vaccines inducing a good cellular immunity may contribute to the development of improved approaches for immunization and treatment.

  7. Vacunas terapéuticas recombinantes contra el cáncer del cuello uterino

    BERUMEN JAIME

    1997-01-01

    Full Text Available Durante el desarrollo del cáncer cervicouterino se inducen mecanismos para evadir el sistema inmune, como son la disminución de la expresión de moléculas de antígeno mayor de histocompatibilidad I y la secreción de citocinas por las células tumorales. Como consecuencia de ello, la estimulación de linfocitos T citotóxicos (LTC y cooperadores (TC, de células asesinas naturales (AN y macrófagos es muy deficiente. Para inducir una respuesta inmune efectiva contra el tumor, se requiere la estimulación simultánea de múltiples componentes del sistema inmune: por vía sistémica la estimulación de LTC y TC contra epítopos del virus del papiloma humano, y en un nivel local, la inducción de la secreción de citocinas por el tumor, para aumentar el procesamiento y la presentación de blancos tumorales, así como la estimulación de los linfocitos, AN y macrófagos que infiltran el tumor.

  8. Avances en el desarrollo de las vacunas neumocócicas conjugadas

    Wendy Chan-Acón; Arturo Abdelnour; Carolina Soley-Gutiérrez; Adriano Arguedas-Mohs

    2010-01-01

    El Streptococcus pneumoniae se encuentra entre los mayores patógenos causantes de infecciones invasoras y no invasoras en los dos extremos de la vida: en niños menores de 5 años y en personas mayores de 65 años de edad. Las principales manifestaciones asociadas a infecciones neumocócicas son: neumonía, bacteriemia febril, septicemia, otitis media y meningitis. Esta bacteria es uno de los principales agentes involucrados en la mortalidad infantil, con un estimado de 1, 000,000 de muertes globa...

  9. Pseudomonas aeruginosa. Vacunas: un reto a la investigación

    2004-01-01

    Pseudomonas aeruginosa, patógeno gramnegativo versátil y oportunista debido a su gran adaptabilidad fisiológica, potencial metabólico y mecanismos de virulencia, es causa frecuente a escala mundial de severas o letales infecciones en pacientes hospitalizados. El empeño por lograr terapias alternativas para prevenir o combatir las infecciones producidas por P. aeruginosa ha ocupado a investigadores de todo el mundo desde la segunda mitad del pasado siglo y actualmente se continúan reportando t...

  10. Case report 469: Spondylitis (lumbar spine) due to Brucella abortus

    The current case is interesting in that, although the plain radiographs were diagnostic of infection and the patient's work history suggested brucellosis, both the negative serum antibody titers to brucella and the CT appearance of large calcified psoas abscesses made the diagnosis of tuberculous spondylitis most probable. Open biopsy with tissue culture proved brucella. From this experience it appears that the presence of large calcified psoas abscesses should not eliminate the diagnosis of brucella spondylitis in the proper clinical setting. (orig.)

  11. Meningen over abortus in West-Europa, 1981-2000

    Need, Ariana; Ultee, Wouter; Levels, Mark; Tienen, Marike van

    2008-01-01

    Summary Abortion attitudes in Western Europe, 1981-2000 This article answers descriptive and explanatory questions about abortion attitudes in Western Europe between 1981 and 2000. It explains country differences and trends in these attitudes with abortion laws of states, with the norms that prevail

  12. Case report 469: Spondylitis (lumbar spine) due to Brucella abortus

    Manaster, B.J.

    1988-03-01

    The current case is interesting in that, although the plain radiographs were diagnostic of infection and the patient's work history suggested brucellosis, both the negative serum antibody titers to brucella and the CT appearance of large calcified psoas abscesses made the diagnosis of tuberculous spondylitis most probable. Open biopsy with tissue culture proved brucella. From this experience it appears that the presence of large calcified psoas abscesses should not eliminate the diagnosis of brucella spondylitis in the proper clinical setting.

  13. Årsager, udredning og behandling af abortus habitualis

    Larsen, Elisabeth Clare; Christiansen, Ole Bjarne

    2012-01-01

    facing RM should be offered tender loving care; i.e. repeated measurements of hCG and ultrasound scans. Further treatments are directed against the underlying cause: surgery, hormone supplementation, anticoagulation and immunomodulation. However, the effect of these treatments needs further documentation....

  14. Inmunidad pasiva en potros de madres inmunoestimuladas con células inactivadas de propionibacterium granulosum y lipopolisacáridos (lps

    Camilo A. Becerra Sandoval

    2008-12-01

    Full Text Available En el presente trabajo se evaluó el efecto del uso de un producto inmunomodulador, preparado con Lipopolisacárido de E. Coli y células inactivadas de Propionibacterium granulosum, y aplicado a yeguas en la última fase de la gestación. Se evaluó en los potros las concentraciones de IgG e IgM después del consumo de calostro y se determinaron los parámetros de morbimortalidad neonatal y pesos al nacimiento y al destete. Se obtuvo un efecto positivo general con el uso del producto bajo las condiciones en las que se realizó el estudio.

  15. Curso rápidamente progresivo de Hepatitis por virus C en pacientes con hipogammaglobulina y deficiencia de la inmunidad celular

    Javier Carbone; Elizabeth Sarmiento; Eduardo Fernández-Cruz

    2005-01-01

    El conocimiento de las bases fisiopatológicas de la fibrogénesis en la hepatopatía por virus de la hepatitis C (VHC) es crítico. Describimos la evolución de la infección por VHC tras 10 años de seguimiento en pacientes con inmunodeficiencia de anticuerpos (inmunodeficiencia variable común (n=3) (IDVC), deficiencia de subclases de IgG (n=2), deficiencia específica de formación de anticuerpos (n=1)). Los pacientes fueron tratados con un preparado de inmunoglobulina intravenosa que se asoció pos...

  16. La comercializaci??n de las medicinas alternativas. Consumo de espacios de inmunidad. El caso de la Ciudad de M??xico

    Saavedra Solano, Nayelhi; Berenzon Gora, Shoshana

    2010-01-01

    El texto aborda algunos aspectos de la comercializaci??n de las medicinas alternativas en la Ciudad de M??xico. Si bien la popularidad que han cobrado estas terapias obedece, por una parte, a espec??ficas demandas de salud; por otra, el consumo de confort y entretenimiento ha estimulado un mercado orientado al bienestar. El texto est?? basado en los hallazgos de una investigaci??n cuyo objetivo fue comprender el sentido de las pr??cticas y discursos relacionados con las medicinas alternativas...

  17. A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia

    A. Morales

    2003-06-01

    la Imovax Gripeâ indujo títulos de anticuerpos protectores en suero contra las tres cepas de virus de la vacuna en 94-99% de los adultos y en 88-97% de los sujetos ancianos, comparado con 88-100% y 88-98%, respectivamente, con respecto a los que recibieron Agrippal S1â. En conclusión: Las vacunas contra la gripe de tipo virus fraccionado y sub-unidad presentan perfiles de inocuidad y reactogenicidad similares, y desarrollan una inmunidad satisfactoria en sujetos adultos y en ancianos. Sin embargo, luego de la vacunación, se observaron valores de medias geométricas de los títulos ("GMT" contra la cepa B superiores con la vacuna de virus fraccionado inactivado Imovax Gripeâ, dando una mejor inmunogenicidad global.

  18. Vigilancia inmunoepidemiológica del sarampión, rubéola, parotiditis, poliomielitis y tos ferina en la provincia Las Tunas, 2010-2013

    Enelis Reyes Reyes

    2014-08-01

    Full Text Available La inmunoepidemiología se ha convertido en imprescindible en el sistema de vigilancia moderno de salud, en la evaluación de los programas de vacunación, en la definición de la inmunidad poblacional y en su papel en la prevención de enfermedades. Este estudio describe el comportamiento en la provincia de Las Tunas de la vigilancia inmunoepidemiológica de cinco enfermedades prevenibles: sarampión, rubéola, parotiditis, poliomielitis y tos ferina. La investigación cubrió el periodo desde el año 2010 hasta el 2013. Los resultados muestran la eficacia de las vacunas empleadas, sin ningún caso positivo registrado y avalan a la vigilancia inmunoepidemiológica establecida desde la atención primaria de salud hasta la red de higiene y epidemiología del municipio, la provincia y la nación. Este sistema es necesario para evaluar con antelación posibles riesgos de enfermedades y la decisión oportuna de medidas de intervención

  19. Evaluation of the seroconversion as a response to rabies vaccination in dogs. The experience of the department of Valle del Cauca, Colombia, 2009 Evaluación de la seroconversión como respuesta a la vacunación antirrábica en perros. La experiencia del departamento del Valle del Cauca, Colombia 2009

    Gloria Rey-Benito

    2011-06-01

    ábica canina como medida preventiva. Objetivos. Medir el impacto de la vacunación en términos de seroconversión de anticuerpos neutralizantes y de porcentaje de perros con respuesta inmune humoral adecuada, correlacionando variables propias de estos animales y de las condiciones de vacunación. Discutir el significado epidemiológico de los resultados, e implicaciones en salud pública.
    Materiales y métodos. Se obtuvo suero e información de 569 perros vacunados en los 42 municipios de Valle del Cauca. La inmunidad humoral se investigó por ELISA cuantitativa. La información fue analizada con el programa EPI-INFO 6.0.
    Resultados. El 9,1% de los perros de la muestra fueron seronegativos y el 25,1% no evidenciaron respuesta inmune humoral adecuada a la vacunación. La concentración de anticuerpos disminuyó gradualmente desde la aplicación de la vacuna, y estuvo asociada a edad y calidad de las vacunas, aunque no estuvo asociada a género o raza.
    Conclusiones. Con el fin de aumentar los porcentajes de perros seropositivos y con respuesta inmune humoral adecuada se hacen las siguientes recomendaciones: 1 utilizar vacunas antirrábicas viables; 2 aplicar dos dosis de vacuna durante los primeros seis meses de vida de los cachorros; 3 aplicar refuerzos de vacuna por lo menos una vez al año; 4 vigilar por autoridad las actividades y procesos programáticos relacionados con la vacunación antirrábica por particulares.

  20. Selección de cepas de Shigella sonnei para el desarrollo de una vacuna efectiva contra la shigellosis

    Olga M. Martínez

    2008-12-01

    Full Text Available En el Instituto Finlay se desarrolló una metodología de trabajo que contribuyó a la selección de cepas de Shigella sonnei como posibles candidatos vacunales contra la shigellosis. Las cepas investigadas, donadas por el Centro Provincial de Higiene y Epidemiología de Ciudad de La Habana, se caracterizaron según los métodos convencionales. La identificación del serogrupo y serotipo se realizó por aglutinación en láminas portaobjetos con antisueros comerciales; mientras que para el estudio de la susceptibilidad antimicrobiana se utilizó el DIRAMIC 10, un equipo semiautomatizado que proporcionó los resultados 4 horas después de su realización. Se investigó también la presencia de plásmidos de virulencia, por el crecimiento de Shigella spp. en medio de agar Triptona Soya con Rojo Congo al 0,025%, así como la expresión de las proteínas de la membrana externa en SDS-PAGE; para las pruebas de virulencia y potencia se emplearon los modelos animales (modelo ratón-pulmón y Test de Sereny. Los resultados obtenidos con la metodología utilizada permitieron la selección de la cepa de S. sonnei A-04 como la más adecuada para la obtención del posible candidato vacunal.

  1. Desarrollo de una vacuna contra Fasciola hepatica basado en el empleo de herramientas de bioinformática

    Rojas Caraballo, José Vicente

    2014-01-01

    [ES]La infección causada por Fasciola hepatica es una trematodosis ampliamente distribuida en el mundo, causando importantes pérdidas económicas a nivel veterinario. Se estima que hay 17 millones de personas infectadas y que entre 91 a 170 millones de personas residen en zonas con posibilidad de adquirir la enfermedad. El triclabendazol continúa siendo el fármaco de elección para el tratamiento de la fasciolosis tanto a nivel veterinario como en humanos. La aparición de estirpes resistentes ...

  2. Avances en el desarrollo de las vacunas neumocócicas conjugadas Update on Pneumococcal Conjugate Vaccines

    Wendy Chan-Acón; Arturo Abdelnour; Carolina Soley-Gutiérrez; Adriano Arguedas-Mohs

    2010-01-01

    El Streptococcus pneumoniae se encuentra entre los mayores patógenos causantes de infecciones invasoras y no invasoras en los dos extremos de la vida: en niños menores de 5 años y en personas mayores de 65 años de edad. Las principales manifestaciones asociadas a infecciones neumocócicas son: neumonía, bacteriemia febril, septicemia, otitis media y meningitis. Esta bacteria es uno de los principales agentes involucrados en la mortalidad infantil, con un estimado de 1, 000,000 de muertes globa...

  3. Desarrollo y pruebas de campo de la vacuna sintética contra la malaria spf66

    Rojas, Mauricio; Amador, Roberto; Posada, Mario Alberto; Patarroyo, Manuel Elkin

    2011-01-01

    De acuerdo a estadísticas recientes de la Organización Mundial de la Salud, se estima que 2100 millones de personas habitan en cerca de 100 países donde la malaria es una enfermedad endémica, afectando cerca de 270 millones de individuos anualmente y siendo la causa directa de por 10 menos dos millones de muertos al año, especialmente de niños menores de cinco años de edad. Las medidas de control del vector y del parásito con insecticidas y quimioterapia parecían ser suficientes para la errad...

  4. Efecto de la inclusión dietética de extracto etanólico de propóleos en la inmunidad de pollos de engorde

    C Eyng

    2015-01-01

    Full Text Available Este estudio evaluó la suplementación de extracto etanólico de propóleos (EEP en dietas de pollos de engorde sobre la respuesta inmune (humoral y celular, peso de órganos linfoides y perfil hematológico. Se utilizaron 192 pollos de engorde, machos, criados en jaulas de metabolismo hasta los 21 días de edad. El diseño experimental fue completamente al azar con seis tratamientos, que consistieron en diferentes niveles de inclusión de EEP (0; 1.000; 2.000; 3.000; 4.000 y 5.000 ppm, con ocho repeticiones y cuatro aves por unidad experimental. La inclusión dietética de EEP provocó un efecto cuadrático (P 0,05 de los tratamientos. La inclusión de EEP no alteró (P > 0,05 el porcentaje de linfocitos, heterófilos, basófilos, eosinófilos y la relación heterófilo:linfocito. Hubo reducción (P 0,05. La reacción interdigital a la fitohemaglutinina presentó efecto lineal negativo y cuadrático (P < 0,05 en función del tiempo y de los niveles de inclusión, respectivamente, resultando en menor reacción con el nivel de 3.074 ppm de EEP. Hubo aumento lineal (P<0,05 de los niveles de anticuerpos séricos contra la enfermedad de Newcastle al incrementar el nivel de EEP en la dieta; sin embargo, al comparar cada nivel de inclusión del extracto con el control no hubo diferencias (P < 0,05. Se concluye que la inclusión de 1.000 a 5.000 ppm de EEP en la dieta inicial de pollos de engorde no demostró efecto inmunoestimulante.

  5. Reconstitución de la inmunidad celular T frente a citomegalovirus y control de la viremia en el paciente receptor de trasplante alogénico de precursores hematopoyéticos

    Tormo Palop, Nuria

    2015-01-01

    Durante los últimos años la incidencia de la enfermedad orgánica causada por el Citomegalovirus (EOC) en los pacientes receptores de un trasplante alogénico de células precursoras hemotopoyéticas ha disminuido por el uso profiláctico o anticipado del ganciclovir e, indirectamente, el advenimiento de procedimientos muy sensibles para detectar la presencia del CMV en la sangre periférica (viremia): la PCR y la prueba de la antigenemia pp65 (AG). Aun así, la EOC continúa siendo una causa demasia...

  6. Estudio de los cambios virológicos y de inmunidad celular en tejido amigdalar tras tratamiento antiretroviral en pacientes infectados por HIV en estado temprano de la infección

    Navarrete Durán, Pilar

    2007-01-01

    [spa] Los reservorios del VIH-1 se establecen en fases muy iniciales de la infección. Un estudio reciente documenta la presencia de gran cantidad de ARN vírico en ganglios linfáticos de individuos expuestos dos días después de la aparición de síntomas asociados con la infección aguda, incluso antes de la detección de anticuerpos.También se ha demostrado la existencia de un pequeño pool de células de vida media larga, linfocitos T CD4+ infectados, a partir del cual se puede recuperar el virus ...

  7. Aspek Hukum Terhadap Abortus Provocatus Dalam Perundang-Undangan di Indonesia

    Nainggolan, Lukman Hakim

    2010-01-01

    These days, mass media through newspaper, television news, and radio gives us information about crimes and lawbreaker such as murderer, stealing, deception and rape and abortion. Abortion is one of a serious crime besides others crimes such as murderer, stealing, deception and rape. It can classify as a serious crimes because there is a baby that carriage in a mother’s womb become a victim.The person who done the abortion threat in criminal law sanction which is not light sentence. Crimi...

  8. Elisa for the diagnosis and epidemiology of Brucella abortus infection in cattle in Chile

    A serum bank of 1251 adult cows sera was prepared. The sera originated from animals of three different epidemiological groups: 1) 244 from infected cows, strain 19 vaccinated when calves; 2) 507 from herds free of infection but all cows were strain 19 vaccinated when calves and 3) the last group, 500 sera from cows free of infection and non-vaccinated. All the sera where tested with the routine Rose Bengal (RB) Rivanol (RIV) and Complement Fixation (CF) tests and additionally three enzyme immunoassays were performed. They included two indirect Elisa both using the kit from the Joint FAO/IAEA Division, Vienna, Austria. One assay used a polyclonal conjugated antibody (I-ELISAp) and the other a monoclonal conjugated antibody (I-ELISAm). The third assay was a competitive ELISA (C-ELISA) performed with sLPS, plus monoclonal antibody, M84, and goat anti-mouse antibody-HRPO. Using the CFT as 'gold standard' the sensitivities of all the methods were: RB 87.1%, RIV 87.1%, I-ELISAp 100% I-ELISAm 100%. The calculated specificity was: RB 100%, RIV 100%, I-ELISAp 96.4% and I-ELISAm 100%. In the group of infected animals (244) the following results were obtained: RB 13.5%, RIV 11.9%, CF 12.7%, I-ELISAp 50.8% and I-ELISAm 22.9%. Results for the non-vaccinated group were: RB 0.2%, RIV 0%, CFT 0.2%, I-ELISAp 6.9% and I-ELISAm 2.9%. The C-ELISA was performed on samples from the positive group or with positivity values close to the cut-off value in the I-ELISAm. In the infected group 28 out of 63 animals were detected as infected and from the non-vaccinated herds none of 15 I-ELISAm positive samples were detected as infected in the C-ELISA. (author)

  9. Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers

    Kaissar Tabynov; Sholpan Ryskeldinova; Zhailaubay Kydyrbayev; Abylai Sansyzbay

    2016-01-01

    ABSTRACT: The present study provides the first information about the safety of a new influenza viral vector vaccine expressing the Brucella ribosomal protein L7/L12 or Omp16 containing the adjuvant Montanide Gel01 in pregnant heifers. Immunization of pregnant heifers was conducted via the conjunctival (n=10) or subcutaneous (n=10) route using cross prime and booster vaccination schedules at an interval of 28 days. The vector vaccine was evaluated in comparison with positive control groups vac...

  10. Evaluation of the effects of erythritol on gene expression in Brucella abortus

    María Cruz Rodríguez; Cristina Viadas; Asunción Seoane; Félix Javier Sangari; Ignacio López-Goñi; Juan María García-Lobo

    2012-01-01

    Bacteria of the genus Brucella have the unusual capability to catabolize erythritol and this property has been associated with their virulence mainly because of the presence of erythritol in bovine foetal tissues and because the attenuated S19 vaccine strain is the only Brucella strain unable to oxydize erythritol. In this work we have analyzed the transcriptional changes produced in Brucella by erythritol by means of two high throughput approaches: RNA hybridization against a microarray cont...

  11. Identification of Brucella abortus virulence proteins that modulate the host immune response

    Wang, Yufei; Chen, Zeliang; Qiu, Yefeng; Ke, Yuehua; Xu, Jie; Yuan, Xitong; Li, Xianbo; Fu, Simei; Cui, Mingquan; Xie, Yongfei; Du, Xinying; Wang, Zhoujia; Huang, Liuyu

    2012-01-01

    Brucellosis is an important zoonotic disease of almost worldwide distribution. One significant immune phenomenon of this disease is the ability of the pathogen to hide and survive in the host, establishing long lasting chronic infections. Brucella was found to have the ability to actively modulate the host immune response in order to establish chronic infections, but the mechanism by which the pathogen achieves this remains largely unknown. In our screening for protective antigens of Brucella...

  12. Evaluation of the effects of erythritol on gene expression in Brucella abortus.

    María Cruz Rodríguez

    Full Text Available Bacteria of the genus Brucella have the unusual capability to catabolize erythritol and this property has been associated with their virulence mainly because of the presence of erythritol in bovine foetal tissues and because the attenuated S19 vaccine strain is the only Brucella strain unable to oxydize erythritol. In this work we have analyzed the transcriptional changes produced in Brucella by erythritol by means of two high throughput approaches: RNA hybridization against a microarray containing most of Brucella ORF's constructed from the Brucella ORFeome and next generation sequencing of Brucella mRNA in an Illumina GAIIx platform. The results obtained showed the overexpression of a group of genes, many of them in a single cluster around the ery operon, able to co-ordinately mediate the transport and degradation of erythritol into three carbon atoms intermediates that will be then converted into fructose-6P (F6P by gluconeogenesis. Other induced genes participating in the nonoxidative branch of the pentose phosphate shunt and the TCA may collaborate with the ery genes to conform an efficient degradation of sugars by this route. On the other hand, several routes of amino acid and nucleotide biosynthesis are up-regulated whilst amino acid transport and catabolism genes are down-regulated. These results corroborate previous descriptions indicating that in the presence of erythritol, this sugar was used preferentially over other compounds and provides a neat explanation of the the reported stimulation of growth induced by erythritol.

  13. Evaluation of the effects of erythritol on gene expression in Brucella abortus.

    Rodríguez, María Cruz; Viadas, Cristina; Seoane, Asunción; Sangari, Félix Javier; López-Goñi, Ignacio; García-Lobo, Juan María

    2012-01-01

    Bacteria of the genus Brucella have the unusual capability to catabolize erythritol and this property has been associated with their virulence mainly because of the presence of erythritol in bovine foetal tissues and because the attenuated S19 vaccine strain is the only Brucella strain unable to oxydize erythritol. In this work we have analyzed the transcriptional changes produced in Brucella by erythritol by means of two high throughput approaches: RNA hybridization against a microarray containing most of Brucella ORF's constructed from the Brucella ORFeome and next generation sequencing of Brucella mRNA in an Illumina GAIIx platform. The results obtained showed the overexpression of a group of genes, many of them in a single cluster around the ery operon, able to co-ordinately mediate the transport and degradation of erythritol into three carbon atoms intermediates that will be then converted into fructose-6P (F6P) by gluconeogenesis. Other induced genes participating in the nonoxidative branch of the pentose phosphate shunt and the TCA may collaborate with the ery genes to conform an efficient degradation of sugars by this route. On the other hand, several routes of amino acid and nucleotide biosynthesis are up-regulated whilst amino acid transport and catabolism genes are down-regulated. These results corroborate previous descriptions indicating that in the presence of erythritol, this sugar was used preferentially over other compounds and provides a neat explanation of the the reported stimulation of growth induced by erythritol. PMID:23272076

  14. Mutant Brucella abortus Membrane Fusogenic Protein Induces Protection against Challenge Infection in Mice

    de Souza Filho, Job Alves; Martins, Vicente de Paulo; Campos, Priscila Carneiro; Alves-Silva, Juliana; Santos, Nathalia V.; de Oliveira, Fernanda Souza; Menezes, Gustavo B.; Azevedo, Vasco; Cravero, Silvio Lorenzo; Oliveira, Sergio Costa

    2015-01-01

    Brucella species can cause brucellosis, a zoonotic disease that causes serious livestock economic losses and represents a public health threat. The mechanism of virulence of Brucella spp. is not yet fully understood. Therefore, it is crucial to identify new molecules that serve as virulence factors to better understand this host-pathogen interplay. Here, we evaluated the role of the Brucella membrane fusogenic protein (Mfp) and outer membrane protein 19 (Omp19) in bacterial pathogenesis. In t...

  15. Whole genome sequence comparison of ten diagnostic brucellaphages propagated on two Brucella abortus hosts

    Tevdoradze, Ekaterine; Farlow, Jason; Kotorashvili, Adam; Skhirtladze, Natia; Antadze, Irina; Gunia, Sophio; Balarjishvili, Nana; Kvachadze, Leila; Kutateladze, Mzia

    2015-01-01

    Background Recently the genome sequences of two brucellaphages, isolated in Georgia (Tb) and Mexico (Pr) were reported revealing pronounced sequence homogeneity and the presence of two major indels discriminating the two phages. Subsequent genome sequencing of six diagnostic brucellaphages: Tbilisi (Tb), Firenze (Fz), Weybridge (Wb), S708, Berkeley (Bk) and R/C phages identified three major genetic groups. However, the propensity for fine-scale genetic variability of diverse brucellaphages gr...

  16. Molecular cloning, purification and immunogenicity of recombinant Brucella abortus 544 malate dehydrogenase protein.

    Reyes, Alisha Wehdnesday Bernardo; Simborio, Hannah Leah Tadeja; Hop, Huynh Tan; Arayan, Lauren Togonon; Kim, Suk

    2016-03-01

    The Brucella mdh gene was successfully cloned and expressed in E. coli. The purified recombinant malate dehydrogenase protein (rMDH) was reactive to Brucella-positive bovine serum in the early stage, but not reactive in the middle or late stage, and was reactive to Brucella-positive mouse serum in the late stage, but not in the early or middle stage of infection. In addition, rMDH did not react with Brucella-negative bovine or mouse sera. These results suggest that rMDH has the potential for use as a specific antigen in serological diagnosis for early detection of bovine brucellosis. PMID:27051349

  17. First Report of Orchitis in Man Caused by Brucella abortus Biovar 1 in Ecuador.

    Ron-Roman, Jorge; Saegerman, Claude; Minda-Aluisa, Elizabeth; Benitez-Ortiz, Washington; Brandt, Jef; Douce, Richard

    2012-01-01

    Abstract. We present a 44-year-old man from a rural community in northern Ecuador who worked on a cattle farm where he was involved with primary veterinary care, including assistance during births (or calving) and placenta retention and artificial insemination, with minimal precautions. In September of 2009, quite abruptly, he developed asthenia and hypersomnia without any apparent cause or symptoms like fever, chills, or night sweats. On November 14, 2009, he suffered from pain and edema in ...

  18. Excretion of Brucella abortus vaccine B19 strain during a reproductive cycle in dairy cows

    W. A. Pacheco

    2012-06-01

    Full Text Available This paper aimed to determine the excretion period of B19 vaccine strain during a complete reproductive cycle (from estrus synchronization, artificial insemination, pregnancy and until 30 days after parturition of dairy cows from 3 to 9 years old that were previously vaccinated from 3 to 8 months. Three groups were monitored with monthly milk and urine collection during 12 months: G1 with seven cows from 3 to 4 years old; G2 with three cows from 5 to 6 years old; and G3 with four cows from 7 to 9 years old. Urine and milk samples were submitted to bacteriological culture and urine and PCR reactions for detection of Brucella spp. and PCR-multiplex for B19 strain identification. Ring test (RT was also performed in the milk samples, and serum samples were tested by buffered acidified plate antigen test (BAPA. All animals were serologically negative at BAPA and Brucella spp. was not isolated from both urine and milk samples. RT revealed 13/210 (6.2% positive milk samples. PCR reactions detected DNA of Brucella spp. in 86/420 (20.5% samples. In urine it was found a significantly higher frequency (35.2%; 74/210 than in milk (5.7%; 12/210, more frequently from the estrus to 150 days of pregnancy and after parturition (6.7%; 10/150, and from 150 days of pregnancy to parturition (3.4%; 2/60, and they were all identified as B19 strain. In three groups, intermittent excretion of B19 strain was detected mainly in urine samples, which confirmed its multiplication and persistence in cows for until 9 years.

  19. Prevalence of brucella abortus antibodies in bovine serum from gusau modern abattoir, Zamfara state, Nigeria

    N. Lawal

    2012-10-01

    Full Text Available A study for bovine brucellosis was conducted using serology to determine the status of the disease in slaughtered cattle. Three hundred and twenty (320 sera were collected from Gusau Modern Abattoir, Zamfara State. The sera were tested using Enzyme Linked Immunosorbent Assay obtained from Veterinary Laboratory Agencies, Weybridge, UK. An overall prevalence of 20% (64 positive was obtained with sex prevalence for males and females being 10.62% (34 positive and 9.37% (30 positive respectively out of 180 males and 140 females tested without significant association (P 24 months while; lower prevalence of 3.13% was recorded in age group

  20. Suplementación con balanceado comercial en crías vacunas lactantes bajo sistema doble propósito

    Esperanza Prieto M.

    2010-12-01

    Full Text Available Objetivo. Evaluar el efecto que ejerce la suplementación con alimento balanceado sobre la ganancia diaria de peso (GDP y el consumo de alimento (CA en terneros lactantes y su impacto económico en una empresa ganadera manejada bajo un sistema vacuno de doble propósito, en el municipio de Sincé, Sucre–Colombia. Materiales y métodos. Se suplementaron 14 crías (6 machos y 8 Hembras entre 3 y 5 meses de edad, con alimento balanceado comercial al 1.5% del peso vivo (Tratamiento 1 y se compararon con un grupo igual sin suplementar (Tratamiento Testigo, durante 113 días en época de lluvias. La GDP y CA fueron evaluados mediante prueba t de Student. Se determinó Relación beneficio: costo y rentabilidad. Resultados. La GDP de las crías lactantes fue afectada de manera altamente significa por la suplementación con alimento balanceado comercial (p0.05, encontrándose el mismo resultado para el consumo de alimento balanceado (p>0.05 explicando así la no diferencia estadística en la GDP entre sexos. El análisis económico confirmó que la estrategia alimenticia es viable al presentarse una relación B:C del 1.1. y una rentabilidad trimestral del 9.27%. Conclusiones. La suplementación de terneros lactantes es una práctica viable, que permite obtener ganancias adicionales.